Reset MapCastle Hill House High Street Huntingdon, Cambridgeshire, PE293TE United KingdomWe empower life-science brands to create remarkable, field first HCP experiences, driving commercial and medical excellence for increased sales and better patient outcomes.
UNIT 10 WEST POINT BUSINESS PARK HARLOW, Essex, CM20 2BU United Kingdom3CR Bioscience are a team of experienced industrial scientists providing high-quality reagents using, our patented technology, at extremely competitive prices. We have many decades of experience, not just in reagent development, manufacture, and quality assurance, but also assay design, optimisation, and troubleshooting. 3CR Bioscience prides itself on the very best levels of customer service and technical support. We believe that we are uniquely positioned to facilitate our vision of Making Science Affordable.
Meadow Lane, St. Ives, Cambridgeshire, PE27 4LG, United Kingdom42 Technology provides consulting for turning science into products.
25 Norman Way Cambridge, Cambridgeshire, CB24 5QE United Kingdom- We manufacture and sell proprietary, synthetic DNA and mRNA products for applications in cell and gene therapies and vaccines. - We offer RUO AAV manufacturing services for partners developing gene therapies. - We offer targeted non-viral vectors for partners wishing to deliver therapeutic nucleic acid or proteins to specific cells and tissues, using our proprietary Hermes™ platform. - We are progressing our own gene therapy and vaccine programs for a range of indications, using our cell and tissue targeting vectors and a combination of nucleic acid payloads.
Winch Road Kent Science Park Sittingbourne England, ME9 8EF United KingdomAt AbBaltis we serve the In Vitro Diagnostics and Biotech markets by offering innovative, reliable and quality biologically-based products for our clients. Our purpose is to supply a wide variety of disease state plasma and residual clinical samples with: Fast Delivery around the Globe Competitive Pricing Outstanding Customer Support We have a passion to improve the lives of patients by focusing on innovations that deliver the highest quality research and the most beneficial products. With a seasoned team of scientists and researchers, AbBaltis brings together leaders with industry experience in assay development, diagnostic research and new market development. Additionally, we know that scientific enterprise brings many challenges so our staff will help you to overcome those challenges by understanding your priorities and delivering a personalized service. Therefore, please do not hesitate to contact us to discover why we are an award winning company.
1020 Innovation Building Kent Science Park Sittingbourne, Kent, ME98HL United KingdomAt AbBaltis we serve the In Vitro Diagnostics and Biotech markets by offering innovative, reliable and quality biologically-based products for our clients. Our purpose is to supply a wide variety of disease state plasma and residual clinical samples with: Fast Delivery around the Globe Competitive Pricing Outstanding Customer Support We have a passion to improve the lives of patients by focusing on innovations that deliver the highest quality research and the most beneficial products. With a seasoned team of scientists and researchers, AbBaltis brings together leaders with industry experience in assay development, diagnostic research and new market development. Additionally, we know that scientific enterprise brings many challenges so our staff will help you to overcome those challenges by understanding your priorities and delivering a personalized service. Therefore, please do not hesitate to contact us to discover why we are an award winning company.
181 Cambridge Science Park Cambridge, CB4 0GJ United KingdomAbbexa is based at the World renowned Cambridge Science Park, in Cambridge, UK. We are a supplier and distributor of biological tools for the life science, pharmaceutical development and biotechnology sectors. We provide the scientific community with primary antibodies, secondary antibodies, proteins, ELISA kits and enzymes as well as other kits and tools for use in research. Working with various laboratories across the World, we aim to develop relevant, high quality, tested products for the biomedical research market. Abbexa is a dedicated worldwide antibody supplier and protein supplier. Whether you are carrying out academic research, pharmaceutical research, disease research or other biological research, our monoclonal antibodies, polyclonal antibodies, proteins and biological reagents are designed to facilitate your research. We appreciate that sometimes it is hard to find the right antibody to match your needs, and we therefore offer a custom protein, peptide and antibody production pipeline. Abbexa is committed to providing scientists and researchers with the best customer experience and high quality products. We want to provide you with the best support available, which is why we guarantee customer satisfaction. If you are unhappy with the performance of your product we will offer you an immediate replacement or refund. Please have a look at our quality guarantee for further details. We are constantly striving to improve in everything we do, so please do get in touch with any comments regarding the website, service, products, or anything else.
20A Cambridge Science Hub Cambridge, CB23 8SQ United KingdomAbbexa is based at the World renowned Cambridge Science Park, in Cambridge, UK. We are a supplier and distributor of biological tools for the life science, pharmaceutical development and biotechnology sectors. We provide the scientific community with primary antibodies, secondary antibodies, proteins, ELISA kits and enzymes as well as other kits and tools for use in research. Working with various laboratories across the World, we aim to develop relevant, high quality, tested products for the biomedical research market. Abbexa is a dedicated worldwide antibody supplier and protein supplier. Whether you are carrying out academic research, pharmaceutical research, disease research or other biological research, our monoclonal antibodies, polyclonal antibodies, proteins and biological reagents are designed to facilitate your research. We appreciate that sometimes it is hard to find the right antibody to match your needs, and we therefore offer a custom protein, peptide and antibody production pipeline. Abbexa is committed to providing scientists and researchers with the best customer experience and high quality products. We want to provide you with the best support available, which is why we guarantee customer satisfaction. If you are unhappy with the performance of your product we will offer you an immediate replacement or refund. Please have a look at our quality guarantee for further details. We are constantly striving to improve in everything we do, so please do get in touch with any comments regarding the website, service, products, or anything else.
20 Cambridge Science Hub Bar Hill Cambridge, CB23 8SQ United KingdomAbbexa is based at the World renowned Cambridge Science Park, in Cambridge, UK. We are a supplier and distributor of biological tools for the life science, pharmaceutical development and biotechnology sectors. We provide the scientific community with primary antibodies, secondary antibodies, proteins, ELISA kits and enzymes as well as other kits and tools for use in research. Working with various laboratories across the World, we aim to develop relevant, high quality, tested products for the biomedical research market. Abbexa is a dedicated worldwide antibody supplier and protein supplier. Whether you are carrying out academic research, pharmaceutical research, disease research or other biological research, our monoclonal antibodies, polyclonal antibodies, proteins and biological reagents are designed to facilitate your research. We appreciate that sometimes it is hard to find the right antibody to match your needs, and we therefore offer a custom protein, peptide and antibody production pipeline. Abbexa is committed to providing scientists and researchers with the best customer experience and high quality products. We want to provide you with the best support available, which is why we guarantee customer satisfaction. If you are unhappy with the performance of your product we will offer you an immediate replacement or refund. Please have a look at our quality guarantee for further details. We are constantly striving to improve in everything we do, so please do get in touch with any comments regarding the website, service, products, or anything else.
Discovery Drive Cambridge, Cambridgeshire, CB2 0AX United KingdomAbcam is committed to supporting life scientists to achieve their mission, faster. We are a pioneering global organisation that identifies, develops, and distributes high-quality biological reagents, protein tools and custom cell engineering to drive crucial research, drug development and diagnostics. Working across the industry, our goal is to help advance the global understanding of biology and causes of disease, which enables new treatments and improved health. We collaborate with the life science community to co-create novel reagents, driven by our proprietary discovery platforms and extensive scientific insight.
Discovery Drive Cambridge Biomedical Campus Cambridge, England, CB2 0AX United KingdomAbcam is committed to supporting life scientists to achieve their mission, faster. We are a pioneering global organisation that identifies, develops, and distributes high-quality biological reagents, protein tools and custom cell engineering to drive crucial research, drug development and diagnostics. Working across the industry, our goal is to help advance the global understanding of biology and causes of disease, which enables new treatments and improved health. We collaborate with the life science community to co-create novel reagents, driven by our proprietary discovery platforms and extensive scientific insight.
Discovery Drive Cambridge Biomedical Campus Cambridge, CB2 0AX United KingdomAbcam is committed to supporting life scientists to achieve their mission, faster. We are a pioneering global organisation that identifies, develops, and distributes high-quality biological reagents, protein tools and custom cell engineering to drive crucial research, drug development and diagnostics. Working across the industry, our goal is to help advance the global understanding of biology and causes of disease, which enables new treatments and improved health. We collaborate with the life science community to co-create novel reagents, driven by our proprietary discovery platforms and extensive scientific insight.
Abcellute Ltd BioPark Braodwater Road Welwyn Garden City Herts AL7 3AXAbcellute prvodies SureTran cell transport technology for pre-clinical drug evaluation and regenerative medicine.
1010 Cambourne Business Park Cambourne Cambridge CB23 6DP UKAbcodia is a clinical stage company engaged in the commercial development of novel, scientifically validated tests for the early detection of cancer. The Company's first product is the ROCA® Test for the early detection of ovarian cancer. It is also expanding its pipeline of early detection technologies for lung, colorectal and pancreatic cancer. Our products are based on expertise in measuring and modelling dynamic changes over time of serum-based biomarkers before cancer is clinically diagnosed and it maintains exclusive commercial access to a biobank of prospectively collected samples donated from over 200,000 individuals over a 10-year period. We hold strategic collaborations with leading global organizations including Cancer Research UK, University College London and other academic and industry partners. Abcodia is a privately held company funded through investments from Albion Ventures, Cambridge Innovative Capital plc, Scottish Equity Partners and UCL Business Plc. Headquartered in Cambridge, U.K., the Company maintains a U.S. corporate presence in Boston.
UK Office Regus House, Highbridge, Oxford Road Uxbridge UB81HRAbdi İbrahim provides pharmaceutical services to the healthcare sector.
Building 400 The Ventures Building Kent Science Park Sittingbourne, Kent, ME9 8AG United KingdomImmundnz, together with its sister company Abundnz, offers advanced in vitro, immunology and (bio)analytical support for biotechnology and diagnostics industries and life sciences research worldwide. A range of solutions are available to our clients. Our services include preclinical immunology research, in vitro research and the characterization and bioanalysis of innovative medicines such as peptide and protein drugs, oligonucleotides and nanomedicines. Due to our experience and track record, you can rely on us as your solid partner in in vitro, immunology and (bio)analytical support for your projects.
Building 900 Babraham Research Campus Cambridge, Cambridgeshire, CB22 3AT United KingdomAbzena is the leading end-to-end bioconjugate (ADC, AOC, RAC & DAC) and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, development, and cGMP facilities across locations in San Diego, CA, Bristol, PA, and Cambridge, UK. We Provide Best-in-Class & End-to-End Support For: • Antibodies (mAbs) • FAbs • Antibody-drug Conjugates (ADCs) • Bispecifics • Radioconjugates (RACs) • Fusion Proteins • Growth Factors • Recombinant & Conjugate Vaccines • Cytokines • Antibody–oligonucleotide conjugates (AOCs) • siRNA conjugates • Degrader Antibody Conjugates (DACs) • Nanoparticles With Comprehensive Capabilities Ranging From: • Early-Stage Research & Discovery, Design and Lead Selection • Robust Analytics, Bioassays and Immunogenicity Assays • Bioconjugation & Chemistry • Antibody Engineering and Developability • GMP-Ready Mammalian Cell Line Development (10g/L in highly stable clones) • Linker Payload Design and Synthesis • Analytical Method & Formulation Development • Process Development and cGMP Manufacturing up to 2000L • Master Cell Banking • Technology Transfer & Scale-Up • Regulatory Support Our extensive toolkit of services is designed to ensure our customers achieve their Target Product Profile (TPP). With early-stage research, process development and cGMP manufacturing capabilities all under a single organization, we can leverage our vast capabilities and knowledge of the product, along with the requisite In Vitro and In Vivo criteria to ensure that the desired TPP can be accomplished from the project outset.
16 Upper Woburn Place London, WC1H 0BS United KingdomAcaster Lloyd Consulting Ltd provides consulting services around clinical outcomes assessments, patient reported outcomes and other subjective self report measures used in the assessment of the impact of disease and treatments on patients lives. Our expertise span qualitative, quantitative and mixed methods studies.
Lacon House 84 Theobalds Road London, WC1X 8NL United KingdomAcaster Lloyd Consulting Ltd provides consulting services around clinical outcomes assessments, patient reported outcomes and other subjective self report measures used in the assessment of the impact of disease and treatments on patients lives. Our expertise span qualitative, quantitative and mixed methods studies.
19 Bloomsbury Way London, England, WC1A 2TH United KingdomAccess Infinity is an industry leading, specialist consultancy focused exclusively on Global and Regional Pricing and Market Access (P&MA). We have built our reputation on delivering exceptional results, consistently exceeding client expectations, earning outstanding satisfaction scores, and growing through trusted referrals. We live and breathe P&MA: our projects span the full spectrum of pricing research and market access strategy, across a wide range of therapeutic areas including oncology, immunology, cardiovascular-metabolic diseases, respiratory disease, CNS, rare diseases, vaccines and more. What sets us apart? • Deep Expertise: Our senior team of Partners combines top-tier consulting experience with real-world industry leadership, offering insights that are both strategic and practical. • Agile, Collaborative Culture: We operate with a flat and highly collaborative model that prioritizes quality, creativity, and team engagement. We work hard, move fast, and make every project both high-impact and enjoyable for our clients and teams. • Leading-edge Tools: Our proprietary AI-enabled platforms, NURO, Access Hub, and Evidence Hub, offer stand-alone solutions as well as integrated support to elevate your strategy and decision-making. • Global Reach: Our curated network of over 1,300 external experts worldwide gives us and our clients direct access to critical national and sub-national insights across markets. If you have a project in mind, or even just a challenge you are starting to think about, we would love to show you how we can help. Please get in touch to start a conversation.
81-87 High Holborn London, WC1V 6DF United KingdomAccess Infinity is an industry leading, specialist consultancy focused exclusively on Global and Regional Pricing and Market Access (P&MA). We have built our reputation on delivering exceptional results, consistently exceeding client expectations, earning outstanding satisfaction scores, and growing through trusted referrals. We live and breathe P&MA: our projects span the full spectrum of pricing research and market access strategy, across a wide range of therapeutic areas including oncology, immunology, cardiovascular-metabolic diseases, respiratory disease, CNS, rare diseases, vaccines and more. What sets us apart? • Deep Expertise: Our senior team of Partners combines top-tier consulting experience with real-world industry leadership, offering insights that are both strategic and practical. • Agile, Collaborative Culture: We operate with a flat and highly collaborative model that prioritizes quality, creativity, and team engagement. We work hard, move fast, and make every project both high-impact and enjoyable for our clients and teams. • Leading-edge Tools: Our proprietary AI-enabled platforms, NURO, Access Hub, and Evidence Hub, offer stand-alone solutions as well as integrated support to elevate your strategy and decision-making. • Global Reach: Our curated network of over 1,300 external experts worldwide gives us and our clients direct access to critical national and sub-national insights across markets. If you have a project in mind, or even just a challenge you are starting to think about, we would love to show you how we can help. Please get in touch to start a conversation.
Cowley Road Cambridge CB4 0WSAcclarogen provides consultancy in all aspects of statistical genomics.
Cambridge, England United KingdomAcclarogen provides consultancy in all aspects of statistical genomics.
59-60 Thames Street Windsor, SL4 1TX United KingdomAccovion provides regulatory consulting, medical services, clinical management, and pharmacovigilance.
Devonshire House, 582 Honeypot Lane Middlesex Stanmore, Middlesex, HA71JS United KingdomAt Acellera, we provide AI and quantum chemistry solutions for early-stage drug discovery. With our QuantumBind® platform, we can go from target to a prioritized list of leads in weeks. We work with you to ensure you have the highest possible chances of success with your discovery program.
a-connect solution (uk) limited 3rd Floor, 12 Gough Square London, EC4A 3DW United Kingdom
7 Bennell Court West Street Comberton Cambridge CB23 7EN UKActivotec offers custom peptide synthesis, and peptide therapeutics.
Hills Road Cambridge, England, CB2 United KingdomThis is a facility for smart storage, processing, retrieval and rearraying of samples prior to high throughput measurements, is being established as a collaboration between the NIHR Cambridge BRC, the MRC Epidemiology Unit and the University of Cambridge. The University has provided the space, with the costs of refurbishment and capital coming from NIHR Cambridge BRC and the MRC Epidemiology Unit. This facility will be overseen by a management committee with representation from NIHR Cambridge BRC, the University and MRC and will be run on a cost recovery basis by the partners.
Box 178 Addenbrookes Hospital Hills Road Cambridge CB2 0QQThis is a facility for smart storage, processing, retrieval and rearraying of samples prior to high throughput measurements, is being established as a collaboration between the NIHR Cambridge BRC, the MRC Epidemiology Unit and the University of Cambridge. The University has provided the space, with the costs of refurbishment and capital coming from NIHR Cambridge BRC and the MRC Epidemiology Unit. This facility will be overseen by a management committee with representation from NIHR Cambridge BRC, the University and MRC and will be run on a cost recovery basis by the partners.
Tissue Typing Laboratory Box 209 Cambridge University Hospitals NHS Foundation Trust Hills Road, Cambridge, CB2 0QQThe Addenbrooke's Hospital Histocompatibility and Immunogenetics (Tissue Typing) laboratory provides a specialist histocompatibility and immunogenetics service for the East of England region and is part of the NIHR Cambridge Biomedical Research Centre. We offer a comprehensive range of molecular and serological techniques to identify Human Leukocyte Antigens (HLA), Killer Cell Immunoglobulin-Like Receptor (KIR) typing and immunological sensitisation to HLA. These tests are performed in support of the regional solid organ and stem cell transplant programmes, in the differential diagnosis of HLA associated diseases and in pharmacogenomics (adverse drug reactions). The laboratory is responsible for the selection of HLA compatible donor and recipient pairs for renal and stem cell transplantation and for HLA typing, HLA specific antibody screening and crossmatching in support of the small intestinal, multi-visceral, hepatic and cardio-thoracic transplant programmes.
1 Avantgarde Tower Suite 86 London, UK, E1 6GS United KingdomSecurely manage chemistry data sets. Empower your SDF (Structure Data File) data. Combine, edit and manage your data quickly and easily. Fully compliant with stereochemistry, providing user-friendly interfaces, rapid uploading, de-duplication, and powerful bulk editing tools. - 100's of millions of molecules - DNA-encoded libraries - Traditional small molecule libraries No matter the size or complexity of your data, Adroit DI has the agility and scalability to organize it all in one place securely. Features list: - Import SDF, SMILES Can & Iso, SMARTS, Mol - Export in SDF, CSV and Excel - Combine disparate data all at once - 10 million records managed - Change attributes en-masse - Accurate stereochemistry - De-duplication & federation on structure - Search/merge on structure - ‘Excel-like’ - Total Security - Export in CSV, Excel & SDF formats - Cut and paste multiple cells - Ready-to-use & cloud-based
Henfield Road Small Dole, England, BN5 9XR United Kingdom
Unit 7, M11 Business Link Parsonage Lane Stansted Essex CM24 8GF EnglandAgar Scientific supplies consumables, accessories and equipment for microscopy.
Stansted Mountfitchet, England, CM24 United KingdomAgar Scientific supplies consumables, accessories and equipment for microscopy.
Buckingham Place, Church Road, Penn Buckinghamshire, HP10 8LN, UKAgropharm was established in 1974 with the objective of providing pest control products that meet customer needs. Since that time the company has grown and developed a range of strong brands and innovative products. The focus is on eco-friendly products designed for powerful pest control with minimum impact on the environment. Agropharm develops and manufactures its own products at its production centre in Telford, Shropshire and is managed from the Head Office in High Wycombe, Buckinghamshire. The facilities include a well equipped analytical and formulation laboratory, product bottling lines, powder handling and many other facilities. Agropharm’s technical staff are highly qualified and have a track record of developing new formulations and innovative products. Many of these products are developed specially for our customer’s own brands. This success is based on a genuine interest in listening to our customer’s needs and ideas and developing strong, lasting partnerships that are beneficial to both parties. Agropharm is also an award winning company having won the prestigious Buckinghamshire International Trade Award in 2007 and the Innovation & Enterprise Award in 2008. These awards recognised Agropharm’s achievement in the export markets and its excellence in product development.
83 Baker St 83 Baker St, London W1U 6AG, W1U 6AG United KingdomAirfinity is a disease forecasting company. It tracks, predicts and simulates population level disease outcomes in real time to inform decisions that can increase the global life span. Multiple industries rely on global structured time series data sets and advanced forecasting, from weather, to transport, to financial markets. The life science industry is far behind and based on siloed, national and static disease data – often based on self-reporting. However, the life science industry is undergoing a data transformation driven by more and better personal health data, lower cost of diagnostics, better global data coverage and a range of other factors. Our approach is to ingest and structure any data point that has signal value and integrate it into our disease models in as close to real time as possible. Airfinity provides scenario planning tools and forecasts that can be understood, relied upon and used for decision making across the life science ecosystem. We use a unique quant analytics approach, combining advanced meta science, statistics, epidemiology and machine learning solutions to dynamically understand true disease prevalence and underlying outcome drivers. Airfinity has become the world's leading source of disease forecasting, specialising in infectious diseases, cardiovascular, metabolic, and renal diseases. For example, ask us about the potential impact of a vaccine or treatment on hospitalisations, the impact of a new variant or strain on candidate effectiveness, or what different uptake scenarios will mean for the burden of disease. Airfinity aims for the highest standards and quality, and at the same time operates at speed - clients get answers in hours, not months, so that we can be relied upon by the decision makers who know that the cost of failure is the cost of lives.
83 Baker St London, W1U 6AG United KingdomAirfinity is a disease forecasting company. It tracks, predicts and simulates population level disease outcomes in real time to inform decisions that can increase the global life span. Multiple industries rely on global structured time series data sets and advanced forecasting, from weather, to transport, to financial markets. The life science industry is far behind and based on siloed, national and static disease data – often based on self-reporting. However, the life science industry is undergoing a data transformation driven by more and better personal health data, lower cost of diagnostics, better global data coverage and a range of other factors. Our approach is to ingest and structure any data point that has signal value and integrate it into our disease models in as close to real time as possible. Airfinity provides scenario planning tools and forecasts that can be understood, relied upon and used for decision making across the life science ecosystem. We use a unique quant analytics approach, combining advanced meta science, statistics, epidemiology and machine learning solutions to dynamically understand true disease prevalence and underlying outcome drivers. Airfinity has become the world's leading source of disease forecasting, specialising in infectious diseases, cardiovascular, metabolic, and renal diseases. For example, ask us about the potential impact of a vaccine or treatment on hospitalisations, the impact of a new variant or strain on candidate effectiveness, or what different uptake scenarios will mean for the burden of disease. Airfinity aims for the highest standards and quality, and at the same time operates at speed - clients get answers in hours, not months, so that we can be relied upon by the decision makers who know that the cost of failure is the cost of lives.
Botanic House 100 Hills Road Cambridge, CB2 1PH United KingdomAt AIX Consultancy, we possess a unique balance of soft skills (creativity, communication, interpersonal, strategic thinking) and hard skills (analytical, financial, modelling, programming) to help our clients tackle the most challenging issues in pharmaceutical/medical technology development and value demonstration We believe that our novel approach can make health technology consulting and product development more efficient, thereby helping to reduce the overall cost of healthcare
55-56 Russell Square, Bloomsbury London, WC1B 4HP United KingdomAlchemab is a biotech company focused on discovering and developing novel therapeutics for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies.
Farringdon London, London, N1 United KingdomAlira Health is an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare. We work with healthcare and life sciences organizations looking for support across their entire solutions lifecycle, from development to medical care, through real-world evidence. Our integrated and multidisciplinary team of over 700 scientists, strategists, economists, clinicians, and biostatisticians collaborate across our North American, European, and Asian offices and advise 80% of the top 50 of MedTech companies and 75% of the top 50 of Pharma companies.
Group Ltd 22/23 Progress Business Centre Whittle Parkway Slough , SL1 6DQ United KingdomAt Allchem Pharma our expertise lies in the sourcing and supply of raw materials and ingredients to manufacturers of pharmaceutical, nutraceutical, veterinarian, medical and supplement products. We have extensive experience in all aspects of the supply chain from evaluating new suppliers through our corporate audit process, customer specific strategic stock holding capabilities, to ensuring deliveries are made complete and on time. We rigorously ensure all our products are fully certified and approved meeting all regulatory requirements. Allchem Pharma Ingredients removes risk and uncertainty from the supply of critical ingredients. Our aim is to: “provide pharmaceutical and supplement manufacturers with a range of actives and excipients from audited partners, through our international service which makes their life easier!”
2 The Heights Brooklands Surrey KT13 0NY United KingdomAlloga provides a complete range of specialist pre-wholesale logistics services across Europe.
Babraham Research Park, Babraham Cambridge, CAMBS CB22 3AT United Kingdom, EuropeAlpha Biologics offers protein production, cell culture, process development, and manufacturing services.
2 Royal College Street, Camden London NW1 0NH - UKWe provide a high content screening service for evidence based acute general toxicity and neurotoxicity. We exploit alternative test methods in respect of the international principles of the 3Rs - Replacement, Refinement and Reduction and our predictive technology can be used to test toxicity and assess safety of chemicals.
Victoria House Bloomsbury Square London, WC1B 4DA United KingdomUltra-sensitive protein biomarker measurement on NULISA, Simoa & MSD – attomolar sensitivity in standard and novel biological matrices. Altheome is a specialist biomarker CRO for teams working at the low end of the detection range, and in sample types where conventional labs can't go. We quantify disease-relevant proteins down to attomolar levels across plasma, serum, CSF, and increasingly novel matrices – translating that data into decisions for discovery, translational, and clinical programs. What sets us apart: Custom assay development – purpose-built singleplex and multiplex assays for your target, your matrix, your study Novel matrix and device validation – including exhaled breath condensate (EBC), interstitial fluid (ISF), and emerging microsampling formats Two-week turnaround on standard panel analysis – one of the fastest biomarker labs on the market Certified Alamar service provider for NULISA – both standard panels and custom assay development Platforms under one roof: NULISA – next-generation ultra-sensitive multiplex proteomics Simoa – single-molecule array, attomolar sensitivity MSD – electrochemiluminescent multiplex immunoassays (certified service provider) Services: Custom assay development, qualification, and validation (singleplex and multiplex) Method validation in novel matrices and collection devices Fit-for-purpose biomarker analysis for clinical trial samples Biomarker discovery and exploratory proteomics in complex biofluids Pre-built panels: inflammation, neurodegeneration, immuno-oncology, cardiometabolic Translational strategy and study design support Quality & compliance: HTA-certified · GCP-compliant · GLP-aligned · ISO 15189-aligned Disease-agnostic by design – we work across any indication where ultra-sensitive protein measurement is the bottleneck, from neurodegeneration and immuno-oncology to rare disease and cardiometabolic research. We bridge biomarker discovery and clinical application – sensitive, reproducible, decision-ready data, delivered fast. From concept, to assay, to clinical insight.
13 Hwaley Street Camden Town London, NW18NP United KingdomThe Amaris Health Economics and Market Access (HEMA) brings together people of diverse backgrounds and combines robust quantitative and qualitative methods in order to provide a range of solutions to our pharmaceutical, biotech and medical device clients. Amaris HEMA is a global team of over 70 consultants spread out in 8 different offices around the world (Europe, North America and APAC). Our activities cover three main practices areas: - Health Economics Modelling (Cost-Effectiveness, Budget Impact, Sequential Modelling, Dynamic Modelling etc.) at both the global and the local levels (model adaptations) - RWE and Biostatistics (Secondary database analysis, Primary data collection, MAIC, ITC, NMAs etc.) - Evidence, Value and Access (SLRs, TLRs, GVDs, Landscape assessments, Evidence generation plans, KOL interviews etc.) The three Amaris HEMA practice areas collaborate on evidence review/package projects such as HTA submissions, with extensive experience in Canada, UK, France etc. Our profound understanding of the pharmaceutical market and solid scientific background makes us a valuable and reliable partner along all phases of development. We have strong expertise in both very specific and technical projects. Amaris’ added value lies in the quality of its teams and their attention to detail, as well as in the way the company capitalizes on their knowhow. Every employee is encouraged to develop a proactive, efficiency-oriented working style in order to provide only the most innovative solutions. The Health Economics and Market Access (HEMA) department of Amaris is part of the Amaris Group (http://amaris.com/en), an independent consulting company specialized in technology and management. Founded in 2007 in Switzerland, Amaris now employs more than 6,500 people based in more than 65 offices in 45 countries. Amaris provides services with a strong added value in all business sectors through five business lines: - Business & Management consulting - Information Systems and Technologies - Engineering and High technology - Telecommunications - Life Sciences (including Amaris HEMA).
Amaris - Work.Life 13 Hawley Crescent LONDON, NW1 8NP United KingdomThe Amaris Health Economics and Market Access (HEMA) brings together people of diverse backgrounds and combines robust quantitative and qualitative methods in order to provide a range of solutions to our pharmaceutical, biotech and medical device clients. Amaris HEMA is a global team of over 70 consultants spread out in 8 different offices around the world (Europe, North America and APAC). Our activities cover three main practices areas: - Health Economics Modelling (Cost-Effectiveness, Budget Impact, Sequential Modelling, Dynamic Modelling etc.) at both the global and the local levels (model adaptations) - RWE and Biostatistics (Secondary database analysis, Primary data collection, MAIC, ITC, NMAs etc.) - Evidence, Value and Access (SLRs, TLRs, GVDs, Landscape assessments, Evidence generation plans, KOL interviews etc.) The three Amaris HEMA practice areas collaborate on evidence review/package projects such as HTA submissions, with extensive experience in Canada, UK, France etc. Our profound understanding of the pharmaceutical market and solid scientific background makes us a valuable and reliable partner along all phases of development. We have strong expertise in both very specific and technical projects. Amaris’ added value lies in the quality of its teams and their attention to detail, as well as in the way the company capitalizes on their knowhow. Every employee is encouraged to develop a proactive, efficiency-oriented working style in order to provide only the most innovative solutions. The Health Economics and Market Access (HEMA) department of Amaris is part of the Amaris Group (http://amaris.com/en), an independent consulting company specialized in technology and management. Founded in 2007 in Switzerland, Amaris now employs more than 6,500 people based in more than 65 offices in 45 countries. Amaris provides services with a strong added value in all business sectors through five business lines: - Business & Management consulting - Information Systems and Technologies - Engineering and High technology - Telecommunications - Life Sciences (including Amaris HEMA).
Commerce Way Edenbridge Kent TN8 6ED United KingdomAmbe Medical offers distribution and logistics of pharmaceutical products.
Sharnbrook, England, MK44 United KingdomAME Bioscience supplies laboratory equipment and instruments.
Colworth Science Park Iselworth Building Sharnbrook, Bedfordshire MK44 1LQ United KingdomAME Bioscience supplies laboratory equipment and instruments.
Oriel House 26, The Quadrant London, TW9 1DL UKAmiculum is an independent healthcare consulting and communications agency with >300 talented team members in key locations worldwide. For over two decades, we’ve partnered with visionary pharmaceutical companies and external medical experts, building connections across the healthcare community and communicating groundbreaking science. We amplify the scientific advances that transform healthcare. Taking our clients’ science, we create evidence-based narratives that ignite understanding and inspire action across the healthcare community. Because when science speaks clearly, it transforms lives.
Luton, England United KingdomAnachem provides pipettes, laboratory equipment, and lab safety materials.
1 Angel Court 14th Floor England, EC2R 7HJ United KingdomAnalysis Group has a global footprint of integrated health care research capabilities. Across offices in North America, Europe, and Asia, we leverage our distinguished network of advanced-degree consultants, affiliated experts, and key opinion leaders to carry out an extensive range of work that includes real-world data (RWD) and real-world evidence (RWE) studies, post-marketing safety and effectiveness studies, indirect treatment comparisons, patient-reported outcomes (PROs), systematic literature reviews (SLRs) and meta-analysis, and AI-aided data solutions. Our clients benefit from our highly qualified teams across the world, which have substantial knowledge of local data, laws, and regulations but are also able to leverage our entire firm’s depth of expertise and integrate it seamlessly with local resources. We have supported the approval, launch, and market acceptance of numerous life sciences innovations in the US, EU and individual European countries. We have also provided expert input and testimony to regulatory and health technology assessment (HTA) bodies.
5th Floor Front, Audrey House 16-20 Ely Place London EC1N 6SN United KingdomAnalytica LASER is a scientific consultancy that specialises in Real World Data, Analytics and HEOR and Market Access services. A significant portion of this work involves developing rigorous, evidence-based materials to help guide research and healthcare decisions. Our international team is a diverse group of experts with a breadth of experience, including high level (MSc and PhD) researchers, former payers, pharmaceutical industry leaders, noted academics, and highly experienced industry consultants. Our diverse scientific team includes statisticians, epidemiologists, mathematicians, economists, physicians, pharmacists and other pertinent expertise that assures the development of scientifically rigorous, insightful and actionable deliverables for our customers. PGRx Real World Datasets are targeted case registries that operate in multiple disease areas. PGRx provides quality data for most real world studies required by our HEOR and market access clients such as burden of illness, treatment patterns, drug utilisation, health resource use and quality of life studies. Programs for new pathologies can be rapidly deployed as a result of the validated protocol/tools and the extensive network of specialists created over the years that PGRx has been operating. PGRx uniquely links detailed medical data and HRU information from the physician with extensive patient-reported data on drug usage, adherence, quality of life and productivity impact. This gives a rich source of ‘deep’ data on patients, their management, possible drivers of effectiveness and the associated patient outcomes. Our other Real World Data solutions services include electronic database analytics, chart reviews, patient/physician surveys and advanced outcomes research and pharmacoepidemiology studies. Analytica LASER has been at the forefront of advising clients on market access issues with strategic consultancy, development of global value dossiers, evidence synthesis amongst other services.
Halton House, 20-23 Holborn, London EC1N 2JD UKAnalytica LASER is a scientific consultancy that specialises in Real World Data, Analytics and HEOR and Market Access services. A significant portion of this work involves developing rigorous, evidence-based materials to help guide research and healthcare decisions. Our international team is a diverse group of experts with a breadth of experience, including high level (MSc and PhD) researchers, former payers, pharmaceutical industry leaders, noted academics, and highly experienced industry consultants. Our diverse scientific team includes statisticians, epidemiologists, mathematicians, economists, physicians, pharmacists and other pertinent expertise that assures the development of scientifically rigorous, insightful and actionable deliverables for our customers. PGRx Real World Datasets are targeted case registries that operate in multiple disease areas. PGRx provides quality data for most real world studies required by our HEOR and market access clients such as burden of illness, treatment patterns, drug utilisation, health resource use and quality of life studies. Programs for new pathologies can be rapidly deployed as a result of the validated protocol/tools and the extensive network of specialists created over the years that PGRx has been operating. PGRx uniquely links detailed medical data and HRU information from the physician with extensive patient-reported data on drug usage, adherence, quality of life and productivity impact. This gives a rich source of ‘deep’ data on patients, their management, possible drivers of effectiveness and the associated patient outcomes. Our other Real World Data solutions services include electronic database analytics, chart reviews, patient/physician surveys and advanced outcomes research and pharmacoepidemiology studies. Analytica LASER has been at the forefront of advising clients on market access issues with strategic consultancy, development of global value dossiers, evidence synthesis amongst other services.
St George s - University of London Cranmer Terrace London SW17 0REAnalytical Services International offers GLP/GCP facilities for bioanalytics in clinical studies, forensic toxicology, and therapeutic monitoring.
5 Lavender Close Caterham Surrey CR3 5DWAnalytical Services International offers GLP/GCP facilities for bioanalytics in clinical studies, forensic toxicology, and therapeutic monitoring.
20, Hanover Square, London, W1S 1JY. United KingdomAndard-Mount supply and manufacture 'state of the art' range of bulk active pharmaceutical materials.
1 Hamden Way Papworth Everard Cambridgeshire CB23 3UG United KingdomAnthias Consulting provides consulting for gas chromatography, scientific instrumentation, and training.
1 Blaydon Rd Sandy, SG19 1RZ United KingdomAntibody Production Services (APS), a division of Life Science Group, provides flexible and professional contract generation of antibodies, both monoclonal and polyclonal, together with a large range of associated services to meet every requirement, including the optimisation and production of existing antibody hybridomas, adaptation of cells to serum-free conditions, bulk antibody production, and purification.
Bedford, England United KingdomAntibody Production Services (APS), a division of Life Science Group, provides flexible and professional contract generation of antibodies, both monoclonal and polyclonal, together with a large range of associated services to meet every requirement, including the optimisation and production of existing antibody hybridomas, adaptation of cells to serum-free conditions, bulk antibody production, and purification.
Unit 14 - Crowhill Farm, Ravensden Road, Wilden, Bedfordshire, MK 44 2QSAntibody Production Services (APS), a division of Life Science Group, provides flexible and professional contract generation of antibodies, both monoclonal and polyclonal, together with a large range of associated services to meet every requirement, including the optimisation and production of existing antibody hybridomas, adaptation of cells to serum-free conditions, bulk antibody production, and purification.
Building 5 Chiswick Park 566 Chiswick High Road London W4 5YFAntisoma focuses on the development of novel drugs for the treatment of cancer.
Babraham Research Campus Babraham Cambridge CB22 3AT United KingdomAntitope offer services for evaluating immunogenicity, identifying T cell epitopes, producing humanized antibodies and generating non-immunogenic proteins.
Unit 8&9, NW Works, 135 Salusbury R London, NW6 6RJ United KingdomLiquid Brain® is a first-of-its-kind technology that captures multi-modal, time-resolved biophysical data to map protein behaviour via thermodynamic state diagrams. From just 10 µg of material, we deliver high-precision developability assessments for antibodies and biophysical characterisation of proteins in under two weeks, dramatically accelerating early-stage decision-making. Working with us is straightforward: submit a request, ship your samples, and receive rich, decision-ready data within two weeks. Our platform is compatible with a wide range of buffers and solvent conditions, so you can work in formats that suit your workflows. Get in touch and we will share all the sample requirements and help you plan your first study.
Flat 15, Crossways Gardens Anstey Way, Trumpington Cambridge, Cambridgeshire, CB2 9JT United KingdomConsultancy business providing services in biostatistics and PK-PD modeling. Our aim is very simple: to deliver a mathematical model or statistical analysis that is customized to your decision-making needs and to your pre-clinical and/or clinical data. We can also help you in the early stages of the process by providing assistance with your study designs (sample size calculations, time point selection for relevant biomarkers, input on dose level/frequency, etc.). This is to ensure that the data is fit for purpose and in line with the regulatory requirements.
21 Albemarle Street, London, W1S 4BS United KingdomApta Biosciences is a synthetic biology company specialised in developing unique, proprietary molecules that can be used broadly across diagnostics & therapeutics to facilitate and expand scientific discovery enabling the development of new healthcare solutions.
Unit 16 Tileyard Tileyard Road London, London, N79AH United KingdomTo complete
2 Cambridge Science Park, Cambridge, CB4 0FE, United KingdomArecor offers protein stabilization technology, protein formulation, manufacturing, and regulatory affairs.
4th Floor 44-46 Whitfield Street London, W1T 2RJ United KingdomArk Therapeutics is focused in the development of therapeutic drugs for vascular disease and cancer but also offers its biological manufacturing operations to provide process development and contract manufacturing services.
Leatherhead, England United KingdomAROXA™ provides more than 250 certified flavour standards which can be used to test the aptitude of potential new tasters; develop the skills they need; and assess their day to day performance in routine tasting.
61 Leucha Road London, e17 7lj United KingdomVideo and animation production company with pharma clients
Endeavour House 3rd Floor, Endeavour House, Coopers End Rd Stansted, Essex, CM24 1SJ United KingdomVacZine Analytics is a strategic research publisher based in the United Kingdom since 2007. We provide high-quality disease and commercial analysis to those working within or in collaboration with the vaccine industry. Our key focus is helping clients build the case for developing new vaccines and immune-based therapies.
Warren House Bells Hill Bishops Stortford, Herts, CM23 2NN United KingdomVacZine Analytics is a strategic research publisher based in the United Kingdom since 2007. We provide high-quality disease and commercial analysis to those working within or in collaboration with the vaccine industry. Our key focus is helping clients build the case for developing new vaccines and immune-based therapies.
5 Premus, Coldharbour Way, Aylesbury, Buckinghamshire, HP19 8APAston Chemicals is an independent distributor of Speciality Chemicals, providing the European Personal Care industry with innovative, high quality raw materials and outstanding levels of customer service. We offer our customers a completely integrated service, from dedicated R&D support to efficient delivery of products to manufacturing plants. We provide: Innovation and Technical Expertise Exceptional Customer Service Communication and Responsiveness Quality, Compliance and Traceability Cost-Effective Solutions and Total Value
Coldharbour Way Aylesbury, England, HP19 United KingdomAston Chemicals is an independent distributor of Speciality Chemicals, providing the European Personal Care industry with innovative, high quality raw materials and outstanding levels of customer service. We offer our customers a completely integrated service, from dedicated R&D support to efficient delivery of products to manufacturing plants. We provide: Innovation and Technical Expertise Exceptional Customer Service Communication and Responsiveness Quality, Compliance and Traceability Cost-Effective Solutions and Total Value
Babraham Hall Cambridge, CB22 3AT United KingdomOur technology enables customers to store and transport cells and tissues at room temperature. This is achieved by encapsulating the cells in an alginate gel using our proprietary technology, and they can be stored in beads, plates, syringes, vials or any other format as required. We supply the gels and reagents necessary for you to encapsulate and then release your cells.
1-4 Argyll Street 1-4 Argyll Street England, W1F 7TA United KingdomAtlant Clinical is a strong multinational contract research organization (CRO) offering a full range of clinical trials (Phases I-IV) and relevant support services throughout the US, Europe, Ukraine, Russia, and Middle Asia.
2nd Floor Midas House 62 Goldsworth Road Woking, Surrey, GU21 6LQ United KingdomMedical writing (regulatory and market access applications) service provider to the pharmaceutical and medical technology industries.
5th floor, 1 Gloucester Place Brighton, England, BN1 4AA United KingdomAt Avalere Health, we are guided by a single mission: EVERY PATIENT POSSIBLE. A truly purpose-led approach uniting our three capabilities – Advisory, Medical, and Marketing – to ensure every patient is identified, supported, treated, and cared for – equally. Our teams are equipped to work across the product lifecycle and poised to advise our clients to prepare, respond, and course correct to the changing landscape pharma is facing today. We are: - On the pulse of the dynamic health policy - Connected to payer, clinical and patient influencers - Underpinned by real-world data, digital and AI capabilities - Structured to integrate without complication This is our difference; we mobilize our depth of expertise to solve the biggest challenges in health and help clients advance access to patients, simplify complex data to effective communication strategies and blend scientific knowledge with strategic creativity. We know your challenges. We’ve experienced them, navigated the solutions, and are best placed to help you guide assets through their lifecycle so that no patient is left behind.
The Featherstone Building, 66 City Road London, England, EC1Y 2AL United KingdomAt Avalere Health, we are guided by a single mission: EVERY PATIENT POSSIBLE. A truly purpose-led approach uniting our three capabilities – Advisory, Medical, and Marketing – to ensure every patient is identified, supported, treated, and cared for – equally. Our teams are equipped to work across the product lifecycle and poised to advise our clients to prepare, respond, and course correct to the changing landscape pharma is facing today. We are: - On the pulse of the dynamic health policy - Connected to payer, clinical and patient influencers - Underpinned by real-world data, digital and AI capabilities - Structured to integrate without complication This is our difference; we mobilize our depth of expertise to solve the biggest challenges in health and help clients advance access to patients, simplify complex data to effective communication strategies and blend scientific knowledge with strategic creativity. We know your challenges. We’ve experienced them, navigated the solutions, and are best placed to help you guide assets through their lifecycle so that no patient is left behind.
7 Sycamore Close Cambridge, Cambridgeshire, CB1 8PG United Kingdom
58 Wood Lane Incubator, Level 2, Phase C, Lab 6, London, W12 7RZ United KingdomPrivate Company - Limited by Shares. Wholly owned by Imperial College of Science, Technology & Medicine With access to nearly 4,000 expert researchers, plus Imperial College London’s state of the art facilities, our dedicated consultancy and commercial services teams have helped organisations, large and small, find solutions to their business needs for over 30 years. Our services are delivered by the world renowned research community at Imperial College London, supported by a dedicated professional services team who ensure your project is delivered on time and to specification. Over the last year, we’ve delivered projects more than 1,000 clients based in the UK and overseas.
Faculty Building South Kensington Campus London, SW7 2AZ United KingdomPrivate Company - Limited by Shares. Wholly owned by Imperial College of Science, Technology & Medicine With access to nearly 4,000 expert researchers, plus Imperial College London’s state of the art facilities, our dedicated consultancy and commercial services teams have helped organisations, large and small, find solutions to their business needs for over 30 years. Our services are delivered by the world renowned research community at Imperial College London, supported by a dedicated professional services team who ensure your project is delivered on time and to specification. Over the last year, we’ve delivered projects more than 1,000 clients based in the UK and overseas.
167 - 169 GREAT PORTLAND STREET 5th floor LONDON, W1W 5PF United Kingdomhttps://www.axiamedicine.com Axia Medicine generates sponsor-defined, multimodal, longitudinal patient cohorts for pharmaceutical R&D, end-to-end, under a single contract. We combine clinical site qualification, data scouting, and multi-site data harmonization into a unified process that delivers governed real-world datasets Pharma cannot source elsewhere. Our work spans biomarker strategy and validation, profiling, disease progression modeling, and natural history and external control arm design, with a data governance architecture built for GDPR-compliant, cross-border, federated data access from day one.
81 Scholars Court Harrison Drive Cambridge, Cambridgeshire, CB2 8EF United Kingdomhttps://www.axiamedicine.com Axia Medicine generates sponsor-defined, multimodal, longitudinal patient cohorts for pharmaceutical R&D, end-to-end, under a single contract. We combine clinical site qualification, data scouting, and multi-site data harmonization into a unified process that delivers governed real-world datasets Pharma cannot source elsewhere. Our work spans biomarker strategy and validation, profiling, disease progression modeling, and natural history and external control arm design, with a data governance architecture built for GDPR-compliant, cross-border, federated data access from day one.
85 Great Portland Street London, England, W1W 7LS United Kingdomhttps://www.axiamedicine.com Axia Medicine generates sponsor-defined, multimodal, longitudinal patient cohorts for pharmaceutical R&D, end-to-end, under a single contract. We combine clinical site qualification, data scouting, and multi-site data harmonization into a unified process that delivers governed real-world datasets Pharma cannot source elsewhere. Our work spans biomarker strategy and validation, profiling, disease progression modeling, and natural history and external control arm design, with a data governance architecture built for GDPR-compliant, cross-border, federated data access from day one.
Little Chesterford, England, CB10 1XL United KingdomBetter human disease models: We use iPSCs to build more relevant models of human disease to expand your understanding and de risk drug development: - Specialist human iPSC CRO - Supporting neurodegenerative / neuroinflammatory drug discovery / cardiotoxicity / dermatology / ophthalmology - Extensive library of donor iPSCs including lines from Alzheimers, ALS, FTD, Parkinsons, Huntingtons - Full services from donor sourcing, line reprogramming, differentiation, end assays and compound screening - Advanced human like models for pre-clinical research and classification At Axol Bioscience, we support your pursuit of more effective, safer therapies. Like you, we believe that having more human relevant disease models will expand scientific knowledge and de risk drug development. We use human iPSCs to achieve this and have been doing so since 2006. We use donated cells from patients and iPSC technology to build physiologically relevant in vitro models. We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well as cardiotoxicity to promote drug safety. When working with candidate compounds or novel therapies, our in vitro platforms give you better earlier stage modeling and safety testing and later stage efficacy evaluation and improved patient selection. With these data comes better insights, helping you de-risk projects, reduce costs, and save time during drug development. At Axol Bioscience, we help your science with better models of human disease. Since our merger, the company is Censo Biotechnologies trading as Axol Bioscience. All invoices and documentation should be addressed to "Censo Biotechnologies trading as Axol Bioscience."
B260 Meditrina Babraham Research Campus Cambridge, Cambridge, CB22 3AT United KingdomBetter human disease models: We use iPSCs to build more relevant models of human disease to expand your understanding and de risk drug development: - Specialist human iPSC CRO - Supporting neurodegenerative / neuroinflammatory drug discovery / cardiotoxicity / dermatology / ophthalmology - Extensive library of donor iPSCs including lines from Alzheimers, ALS, FTD, Parkinsons, Huntingtons - Full services from donor sourcing, line reprogramming, differentiation, end assays and compound screening - Advanced human like models for pre-clinical research and classification At Axol Bioscience, we support your pursuit of more effective, safer therapies. Like you, we believe that having more human relevant disease models will expand scientific knowledge and de risk drug development. We use human iPSCs to achieve this and have been doing so since 2006. We use donated cells from patients and iPSC technology to build physiologically relevant in vitro models. We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well as cardiotoxicity to promote drug safety. When working with candidate compounds or novel therapies, our in vitro platforms give you better earlier stage modeling and safety testing and later stage efficacy evaluation and improved patient selection. With these data comes better insights, helping you de-risk projects, reduce costs, and save time during drug development. At Axol Bioscience, we help your science with better models of human disease. Since our merger, the company is Censo Biotechnologies trading as Axol Bioscience. All invoices and documentation should be addressed to "Censo Biotechnologies trading as Axol Bioscience."
The Science Village, Chesterford Research Park United Kingdom Cambridge, Cambridgeshire, CB10 1XL United KingdomBetter human disease models: We use iPSCs to build more relevant models of human disease to expand your understanding and de risk drug development: - Specialist human iPSC CRO - Supporting neurodegenerative / neuroinflammatory drug discovery / cardiotoxicity / dermatology / ophthalmology - Extensive library of donor iPSCs including lines from Alzheimers, ALS, FTD, Parkinsons, Huntingtons - Full services from donor sourcing, line reprogramming, differentiation, end assays and compound screening - Advanced human like models for pre-clinical research and classification At Axol Bioscience, we support your pursuit of more effective, safer therapies. Like you, we believe that having more human relevant disease models will expand scientific knowledge and de risk drug development. We use human iPSCs to achieve this and have been doing so since 2006. We use donated cells from patients and iPSC technology to build physiologically relevant in vitro models. We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well as cardiotoxicity to promote drug safety. When working with candidate compounds or novel therapies, our in vitro platforms give you better earlier stage modeling and safety testing and later stage efficacy evaluation and improved patient selection. With these data comes better insights, helping you de-risk projects, reduce costs, and save time during drug development. At Axol Bioscience, we help your science with better models of human disease. Since our merger, the company is Censo Biotechnologies trading as Axol Bioscience. All invoices and documentation should be addressed to "Censo Biotechnologies trading as Axol Bioscience."
Bullocks Lane Hope End Takeley, Essex, CM22 6TA United KingdomAs a global leader in R&D genomics services, GENEWIZ from Azenta Life Sciences, leads the way in providing superior data quality with unparalleled technical support to enable researchers around the world to advance their scientific discoveries faster than ever before. Our customers at top-tier pharmaceutical, biotechnology, and academic institutions, as well as cutting-edge start-ups, rely on our proprietary technologies for consistent, reliable, high-quality data, even on the most difficult projects. A full-service provider, we provides Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next generation sequencing, bioinformatics, and GLP regulatory services. Our customers are supported by state-of-the-art facilities and highly-qualified scientific teams. Our Pre-Clinical and Clinical Services, located in South Plainfield, NJ, are subject to rigorous quality systems based on Good Laboratory Practice (GLP), Clinical Laboratory Improvement Amendments (CLIA) regulations and College of American Pathologist (CAP) standards. GENEWIZ Suzhou, China and Takeley, UK locations also hold the ISO:9001 Quality Management Certification, a voluntary international certification noting operational excellence and quality standards.
Bullocks Lane Hope End Takeley, Essex, CM22 6TA United KingdomAs a global leader in R&D genomics services, GENEWIZ from Azenta Life Sciences, leads the way in providing superior data quality with unparalleled technical support to enable researchers around the world to advance their scientific discoveries faster than ever before. Our customers at top-tier pharmaceutical, biotechnology, and academic institutions, as well as cutting-edge start-ups, rely on our proprietary technologies for consistent, reliable, high-quality data, even on the most difficult projects. A full-service provider, we provides Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next generation sequencing, bioinformatics, and GLP regulatory services. Our customers are supported by state-of-the-art facilities and highly-qualified scientific teams. Our Pre-Clinical and Clinical Services, located in South Plainfield, NJ, are subject to rigorous quality systems based on Good Laboratory Practice (GLP), Clinical Laboratory Improvement Amendments (CLIA) regulations and College of American Pathologist (CAP) standards. GENEWIZ Suzhou, China and Takeley, UK locations also hold the ISO:9001 Quality Management Certification, a voluntary international certification noting operational excellence and quality standards.
The Babraham Research Campus, Babraham, Cambridge CB22 3AT, UKBabraham Cambridge CB22 3AT UKBabraham Biomarker Service provides molecular biology services for sample analysis and processing.
Babraham Research Campus Cambridge, CB22 3AT United KingdomBabraham Bioscience Technologies (BBT) of the Babraham Institute offers its scientific facilities to support bioinformatics, epigenomics, FACS analysis, gene targeting, mass spectrometry, and antibody production.
, Babraham, England CB22 3AU, GBAt the Babraham Institute, our discovery science is powered by eight state-of-the-art Science Facilities that operate as open-access, service-orientated cores. Collectively they give every group—internal and external—seamless access to the instruments, expertise and data workflows needed to interrogate signalling and epigenetic mechanisms from single molecules to whole organisms. Genomics – High-throughput and single-cell sequencing, methylome and chromatin-accessibility profiling, supported by end-to-end library prep and QC pipelines. Bioinformatics – Dedicated analysts who develop and run bespoke pipelines, provide statistics support and help visualise complex multi-omics data. Flow Cytometry – Eight analysers plus high-speed sorters, including the new image-enabled Attune CytPix and a spectral-flow platform added in 2024 for >30-parameter panels. Expert staff offer training, experimental design and data analysis. Imaging – Confocal, super-resolution (STED & SIM), light-sheet and intravital microscopy, with automated analysis workflows and a 24/7 booking model. Mass Spectrometry – Quantitative proteomics, phosphoproteomics, metabolomics and lipidomics on Orbitrap and Q-ToF platforms, plus specialist bio-informatics for pathway mapping. Biological Chemistry – Custom synthesis, protein–ligand interaction assays and high-throughput screening to generate probes and validate targets. Gene Targeting – CRISPR/Cas9 and ES-cell engineering services for mouse, rat and cell-line models, including conditional alleles and reporter knock-ins. Biological Support Unit (BSU) – A high-health-status animal facility with quarantine, CL-2 suites and specialist ageing, germ-free and gnotobiotic husbandry, all overseen by dedicated veterinary and welfare teams. By integrating these platforms we can capture cell-signalling dynamics, map epigenomic states and link them to functional outcomes in immune, nervous and developmental systems across the life course. The shared-cost model means researchers can pivot quickly between assays—e.g. coupling image-enabled flow sorting of aged immune cells to single-cell ATAC-seq—accelerating both fundamental insight and translational impact. Together, the core facilities form the technological backbone that turns Babraham’s bold biological questions into reproducible, high-resolution answers.
Babraham Hall Babraham Cambridge, CB22 3AT United KingdomAt the Babraham Institute, our discovery science is powered by eight state-of-the-art Science Facilities that operate as open-access, service-orientated cores. Collectively they give every group—internal and external—seamless access to the instruments, expertise and data workflows needed to interrogate signalling and epigenetic mechanisms from single molecules to whole organisms. Genomics – High-throughput and single-cell sequencing, methylome and chromatin-accessibility profiling, supported by end-to-end library prep and QC pipelines. Bioinformatics – Dedicated analysts who develop and run bespoke pipelines, provide statistics support and help visualise complex multi-omics data. Flow Cytometry – Eight analysers plus high-speed sorters, including the new image-enabled Attune CytPix and a spectral-flow platform added in 2024 for >30-parameter panels. Expert staff offer training, experimental design and data analysis. Imaging – Confocal, super-resolution (STED & SIM), light-sheet and intravital microscopy, with automated analysis workflows and a 24/7 booking model. Mass Spectrometry – Quantitative proteomics, phosphoproteomics, metabolomics and lipidomics on Orbitrap and Q-ToF platforms, plus specialist bio-informatics for pathway mapping. Biological Chemistry – Custom synthesis, protein–ligand interaction assays and high-throughput screening to generate probes and validate targets. Gene Targeting – CRISPR/Cas9 and ES-cell engineering services for mouse, rat and cell-line models, including conditional alleles and reporter knock-ins. Biological Support Unit (BSU) – A high-health-status animal facility with quarantine, CL-2 suites and specialist ageing, germ-free and gnotobiotic husbandry, all overseen by dedicated veterinary and welfare teams. By integrating these platforms we can capture cell-signalling dynamics, map epigenomic states and link them to functional outcomes in immune, nervous and developmental systems across the life course. The shared-cost model means researchers can pivot quickly between assays—e.g. coupling image-enabled flow sorting of aged immune cells to single-cell ATAC-seq—accelerating both fundamental insight and translational impact. Together, the core facilities form the technological backbone that turns Babraham’s bold biological questions into reproducible, high-resolution answers.
BioPark, Broadwater Road Welwyn Garden City, Hertfordshire AL7 3AX United KingdomBABS Biomarker Services offers biomarker services.
Silvaco Technology Centre Compass Point, St. Ives, Cambridgeshire PE27 5JL United KingdomBacklogs is the UK division of Online Pathology Services and offers internet pathology services to specifically address the difficulties of recruitment currently encountered by pathology departments in the UK.
Slough, England United KingdomA specialist clinical trial supplier of comparator drugs with a global reach
London, England United KingdomAt Barts Health, our vision is to change lives. We are the largest NHS Trust in the UK serving a population of 2.5 million in east London and beyond. Our Trust, established on 1 April 2012, consists of five local hospital sites: Mile End Hospital, The Royal London Hospital, Newham University Hospital, St Bartholomew's Hospital and Whipps Cross University Hospital. Read more about our hospitals. Barts Health is also proud to be part of UCLPartners, Europe’s largest and strongest academic health science partnership. The objective of UCLPartners is to translate cutting edge research and innovation into measurable health gain for patients and populations through partnership across settings and sectors, and through excellence in education.
Charterhouse Square London, England, EC1M United KingdomThe Flow Cytometry Core Facility aim is to provide high quality professional service related to flow cytometric techniques using cutting edge equipment. To achieve this goal, we encourage interaction between users and lab members of the core facility. Support and training is provided for the use of all analysers, help is provided in experiment design, data interpretation, presentation and troubleshooting. A full sorting service is also provided. Equipment The lab is equipped with the following flow cytometers: - Three Becton Dickinson LSR Fortessa - One Becton Dickinson FACSCalibur, - One Amnis/Merck ImageStream X Mark II, - Two Becton Dickinson ARIA cell sorters. - We also have a CyTOF2 Mass Cytometer
John Vane Science Centre Charterhouse Square London EC1M 6BQWe are a constantly evolving genomics core facility. With our experienced team of scientists our goal is to partner all stages of your genetic or genomic research projects, including project proposal, experimental design, training, technical support, analysis and interpretation of data Our Timeline. Founded in 2000 the Genome Centre at Barts and The London School of Medicine and Dentistry has successfully provided genetic and genomic research facilities to researchers within Queen Mary University and the wider Life Sciences research community for over 10 years Initial investment in 2000 provided robotics, capillary sequencing and real-time PCR capability which we still support. Further investment in 2006 in microarray from Illumina (updated in 2011 to the iScan) enabled us to support high density SNP, Gene Expression and Methylation analysis. 2008 and 2009 saw adoption of Illumina's next generation sequencing technology and the associated IT infrastructure. 2012 has seen us rolling out library preps using the Fluidigm and targeted sequencing on the MiSeq. With this portfolio of platforms the centre can facilitate studies of the genome, transcriptome and epigenome on any scale.
Broad Oak Road, Sittingbourne, Sittingbourne, Kent, ME9 8AQ United KingdomBBI Solutions has served the global diagnostics industry for over 50 years, as a leading developer and manufacturer of raw materials and finished test platforms for the in-vitro diagnostics market. Over the past 50 years, BBI has grown from a small specialist company, to a global business with manufacturing sites in five different countries, spanning three continents. Our product ranges include: Biological Raw Materials Antigens Enzymes Monoclonal Antibodies and Recombinant Fab Antibodies Serum & Plasma Products Depleted Serum Disease State Plasma Normal Serum and Patient Samples In addition, we manufacture world renowned labels for lateral flow, ELISA assay and biosensors, these include: Gold Nanoparticles Horseradish Peroxidase and Glucose Oxidase BBI Solutions also offers end to end Contract Development and manufacturing services, with a core focus on custom gold conjugation and lateral flow test manufacture. Innovative new projects include the integration of emerging technologies into our products, such as the Novarum Smartphone Reader. BBI Solutions is part of the BBI Group www.the-bbigroup.com
Crown House 72 Hammersmith Road Hammersmith London W14 8TH United KingdomBBK Worldwide provides investigator and ptient recruitment services.
1030 Eskdale Road Winnersh Triangle WOKINGHAM, United Kingdom, RG41 5TS United KingdomBD Biosciences offers ADME/Tox services, cell analysis and reagent services, bioprocessing media and supplement services, custom coating services and microplate barcoding services.
10D Reads Street Stretham Ely, Cambridge, CB6 3JT United KingdomPrecision Medicine Experts consulting across Biomarker Discovery, Validation, Diagnostic development, clinical development and launch of Precision Medicines and Diagnostics - includes regulatory, clinical operations, program management, drug project strategy and market access Beacon: Guiding innovators, delivering hope for patients. A network of independent, experienced Precision Medicine Experts with an extensive track record of developing and launching Precision Medicines and associated diagnostics to the global markets. Providing larger pharma expertise to Pharma, Biotech, Medtech and VCs seeking to transform patient outcomes with Precision Medicines, Biomarker Science and Diagnostic technologies. Your Vision, Our Expertise, Strategies Tailored to You
The Bradfield Centre 184 Cambridge Science Park CAMBRIDGE, Cambridgeshire, CB4 0GA United KingdomPrecision Medicine Experts consulting across Biomarker Discovery, Validation, Diagnostic development, clinical development and launch of Precision Medicines and Diagnostics - includes regulatory, clinical operations, program management, drug project strategy and market access Beacon: Guiding innovators, delivering hope for patients. A network of independent, experienced Precision Medicine Experts with an extensive track record of developing and launching Precision Medicines and associated diagnostics to the global markets. Providing larger pharma expertise to Pharma, Biotech, Medtech and VCs seeking to transform patient outcomes with Precision Medicines, Biomarker Science and Diagnostic technologies. Your Vision, Our Expertise, Strategies Tailored to You
1030 Eskdale Road Winnersh Triangle WOKINGHAM, United Kingdom, RG41 5TS United Kingdom
Cantium House, Citylink Centre Railway Approach Wallington Surrey SM6 0DZ UKBibra provides consultancy services in a number of important toxicology areas.
England, CB22 3AT United KingdomBicycle Therapeutics was founded in mid-2009 as a spin out of the Medical Research Council Laboratory of Molecular Biology (Cambridge, UK), based on work of the scientific founders Professor Sir Gregory Winter and Professor Christian Heinis with initial seed funding from Atlas Ventures and Novartis Venture Fund.
St Julians, Sevenoaks Kent, TN15 0RX United KingdomBethyl Laboratories provides antibody products and services for both clinical and research applications.
2 Royal College St Kings Cross London, NW1 0NH United KingdomThe Bio-Analysis Centre offers a Triple Quad Mass Spectrometer, two advanced HPLC instruments plus the latest High Performance label free Capillary Electrophoresis instrument from deltaDOT. With these instruments the Centre can help identify and quantitate a wide range of analytes. The Centre allows users to run their own samples on the instruments (after training) which can reduce their analysis costs and allow them to keep control of their work. The range of instruments in the Centre will be kept under review and may be extended depending on Clients’ analytical needs. The Centre is working towards being GLP compliant so that it will be able to meet a wider range of clients’ analytical requirements from that point onwards.
2 Royal College Street England, NW1 0PB United KingdomThe Bio-Analysis Centre offers a Triple Quad Mass Spectrometer, two advanced HPLC instruments plus the latest High Performance label free Capillary Electrophoresis instrument from deltaDOT. With these instruments the Centre can help identify and quantitate a wide range of analytes. The Centre allows users to run their own samples on the instruments (after training) which can reduce their analysis costs and allow them to keep control of their work. The range of instruments in the Centre will be kept under review and may be extended depending on Clients’ analytical needs. The Centre is working towards being GLP compliant so that it will be able to meet a wider range of clients’ analytical requirements from that point onwards.
The Business Centre Church End Cambridge CB1 3LB United KingdomBiocair provides shipping for scientific materials.
Biocon (London) Limited 50, Elm Quay Court 30, Nine Elms Lane SW8 5DF, London, UKBiocon Pharmaceuticals offers synthetic chemistry, molecular biology, and APIs.
330 Cambridge Science Park Milton Road Cambridge, Cambridge, CB4 0WN United KingdomResearch, development and provision of medical diagnostic testing
England United KingdomBioFocus offers a comprehensive suite of discovery products and services. These are available separately or as an integrated drug discovery solution, backed by a centralized project management system.
BioFocus Chesterford Research Park Saffron Walden Essex CB11 4BEBioFocus offers a comprehensive suite of discovery products and services. These are available separately or as an integrated drug discovery solution, backed by a centralized project management system.
Howbery Business Park Benson Lane Wallingford, Oxfordshire, OX10 8BA United KingdomBioFrey has led CMC activities for early and late phase biologics as well as cell and gene therapies. BioFrey has experience in process development CDMO selection and tech transfer. Key highlights include: - Successful transfer to Chinese CDMO for Phase III+ Covid therapeutic - Identification of process changes leading to elevated HCP in BDS (Corrected batch was cleanest at CDMO and in line with other sites) - Disaster recovery with support from supply chain (Column repacked in 3 weeks following CDMO error) - Rapid identification of root cause driving differences in batch duration for 1st WCB batch (at phase III). - Technical audit of CDMO sites - Driving a company to CDMO selection in 6 months following 18 months of indecision for a marketed product - Upstream and Downstream Processing - Process Development - Technology Transfer - Creation of RFPs and selection of CDMOs/CROs - Process extractables and Leachables - Project management - Authoring/reviewing module 3 sections - Commercial planning (Demand, scale, COGs) - Early Phase - Late Phase
Hailsham, England United KingdomBiognosis specialises in the supply of quality kits and reagents for the diagnosis of human and veterinary diseases. Our products are sourced from around the world and currently totals over 100,000 kits.
2A Orchard Road Royston, England, SG8 5HD United KingdomBioIVT enables smarter science and accelerates medical breakthroughs by delivering high-quality personalized biospecimen solutions and research services to life science and diagnostic industries. Recognized as an industry leader, BioIVT specializes in control and disease state samples including human and animal tissues or preparations, ADME-Tox products and research services, cell and gene therapy products, blood, and other biofluids. BioIVT has simplified the way you work with human tissue samples by introducing 2 levels of informed consent: - Fully Consented – IRB/IEC approved. All BioIVT sponsored collections that meets the fully consented list of elements. - Common Rule – IRB/IEC approved. All third parties that meet 45 CFR 46 and/or Good Clinical Practice requirements for elements of consent. Plus, we're proud to announce that all ASTERAND Human ELITE tissue is now IRB-consented. This ensures that every sample you work with is backed by industry-leading regulatory oversight. By combining technical expertise and exceptional customer service with unmatched access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®. For more information about our processes on the regulatory oversight of Human Biological Specimens (HBS), please visit our website, www.bioivt.com. Specific information related to our quality and ethical assurances can be found here: https://www.bioivt.com/about/quality-assurance
15 Albert Drive Site J Unit 2 Burgess Hill, West Sussex, RH15 9TN United KingdomBioIVT enables smarter science and accelerates medical breakthroughs by delivering high-quality personalized biospecimen solutions and research services to life science and diagnostic industries. Recognized as an industry leader, BioIVT specializes in control and disease state samples including human and animal tissues or preparations, ADME-Tox products and research services, cell and gene therapy products, blood, and other biofluids. BioIVT has simplified the way you work with human tissue samples by introducing 2 levels of informed consent: - Fully Consented – IRB/IEC approved. All BioIVT sponsored collections that meets the fully consented list of elements. - Common Rule – IRB/IEC approved. All third parties that meet 45 CFR 46 and/or Good Clinical Practice requirements for elements of consent. Plus, we're proud to announce that all ASTERAND Human ELITE tissue is now IRB-consented. This ensures that every sample you work with is backed by industry-leading regulatory oversight. By combining technical expertise and exceptional customer service with unmatched access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®. For more information about our processes on the regulatory oversight of Human Biological Specimens (HBS), please visit our website, www.bioivt.com. Specific information related to our quality and ethical assurances can be found here: https://www.bioivt.com/about/quality-assurance
The Stone House, 9 Weymouth Street London, W1W 6DB United KingdomBiolab Medical Unit is a nutritional biochemistry laboratory that can measure vitamin and mineral levels, toxic metals, and other biochemical levels.
4B Highgate Business Centre 33 Greenwood Place London NW5 1LB United KingdomBioLegend strives to provide quality research reagents and expert technical support to the scientific community worldwide. We look forward to serving your research needs and becoming your long term research partner.
Business & Technology Centre, Bessemer Drive Stevenage, Herts, SG1 2DX United KingdomBio-Mimetic Chromatography Ltd offers HPLC based bio-mimetic property measurements for drug discovery compounds. it includes protein and phospholipid binding as well as lipophilicity of the compounds at three different pH. Based on the data we estimate and rank in-vivo properties of the compounds based on published and validated models. These models include volume of distribution, drug efficiency, brain tissue binding, lung tissue binding, skin absorption, blood/brain distribution, phospholipidotic potential, cellular accumulation. We offer consultancy to setup these measurements and we are offering developing new local models based on the client's compounds data.
1st Floor Unit 20 Furmston Court Icknield Way Letchworth Garden City, Hertfordshire, SG6 1UJ United KingdomBio-Mimetic Chromatography Ltd offers HPLC based bio-mimetic property measurements for drug discovery compounds. it includes protein and phospholipid binding as well as lipophilicity of the compounds at three different pH. Based on the data we estimate and rank in-vivo properties of the compounds based on published and validated models. These models include volume of distribution, drug efficiency, brain tissue binding, lung tissue binding, skin absorption, blood/brain distribution, phospholipidotic potential, cellular accumulation. We offer consultancy to setup these measurements and we are offering developing new local models based on the client's compounds data.
33D Julians Road Stevenage, Hertfordshire, SG1 3ES United KingdomBio-Mimetic Chromatography Ltd offers HPLC based bio-mimetic property measurements for drug discovery compounds. it includes protein and phospholipid binding as well as lipophilicity of the compounds at three different pH. Based on the data we estimate and rank in-vivo properties of the compounds based on published and validated models. These models include volume of distribution, drug efficiency, brain tissue binding, lung tissue binding, skin absorption, blood/brain distribution, phospholipidotic potential, cellular accumulation. We offer consultancy to setup these measurements and we are offering developing new local models based on the client's compounds data.
Trinity Building Chesterford Research Park Cambridge, Cambs, CB10 1XL United Kingdombiomodal is focused on building technologies and analytics as research tools for life scientists & clinical developers. We enable you to capture the 6-base genome and provide insight into the complexity and dynamism of cellular interactions. Our solution works with your existing infrastructure, integrating a pre-sequencing workflow with post-sequencing informatics to generate highly accurate genetic and epigenetic data from a single sample in a single run.
B400 The Trinity Building Chesterford Business Park Little Chesterford, Saffron Walden, CB10 1XL United Kingdombiomodal is focused on building technologies and analytics as research tools for life scientists & clinical developers. We enable you to capture the 6-base genome and provide insight into the complexity and dynamism of cellular interactions. Our solution works with your existing infrastructure, integrating a pre-sequencing workflow with post-sequencing informatics to generate highly accurate genetic and epigenetic data from a single sample in a single run.
Broadwater Road Welwyn Garden City, England United KingdomLocated close to the heart of London's biomedical technology community, BioPark provides specialist facilities and support for bioscience and health technology businesses, encouraging growth and the development of new products and technologies.
England United KingdomBioProgress Technology offers an array of enabling systems for the food, medical and pharmaceutical industries.
5 Orwell Furlong Cowley Road Cambridge, Cambridgeshire, CB4 0WY United KingdomBiorbyt supplies antibodies, proteins, small molecules, kits, and molecular biology products.
7 Signet Court Swann Road Cambridge, Cambridgeshire, CB5 8LA United KingdomBiorbyt supplies antibodies, proteins, small molecules, kits, and molecular biology products.
2 Bartholemew's Walk Ely, England, CB7 4ZE United KingdomALS in Europe provides analytical testing, method development and microbiology services to pharmaceutical and biotechnology clients. With strategically located GMP-compliant laboratories, ALS in Europe supports drug development, manufacturing and quality release across the product lifecycle, from raw material testing and stability studies to sterility testing and container-closure integrity.
12 Pembroke Avenue, Denny Industrial Centre Waterbeach Cambridge CB25 9QR UNITED KINGDOMBiosynergy offers antibody production, cell culture, downstream processing, and assay development.
Unit F, Heathrow West Business Park Heron Drive Langley, Slough , SL3 8XP United KingdomAs Bio-Techne, we have united multiple brands to provide a unique and comprehensive product portfolio. Our Life Science brands include R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Boston Biochem and Advanced Cell Diagnostics. Our Diagnostic brands include R&D Systems Diagnostics, Biospacific, RNA Medical, Bionostics and Cliniqa. Together, our brands provide world-class products and services for life science research and clinical applications. Our custom services include but not limited to custom proteins, antibodies, conjugation, biophysical testing, Luminex assays, biomarker testing services, custom cell culture services, recombinant antibodies, monoclonal antibody panels, molecular biology, ubiquitin/proteasome custom services, and expert RNAscope® In Situ Hybridization Gene Expression Services.
77 Arthur Road London, England, SW19 7DP United KingdomSynthesis Bioconsulting is a global AI and data science consultancy powering innovation across biotechnology, life sciences, and healthcare. From early-stage startups to multinational pharma, we build bespoke machine learning and data solutions that integrate biological, clinical, and technical expertise. Our work spans drug discovery, diagnostics, digital health, and beyond — helping clients turn complex data into clear, actionable outcomes. We've supported everything from academic spinouts to industry leaders, accelerating R&D, improving decision-making, and driving real-world impact. If you’re solving hard problems in biotech or health, we’re here to help you move faster and smarter.
Temple Chambers 3-7 Temple Avenue London, EC4Y 0HP United KingdomBiotrial is a leading CRO specializing in Drug Development with a wide range of expertise in Preclinical Pharmacology, Clinical Development (Phase I studies with healthy volunteers/special populations, studies with patients), Bioanalysis, Biometrics, ECG, CNS & Imaging Core Lab. Biotrial performs hundreds of studies each year and offers tailor-made solutions to biotechnology and pharmaceutical industry. Biotrial’s preclinical pharmacology unit offers a comprehensive range of services to support the drug discovery and development process, from in vitro to in vivo pharmacology studies. Our team of experienced scientists has over 35 years of experience in designing and conducting preclinical studies, and we are committed to providing our clients with the highest quality data and support. Our state-of-the-art, 27,000-square-foot preclinical facility is AAALAC and GLP accredited, and equipped to work with a wide range of species, including rodents, dogs, mini-pigs, and non-human primates. Our drug efficacy services assess the therapeutic potential of the drug candidate using a diverse range of disease models. We execute studies that measure the effects of the drug on disease-related biomarkers and endpoints. Our drug efficacy services include in-vitro assays, in-vivo models and translation studies between preclinical findings and clinical applications. Our drug safety services are dedicated to evaluating the safety profile of the drug candidate using animal models. Our drug safety services include safety pharmacology to assess the potential effects of the drug on vital organ systems and safety de-risking to mitigate risks, minimize time delays and reduce costs. Our pharmacokinetics services assess the absorption, distribution metabolism and excretion of drug candidates. We measure the concentration of the drug in blood and tissues over time and provide critical insight to optimize the drug development. We assess the pharmacokinetics of the drug candidate in rodents and non-rodents to determine optimal dosing and formulation. We use pharmacokinetic data to develop models that predict the concentration of the drug in blood and tissues over time. Our in-vivo pharmacokinetics uses advanced analysis methods (non-compartmental analysis NCA, compartmental analysis CA, mechanism understanding, pharmacokinetics-pharmacodynamic analysis, population pharmacokinetics) and safety de-risking. Our model development services help select and develop the best animal models for drug discovery and its development. We have expertise in disease modeling, pharmacology design, model validation and model selection.
7 Romans Business Park, East Street Farnham, Surrey GU9 7SX United KingdomBioventix supplies and offers custom production of sheep monoclonal antibodies.
Farnham, England United KingdomBioventix supplies and offers custom production of sheep monoclonal antibodies.
The Dorothy Hodgkin Building Babraham Research Campus Cambridge, CB22 3FH United Kingdombit.bio provides human iPSC-derived cells and related services for research, drug discovery, and toxicology. Using a deterministic cell programming approach, bit.bio produces defined human neurons, glial cells, muscle cells and hepatocytes that enable researchers to work with physiologically relevant human models. Cells are supplied cryopreserved and can be used in experiments within days, supporting reproducible and scalable in vitro studies. The cells are generated using opti-ox™, a transcription factor-based cell programming technology that precisely controls gene expression in human induced pluripotent stem cells (iPSCs). This deterministic approach converts stem cells into a single defined cell type rapidly and consistently, avoiding the heterogeneity and long timelines often associated with traditional differentiation methods. bit.bio cells are used in drug discovery workflows including disease modelling, target validation, and safety assessment. Researchers use these human cell models to study neurodegeneration, neuromuscular biology and metabolism, and to run screening workflows such as electrophysiology assays (including MEA and patch clamp), CRISPR screening and high-throughput compound screening and safety or toxicity studies. In addition to supplying ready-to-use human cell models, bit.bio also supports custom cell engineering, CRISPR-based screening and small molecule screening projects. induced pluripotent stem cells iPSC-derived cells human stem cell models Human cells cellular reprogramming transcription factor programming forward programming stem cell differentiation human neurons glutamatergic neurons Excitatory neurons GABAergic neurons Inhibitory neurons motor neurons sensory neurons microglia astrocytes oligodendrocytes oligodendrocyte precursor cells OPCs glial cells human hepatocytes Human liver cells skeletal muscle cells human myocytes disease modeling target validation pathway analysis functional genomics phenotypic screening high-throughput screening compound screening CRISPR screening genetic perturbation screening electrophysiology multi-electrode array MEA assays patch clamp hepatotoxicity drug-induced liver injury DILI neurotoxicity safety pharmacology cytotoxicity drug metabolism CYP induction CYP inhibition metabolic stability neuronal culture neuron-glia co-culture 3D cell culture neuroscience neurobiology neurodegeneration cell biology stem cell biology functional genomics Disease model cells amyotrophic lateral sclerosis ALS models ALS frontotemporal dementia FTD models FTD Motor neuron disease MND Parkinson's disease Parkinson’s models PD Huntington's disease Huntington’s disease models HD Alzheimer's disease Alzheimer’s disease models AD neurodegenerative disease Multiple sclerosis Demyelinating disease Duchenne muscular dystrophy DMD neuromuscular disease muscle biology muscle disease DMD models liver biology metabolism research metabolic disease drug metabolism
128 City Road London, England, EC1V 2NJ United KingdomOn premise AI platform to train and run AI models without data moving. Main use case is running AI image analysis and EHR data mining in a clinical site for site feasibility and patient recruitment, additionally can be used for data transfers (RWE/Observational Studies) and AI model training/validation.
11-29 Fashion Street London, 1E 6PX United KingdomBlack Swan Analysis is a boutique business analysis consultancy based in the UK. Founded in 2007, the company provides a range of services to biotechs and university spin-outs, business development departments, CROs and investment companies. Our areas of expertise include forecasting excellence and patient segmentation which are supported by an array of proprietary tools such as comprehensive epidemiology and pricing databases. Typical services include: • Dynamic oncology flow modelling to value oncology assets at any stage of development (Onco-Strat) • Regulator/ due- diligence- ready epidemiology data (Epiomic segmentation database) • Prescription-only medicine ex-manufacturer pricing data for Europe (Rx Price Index) • Custom disease area reports • Competitive intelligence & market landscape assessments • Product valuations / forecast models and market assessments Our philosophy at Black Swan Analysis is to create a collaborative environment that enables us to provide an unparalleled level of satisfaction and quality to our clients. Black Swan Analysis is part of Evaluate Ltd
Bloodwise, 39-40 Eagle Street, London, WC1R 4THCell Bank is a national collection of samples from patients with paediatric haematological malignancies. Samples include live cells from bone marrow, plasma from peripheral blood and CSF. The Bank also holds a collection of HLA typed cord blood. The Bloodwise CellBank is comprised of samples donated by children diagnosed with leukaemia in the UK. These samples are available for use in research into childhood leukaemia. UK-based researchers can apply to use samples from CellBank for peer-reviewed and fully-costed research projects.
The Featherstone Building 66 City Road London, EC1Y 2AL United KingdomFishawack Health (previously Blue Latitude Health) Blue Latitude Health is now Fishawack Health. Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in the UK, the organization is powered by a 1,300+ globe-spanning pack of strategic, creative, and scientific experts. We empower healthcare professionals and patients with the knowledge they need to live better lives. Our core operating units—Medical, Marketing, Market Access, and Consulting—bring together best-in-class capabilities from around the world. We empower our pharmaceutical, biotech, and medical technology clients to navigate the most complex of ecosystems, helping them on an effective path to develop, launch, and grow their brands, services, and portfolios. Our internationally recognized, award-winning teams collaborate across operations in the UK (Brighton, Fleet, London, Knutsford, Manchester, Oxford, and Sale), Ireland (Dublin), USA (Chicago, Evansville, Minneapolis, New York, Philadelphia, San Diego, Scottsdale, and St. Louis), Greece (Athens), and Singapore.
St Johns Innovation Centre Cowley Rd Cambridge, Cambs, CB4 0WS United KingdomSupply and service of scientific instruments primarily for materials and surface R&D and QC
Adam House, 1st Floor 1 Fitzroy Square London, W1T5HE United KingdomBostwick Laboratories provides anatomic and clinical pathology laboratory services specializing in the monitoring and diagnosis of cancer.
Abbey Square England, RG1 3EH United KingdomBracket was created in 2011 through the merger of the Specialty Clinical Services and Clinical Technologies Group business units within United BioSource Corporation (UBC), which was acquired by pharmacy benefit manager Medco Health Solutions. Express Scripts acquired Medco Health Solutions in 2012. In August 2013, Bracket became an independent portfolio company of Parthenon Capital Partners, a Boston- and San Francisco-based growth-oriented private equity firm that provides capital and strategic resources to growing middle market companies for acquisitions and internal growth. Together, Bracket and Parthenon Capital Partners are committed to continued innovation and growth, and to providing exceptional service to our pharma, biotech and medical device industry clients.
Breast Cancer Now, Fifth floor, Ibex House, 42-47 Minories, London EC3N 1DYThe BCNTB is a unique initiative designed for the breast cancer research community. It is a collection of well-characterised, validated clinical material including tissue (tumour and normal) in a variety of formats, blood, cells and other derivatives, matched with clinical information.
2 Marsault Court, 11 Kew Foot Road, Richmond, , London, TW9 2SS United KingdomWe provide evidence sciences services to global bio-pharmaceutical companies We service clients across the globe in following areas: Evidence planning Clinical research Health outcomes Epidemiology and RWE Scientific and Value writing
17B Robertson Street London, England, SW8 3TR United KingdomBriefly have created an interface for lab automation devices that anyone can use, every day.
London, England United KingdomBritish Enterprises offers manufacturing of hard gelatine and vegetarian capsules, soft capsules,vitamins,tablets, and paracetamol and ibuprofen powders.
5 Rockware Avenue Greenford Middlesex - UB6 OAA London UKBritish Enterprises offers manufacturing of hard gelatine and vegetarian capsules, soft capsules,vitamins,tablets, and paracetamol and ibuprofen powders.
54-56 Waldegrave Road Teddington, Middlesex TW11 8NY, United KingdomButterworth Laboratories provides wet chemistry, spectroscopy, chromatography and elemental microanalysis.
Caltag Medsystems United Kingdom Buckingham, Bucks, MK18 1TF United KingdomLooking for niche reagents? With Caltag, source hard-to-find reagents, standard tools and custom services — all in one place. Our portfolio includes a wide range of RUO, GMP and IVD products spanning immunology, cell biology and molecular applications. As a trusted partner of universities and biotech leaders across the UK, with 20+ years of experience, we understand the importance of reliable service and expert support. Whether you’re starting a new project or scaling an existing one, we’re here to support your research & diagnostic needs.
Whiteleaf Business Centre 11 Little Balmer Buckingham Bucks UK MK18 1TFLooking for niche reagents? With Caltag, source hard-to-find reagents, standard tools and custom services — all in one place. Our portfolio includes a wide range of RUO, GMP and IVD products spanning immunology, cell biology and molecular applications. As a trusted partner of universities and biotech leaders across the UK, with 20+ years of experience, we understand the importance of reliable service and expert support. Whether you’re starting a new project or scaling an existing one, we’re here to support your research & diagnostic needs.
8 Tennis Court Road University of Cambridge, 8 Tennis Court Road England, CB2 1QW United KingdomSpin-out from the Farndale Lab in University of Cambridge, designed to take forward the manufacture and supply of collagen peptides to academia and the pharma industry. CambCol Laboratories is a new venture, that was established to transfer the peptide synthesis facility and related interests of the Farndale Lab in Biochemistry at the University of Cambridge into a new, commercial entity. The core business of CambCol Laboratories is the synthesis and distribution of collagen-like, triple helical peptides and platelet-related materials. These have been developed over 20 years of research in the “Farndale Lab” in Cambridge and are supplied to over 100 laboratories worldwide to underpin diverse basic and clinical research projects in thrombosis and haemostasis in academic and commercial settings for many years. The range is under constant review and continuous expansion and the company also offers a “bespoke” peptide synthesis service where required.
15 Station Road, Wilburton England, CB7 4DL United KingdomSpin-out from the Farndale Lab in University of Cambridge, designed to take forward the manufacture and supply of collagen peptides to academia and the pharma industry. CambCol Laboratories is a new venture, that was established to transfer the peptide synthesis facility and related interests of the Farndale Lab in Biochemistry at the University of Cambridge into a new, commercial entity. The core business of CambCol Laboratories is the synthesis and distribution of collagen-like, triple helical peptides and platelet-related materials. These have been developed over 20 years of research in the “Farndale Lab” in Cambridge and are supplied to over 100 laboratories worldwide to underpin diverse basic and clinical research projects in thrombosis and haemostasis in academic and commercial settings for many years. The range is under constant review and continuous expansion and the company also offers a “bespoke” peptide synthesis service where required.
1 The Irwin Centre Scotland Road Dry Drayton, Cambridge CB23 8AR United KingdomCambio supplies and distributes various kits, reagents, and enzymes to support research in molecular biology.
Trafalgar Way Bar Hill, England, CB23 8SQ United KingdomCambridge Bioscience is a UK-based distributor of life science research and diagnostic products. Throughout our history we have collaborated with many companies who have developed the research tools which have shaped the modern world of biological research. Today, we offer a unique range of products and services that we have carefully selected for their ability to contribute to future discoveries. We mostly offer three key types of products and services : Human biospecimens - We have decades of experience in sourcing human biospecimens that have been collected, processed and transported in a manner that makes them suitable for the most demanding research applications. Reagents - we source 1000's of reliable and innovative biological and chemical reagents. Instruments - We focus on innovative, instrument-based products for cell and molecular biology research that help researchers gain greater understanding of complex biological systems.
Cambridge, UKCambridge Bioscience is a UK-based distributor of life science research and diagnostic products. Throughout our history we have collaborated with many companies who have developed the research tools which have shaped the modern world of biological research. Today, we offer a unique range of products and services that we have carefully selected for their ability to contribute to future discoveries. We mostly offer three key types of products and services : Human biospecimens - We have decades of experience in sourcing human biospecimens that have been collected, processed and transported in a manner that makes them suitable for the most demanding research applications. Reagents - we source 1000's of reliable and innovative biological and chemical reagents. Instruments - We focus on innovative, instrument-based products for cell and molecular biology research that help researchers gain greater understanding of complex biological systems.
Munro House Trafalgar Way Cambridge , CB23 8SQ United KingdomCambridge Bioscience is a UK-based distributor of life science research and diagnostic products. Throughout our history we have collaborated with many companies who have developed the research tools which have shaped the modern world of biological research. Today, we offer a unique range of products and services that we have carefully selected for their ability to contribute to future discoveries. We mostly offer three key types of products and services : Human biospecimens - We have decades of experience in sourcing human biospecimens that have been collected, processed and transported in a manner that makes them suitable for the most demanding research applications. Reagents - we source 1000's of reliable and innovative biological and chemical reagents. Instruments - We focus on innovative, instrument-based products for cell and molecular biology research that help researchers gain greater understanding of complex biological systems.
Cambrigbe, UKThe Cambridge Brain Bank was established in 1975 to allow researchers access to brain tissue to investigate disorders of the nervous system, and offers a well-characterised resource of frozen and paraffin embedded brain tissue from donors with Dementia, including Alzheimer’s disease, Motor Neurone disease and Huntington’s disease, as well as a comprehensive histological service. Normal control brain tissue from people without neurological disorders is also available. The CBB is licensed by the Human Tissue Authority (HTA) and accredited by Clinical Pathology Accreditation (CPA). The facility routinely supplies material to researchers working in Neuroscience, as well as University and Medical Research Council (MRC) funded research projects. The brain bank is also a member of the MRC Brain UK network.
78 Lancaster Way Business Park, Ely, Cambridgeshire, CB6 3NW, United KingdomCambridge Commodities Limited (CCL) is located in Cambridgeshire, England. We are the leading importer, distributor and manufacturer of nutritional ingredients, as well as made-to-specification finished products.
12 Union Road Cambridge. CB2 1EZ UKCambridge Crystallographic Data Center offers x-ray crytallography.
Church Road Toft England, CB23 United KingdomWe are a leading product and technology innovation partner focused on helping our customers realise new opportunities. Specialising in the healthcare, consumer, and industrial equipment sectors, our solutions start at the point a business decides upon the need for innovation and finish with the launch of a breakthrough new product that is customer focused and commercially effective. Our product development and prototype manufacturing quality systems are certified to ISO 13485/9001.
Church Road Toft Cambridge, CB23 2RF United KingdomWe are a leading product and technology innovation partner focused on helping our customers realise new opportunities. Specialising in the healthcare, consumer, and industrial equipment sectors, our solutions start at the point a business decides upon the need for innovation and finish with the launch of a breakthrough new product that is customer focused and commercially effective. Our product development and prototype manufacturing quality systems are certified to ISO 13485/9001.
The Merrifield Centre Rosemary Lane Cambridge CB1 3LQCambridge Discovery Chemistry provides innovative chemistry services to accelerate discovery and process research, serving the pharmaceutical, agrochemical and biotechnology industries.
Battlegate Road, Boxworth Cambridge CB23 4NN, United KingdomCambridge Environmental Assessments (CEA) are part of ADAS UK Ltd., the UK's largest environment and agricultural consultancy. CEA are specialists in regulatory environmental risk assessments for chemicals, toxicology and REACH compliance, providing strategic support for product registrations across Europe. In the pesticidal products area, CEA undertakes data evaluation, the preparation of risk assessments and regulatory documentation (dossier segments), including project management and co-ordination of work packages. In addition, CEA offer bespoke higher tier aquatic (mesocosms and laboratory studies) and higher tier environmental fate studies, according to GLP. Our chemical regulatory compliance team supports our clients to ensure they are compliant with all EU Chemical Regulations including REACH, CLP/GHS, the Seveso Directive (COMAH) and food additives. The compliance team also provides support in toxicology, ecotoxicology, exposure assessments, chemical safety reports, dossier preparation, substance identity confirmation and preparation of Safety Data Sheets. We also have extensive experience of non-standard toxicology and ecotoxicology studies, and modelling of substances in the environment.
Cambridge, England United KingdomCambridge Genomic Services offers gene expression profiling, SNP genotyping, methylation analysis, bioinformatics, and slide printing services.
Cambridge University Tennis Court Road Cambridge CB2 1QP, UKCambridge Genomic Services offers gene expression profiling, SNP genotyping, methylation analysis, bioinformatics, and slide printing services.
8 Mangers Lane Duxford, Cambs, CB22 4RN United KingdomCambridge MedChem Consulting provides a range of consultancy services in drug discovery and medicinal chemistry. https://www.cambridgemedchemconsulting.com High-Throughput Screening analysis Screening or Focused molecular Library Design Fragment-based screening support Hit to Lead project supervision Lead optimisation Computational support, in particular virtual screening and QSAR analysis. Licensing oversight Drug Discovery Resources an online resource for scientists undertaking drug discovery Training courses on the drug discovery process and medicinal chemistry.
The Bradfield Centre, 184 Cambridge Science Park Milton Road Cambridge, England, CB4 0GA United KingdomCambridge Molecular is a computational drug discovery company devoted to DNA-encoded libraries and other next-generation small molecule screening technologies. We leverage novel algorithms and high-performance cloud computing to accelerate and derisk drug discovery.
1010 Cambourne Business Park Cambridge, England, CB23 6DP United KingdomCambridge Molecular is a computational drug discovery company devoted to DNA-encoded libraries and other next-generation small molecule screening technologies. We leverage novel algorithms and high-performance cloud computing to accelerate and derisk drug discovery.
Cambridge Protein Arrays Ltd. MAIA Building, Babraham Research Campus Cambridge, England, CB22 3AT, UK United KingdomCambridge Protein Arrays offers proteome array research products and custom screening services. We supply the up-to-date HuProt™ Human Proteome Microarrays v3.1, the most extensive array of human proteins available on the market, containing 20,000 proteins on one slide. Our services are tailored to customer requirements and include quality control and profiling of antibody specificity, autoantibody target discovery and protein interactomics.
Maia Building, B270 Babraham Research Campus Cambridge, Cambridgeshire, CB22 3AT United KingdomManufacturer of Recombinant Proteins and Contract Research.
5/6 Science Village Chesterford Research Park Little Chesterford Saffron Walden, Essex, CB10 1XL United KingdomCamena Bioscience produces long and complex synthetic genes using a pioneering new technology
Angel Building 407 St John Street London EC1V 4AD, UKCancer Research Technology offers translational development and commercialization with its primary focus on cancer.
University College London The Cruciform Building Gower Street London, WC1E 6BT, UKCancer Research Technology offers translational development and commercialization with its primary focus on cancer.
London, England United KingdomCancer Research Technology offers translational development and commercialization with its primary focus on cancer.
12 Rosemary Lane Cambridge CB1 3LQCancer Research Technology offers translational development and commercialization with its primary focus on cancer.
407 St John Street London EC1V 4AD
155 Cambridge Science Park , Milton Road Cambridge, CB4 0GN United KingdomCantab Biopharmaceuticals is focused on the development of "biosuperior" products with extensive experience in biopharmaceutical discovery, process development and GMP manufacturing.
Cambridge, England United KingdomCantab Biopharmaceuticals is focused on the development of "biosuperior" products with extensive experience in biopharmaceutical discovery, process development and GMP manufacturing.
UNIT 304, 121 ABILITY HOUSE, BROOKER ROAD, London, essex, EN9 1JH United KingdomCapsid Biotechnology is one of the world's leading suppliers of high-purity bioactive small molecules for life science research. We offer a catalogue of over 20,000 inhibitors, activators, antibodies and research reagents, alongside custom compound libraries and laboratory consumables, serving academic institutions, biotech and pharmaceutical companies around the globe.
London, UKCarbone scientific is located at London, UK. We are mainly engaged in the marketing development, R &D, technical support and service. Carbone scientific provides fine chemicals, pharmaceutical intermediates, and active pharmaceutical ingredients to the global marketplaces. Our aim is to make those most popular products available to these pharmaceutical and biotech companies, research organizations and university labs worldwide. Our online catalogue has already listed over 50,000 products and over 6000 products in stock. Any customers could be easily to select any products from our online catalogue for creating purchase orders. The very competitive price and lead time information are available for you after you register at our web site.
SUITE LG01, CHANCERY HOUSE CHANCERY LANE London, WC2A 1QU United KingdomCarbone scientific is located at London, UK. We are mainly engaged in the marketing development, R &D, technical support and service. Carbone scientific provides fine chemicals, pharmaceutical intermediates, and active pharmaceutical ingredients to the global marketplaces. Our aim is to make those most popular products available to these pharmaceutical and biotech companies, research organizations and university labs worldwide. Our online catalogue has already listed over 50,000 products and over 6000 products in stock. Any customers could be easily to select any products from our online catalogue for creating purchase orders. The very competitive price and lead time information are available for you after you register at our web site.
The Cube, LondonEast-UK Business and Technical Park Yew Tree Avenue, Dagenham London, Yes, RM107FN United KingdomCatSci is an award-winning process research and development CRO that provides perfect-for-purpose analytical and chemistry services as well as non-GMP material supply to emerging, mid-sized and large pharma. We proudly serve customers across the globe delivering projects from lead optimisation through to product launch and life-cycle management. As an independent, scientifically-unbiased and commercially-minded CRO, CatSci is dedicated to understanding and optimising your chemical reactions and manufacturing processes. Favouring a consultative approach, we take the time to understand your project objectives to design and deliver tailored solutions to match your specific demands. Our large pharma pedigree and extensive experience working on small molecule drug discovery and development projects mean that we can expedite your candidate selection, route design, process scale-up and optimisation. Non-GMP material supply from milligrams to kilograms is conveniently carried out in our laboratory, whilst for larger quantities and/or GMP manufacture, we are able to work with our trusted partners or your preferred supplier.
12 Union Road Cambridge, Cambridgeshire, CB2 1EZ United KingdomScientific consultancy from CCDC allows you to gain access to our talented and enthusiastic structural science researchers, developers and technical specialists; and a wealth of knowledge and expertise. Our services include contract research, solid-form services, discovery services and data curation. Your time and resource to spend on research projects is limited, and you want to be sure you are utilizing all tools to best advantage. Why not let our contract research team take on some of the load? Harness our extensive expertise in structural chemistry including structure based virtual screening, series optimization, 3D model validation and much more. Get extra assurances about your solid form product, backed by the world’s structural chemistry knowledge. Our secure, cheminformatics-based analyses can help to identify potential polymorphs, solvates, hydrates, stability issues, and more. The CCDC has a long history of partnerships with top pharmaceutical companies. We deeply understand solid form informatics, data security, and the need for reliable, timely results. We analyze your crystal structure data using software and scripts powered by the Cambridge Structural Database, or CSD, the world’s repository of experimentally determined small molecule organic and metal-organic crystal structures. With this collective knowledge, harnessed from the scientific literature and direct data sharing since 1965, your structure’s properties are assessed. This does not replace experimental solid form screening but helps to inform, prioritize and validate this work. Our trusted Solid Form Healthcheck approach has seen success in the literature, with Pfizer using this method to identify risks in a viral entry inhibitor that had been missed in the experimental screen (Docherty et al. Journal of Pharmacy and Pharmacology, 2015, 67, 6, 857-868).
31 Frederick Sanger Road Surrey Research Park Guildford, Surrey, GU2 7YD United KingdomCelLBxHealth (formerly ANGLE) is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. CelLBxHealth's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis.
10 Nugent Road Surrey Research Park Guildford, Surrey, GU2 7AF United KingdomCelLBxHealth (formerly ANGLE) is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. CelLBxHealth's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis.
Occam Road Surrey Research Park Guildford, England, GU2 7QB United KingdomCelLBxHealth (formerly ANGLE) is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. CelLBxHealth's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis.
2 Occam Court Occam Road Guildford, Surrey, GU2 7QB United KingdomCelLBxHealth (formerly ANGLE) is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. CelLBxHealth's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis.
2 Occam Court Occam Rd Guildford, Surrey, GU2 7QB United KingdomCelLBxHealth (formerly ANGLE) is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. CelLBxHealth's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis.
Chesterford Research Park Little Chesterford Cambridge CB10 1XL UKCellCentric offers a discovery platform in epigenetics.
Cell Guidance Systems Ltd, Babraham Bioscience Campus, Cambridge CB22 3AT United KingdomCell Guidance Systems provides reagents and services to control, manipulate and monitor the cell, both in-vitro and in-vivo. Our technologies enable novel insights for research as well as fresh approaches to treating disease. We have developed a range of products and services to support your exosome research, from isolation to characterization to assay. Our range of products includes exosome purification kits for all biological fluids and applications, exosome marker antibodies, and exosome detection options, as well as a nanoparticle tracking analysis (NTA) service. Conventional growth factors limit the possibilities of cell culture, biomanufacturing, and therapeutics. PODS® technology addresses the limitations of conventional growth factors by placing them in a protective protein crystal lattice. This lattice stabilizes cargo proteins even at high temperatures. In the presence of proteases secreted by cells, pores develop in the lattice which allows the cargo growth factor to slowly escape. This gradual, sustained release maintains bioavailability at steady-state levels (near zero-order kinetics). The crystals can also be readily used for patterning by attachment to surfaces or suspension at specific positions in hydrogels. PODS® nanocrystals have a wide range of applications either in-vitro (2D or 3D culture) or in-vivo.
Maia Building Babraham Research Pack Cambridge, CB22 3AT United KingdomCell Guidance Systems provides reagents and services to control, manipulate and monitor the cell, both in-vitro and in-vivo. Our technologies enable novel insights for research as well as fresh approaches to treating disease. We have developed a range of products and services to support your exosome research, from isolation to characterization to assay. Our range of products includes exosome purification kits for all biological fluids and applications, exosome marker antibodies, and exosome detection options, as well as a nanoparticle tracking analysis (NTA) service. Conventional growth factors limit the possibilities of cell culture, biomanufacturing, and therapeutics. PODS® technology addresses the limitations of conventional growth factors by placing them in a protective protein crystal lattice. This lattice stabilizes cargo proteins even at high temperatures. In the presence of proteases secreted by cells, pores develop in the lattice which allows the cargo growth factor to slowly escape. This gradual, sustained release maintains bioavailability at steady-state levels (near zero-order kinetics). The crystals can also be readily used for patterning by attachment to surfaces or suspension at specific positions in hydrogels. PODS® nanocrystals have a wide range of applications either in-vitro (2D or 3D culture) or in-vivo.
Moneta Building Babraham Bioscience Campus Cambridge, CB22 3AT United KingdomCell Guidance Systems provides reagents and services to control, manipulate and monitor the cell, both in-vitro and in-vivo. Our technologies enable novel insights for research as well as fresh approaches to treating disease. We have developed a range of products and services to support your exosome research, from isolation to characterization to assay. Our range of products includes exosome purification kits for all biological fluids and applications, exosome marker antibodies, and exosome detection options, as well as a nanoparticle tracking analysis (NTA) service. Conventional growth factors limit the possibilities of cell culture, biomanufacturing, and therapeutics. PODS® technology addresses the limitations of conventional growth factors by placing them in a protective protein crystal lattice. This lattice stabilizes cargo proteins even at high temperatures. In the presence of proteases secreted by cells, pores develop in the lattice which allows the cargo growth factor to slowly escape. This gradual, sustained release maintains bioavailability at steady-state levels (near zero-order kinetics). The crystals can also be readily used for patterning by attachment to surfaces or suspension at specific positions in hydrogels. PODS® nanocrystals have a wide range of applications either in-vitro (2D or 3D culture) or in-vivo.
Imperial House, Oaklands Business Centre Oaklands Park, Wokingham Berkshire , RG41 2FD United KingdomCEMAS (CEM Analytical Services) is a trusted, dynamic, independent UK-based contract research organisation (CRO), fully compliant with GxP standards. Since 1989, we’ve been delivering high-quality analytical testing to support global clients in the chemical, biocides, plant protection, life sciences, and cosmetics sectors. We specialise in generating robust, regulatory-ready data for the pharmaceutical, agrochemical, and biocides industries. Our comprehensive solutions include: residue analysis (including ILV & method development), animal transfer studies, OPEX studies, agrochemical product analysis, formulation development, efficacy studies, REACH compliance support, pharmaceutical & veterinary medicine analysis, bioanalysis and the provision of data for regulatory dossiers. With deep technical expertise, modern laboratory facilities, and a collaborative approach, CEMAS delivers tailored analytical solutions to clients worldwide.
18 Sedley Taylor Road Cambridge, England, CB2 8PW United KingdomThe Centre for Business Innovation Limited (CfBI) headquartered in Cambridge, UK, creates and facilitates communities whose participants share the benefits and costs of working together in a trusting environment, towards common goals or under a brand which reflects their values and beliefs in the spirit of Open Innovation
London, England United KingdomCENTUVA provides efficient and cost-effective MD and PhD contract services right across the industry. Our experienced team of MDs and PhDs work with Marketing/Sales and Medical Affairs departments across North America and Europe. We work on demand with pharmaceutical, medical device and medical diagnostics companies through a personalized approach. We offer several services including our award-winning Doctors Speaking With Doctors. See our service offer at www.centuva.com. Centuva’s unparalleled access to the medical community, expertise, value and credibility lets you target your markets, build ongoing dialogue and achieve your goals.
8 Finsbury Circus London, EC2M 7EA United KingdomCharles River Associates (CRA) is a leading global consulting firm that offers economic, financial, and strategic expertise to major law firms, corporations, accounting firms, and governments around the world.
Robinson Building Little Chesterford, CB10 1XL United KingdomFor over 75 years, Charles River has provided essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe, helping to accelerate their research and drug development efforts. With over 90 sites globally, we’re ready to tackle your product’s most unique challenges. Our focus on timeliness and accuracy in every stage of drug development means you can count on us to deliver reliable results – every step of the way. Visit our website to learn more about our portfolio and how we can support your research. www.criver.com
8/9 Spire Green Flex Meadow Harlow, Essex, CM19 5TR United KingdomFor over 75 years, Charles River has provided essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe, helping to accelerate their research and drug development efforts. With over 90 sites globally, we’re ready to tackle your product’s most unique challenges. Our focus on timeliness and accuracy in every stage of drug development means you can count on us to deliver reliable results – every step of the way. Visit our website to learn more about our portfolio and how we can support your research. www.criver.com
Unit J, Broad Lane Industrial Estate Cottenham, Cambridge CB24 8SW, UKChemex are a long established GLP Compliant laboratory based in the UK, performing a range of aquatic and terrestrial ecotoxicology studies for an international client base. In addition, our Consultancy Group are on hand to assist with projects including laboratory auditing and training and have experience working in many countries around the globe. Over 25 years since its founding, Chemex remains dedicated to the same quality philosophies, which have driven the company’s success. The company has assembled a technically diverse staff, enabling us to develop and expand our Ecotoxicology services delivering timely reports to an ever-expanding international client base. Chemex performs a range of aquatic toxicology studies to both Marine & Freshwater species and also offer terrestrial toxicology studies. In addition, biodegradation and bioaccumulation studies and many other study types are available to fulfil international regulatory requirements. To compliment our toxicology studies Chemex has a comprehensive range of analytical instrumentation and expert analysts to enable confirmation of test substance concentrations throughout studies, where specified. Our GLP compliant facility near Cambridge, UK provides independent laboratory testing of the highest quality and excellent customer service to a diverse range of clients. Chemex are one of the few UK laboratories that offer a wide range of marine studies suitable for OCNS (Offshore Chemicals Notification System)/HOCNF (Harmonised Offshore Chemicals Notification Format) purposes. More cost effective screening methods are also available for initial determination of the most suitable chemicals/products to proceed with. In addition, Chemex' multilingual Consultancy Group are able to assist with projects such as, Laboratory Auditing, Staff Training in various aspects of sampling or analysis techniques, off-shore sampling, production of Quality Plans and data review services. Our team are on hand to assist with projects around the globe. Chemex professional staff comprises skilled and experienced scientists, chemists, biologists and technicians with many years’ experience in ecotoxicology and analytical chemistry. We place a great deal of emphasis on training in order to maintain the highest levels of expertise, efficiency and GLP compliance.
12 Bradleys Corner Hitchin, Hertfordshire, SG4 0PR United KingdomWe provide consultancy in Molecular Modelling, Computational Chemistry, Cheminformatics, Data Science and AI. With several years experience in pharmaceutical industry, both in large pharama and CROs, we are experts in applying modern computational chemistry methods for lead generation and optimization. We stay on top of the current computational chemistry techniques, incubate them and apply it for our clients.
ChemOvation Ltd. Graylands Estate Langhurstwood Road Horsham West Sussex RH12 4QD United KingdomChemOvation provides organic chemistry and synthesis, computational chemistry, medicinal chemistry, screening, and purification.
14 Cundel Dr. Cambridge CB24 8RU UKChemPharmaServe provides innovative solutions to pharmaceuticals and biotechs to help fast tracking their drug discovery and developmental projects by making novel molecules they need.
14 Cundell Drive, Cottenham Cambridge CB4 8RU UKChemPharmaServe provides innovative solutions to pharmaceuticals and biotechs to help fast tracking their drug discovery and developmental projects by making novel molecules they need.
Cambridge, England United KingdomChemPharmaServe provides innovative solutions to pharmaceuticals and biotechs to help fast tracking their drug discovery and developmental projects by making novel molecules they need.
Depot Road, Newmarket, CB8 0ALChemtest is a leading supplier of high quality, fast response analytical services. "Customer focus and continuous investment in our personnel, processes and technology are at the forefront of our business planning, enabling reliability and confidence in the results we provide." Analysis is undertaken for the following industry sectors: Environmental Industry Geotechnical Industry Rail Industry Airports Local Government Construction Industry Asbestos Management Chemtest offers both fast and standard turnarounds to meet with clients' requirements and deadlines. The provision of sample containers and custody documentation, sample collection and reporting costs are included in the price of analysis. Sample collection is mostly provided utilising in-house drivers to ensure timely and safe sample delivery to the laboratory so that samples are received in optimum condition for analysis with traceability from the sample origin. Couriers are sometimes used when this is not practical. Chemtest can provide bespoke reporting formats in several different media according to clients' specifications.
Department of Surgery and Cancer Imperial College London Room 11L05 Charing Cross Hospital Fulham Palace Road London W6 8RFThe CTB (Chernobyl Tissue Bank) is a unique venture. It is the first international cooperation that seeks to establish a collection of biological samples from tumours and normal tissues from patients for whom the aetiology of their disease is known - exposure to radioiodine in childhood. The project, which started in October 1998, has been supported by a number of sponsors including the European Commission, the WHO, the National Cancer Institute (NCI) of the USA and the Sasakawa Memorial Health Foundation of Japan (SMHF). The project is currently jointly funded by the NCI and the SMHF. The project is coordinated from Imperial College, London and works with Institutes in the Russian Federation (the Medical Radiological Research Centre in Obninsk) and Ukraine (the Institute of Endocrinology and Metabolism in Kiev) to support local scientists and clinicians to manage and run a tissue bank for those patients who have developed thyroid tumours following exposure to radiation from the Chernobyl accident. Belarus was also initially included in the project, but is currently suspended for political reasons.
171 Bath Road, Slough Berkshire, SL1 4AA U.K.Chiltern International offers clinical development, biometrics, and pharmacology for the central nervous system, oncology, opthalmology, and pediatrics.
Milton Hall Ely road, Milton Cambridge, CB24 6WZ United KingdomChiral Quest offers chemistry process development and manufacturing of Intermediates and regulatory starting materials for the biotech and pharma industry. Our capacity starts with low kg quantities and can be scaled-up towards metric ton manufacturing scale. Our expertise is in chiral chemistry via asymmetric hydrogenations, but we can hanlde all kind of chemical reactions; we are able to scale both non-chiral as well as chiral chemistry. We also supply chiral fragments for the genericindustry hence our focus is on cost reduction
Cambridge, UKChiral Quest offers chemistry process development and manufacturing of Intermediates and regulatory starting materials for the biotech and pharma industry. Our capacity starts with low kg quantities and can be scaled-up towards metric ton manufacturing scale. Our expertise is in chiral chemistry via asymmetric hydrogenations, but we can hanlde all kind of chemical reactions; we are able to scale both non-chiral as well as chiral chemistry. We also supply chiral fragments for the genericindustry hence our focus is on cost reduction
71 Shelton Street London, WC2h 9JQ United Kingdom
9 High Street Stevenage Old Town, SG1 3BG United KingdomCK Clinical offers clinical and pharmaceutical recruitment services.
70 Saint Mary Axe London, England, EC3A 8BE United KingdomClarivate is a leading global provider of transformative intelligence, including Cortellis and Decision Resources Group ("DRG"). We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit clarivate.com
50 Sloane Avenue London, England, SW3 3DZ United KingdomClinical Services International (CSI) is a global leader in the sourcing and management of quality certified commercially available medicines – comparators, concomitant drugs and rescue medication – for clinical trials. Headquartered in London, we have offices in the United Kingdom, Germany and the United States. With an international network of over 200 manufacturers and depots spanning six continents, we have worldwide access and global project management expertise, sourcing medicines from Europe, the United States, Central and South America, and Asia Pacific. With over 150 years of combined experience in intelligent sourcing and clinical trial supply, our team are in an unrivalled position to deliver bespoke strategies and efficient solutions to support any study, even with the most complex requirements. Our fully integrated services reduce timelines and costs, ultimately accelerating drug development.
Scott House Alencon Link Basingstoke, RG21 7PP United KingdomClinical Solutions International provides market research, clinical consulting, medical device experience, and study design.
11 Whittle Parkway, Progress Business Park Slough, SL1 6DQ United KingdomCliniSciences is a European distributor of products & services from suppliers based all around the world. With a direct presence in 18 countries, CliniSciences serves customers through its own commercial and technical teams in Austria, Belgium, Denmark, Finland, France, Germany, Iceland, Ireland, Italy, the Netherlands, Norway, Poland, Portugal, Spain, Sweden, Switzerland, the United Kingdom, and the United States. Through these companies, CliniSciences offers a broad portfolio of life science reagents, instruments and services for research and diagnostic applications. Our product range includes reagents, antibodies, cells, assay kits, instruments, and a strong offering of human biological samples, including blood-derived products, tissues, primary cells, biofluids, DNA/RNA and other clinically relevant biospecimens. Our services include antibody development, peptide and protein synthesis, bulk manufacturing, humanization, custom production and other tailored solutions to support life science, biotech and diagnostic projects.
11, Progress Business Centre, Whittle Parkway Slough, SL1 6DQ United KingdomGeneron offers protein expression, purification, characterization and custom peptide synthesis services as well as consumables and reagents for purchase.
12 Rawcliffe House, Howarth Road Maidenhead, Berkshire SL6 1AP United KingdomGeneron offers protein expression, purification, characterization and custom peptide synthesis services as well as consumables and reagents for purchase.
Maidenhead, England, SL6 United KingdomGeneron offers protein expression, purification, characterization and custom peptide synthesis services as well as consumables and reagents for purchase.
Unit G Perram Works Merrow Lane Guildford GU4 7BN United KingdomClin-Tech provides manufacture and sale of reagents, stains, and diagnostic kits.
Holmwood - Broadlands Business Campus Langhurstwood Road Horsham RH12 4QP United KingdomCmed Research provides clinical services for a wide range of therapeutic areas.
Burnham, England United KingdomCMOpharma offers CMC consultancy services with expertise in outsourcing chemical development, solid-state physicochemical studies and API manufacture.
BioPark Hertfordshire Broadwater Road Welwyn Garden City Hertfordshire AL7 3AX, UKCN Bio is a leading organ-on-a-chip (OOC) company that offers a portfolio of products and services to optimise the accuracy and efficiency of bringing new medicines to market; providing significant savings in cost and time to drug discovery and development pipelines. Our range of lab-benchtop PhysioMimix™ microphysiological systems (MPS) enables researchers to model human biology in the lab through rapid and predictive 3D human tissue-based studies that harness microfluidic technology to provide nutrients and mimic blood flow. The technology bridges the gap between traditional cell culture and human studies, advancing towards the simulation of human biological conditions to support the accelerated and more efficient development of new therapeutics, whilst reducing the dependence on animal model usage. CN Bio’s MPS support researchers that require reliable, data-rich, in vitro studies, to uncover the mechanisms of disease (e.g non-alcoholic steatohepatitis (NASH), Hepatitis B virus, or COVID-19 infection), identify novel therapeutic targets, or investigate drug efficacy, pharmacokinetics and potential toxicity. Next-generation PhysioMimix OOC models span a range of organ types, including lung, liver and gut. Single organs can be linked together into multi-organ systems to simulate processes such as drug absorption and metabolism, or to understand interactions between organs, such as inflammation. Harnessing these assays, our portfolio of MPS, NASH-in-a-box kit, 3D validated cells, compatible consumable plates and contract research services have been developed to address drug development bottlenecks across a range of therapeutic areas, including metabolic and infectious diseases, oncology, and inflammation.
CN Bio Innovations 332 Cambridge Science Park, Cambridge, Cambridgeshire, CB4 0WN United KingdomCN Bio is a leading organ-on-a-chip (OOC) company that offers a portfolio of products and services to optimise the accuracy and efficiency of bringing new medicines to market; providing significant savings in cost and time to drug discovery and development pipelines. Our range of lab-benchtop PhysioMimix™ microphysiological systems (MPS) enables researchers to model human biology in the lab through rapid and predictive 3D human tissue-based studies that harness microfluidic technology to provide nutrients and mimic blood flow. The technology bridges the gap between traditional cell culture and human studies, advancing towards the simulation of human biological conditions to support the accelerated and more efficient development of new therapeutics, whilst reducing the dependence on animal model usage. CN Bio’s MPS support researchers that require reliable, data-rich, in vitro studies, to uncover the mechanisms of disease (e.g non-alcoholic steatohepatitis (NASH), Hepatitis B virus, or COVID-19 infection), identify novel therapeutic targets, or investigate drug efficacy, pharmacokinetics and potential toxicity. Next-generation PhysioMimix OOC models span a range of organ types, including lung, liver and gut. Single organs can be linked together into multi-organ systems to simulate processes such as drug absorption and metabolism, or to understand interactions between organs, such as inflammation. Harnessing these assays, our portfolio of MPS, NASH-in-a-box kit, 3D validated cells, compatible consumable plates and contract research services have been developed to address drug development bottlenecks across a range of therapeutic areas, including metabolic and infectious diseases, oncology, and inflammation.
10 Devonshire Square London, England, EC2M 4YA United KingdomCo:cubed is an innovation consultancy focusing on helping the world’s biggest companies solve the world’s biggest problems, powered by our global network of 12 million startups.
Tintagel House 92 Albert Embankment London, SE1 7TY United KingdomCo:cubed is an innovation consultancy focusing on helping the world’s biggest companies solve the world’s biggest problems, powered by our global network of 12 million startups.
29 South Albert Road Reigate, England, RH2 9DP United KingdomOur mission is to help healthcare providers, research institutions, and life sciences organisations across the public and private sectors unlock the value of genomic data for precision medicine, diagnostics, and discovery. Our team combines expertise in software engineering, clinical bioinformatics and applied machine learning to design secure, scalable solutions for managing and interpreting complex biological data. With experience in both research and clinical environments, we bridge the gap between cutting-edge science and real-world application, transforming data into actionable insights. We provide end-to-end support: strategy, architecture, system design and development; data integration and analytics; and alignment with international interoperability standards. By combining cloud technologies, advanced bioinformatics and machine learning we enable innovation while safeguarding sensitive patient and participant data.
20 Mastmaker Road England, E14 9UB United KingdomCogent expedites the secure transfer of large data files between domestic and global locations including the U.S., U.K., Europe, Japan, China, Korea, Singapore, Australia, and Brazil. [NASDAQ: CCOI] Cogent is a Tier 1 Global Internet Service Provider with the most interconnected network in the world – connecting to 6700 networks and 1200 Data Centers in over 200 markets spanning 45 countries. Approximately 21% of the world’s Internet traffic travels our network daily. Our core product offerings include Dedicated Internet Access, Ethernet Point-to-Point, Ethernet VPLS, SDWAN, and Colocation services offered over our award-winning fiber optic, IP data-only network.
16-20 Regent Street Cambridge CB2 1DB United KingdomFounded in 2010, Cogentia is a healthcare consulting company based in Cambridge in the UK. We provide market access skills, knowledge and expertise to the pharmaceutical, biotech and device industries. We help our clients to identify, understand and overcome the wide-ranging market access challenges that emerge throughout the life-cycle of their products. With a strong combination of public sector, industry and consulting experience we are able to deliver genuine insights across multiple stakeholder perspectives ensuring that our clients get both the highest quality research and the know-how to make it count.
9 Cromwell Place London, SW7 2JN United KingdomMarket Access consulting services
Nucleus The Bridge, Brunel Way, Dartford Kent DA1 5GA United KingdomCogtest provides the latest developments in cognitive neuroscience to the measurement of cognitive function in clinical trials.
Hanwell, London, UKCole-Parmer offers laboratory and industrial fluid handling products, instrumentation, equipment, and supplies.
71 Shelton Street London, England, WC2H 9JQ United KingdomEngaging with overwhelmed healthcare professionals is challenging. Yet, most healthcare communication agencies adopt an engagement approach for healthcare audiences focused solely on a single touchpoint, with no enduring experience. Consequently, there is no message recall, no behaviour change, no improvement in people care. To make a lasting impact that commands attention and memorability, you need to go beyond making a single connection. Collected Group is a forward-thinking healthcare communication company specialised in innovative and immersive omniverse centred engagement experiences for healthcare professionals. We work hard to understand the needs of audiences and stimulate them by creating new and original ways of continual engagements that leave meaningful and lasting impressions.
Cambridge, UKCompChem Solution provides computational chemistry support, library design and chemoinformatics services.
Cambridge, England United KingdomCompChem Solution provides computational chemistry support, library design and chemoinformatics services.
11 Milbrook Esher, KT10 9EJ United KingdomDeeptech astrophysics-rooted company providing digital twin simulations of individual cancer patients and pre-clinical models for precision oncology. Our platform FarrSight® applies proprietary Bayesian foundation model of cancer biology to simulate "what if?" treatment scenarios pre-clinically and for individual trial participants, to maximise confidence before deploying capital. Validated in over 5K patients across different cancers; in 17 clinical trials and in early-stage drug development. For our biotech and pharma customers we identified new indications, provided 100+ molecular digital controls, simulated in silico trials to test early signal and delivered £10m+ of direct cost savings. We specialise in handling small and fragmented data (e.g. rare cancers; translational R&D) and quantify uncertainty at every stage of development.
5 ST. JOHN'S LANE London, EC1M 4BH United KingdomConnectHEOR is a healthcare consulting company specialised in providing high-quality Health Economics & Outcomes Research (HEOR) services and training. We are able to support requests from the world's top pharma and biotechs using scientist.com "SEND US A REQUEST FOR PROPOSAL TODAY" At ConnectHEOR, we advance healthcare with the power of data and research by hiring HEOR experts with technical rigour to provide creative solutions to complex HEOR problems. Our key services include: 1. Decision Modelling 2. Real-World Evidence and Data Analytics 3. Review and Evidence Synthesis 4. Market Access and Value Communication 5. Training Why us? : 1. Academic rigour with commercial awareness 2. Senior team works on the project materially - unlike other vendors 3. Small and focused team, supports clients hands-on from start to end (and beyond) of the projects 4. High quality deliverables, cost-effective pricing
38 Kingsley Crescent High Wycombe, Buckinghamshire, HP11 2UL United KingdomConnectHEOR is a healthcare consulting company specialised in providing high-quality Health Economics & Outcomes Research (HEOR) services and training. We are able to support requests from the world's top pharma and biotechs using scientist.com "SEND US A REQUEST FOR PROPOSAL TODAY" At ConnectHEOR, we advance healthcare with the power of data and research by hiring HEOR experts with technical rigour to provide creative solutions to complex HEOR problems. Our key services include: 1. Decision Modelling 2. Real-World Evidence and Data Analytics 3. Review and Evidence Synthesis 4. Market Access and Value Communication 5. Training Why us? : 1. Academic rigour with commercial awareness 2. Senior team works on the project materially - unlike other vendors 3. Small and focused team, supports clients hands-on from start to end (and beyond) of the projects 4. High quality deliverables, cost-effective pricing
The Recodery, Lion Works, Station Road East Whittlesford, Cambridge, Cambridgeshire, CB22 4WL United KingdomConstructive Bio offers contract molecular biology, protein engineering, mutagenesis, and screening services.
9 Roffords Goldsworth Park, Surrey, GU21 3BH United KingdomAt Cope Pharma Consultancy, we provide a service tailored to your company’s requirements. Working closely with our clients, we can deliver a friendly, efficient and cost-effective service for both Human Pharma and Veterinary Products. We have considerable experience in the GMP auditing of CMOs, CROs, APIs, Raw Materials, Excipients, Medical Devices and Packaging Materials. We have extensive expertise in stability report writing and the preparation of CMC documentation.
12-18 Grosvenor Gardens London, London, SW1W 0DH United KingdomSpecialists in Pharmaceutical, Medical Device and Combination Product Testing Cormica is a global contract laboratory partner with over 60 years of scientific heritage, dedicated to accelerating safe product development and improving patient outcomes. Our integrated group of laboratories delivers high-quality, regulatory-aligned testing from early development support through to post-market surveillance. With the largest service offering in our space, Cormica supports pharmaceutical, medical device, and combination product manufacturers across the UK, EU, and US. Our sites are accredited to GMP, GLP, and ISO 17025 standards, and our services are trusted by all of the world’s top 20 pharmaceutical companies. We have helped over 500 clients in the past three years and continue to expand our capabilities to meet evolving industry needs. Our Laboratories: Cormica operates world-class laboratories across multiple regions, each with specialised capabilities: - Wickham Micro (UK) – Microbiology, Sterility Testing, Biocompatibility - MET – Medical Engineering Technologies (UK) – Physical, Functional, Packaging, Analytical Chemistry, Biocompatibility - Cormica Bradford (UK) – Analytical Chemistry - TPM Labs (US) – Analytical Chemistry - Zwiser Labs (EU) – Microbiology - Focus Labs (US) – Microbiology Our Capabilities Cormica offers an extensive portfolio of services designed to support your products throughout their lifecycle: - Analytical Chemistry: Method development, validation, extractables and leachables, deformulation, generics support, IVBE studies - Microbiology & Sterility: Bioburden, endotoxin, sterility (USP <71>), antimicrobial effectiveness, environmental monitoring - Physical & Functional Testing: ISO 11040, ISO 80369, ISO 11608, container closure integrity, dose accuracy, packaging, transit and ageing studies - Biocompatibility Testing: ISO 10993 testing, cytotoxicity, irritation, sensitisation, systemic toxicity, pyrogenicity - GMP Release & Stability Testing: Batch release of raw materials and finished products, ICH stability storage and testing - Consultancy Services: Regulatory strategy, biological evaluation plans/reports, clinical evaluation support for MDR/FDA submissions Why Cormica - End-to-end testing: From early-stage development to post-market surveillance - Rapid turnaround times: Agile, efficient project delivery - Custom project expertise: Adaptable services for unique and complex studies - High quality systems: Underpinned by rigorous QA and compliance culture - Global reach, local expertise: Laboratories across the UK, EU and US - Industry-leading equipment: Cutting-edge instrumentation and facilities Cormica is proud to be the trusted partner for some of the most innovative life science companies worldwide.
1st Floor One Suffolk Way Sevenoaks, Kent, TN13 1YL United KingdomCoronado Research is a consultancy-led, professional services organisation, which provides support to pharmaceutical, biotechnology, and medical device companies. Our objective is to optimise the clinical development process by leveraging all the data available using AI, ML, and leading technologies. Our practices cover Clinical Development, Regulatory, Medical Affairs and Market Access and HEOR (Health Economics and Outcomes Research). Our teams work with customers to “join-the-dots” between these disciplines to ensure treatments are developed with the end in mind and better match market needs.
126 Wigmore Street London, England, W1U 3RZ United KingdomCosmeservice is a global company specializing in cosmetic safety and regulation. We offer support and advice to cosmetic companies worldwide which plan to market their products in the European Union, the United Kingdom, USA and Canada. Based on a customer-oriented philosophy, Cosmeservice strives to adapt to each new product and offer a comprehensive service. Cosmeservice arose from the experience of highly qualified professionals in Cosmetic Safety and Regulation. We offer comprehensive advice/service to cosmetic manufacturers and distributors in compliance with the regulatory requirements of the European Regulation. The purpose of Cosmeservice is to actively contribute to the consolidation of manufacturers and distributors in the main cosmetic markets. We operate with the highest quality, reliability, and safety for the consumers.
50/60 Station Road Cambridge, CB1 2JH United KingdomCostello Medical is an award winning, independent, global healthcare agency specialising in medical communications, market access and HEOR. Since our founding in 2008, we have grown organically to a team of more than 500 colleagues, supporting over 300 different client organisations globally, from our offices based in the UK, US, Canada, Singapore and China. As an independent agency we are not beholden to external shareholders, allowing us to remain fully client-focused, flexible in how we work, and uncompromising on scientific quality. Together, our global presence, diverse scientific expertise, values driven culture and award winning performance position Costello Medical as a trusted, long term partner for organisations seeking strategic insights coupled with excellent scientific support across the healthcare sector. Our core service offerings are as follows: Medical Communications Our Medical Communications services cover publications, medical affairs, and creative support. We provide publications development, planning and consultancy, enhanced content such as infographics, videos and podcasts, and policy reports. Medical affairs work includes strategy development, omnichannel delivery, scientific exchange, insight gathering through advisory boards, surveys and Delphi panels, and congress engagement such as symposia and scientific coverage. Creative services span graphic, digital and motion design, branding, web and app development, and interactive experiences. We also deliver commercial and marketing support including brand positioning, launch communications, promotional materials, congress resources and disease awareness campaigns. Evidence Development Our Evidence Development services cover literature reviews, statistics and real-world evidence. Literature review expertise includes systematic, pragmatic, rapid and scoping reviews, as well as strategic evidence reviews, competitor intelligence and gap analyses. Statistics support spans analysis plan development, meta-analyses, indirect treatment comparisons, trial and utility analyses, survival modelling and epidemiology, with training and publications support also provided. Real-world evidence services include study design and analysis across databases, registries, electronic health records, observational studies, surveys, qualitative research and expert elicitation, alongside strategic evidence generation planning, data source mapping and dissemination through publications. Value and Access Our Value and Access services cover health economics, health technology assessment and market access. Our health economics services include cost-effectiveness and budget impact models, feasibility assessments, early modelling, technical validation, customer-facing interactive tools, advisory boards and training. HTA support includes strategy development, multi-country HTA submissions, JCA activities, early Scientific Advice, mock stakeholder meetings, payer and clinician advisory boards, training and HEOR publications. We also provide market access strategy and planning, the development of global, regional and local value dossiers, value propositions and messaging, roll-out workshops and objection handlers, as well as local country-specific resources such as AMCP dossiers, interactive tools, brochures, ABN materials and formulary packs. Health Policy & Public Affairs Our Health Policy and Public Affairs services cover the preparation of white papers, position papers, policy briefs, roundtable reports and policy research reports. We also produce best practice, consensus and recommendation articles, expert opinion papers and options appraisals. In addition, we can support multi-stakeholder engagement through Delphi panels, surveys, focus groups, interviews, policy landscape mapping, stakeholder mapping, roundtables and steering committees. Our services also include the creation of advocacy toolkits and policy campaign materials. We also have a dedicated Patient Engagement team who deliver patient engagement activities such as landscape assessments, strategic recommendations, surveys, advisory boards and workshops, as well as the development of patient information, education and support resources and communication of patient commitments. In addition, we collaborate with government bodies and public institutions to deliver policy research, healthcare evaluation projects and strategic initiatives. MedTech and Rare Diseases Expertise In addition to our experience in all major therapeutic areas, we have dedicated MedTech and Rare Diseases teams who work seamlessly across all of our teams with specialist knowledge of the challenges and nuances inherent to MedTech products and rare and ultra-rare diseases.
55, Old Broad Street London, EC2M 1RX United KingdomCostello Medical is an award winning, independent, global healthcare agency specialising in medical communications, market access and HEOR. Since our founding in 2008, we have grown organically to a team of more than 500 colleagues, supporting over 300 different client organisations globally, from our offices based in the UK, US, Canada, Singapore and China. As an independent agency we are not beholden to external shareholders, allowing us to remain fully client-focused, flexible in how we work, and uncompromising on scientific quality. Together, our global presence, diverse scientific expertise, values driven culture and award winning performance position Costello Medical as a trusted, long term partner for organisations seeking strategic insights coupled with excellent scientific support across the healthcare sector. Our core service offerings are as follows: Medical Communications Our Medical Communications services cover publications, medical affairs, and creative support. We provide publications development, planning and consultancy, enhanced content such as infographics, videos and podcasts, and policy reports. Medical affairs work includes strategy development, omnichannel delivery, scientific exchange, insight gathering through advisory boards, surveys and Delphi panels, and congress engagement such as symposia and scientific coverage. Creative services span graphic, digital and motion design, branding, web and app development, and interactive experiences. We also deliver commercial and marketing support including brand positioning, launch communications, promotional materials, congress resources and disease awareness campaigns. Evidence Development Our Evidence Development services cover literature reviews, statistics and real-world evidence. Literature review expertise includes systematic, pragmatic, rapid and scoping reviews, as well as strategic evidence reviews, competitor intelligence and gap analyses. Statistics support spans analysis plan development, meta-analyses, indirect treatment comparisons, trial and utility analyses, survival modelling and epidemiology, with training and publications support also provided. Real-world evidence services include study design and analysis across databases, registries, electronic health records, observational studies, surveys, qualitative research and expert elicitation, alongside strategic evidence generation planning, data source mapping and dissemination through publications. Value and Access Our Value and Access services cover health economics, health technology assessment and market access. Our health economics services include cost-effectiveness and budget impact models, feasibility assessments, early modelling, technical validation, customer-facing interactive tools, advisory boards and training. HTA support includes strategy development, multi-country HTA submissions, JCA activities, early Scientific Advice, mock stakeholder meetings, payer and clinician advisory boards, training and HEOR publications. We also provide market access strategy and planning, the development of global, regional and local value dossiers, value propositions and messaging, roll-out workshops and objection handlers, as well as local country-specific resources such as AMCP dossiers, interactive tools, brochures, ABN materials and formulary packs. Health Policy & Public Affairs Our Health Policy and Public Affairs services cover the preparation of white papers, position papers, policy briefs, roundtable reports and policy research reports. We also produce best practice, consensus and recommendation articles, expert opinion papers and options appraisals. In addition, we can support multi-stakeholder engagement through Delphi panels, surveys, focus groups, interviews, policy landscape mapping, stakeholder mapping, roundtables and steering committees. Our services also include the creation of advocacy toolkits and policy campaign materials. We also have a dedicated Patient Engagement team who deliver patient engagement activities such as landscape assessments, strategic recommendations, surveys, advisory boards and workshops, as well as the development of patient information, education and support resources and communication of patient commitments. In addition, we collaborate with government bodies and public institutions to deliver policy research, healthcare evaluation projects and strategic initiatives. MedTech and Rare Diseases Expertise In addition to our experience in all major therapeutic areas, we have dedicated MedTech and Rare Diseases teams who work seamlessly across all of our teams with specialist knowledge of the challenges and nuances inherent to MedTech products and rare and ultra-rare diseases.
Cowley Road, Cambridge, UKCovalAb offers antibodies, peptide design, antibody services, synthesis, and ELISAs.
Rivers Lodge West Common Harpenden, Hertforshire, AL5 2JD United KingdomCovalence Research Ltd is a small-scale agency focussed on delivering high-quality health economic models and analyses, systematic literature reviews, medical writing services, and data dashboards including off-the-shelf access to UK Secondary Care Medicines Data (SCMD).
51 Hayes Grove London, SE22 8DF United KingdomCovalence Research Ltd is a small-scale agency focussed on delivering high-quality health economic models and analyses, systematic literature reviews, medical writing services, and data dashboards including off-the-shelf access to UK Secondary Care Medicines Data (SCMD).
6 - 7 Saint Cross Street London, England, EC1N 8UA United KingdomTransformation Done, Together. Crackle was founded to solve a common failure in life sciences: strong strategy that never translates into real-world impact. Too often, Medical and Commercial teams operate in parallel — generating insight, evidence and plans that don’t fully connect to how care is actually delivered or adopted. We exist to close that gap. Based in London, we are a digital and AI-enabled strategic implementation team that works across Medical and Commercial functions to turn ambition into action. By integrating strategy, design and delivery, we ensure that what gets planned is implemented, adopted and scaled within real health system conditions. We help Medical and Commercial teams move faster from insight to measurable impact. Our focus is on unlocking adoption — connecting scientific evidence, clinical pathways and market dynamics to drive real-world change. We identify where to act through data and system insight, redesign pathways and services to remove barriers, and enable teams with the tools, capabilities and operating models required for execution. Our work spans early strategy through to in-market delivery, including pathway diagnostics, market readiness and launch enablement, modular “solutions-in-a-box”, and AI-enabled decision support. The result is aligned Medical–Commercial execution that accelerates uptake, improves patient outcomes, and delivers tangible commercial and system value.
58 Wood Lane London London, England, W127RZ United KingdomRed blood cell-derived nanoparticles for RNA delivery.
Cranfield Bedfordshire MK43 0AL United KingdomThe mission of the Applied Mycology and Predictive Microbiology Group is to understand the effect of environmental factors on the physiology of economically important microbes, particularly fungi, and to exploit these understandings for the food, environment and health sectors.
Cranfield Bedfordshire MK43 0AL United KingdomCranfield University is recognised internationally for its work in relation to soil and water management and the interface between agriculture and the environment. This is underpinned by our specialist expertise and a range of laboratory and field research facilities. Largest of these is the Cranfield University Experimental Farm. This is a commercially run farm which is also used for field scientific and engineering research. Located at Silsoe, Bedfordshire, the Cranfield University Experimental Farm comprises 120 hectares of arable land with a number of small farm woods and a mature agro-forestry trial site. Draining to either groundwater or local surface waters, the farm covers several different soil types, slope conditions and cropping histories that offer opportunities for replicated plot experiments, as well as field and subcatchment scale studies. Research work includes: 1. Soil and water engineering and management (soil mechanics and dynamics, on-the-go sensors to monitor soil properties, soil remediation, soil degradation, soil-plant-water interactions, nutrient management, hydraulics, tillage and cultivations) 2. Field and environmental engineering (irrigation and drainage, soil conservation, soil injection and land application of biosolids, controlled traffic farming systems, water well pumping technologies, irrigation studies and off-road vehicle capability) 3. Agricultural mechanisation (precision seeding and weeding, variable input agriculture, harvest machinery, crop processing machinery, precision drills and tillage equipment) Activities on the farm are supported by a fully dedicated Land Equipment Centre and workshops, with a range of tractor units, farm machinery and agricultural implements. The farm is used by Cranfield staff as a valuable research, training and teaching resource.
Cranfield Bedfordshire MK43 0AL United KingdomWater is the most important factor limiting crop production on a global scale; water resources are increasingly under pressure due to population growth, climate change, competition from diverse users and the desire to prevent environment damage. The Crop Water Use Group takes a multidisciplinary approach to improve crop production when water is limiting. Our research projects include the disciplines of plant physiology, molecular biology, molecular genetics, soil water dynamics and irrigation science.
Cranfield Bedfordshire MK43 0AL United KingdomPostharvest Biology and Technology houses the Plant Science Laboratory which is one of the largest centres dedicated to research, consultancy and education in postharvest biology and technology of fresh produce in Europe. Since our establishment in 2002 we continue to grow our research in terms of revenue, national and international reputation and scientific excellence. We service all sectors of the fresh produce supply chain including many of the major multinational food companies, multiple food retailers and undertake research for both national and international Governments, research councils, multinationals and various grower levy bodies. Key research areas Fundamental postharvest physiology and biochemistry of fresh produce Targeted and non-targeted metabolomics Technology development for reducing waste and extending storage, shelf- and home-life of fresh produce Sensor and product development (including packaging).
Cranfield Bedfordshire MK43 0AL United KingdomCranfield’s Soil Management Facility is a purpose built, state of the art resource for the advancement of soil dynamics, soil management and soil conservation techniques. The facility features environment simulation tools, which provide a world-class resource for the detailed study of soil-implement, soil-human and soil-plant-water interactions and the optimisation of machinery efficiency, performance testing and method development.
Cranfield Bedfordshire MK43 0AL United KingdomA state-of-the-art analytical facility to determine concentrations of organic compounds in vapour phase in media such as soil gas, ambient and indoor air. Technology is focused particularly on thermal desorption/gas chromatography/mass spectrometry (TD/GC/MS) with other associated systems including liquid injection GC/MS and Selected Ion Flow Tube Mass Spectrometry (SIFT-MS). Field instrumentation such as photoionisation detectors (PID) and air sampling pumps is available for site investigations. Our passive and pumped sorbent tube sampling technology enables determination of ppb concentrations of a wide range of organic chemicals in air. Sensitivity and specificity is enhanced by use of TD/GC/Time-of-Flight mass spectrometer (TOF-MS). Our experienced staff have applied technology to studies of contaminated land, occupational, ambient and indoor air quality and applied data to the assessment of risk of exposure and consequential human health effects.
Cranfield Bedfordshire MK43 0AL United KingdomThe laboratory is for measuring whole-soil carbon balances and greenhouse gas fluxes, including stable-isotope compositions, in large, intact, hydrologically-isolated soil monoliths (lysimeters) under field conditions. It contains 24 lysimeters connected to automated gas flux chambers and instruments. The lysimeters are 0.8m in diameter and 1m deep, i.e., at least the size of a soil pedon, and therefore representative of field soil conditions. Each is equipped with systems for controlling soil moisture and surface temperature, and instruments to allow near continuous sampling of gases emitted from the surface, dissolved solutes passing out of the bottom, and temperature, moisture and soil solution at different depths. Onsite environmental conditions are monitored with a weather station. The gas flux chambers (26cm head space) are fixed over the soil surface and have pneumatically operated lids. Gases accumulated in the head space when the lids are closed are passed through a continuous loop to an infra red gas analyser (IRGA) and an isotope ratio mass spectrometer (IRMS) housed in an instrument building. This allows simultaneous analysis of CO2 , CH4 , N2O, O2 and N2 and their C, O and N isotope compositions at natural or enriched abundances. The soil monoliths in the lysimeters contain electrical heating elements in the surface, capable of maintaining the soil surface at up to 5 o C above ambient temperature. They also have automated sprinkler irrigation systems, delivering rainwater collected from the roof of the instrument building. Presently the system contains two soil types planted with grass. These are a well-drained, acid, coarse loamy soil from Bedfordshire, and a poorly-drained, seasonally waterlogged loamy soil over clay from Warwickshire. The soil monoliths were taken intact from these sites, preserving the natural soil structure, and brought to Cranfield.
Maidstone House King Street Maidstone, Kent, ME15 6JQ United KingdomCREATION Interactive Limited (t/a CREATION.co) is an insights product company specialising in digital intelligence, with a focus on the online voice of healthcare professionals and Digital Opinion Leaders.
Meditrina Building 260 Babraham Research Campus Cambridge CB22 3ATCrescendo Biologics focuses on in vivo generation of human heavy chain antibodies through transgenic mice, developing therapeutic antibodies, and affinity optimization using ribosome display platforms.
New Cambridge House Bassingbourn Road Litlington, Cambridgeshire, SG8 0SS United KingdomCresset Discovery Services manages and delivers outsourced computational chemistry programs for pre-clinical research. Engage our experienced scientists to work alongside your chemists to solve problems, provide fresh ideas, remove roadblocks and add direction and insight, and reach your next milestone faster and more cost effectively. Computational chemistry helps your chemists understand as much as possible about the systems they are working on. This makes it easier to direct your resources in the direction most likely to succeed, saving you time and money. Every client brings a different approach, new science and a fresh way of working. We propose methods that provide answers in the most intelligent and innovative way we can. Collaboration often sparks new and better methods and ideas, through new challenges and by the synergistic nature of contract research. We have extensive industry experience and a proven track record working on over 450 projects with many leading pharmaceutical, biotech, agrochemical, flavor and fragrance companies. As our services are flexible, you can access expertise where and when you need it you eliminate unnecessary overheads while obtaining a world class service. Use us as your long term CRO or to help navigate bottlenecks in your project.
Bassingbourn Road Bassingbourn Road Litlington, England, SG8 0SS United KingdomCresset Discovery Services manages and delivers outsourced computational chemistry programs for pre-clinical research. Engage our experienced scientists to work alongside your chemists to solve problems, provide fresh ideas, remove roadblocks and add direction and insight, and reach your next milestone faster and more cost effectively. Computational chemistry helps your chemists understand as much as possible about the systems they are working on. This makes it easier to direct your resources in the direction most likely to succeed, saving you time and money. Every client brings a different approach, new science and a fresh way of working. We propose methods that provide answers in the most intelligent and innovative way we can. Collaboration often sparks new and better methods and ideas, through new challenges and by the synergistic nature of contract research. We have extensive industry experience and a proven track record working on over 450 projects with many leading pharmaceutical, biotech, agrochemical, flavor and fragrance companies. As our services are flexible, you can access expertise where and when you need it you eliminate unnecessary overheads while obtaining a world class service. Use us as your long term CRO or to help navigate bottlenecks in your project.
24 Cornhill London, EC3V 3ND United KingdomCrysalin develops rapid and cost effective solutions for determining protein structures where current methodologies have proved ineffective, including GPCRs and other membrane bound proteins.
Chilterns House Dean Street Marlow SL7 3AA UKCuro Consulting provides highly differentiated value communication solutions to the Pharmaceutical sector, enabling our clients to discuss the value and return on investment proposition to their new therapies with budget holders in state and private health services. With over a decade’s experience in the wider consulting industry, Curo offers a new perspective and a different approach to Market Access. Well respected in the industry, we pride ourselves on thinking beyond the usual parameters of the pharma world. True, we have a team of Health Economics experts and specialist software builders, but we are not data processors, nor a software company. Instead, we use our resources to build narratives that speak to Payers and answer their questions; helping you to show that it’s value that matters, not cost. Curo are also proud winners of The Queen’s Award for Enterprise – International Trade, 2015, the UK’s highest accolade for business success.
Curo Consulting Ltd, 49-51 Dean Street United Kingdom MARLOW, Buckinghamshire, SL7 3AA United KingdomCuro Consulting provides highly differentiated value communication solutions to the Pharmaceutical sector, enabling our clients to discuss the value and return on investment proposition to their new therapies with budget holders in state and private health services. With over a decade’s experience in the wider consulting industry, Curo offers a new perspective and a different approach to Market Access. Well respected in the industry, we pride ourselves on thinking beyond the usual parameters of the pharma world. True, we have a team of Health Economics experts and specialist software builders, but we are not data processors, nor a software company. Instead, we use our resources to build narratives that speak to Payers and answer their questions; helping you to show that it’s value that matters, not cost. Curo are also proud winners of The Queen’s Award for Enterprise – International Trade, 2015, the UK’s highest accolade for business success.
Hove, England United KingdomCustom Pharmaceuticals offers packing, gateway testing, regulatory services, product development, clinical trials manufacture and packing and analytical development services.
BioPark Broadwater Road Welwyn Garden City, Hertfordshire AL7 3AX United KingdomCyclofluidic is using CyclOps™, its proprietary drug discovery platform, to revolutionise hit-to-lead optimisation. CyclOps™ connects chemistry, purification, screening and drug design with complex algorithms allowing drug lead molecules to be assayed minutes, rather than weeks, after they are designed. Using the power of flow or batch chemistry, our unique approach puts synthesis, screening and molecular design firmly back together in a single laboratory allowing fast iterative exploration of vast areas of diverse chemical space. CyclOps™ is the ultimate lean approach to lead discovery, allowing us to optimise hits in real time, making and screening only those key compounds that progress a hypothesis towards the best possible lead molecules.
Welwyn Garden City, England United KingdomCyclofluidic is using CyclOps™, its proprietary drug discovery platform, to revolutionise hit-to-lead optimisation. CyclOps™ connects chemistry, purification, screening and drug design with complex algorithms allowing drug lead molecules to be assayed minutes, rather than weeks, after they are designed. Using the power of flow or batch chemistry, our unique approach puts synthesis, screening and molecular design firmly back together in a single laboratory allowing fast iterative exploration of vast areas of diverse chemical space. CyclOps™ is the ultimate lean approach to lead discovery, allowing us to optimise hits in real time, making and screening only those key compounds that progress a hypothesis towards the best possible lead molecules.
1st Floor, One Suffolk Way Sevenoaks, Kent, TN13 1YL United KingdomCyentia Biosource provides researchers with access to high-quality, ethically sourced human biospecimens. Leveraging our extensive clinical network of vetted partners, we offer prospectively collected fresh or preserved samples with detailed clinical annotation, tailored to meet specific client needs. In addition, we provide access to banked human tissues and biofluids from both disease state and control donors. Our mission is to set the industry standard in biospecimen provision through rigorous feasibility assessment, ethical sourcing, and uncompromising quality so researchers can trust every sample and accelerate scientific discovery.
4 Technopark, Newmarket Road Cambridge, CB5 8PB United KingdomCytocell offers FISH probes and DNA screening solutions.
2 HARDING WAY CAMBRIDGE, CAMBRIDGESHIRE, CB43RR United KingdomProvide technical and managerial consultancy services to the biopharmaceutical industry.
2 Harding Way England, CB4 3RR United KingdomProvide technical and managerial consultancy services to the biopharmaceutical industry.
London, United KingdomOur expertise is antibody humanization. The founders have humanized >40 therapeutic candidates. Our royalty-free design service is individually tailored to your needs and budget.
Units 13-14 Swan Business Park Sandpit Road Dartford Kent DA1 5ED ENGLANDDavid Norris Analytical Laboratories was founded in September 2005 by David and Kirsty Norris. David set up DNAL to provide a specialist service to the Agrochemical Industry. The business is a family Company, established and wholly owned by David and Kirsty Norris. Over the years our team has continued to grow steadily in size and experience and we have invested heavily in a variety of new technologies to offer first class analytical services to meet our Clients needs both now and in the future. We have doubled our laboratory floor space recently and have the capacity to continue to grow and take on new projects to meet demand.
Monmouth House 38 Artillery Lane London E1 7LS United KingdomDeallus provides offerings to support strategy development and decision making in life-science organizations.
Friars House, 160 Blackfriars Road London, SE1 8EZ United KingdomDRG is the premier provider of healthcare analytics, data and insight products and services to the worlds leading pharmas, biotech and medical technology companies.
70 St. Mary Axe London, EC3A 8BE United KingdomDRG is the premier provider of healthcare analytics, data and insight products and services to the worlds leading pharmas, biotech and medical technology companies.
1 Minster Court Tuscam Way Camberey, Surrey, GU15 3YY United KingdomDecisive Consulting is a global Market Access consultancy, created in 2020 as a solution to a gap our founder, Esther Nzenza, saw during her 24 years in the pharmaceutical industry. Our experienced team have worked in industry leadership roles, on average for 20 years+. We are proficient at identifying what needs to be achieved, and make sure it delivered, we lean-in where other consultancies step back. We serve a variety of clients ranging from global pharmaceutical companies to emerging biotech organisations. We solve our clients’ most challenging issues, including pricing, access, value, portfolio design, launch strategy, partnership strategy, and policy development, from early concepts through to in-country P&R negotiation: Strategic Planning throughout lifecycle Market Access and Pricing Strategy & Execution Launch sequencing Commercial Assessments We help you find the weaknesses in your cross functional plans and devise ways to address them: Gap analysis and mitigation planning Launch Readiness Reviews Mock Payer Negotiations Advisory Boards and targeted insight gathering JCA readiness (PICO Predict & JCA Lab) https://teamdecisive.com/ https://www.picopredict.com/ https://www.jca-lab.com/ Rebel thinking for Decisive moments We believe there needs to be more creativity in access strategy We challenge the status quo to realise what’s possible
84 Eccleston Square London, Greater London, SW1V 1NP United KingdomDecisive Consulting is a global Market Access consultancy, created in 2020 as a solution to a gap our founder, Esther Nzenza, saw during her 24 years in the pharmaceutical industry. Our experienced team have worked in industry leadership roles, on average for 20 years+. We are proficient at identifying what needs to be achieved, and make sure it delivered, we lean-in where other consultancies step back. We serve a variety of clients ranging from global pharmaceutical companies to emerging biotech organisations. We solve our clients’ most challenging issues, including pricing, access, value, portfolio design, launch strategy, partnership strategy, and policy development, from early concepts through to in-country P&R negotiation: Strategic Planning throughout lifecycle Market Access and Pricing Strategy & Execution Launch sequencing Commercial Assessments We help you find the weaknesses in your cross functional plans and devise ways to address them: Gap analysis and mitigation planning Launch Readiness Reviews Mock Payer Negotiations Advisory Boards and targeted insight gathering JCA readiness (PICO Predict & JCA Lab) https://teamdecisive.com/ https://www.picopredict.com/ https://www.jca-lab.com/ Rebel thinking for Decisive moments We believe there needs to be more creativity in access strategy We challenge the status quo to realise what’s possible
Dawson Road Mount Farm Bletchley Milton Keynes Buckinghamshire MK1 1JNDeli 24 are the first UK Contract Processing Facility to offer High Pressure Processing. We are a privately owned company with extensive management experience in the creation and successful operation of innovative manufacturing processes.
Building B, Watchmoor Park, Camberley, , Surrey, GU15 3YL United KingdomDELPHIC HSE Delphic HSE is a leading provider of product safety and regulatory compliance services to the global consumer and industrial chemical markets. WHO WE ARE Delphic HSE has provided its industry-leading services since 2009. From its origins as a UK company, Delphic HSE responded to the growth in global demand for chemical safety of consumer products. We expanded rapidly to our current workforce of over 60 technical and support experts in our operations centres in UK, Hong Kong, Australia, the United States and The Netherlands. With further offices announced for China, we are proud to be a dominant international partner to some of the world’s most respected brands. Delphic HSE has remained true to its roots and we strive to support start-up or smaller companies with the advice and guidance they need to flourish. What makes Delphic HES different to other compliance consultancies, is the way we partner with our clients to meet their compliance needs, at speed that suits the client. We treat each partnership as an investment, knowing that if the client succeeds, we succeed. WHAT WE DO PAST AND PRESENT Delphic HSE supports companies to ensure their products are safe, compliant and correctly registered. This includes a range of specialist services, including: • Toxicological risk assessments of ingredients and formulations • Regulatory and compliance documentation to ensure products can be registered • Review of product labelling and claims • Guidance to navigate and achieve regulatory compliance in global markets • Product registration to meet national requirements • Regulation monitoring to ensure product compliance ‘in-the-market’ • Responsible Person (EU & UK) services and other mandated legal representation of products • Training for regulatory compliance • Ongoing engagement with supply chain and NPD (e.g. responsibilities of manufacturers) on behalf of our clients • Expert Witness and professional consultation • Monitoring, analysis and recommendation on global ingredients and impact on formulation. WHAT WE WILL BE DOING Delphic HSE will develop an even more expansive global footprint while offering holistic services, utilising innovative digital platforms to help bring products to market, quicker, smarter and more widespread, without compromising on product compliance. The Delphic HSE future: • Using automation to expedite compliance reporting and reduce human error • Provide client ‘owned’ portals that allow clients to feel ‘in-control’ of their critical path • Providing strategic locations hubs that allow for ‘inception-to-registration’ product support • Build global regulatory scanning, templates and ‘checks’ to aid R&D plans • Next generation service delivery, research and product commercialisation • Diversifying service offerings and offering a more ‘one-stop-shop’ approach to product safety and compliance
2 Royal College StreetLondon NW1 0NH United KingdomdeltaDOT is a spin out company from Imperial College London UK - a team of scientists and engineers dedicated to the advancement of analytical techniques using patented methods and instrumentation in High Performance Capillary Electrophoresis (HPCE). We design and produce HPCE instruments which we are marketing worldwide. We also use the same instruments to offer Analytical Services and Contract Research. Our offices and laboratories are based in the London Bioscience Innovation Centre (LBIC). High Performance Capillary Electrophoresis (HPCE) analytical instruments are designed, manufactured and marketed by deltaDOT. These instruments use deltaDOT’s proprietary imaging and analysis technology called Label Free Intrinsic Imaging (LFII®). High Performance Capillary Electrophoresis and Label Free Intrinsic Imaging applied to a CE analytical system offers dramatically improved discovery power in comparison to other conventional CE systems. deltaDOT team of scientists has developed considerable expertise in CE based analysis and in solving clients’ analytical problems. Using our own HPCE LFII® analytical instruments we also offer Analytical Services and Contract Research to industry and academia from our laboratories in the London Bioscience Innovation Centre
London BioScience Innovation Centre 2 Royal College St, Kings Cross London, NW1 0NH United KingdomdeltaDOT is a spin out company from Imperial College London UK - a team of scientists and engineers dedicated to the advancement of analytical techniques using patented methods and instrumentation in High Performance Capillary Electrophoresis (HPCE). We design and produce HPCE instruments which we are marketing worldwide. We also use the same instruments to offer Analytical Services and Contract Research. Our offices and laboratories are based in the London Bioscience Innovation Centre (LBIC). High Performance Capillary Electrophoresis (HPCE) analytical instruments are designed, manufactured and marketed by deltaDOT. These instruments use deltaDOT’s proprietary imaging and analysis technology called Label Free Intrinsic Imaging (LFII®). High Performance Capillary Electrophoresis and Label Free Intrinsic Imaging applied to a CE analytical system offers dramatically improved discovery power in comparison to other conventional CE systems. deltaDOT team of scientists has developed considerable expertise in CE based analysis and in solving clients’ analytical problems. Using our own HPCE LFII® analytical instruments we also offer Analytical Services and Contract Research to industry and academia from our laboratories in the London Bioscience Innovation Centre
28 Hanbury St. London, E1 6QR United KingdomDesktop Genetics is a UK biotechnology company that imagines and creates intuitive software solutions and high performance assays for genome editing experiments.
Science and Technology Centre Earley Gate Whiteknights Road Reading RG6 6BZ United KingdomDextra are carbohydrate specialists with an international reputation in all areas of research, synthesis and analysis of carbohydrates and complex sugars.
No.4 East Wing Gemini House, Flex Meadow Harlow, CM19 5TJ United KingdomDiamond Pharma Services is a group of companies offering consulting services to support regulatory affairs and product development in the EU and US. Diamond BioPharm Ltd provides consultancy services in European regulatory affairs and product development to the biotech and pharmaceutical industries. The company was founded in 2005 under the leadership of Dr. Maureen Graham (ex. Amgen, MSD, Glaxo & IVAX). The team Dr Graham has established includes those with a broad and varied industry experience and former regulators, offering both breadth and depth of expertise, from which our clients can benefit. Our many years of industry experience and expertise is across a broad range of therapeutic areas and product types (biotechnology including monoclonal antibodies, gene-therapy and new chemical entities - both innovative and generics). The entire team has significant experience and knowledge of European regulatory procedures (national, mutual recognition, decentralised and centralised) and an in-depth awareness of current legislation and industry trends. Diamond BioPharm consultants have extensive experience of assisting clients with regulatory support from early stages of product development through to achievement of marketing authorisations, orphan designations, scientific advice and have also assisted with the maintenance of marketing authorisations through variations, and monitoring and updating of prescribing information. Diamond BioPharm Ltd was awarded TOPRA Innovation Award 2013 for supporting the first gene therapy product approval in Europe. Diamond Pharma Services, Inc. provides consultancy services in US regulatory affairs and product development to the biotech and pharmaceutical industries. The company was founded in 2015 as a subsidiary of Diamond BioPharm Ltd. Diamond Pharma Services, Inc. consultants have extensive experience of assisting clients with regulatory support from early stages of product development and IND initiation through to achievement of marketing authorisations, orphan designations and successful FDA meetings.
No.4 East Wing Gemini House Flex Meadow Harlow, Essex CM19 5TJ United KingdomDiamond Pharma Services is a group of companies offering consulting services to support regulatory affairs and product development in the EU and US. Diamond BioPharm Ltd provides consultancy services in European regulatory affairs and product development to the biotech and pharmaceutical industries. The company was founded in 2005 under the leadership of Dr. Maureen Graham (ex. Amgen, MSD, Glaxo & IVAX). The team Dr Graham has established includes those with a broad and varied industry experience and former regulators, offering both breadth and depth of expertise, from which our clients can benefit. Our many years of industry experience and expertise is across a broad range of therapeutic areas and product types (biotechnology including monoclonal antibodies, gene-therapy and new chemical entities - both innovative and generics). The entire team has significant experience and knowledge of European regulatory procedures (national, mutual recognition, decentralised and centralised) and an in-depth awareness of current legislation and industry trends. Diamond BioPharm consultants have extensive experience of assisting clients with regulatory support from early stages of product development through to achievement of marketing authorisations, orphan designations, scientific advice and have also assisted with the maintenance of marketing authorisations through variations, and monitoring and updating of prescribing information. Diamond BioPharm Ltd was awarded TOPRA Innovation Award 2013 for supporting the first gene therapy product approval in Europe. Diamond Pharma Services, Inc. provides consultancy services in US regulatory affairs and product development to the biotech and pharmaceutical industries. The company was founded in 2015 as a subsidiary of Diamond BioPharm Ltd. Diamond Pharma Services, Inc. consultants have extensive experience of assisting clients with regulatory support from early stages of product development and IND initiation through to achievement of marketing authorisations, orphan designations and successful FDA meetings.
Digital Bio pharm LTD 145-157 St. John Street London, UK EC1V 4PWDigital BioPharm offers in silico drug discovery and hit to lead optimization services.
Kemp House 152 City Road London, EC1V 2NX United KingdomDigital BioPharm offers in silico drug discovery and hit to lead optimization services.
145-157 Saint John Street London, England, EC1V 4PW United KingdomDigitalBioPharm ltd is consulting company, working in the field of biomedicine. Our main philosophy – IT-solutions usage in drug discovery and biotechnology. Our services include: preclinical drug discovery, virtual prediction of molecular docking, QSAR, medical 3D animation, venture investments consulting and due dilligence.
145-157 St. John Street London,UK EC1V4PWDigitalBioPharm ltd is consulting company, working in the field of biomedicine. Our main philosophy – IT-solutions usage in drug discovery and biotechnology. Our services include: preclinical drug discovery, virtual prediction of molecular docking, QSAR, medical 3D animation, venture investments consulting and due dilligence.
72 York Terrace United Kingdom Cambridge, Cambridgeshire, CB1 2PR United KingdomWe work with Pharmaceutical and Biotech companies to ensure their analytical functions outperform the demands and objectives of modern drug discovery. Consulting services encompass the conduct of operational reviews, mitigating resource or expertise shortages with in-laboratory-based support, training and bespoke software/automation solutions.
Suite 4, De Walden Court 85 New Cavendish Street London W1W 6XD United KingdomDishman CRAMS offers development services, kilo supply, cGMP pilot production and full scale cGMP manufacture.
Newport Pagnell, England, MK16 United KingdomDJB Labcare provides servicing for centrifuges and incubators.
Unit 20, Howard Way Interchange Park, Newport Pagnell, Buckinghamshire MK16 9QS, United KingdomDJB Labcare provides servicing for centrifuges and incubators.
Chesterford Research Park Little Chesterford Saffron Walden, Essex, Cb10 1xl United KingdomDomainex offers a range of services in the following fields: - Protein expression and characterisation, including using a proprietary gene fragmentation technology known as Combinatorial Domain Hunting (CDH) to generate up to 100K constructs of a soluble target of interest - Structural biology : X-ray crystallography and cryo-EM - Assay development and compound screening - Computer-Aided Drug Design (CADD), supported by AI/ML - Virtual screening - Integrated fragment-based drug discovery, including screening my microscale thermophoresis - Hit-to-lead and lead optimization medicinal chemistry - Bioanaytical method development -Direct-to-biology (D2B) platform for rapid synthesis and assay screening -Proprietary PureDisc membrane protein isolation & purification platform -Biotherapeutics and antibody characterisation
Little Chesterford Little Chesterford, England, CB10 1XL United KingdomDomainex offers a range of services in the following fields: - Protein expression and characterisation, including using a proprietary gene fragmentation technology known as Combinatorial Domain Hunting (CDH) to generate up to 100K constructs of a soluble target of interest - Structural biology : X-ray crystallography and cryo-EM - Assay development and compound screening - Computer-Aided Drug Design (CADD), supported by AI/ML - Virtual screening - Integrated fragment-based drug discovery, including screening my microscale thermophoresis - Hit-to-lead and lead optimization medicinal chemistry - Bioanaytical method development -Direct-to-biology (D2B) platform for rapid synthesis and assay screening -Proprietary PureDisc membrane protein isolation & purification platform -Biotherapeutics and antibody characterisation
England United KingdomDotmatics offers compound sourcing, analytics, chemical libraries, structure elucidation, and assay reporting.
1-2 Thorley Hall Stables Bishop's Stortford Herts CM23 4BE UNITED KINGDOMDotmatics offers compound sourcing, analytics, chemical libraries, structure elucidation, and assay reporting.
Newmarket Rd Fordham, Ely Cambridge, Cambridgeshire, CB7 5WW United KingdomDrug Development Solutions is a contract research organisation (CRO) offering GLP and GCP bioanalysis of small molecules, large proteins for pharmacokinetics, biomarkers and immunogenicity. We also provide cGMP analytical sciences research and testing services, consultancy and quality control solutions to support Chemistry Manufacturing and Control (CMC) requirements at all stages of the drug development pipeline from discovery through preclinical and clinical development to commercial manufacture. Our Cambridge (Fordham) site is one of the largest bioanalytical centres in the world. The site employs around 380 scientists operating from 8,000m2 purpose-built, state-of-the-art analytical labs.
Cart House 2, Copley Hill Business Park, Cambridge Road Babraham Cambridge, Cambridgeshire, CB22 3GN United Kingdom3DConsultants provide scientific consultancy, due diligence services and project management as well as support in helping you to start or sell your company. Our business model is based upon the partnership’s capability of providing a specialist solution for those looking for expert advice and support across all aspects of the drug discovery and development process. We are able to achieve this through deploying a team of highly experienced scientists with core competencies across a broad range of disciplines including in vitro/in vivo biology, medicinal chemistry, DMPK, pre-clinical development (CMC, tox, scale-up) through clinical development (operations, management, regulatory). With more than a hundred years of collective experience in both biotech and pharma across the discovery and development spectrum, our team has the skill sets and experience to provide practical, cost-efficient and timely solutions to your project through consultation on an individual basis or as a team.
Wrecclesham Road Wrecclesham, England, GU10 4PS United Kingdom DXS International has been providing clinical decision support to the primary care and retail pharmacy sectors in the UK for the past ten years. DXS has a range of products that enables healthcare stakeholders, such as Primary Care Organisations, Pharmaceuticals, Healthcare Educators, Service Providers and many more to provide pertinent information regarding patient treatment to a busy clinician in the workflow. The result is improved outcomes delivered cost effectively. DXS achieves this through its standard DXS Point of Care platform which integrates with any patient record system and delivers content relevant to the patient’s condition during the consultation. This is why 20,000 GPs and 4,500 retail pharmacies have DXS in the UK.
Wrecclesham House Wrecclesham Road Farnham GU10 4PS United Kingdom DXS International has been providing clinical decision support to the primary care and retail pharmacy sectors in the UK for the past ten years. DXS has a range of products that enables healthcare stakeholders, such as Primary Care Organisations, Pharmaceuticals, Healthcare Educators, Service Providers and many more to provide pertinent information regarding patient treatment to a busy clinician in the workflow. The result is improved outcomes delivered cost effectively. DXS achieves this through its standard DXS Point of Care platform which integrates with any patient record system and delivers content relevant to the patient’s condition during the consultation. This is why 20,000 GPs and 4,500 retail pharmacies have DXS in the UK.
Babraham, England, CB22 3AU United KingdomEagle Genomics specializes in bioinformatics and offers data mining, next generation sequencing data analysis, microarray analysis, and other applications.
Babraham Hall Babraham Research Campus\ Babraham, Cambridge CB22 3AT United KingdomEagle Genomics specializes in bioinformatics and offers data mining, next generation sequencing data analysis, microarray analysis, and other applications.
New Road East Malling Kent ME19 6BJEast Malling Research (EMR), located in Kent, England, has a history dating back to 1913 when it was established by the fruit growing sector to address the many challenges faced by growers. Since its establishment, the team at East Malling have introduced wide-ranging advances to horticulture which have shaped the way produce is grown and supplied to the consumer. Today, our mission is to conduct high-quality strategic and applied research in horticultural and environmental sciences, and to deliver knowledge, products and services that benefit public and private customers. Our vision is to be recognised as the pre-eminent research institute in the UK, with a significant international reputation for strategic and applied research, development and innovation in horticulture, with particular emphasis on perennial and clonally propagated crops.
New Road East Malling, England United KingdomEast Malling Research (EMR), located in Kent, England, has a history dating back to 1913 when it was established by the fruit growing sector to address the many challenges faced by growers. Since its establishment, the team at East Malling have introduced wide-ranging advances to horticulture which have shaped the way produce is grown and supplied to the consumer. Today, our mission is to conduct high-quality strategic and applied research in horticultural and environmental sciences, and to deliver knowledge, products and services that benefit public and private customers. Our vision is to be recognised as the pre-eminent research institute in the UK, with a significant international reputation for strategic and applied research, development and innovation in horticulture, with particular emphasis on perennial and clonally propagated crops.
3 Bishop Square Hatfield, AL10 9NA United KingdomeBioscience offers custom antibody conjugation services, antibody and recombinant protein products, and detection kits.
1259 London Road C/O MCL ACCOUNTANTS LEIGH-ON-SEA , Essex, SS9 2AF United KingdomEight 9 Health is a medical communications agency that helps biopharmaceutical and diagnostic teams bring their science to life. By combining scientific expertise with creative storytelling, we turn complex data into clear, engaging content that connects with healthcare professionals, patients, and stakeholders.
10 Albemarle Street, London, W1S 4HH, United KingdomElementis Specialties provides high value functional additives to many markets including architectural and industrial coatings, personal care and oilfield drilling. These additives improve the flow characteristics and performance of our customers’ products or production processes. We offer a comprehensive product portfolio that includes rheology modifiers for aqueous and solvent systems, defoamers, colorants, waxes, dispersing and wetting agents, adhesion promoters and surface active additives.
71-75 Shelton Street Covent Garden London, England, WC2H 9JQ United KingdomWelcome to Elevate. We are committed to elevating outcomes and empowering access with technology-driven and human-led innovative solutions. Leading in Health Economics, Real World Evidence, Market Access, and Value Communications across the technology development and commercialisation lifecycle: AI-powered Research, Consulting and Communication Solutions. Disease Areas: Chronic Diseases (progressive and episodic); Rare Diseases; Infectious Diseases Key Markets: US, Europe (including UK), EMEA, APAC, LATAM Elevate HE: Health Economics: Modelling & Evaluation. We provide sophisticated economic models and analyses to help you make informed decisions and optimise healthcare resources. Elevate RWE: Real-World Evidence: Generation & Synthesis. Utilising real-world data, we offer insights that drive decision-making and improve patient outcomes. Elevate Access & Value Communication: Market Access & Value Communication. We navigate regulatory, reimbursement and post-access pathways and communicate the value of healthcare products to stakeholders creatively and effectively. Tech-enabled solutions: Technology and AI meets Science and Consulting Excellence. We are on a mission to innovate life sciences research, consulting and communication to transform outcomes for our clients and patients worldwide. Service Packages: An integrated and holistic product lifecycle perspective. Service packages designed to meet specific product and market needs.
20 Station Road Cambridge, CB1 2JD United KingdomWe're embrace, a results-driven communications agency. We specialise in supporting clients operating within the life science / pharmaceutical sector where speed of innovation for accelerating patient impact is paramount. Our design solutions are focused on producing productive outcomes and demonstrable progress, ensuring that meetings and events fulfil their goal and purpose. We support our clients throughout the process, end-to-end, from strategic direction, creative design and development, to delivery to ensure long-term impact. Bringing best-in-class thinking, expertise, and rigour to where it matters most.
Parkshot House, 5 Kew Road Richmond, Surrey TW9 2PR United KingdomEmergent is dedicated to one simple mission—to protect and enhance life. As a global specialty pharmaceutical company, Emergent offers specialized products to healthcare providers and governments to address medical needs and emerging health threats. Our goal We pursue innovative ways to protect life. Whether it is developing and delivering specialized products that can make life better for millions of adults and children or medical countermeasures that protect the nation against chemical and biological threats, we are passionate in pursuit of our mission—to protect and enhance 50 million lives by 2025. We give highest priority to: • Delivering on our commitments to patients, customers and partners • Pursuing innovation in our product portfolio • Developing our employees • Giving back to our communities • Achieving our financial goals
Bessemer Drive Business and Technology Centre, Stevenage, SG1 2DX United KingdomeMolecules is an eCommerce company that supplies samples to customers all over the world with a strong background in cheminformatics.
Rowland Hill Street England, NW3 United KingdomEngitix is the first biotech in the world applying human extracellular matrix (ECM) biomaterials for drug discovery and development in fibrosis and solid tumours. The ECM is the non-cellular component present within all tissues and organs and provides not only essential physical scaffolding for the cellular constituents but also initiates crucial biochemical and biomechanical cues that are required for tissue morphogenesis, differentiation and homeostasis. However, dysregulated ECM remodelling is associated with pathological conditions and can exacerbate disease progression such as fibrosis and cancer. The loss of tissue ECM homeostasis and integrity is seen as one of the hallmarks of cancer and typically defines transitional events in cancer progression and metastasis. Consequently, ECM molecules and/or mechanisms associated to ECM remodelling are important targets for pharmacotherapy. Unfortunately, until recently, ECM has been largely ignored in drug discovery. The rapidly increasing knowledge in the biology of the ECM will likely lead to compounds able to directly target the ECM with significant advantages in the treatment of chronic fibrogenic human and oncology diseases.
Rowland Hill street United Kingdom London, London, City of, NW3 2PF United KingdomEngitix is the first biotech in the world applying human extracellular matrix (ECM) biomaterials for drug discovery and development in fibrosis and solid tumours. The ECM is the non-cellular component present within all tissues and organs and provides not only essential physical scaffolding for the cellular constituents but also initiates crucial biochemical and biomechanical cues that are required for tissue morphogenesis, differentiation and homeostasis. However, dysregulated ECM remodelling is associated with pathological conditions and can exacerbate disease progression such as fibrosis and cancer. The loss of tissue ECM homeostasis and integrity is seen as one of the hallmarks of cancer and typically defines transitional events in cancer progression and metastasis. Consequently, ECM molecules and/or mechanisms associated to ECM remodelling are important targets for pharmacotherapy. Unfortunately, until recently, ECM has been largely ignored in drug discovery. The rapidly increasing knowledge in the biology of the ECM will likely lead to compounds able to directly target the ECM with significant advantages in the treatment of chronic fibrogenic human and oncology diseases.
Jeffreys Building, Unit 1 St John’s Innovation Park Cambridge, CB4 0DS United KingdomEnhanced Genomics, the therapeutics company rapidly transforming massive amounts of disease-associated genetic variant data into causal biology to deliver new, high-confidence, genetically validated drug targets for common diseases via its proprietary cell type-specific 3D multi-omics platform.
Newton Hall, Town Street Newton, Cambridge CB22 7ZE United KingdomEnzagen has over 20 years of experience in industrial biocatalysis, covering all aspects of manufacturing processes using enzymes.
London, UKThe ERA Consulting Group provides biopharmaceutical consulting relating to quality, nonclinical, and clinical aspects.
15 Brackenbridge Drive, South Ruislip London, HA4 0NF United KingdomHealthcare technology company building tools to drive better decision making in healthcare. We specialise in consulting and technology for pharmaceutical clients in the area of health economics and outcomes research with a particular focus on network meta analysis.
84 Wood Lane London, London, W12 0BZ United KingdomAll Alamar panels. Femtogram sensitivity. One platform to decode disease biology at scale. • Full Alamar offering: NULISAseq CNS Disease Panel 120, Inflammation Panel, Mouse Panel, oncology panels, custom assays, and full bioinformatics support. • Deepest sensitivity on the market: femtogram-level LoD powered by NULISA chemistry. • Massive multiplexing: 120+ CNS markers plus broad inflammatory and immunology coverage from a single 10 µL sample (25 µL input). • End-to-end insight generation: raw data → QC → differential expression → pathway + network analysis → AI-driven interpretation. • Works across modalities: neurodegeneration, neuroinflammation, oncology, immunology, precision medicine. • Ideal for preclinical & clinical programs: stratification, target discovery, PK/PD, MoA, responder analysis. • Minimal sample burden, maximal biological resolution. Esya holds numerous chemical biology patents for ground-breaking and novel research assays which ratiometrically quantify ion levels within endocytic organelles.
2 Royal College Street, Camden London NW1 0NH - UKThe ETT - ‘ALTERNATIVE TOXICITY SERVICES’ platform provides a high content screening services for evidence based acute general toxicity and neurotoxicity, taking advantage of alternative test methods in compliance with the international principles of the 3Rs - Replacement, Refinement and Reduction.
Fyfield Business & Research Park Fyfield Road Ongar Essex, CM5 0GS United KingdomEurofins Discovery built its industry-leading reputation on successfully delivering best-in-class drug discovery & development outsourcing services to any organization, large or small. No matter where you are in the preclinical process—or if you need full end-to-end solutions—our experts and industry’s largest catalog of phase-appropriate off-the-shelf catalog assays can support you every step of the way with purpose, precision, and innovation. As a global leader in drug discovery solution provider for over 40 years, we have strategically curated a deep and broad range of over 8,000 off-the shelf and custom assays and related services covering cell line engineering, bioassay development for biologic and biosimilar drug lot release, chemistry, safety & efficacy, mechanism-of-action, ADME-toxicology, and translational biology. Our team of industry experts for, in vitro and in vivo services, GPCRs, and custom protein, cell line, bulk cells and assay development gene editing projects work across disciplines to collaborate with you. Eurofins Discovery’s comprehensive capabilities, knowledge base, and skill sets enable the company to provide clients the benefit of working with a single outsourcing provider (CRO) for all drug discovery programs whether you choose to conduct the project in house or outsource. Delve into all the ways we can work together by choosing the best path forward for you from our comprehensive services.
3, Crossfield Close Shinfield Reading RG2 9AY, United KingdomEurofins EAG Materials Science, LLC has a long history, dating back to the birth of the company in 1978 in California, as Charles Evans & Associates. Over the years we have expanded from a single location offering SIMS only to having over 200 employees offering over 30 different services via 14 locations in 8 different countries. The original focus of the company was supporting semiconductor manufacturing but now we also work with multiple further industries beyond semiconductors, including: solar/PV, lighting, photonics, energy storage, aerospace & defense, medical devices, raw materials, glass, polymers and plastics and consumer products. EAG's analytical expertise is what enables us to help our clients to meet their goals. Our on-demand analytical testing services can help streamline R&D, solve urgent problems during manufacturing and help resolve materials related issues in the global supply chain, both within and between organizations.
Fyfield Business & Research Park Fyfield Road Ongar, Essex, CM5 0GS United KingdomEurofins Integrated Discovery UK Ltd is a leading provider of contract research services in drug discovery to the pharmaceutical and biotechnology industries as well as academic institutions, charities and not-for-profit organisations. Eurofins Integrated Discovery exclusively offer a Peptidyl-Prolyl-Isomerase (cyclophilin, FKBP and pin1) Profiling Portfolio that includes both binding and functional assays. In addition we offer cell-based assays to assess mitochondrial function and death, and cell-based models for Parkinson’s disease. We specifically provide expertise, resource and project management of integrated drug discovery services, including medicinal and synthetic chemistry, biology and ADME, as required to accelerate early drug discovery customer projects and deliver preclinical drug candidates. The highly industry experienced Eurofins Integrated Discovery team has a 100% track record of delivering preclinical candidates for our customers, with a number entering the clinic most recently. In addition, Eurofins Integrated Discovery scientists provide innovative solutions to customer drug discovery projects as proven by their co-authorship on >100 patents and publications. Furthermore, Eurofins Integrated Discovery assists academic groups and biotechnology companies with scientific expertise to support grant applications; to date Eurofins Integrated Discovery has helped such groups to receive a total of over $10 million funding to initiate and advance their drug discovery projects
Fyfield Business and Research Park Fyfield Road Ongar, Essex, CM5 0GS United KingdomEurofins Selcia is a global leader in 14C custom radiolabelling, stable isotope labelling and analytical services. With many years of experience our team of expert synthetic radiochemists can prepare radiolabelled molecules of almost any complexity for use in regulatory studies by the life sciences and chemical industries to understand: preclinical and clinical drug metabolism, human mass balance (GMP 14C Radiolabelled API), dermal penetration, tissue distribution and environmental fate. Selcia also offers GLP NMR and analytical problem solving services to support regulatory submissions, as well as the profiling and synthesis of metabolites and process impurities.
Fyfield Business and Research Park Fyfield Road Ongar, Essex, CM50GS United KingdomEurofins Selcia is a global leader in 14C custom radiolabelling, stable isotope labelling and analytical services. With many years of experience our team of expert synthetic radiochemists can prepare radiolabelled molecules of almost any complexity for use in regulatory studies by the life sciences and chemical industries to understand: preclinical and clinical drug metabolism, human mass balance (GMP 14C Radiolabelled API), dermal penetration, tissue distribution and environmental fate. Selcia also offers GLP NMR and analytical problem solving services to support regulatory submissions, as well as the profiling and synthesis of metabolites and process impurities.
North Street, Wicken Ely, Cambridge CB7 5XW United KingdomEuropa Bioproducts supplies various antibodies, proteins, cell products, and other reagents in addition to custom services including protein conjugation, antibody production, and glycan analytical services.
Hinxton, England, CB10 United KingdomThe EMBL-EBI maintains the world's most comprehensive range of molecular databases.
40 Occam Road, The Surrey Research Park, Guilford, Surrey, GU2 7YG, UKEuropean Centre for Chirality (EC2), through the partnership of the BioTools Inc, University of Antwerp and Ghent University, offers chiral related analytical services to support structure determination.
88 Wood Street London, EC2V 7RS United KingdomThe European Medical Journal (EMJ) is an Independent, open-source medical journal which is dedicated to delivering insights into ground-breaking changes and advancements in Medicine. At the core of our content community is a portfolio of peer-reviewed, open-access journals, which are complemented by alternative formats such as interactive content, podcasts, webinars, videos, and infographics. These provide an essential resource for senior medical professionals today and the brilliant new minds of tomorrow. EMJ About us: https://www.emjreviews.com/about-us/#
Metro Building 6th Floor, 1 Butterwick London, W6 8DL United KingdomEvidera, part of PPD clinical research business, Thermo Fisher Scientific, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of healthcare products. We help biopharmaceutical, biotechnology, and medical technology companies identify, generate and communicate the evidence needed to optimize the market access and commercial potential of their products. Our strategic, scientific and operational experts listen to your needs and provide integrated and tailored solutions to provide you the evidence and insights to move your products forward. We support our clients throughout the full drug development cycle, from pre-clinical to post-launch and real-world use. We have partnered with every one of the top 20 biopharmaceutical companies and over 250 small and mid-sized biotechnology companies — supporting their evidence-generation needs for over 35 years. U.S. headquarters in Bethesda, MD (Washington, D.C.) European headquarters in London Primary offices in Boston, Budapest, Harrisburg, Montreal, San Francisco and Seattle
201 Talgarth Rd Hammersmith, London, W6 8BJ United KingdomEvidera, part of PPD clinical research business, Thermo Fisher Scientific, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of healthcare products. We help biopharmaceutical, biotechnology, and medical technology companies identify, generate and communicate the evidence needed to optimize the market access and commercial potential of their products. Our strategic, scientific and operational experts listen to your needs and provide integrated and tailored solutions to provide you the evidence and insights to move your products forward. We support our clients throughout the full drug development cycle, from pre-clinical to post-launch and real-world use. We have partnered with every one of the top 20 biopharmaceutical companies and over 250 small and mid-sized biotechnology companies — supporting their evidence-generation needs for over 35 years. U.S. headquarters in Bethesda, MD (Washington, D.C.) European headquarters in London Primary offices in Boston, Budapest, Harrisburg, Montreal, San Francisco and Seattle
Units 1-4 Craven Court Camberley Surrey GU15 3BW UKExova provides environmental testing, pharmaceutical testing, immunoassay development, formulation, characterization, and batch release testing.
Babraham Hall Babraham Cambridge Cambridgeshire CB22 3AT UNITED KINGDOMExpedeon Ltd provides protein folding, analytics, purification, stabilization, and scale-up.
Summer Road, Thames Ditton, Surrey KT7 0RH, EnglandExpo Technologies provides consultancy, engineering solutions, on-site services and training programs.
FABRX 29-39 Brunswick Square London, UK, WC1N 1AX United Kingdom*Pharmaceutical 3D Printer* The M3DIMAKER is the world's first GMP-ready pharmaceutical 3D printer series with in-built quality control features for human and veterinary precision medicine manufacture, available to purchase or rent. *Software* Our comprehensive M3DIMAKER Studio software packages can be used to control the printer, ensure quality and collect patient feedback. *Printlets™ & Formulation* Our world leading scientists can help you design, develop and test 3D printable formulations for your chosen active ingredients.
3 Clay chimney Albury road Furneux pelham, Hertfordshire, SG9 0LP United KingdomFacilipharma provides medical writing, market access consulting, workshop support and pharmaceutical consulting services.
7300 Cambridge Research Park Cambridge, CB25 9TN United KingdomFahy Gurteen Laboratories develops nucleic acid tests and high throughput systems for fully automated immunohistochemistry and immunocytochemistry staining of tumour tissues and cytospin preparation.
7300 Cambridge Research Park Beach Drive Waterbeach, Cambridge, Cambridgeshire, CB25 9TN United KingdomFahy Gurteen Laboratories develops nucleic acid tests and high throughput systems for fully automated immunohistochemistry and immunocytochemistry staining of tumour tissues and cytospin preparation.
82B High Street, Sawston, Cambs, CB22 3HJ United KingdomFairJourney Bio (FJBio) is a leading antibody discovery and engineering CRO supporting biotech and pharmaceutical companies in the discovery and development of next-generation therapeutic antibodies and biologics. FJBio provides integrated end-to-end solutions from target validation to optimized development candidate, combining advanced discovery technologies with deep expertise in antibody engineering, developability and functional characterization. Antibody Discovery Platforms Our discovery capabilities combine multiple complementary technologies to maximize success rates: Phage display antibody libraries (human, synthetic and immune repertoires) Single B-cell antibody discovery from human donors, immunized animals and transgenic platforms Hybridoma antibody generation Nanobody (VHH) discovery from llama immune libraries These platforms enable rapid identification of high-affinity binders across multiple antibody formats including IgG, Fab, scFv, VHH and engineered antibody fragments. Antibody Engineering & Optimization FJBio provides advanced antibody engineering services to optimize lead candidates for therapeutic development: affinity maturation and CDR engineering antibody humanization sequence optimization and developability improvement bispecific and multispecific antibody engineering antibody format conversion and optimization Biophysical Characterization & Developability Our comprehensive characterization capabilities ensure robust candidate selection and early risk mitigation: SPR kinetics and affinity measurement epitope binning and epitope mapping stability and aggregation analysis glycan profiling and HPLC analytics hydrophobicity, polyreactivity and developability screening Functional Assays FJBio provides a broad portfolio of cell-based and functional assays to evaluate antibody mechanism of action: receptor binding and blocking assays internalization assays reporter gene assays immune effector function analysis including ADCC, ADCP and CDC Antibody Production & Expression We offer flexible recombinant antibody expression and production capabilities including: mammalian expression systems bacterial expression systems antibody fragment production scalable antibody production for discovery and preclinical research Structural Biology & AI-Driven Antibody Design FJBio combines experimental platforms with advanced computational capabilities including: cryo-EM structural biology for antibody–antigen complex analysis rational antibody engineering supported by machine learning-driven sequence analysis Proven Track Record With more than 250 industry partners, over 1,400 projects completed and more than 19 antibodies advanced to clinical development or market, FJBio has established itself as a trusted scientific partner for antibody discovery programs worldwide. Our collaborative science-driven approach, combined with flexible discovery platforms and integrated characterization capabilities, enables partners to accelerate biologics discovery while reducing development risk. For more information, please visit: www.fjbio.com/
Unit 2 London Road Cambridge, CB22 3EG United KingdomFairJourney Bio (FJBio) is a leading antibody discovery and engineering CRO supporting biotech and pharmaceutical companies in the discovery and development of next-generation therapeutic antibodies and biologics. FJBio provides integrated end-to-end solutions from target validation to optimized development candidate, combining advanced discovery technologies with deep expertise in antibody engineering, developability and functional characterization. Antibody Discovery Platforms Our discovery capabilities combine multiple complementary technologies to maximize success rates: Phage display antibody libraries (human, synthetic and immune repertoires) Single B-cell antibody discovery from human donors, immunized animals and transgenic platforms Hybridoma antibody generation Nanobody (VHH) discovery from llama immune libraries These platforms enable rapid identification of high-affinity binders across multiple antibody formats including IgG, Fab, scFv, VHH and engineered antibody fragments. Antibody Engineering & Optimization FJBio provides advanced antibody engineering services to optimize lead candidates for therapeutic development: affinity maturation and CDR engineering antibody humanization sequence optimization and developability improvement bispecific and multispecific antibody engineering antibody format conversion and optimization Biophysical Characterization & Developability Our comprehensive characterization capabilities ensure robust candidate selection and early risk mitigation: SPR kinetics and affinity measurement epitope binning and epitope mapping stability and aggregation analysis glycan profiling and HPLC analytics hydrophobicity, polyreactivity and developability screening Functional Assays FJBio provides a broad portfolio of cell-based and functional assays to evaluate antibody mechanism of action: receptor binding and blocking assays internalization assays reporter gene assays immune effector function analysis including ADCC, ADCP and CDC Antibody Production & Expression We offer flexible recombinant antibody expression and production capabilities including: mammalian expression systems bacterial expression systems antibody fragment production scalable antibody production for discovery and preclinical research Structural Biology & AI-Driven Antibody Design FJBio combines experimental platforms with advanced computational capabilities including: cryo-EM structural biology for antibody–antigen complex analysis rational antibody engineering supported by machine learning-driven sequence analysis Proven Track Record With more than 250 industry partners, over 1,400 projects completed and more than 19 antibodies advanced to clinical development or market, FJBio has established itself as a trusted scientific partner for antibody discovery programs worldwide. Our collaborative science-driven approach, combined with flexible discovery platforms and integrated characterization capabilities, enables partners to accelerate biologics discovery while reducing development risk. For more information, please visit: www.fjbio.com/
Food & Drug Analytical Services, Biocity, Pennyfoot Street, Nottingham, NG1 1GF, United KingdomFDAS was founded in 2004 to better address the third-party laboratory analytical needs of the pharmaceutical industry. Drawing on significant experience in pharmaceutical manufacturing and contract laboratory testing, our management team continues to develop an offering that is relevant to and integrates with the evolving pharma-CMO landscape. Quality Working in MHRA accredited facilities, FDAS conducts all analysis at its Nottingham cGMP facility. With a team of over 20 and a focus on training and retention, we therefore build and retain control of all aspects of quality management.
3 COLLEGE YARD LOWER DAGNALL STREET St Albans, Hertfordshire, AL3 4PA United KingdomWe are a consultancy committed to launching products that make a difference in people’s lives. We work across a product’s lifecycle, supporting biotech, pharmaceutical, and medical technology companies across the globe. Our 5 key services and two products include: Outcomes Research Our team provide unequalled accuracy and quality whilst delivering all aspects of systematic reviews, meta-analyses and patient-level data analyses. Economic Modelling We develop a range of robust health economic models that meet the commercial needs of our clients from simple Markov models to complex discrete event simulations. Health Technology Assessment We have extensive experience delivering successful HTA submissions in the UK and across the globe. Value Communication We effectively communicate the value of your products in a logical and insightful manner; from internal value dossiers to external scientific publications. Pricing & Reimbursement We partner with our clients to develop strategies for global pricing and reimbursement, harnessing our extensive KOL and payer network. FIECON challenge the conventional and think outside the box to provide game-changing, innovative products that meet your commercial needs. FIECON Model Builder can help you build best-in-class Excel-based cost-effectiveness models, whilst significantly reducing building time. Our online platform automates the design and development process of cost-effectiveness models, removing the risk of human error and guaranteeing accuracy. Ratified, endorsed, and used by key payers and HTA agencies, models can be built in a matter of minutes rather than weeks. FIECON Value Platform can help you manage and optimise your product’s pricing and market access processes. Your online portal helps Global teams quickly understand progress, priorities, and support needs in local markets, saving you time, increasing team efficiency, and ensuring unity and alignment.
Hodgkin Huxley house 30 Farringdon Lane London, EC1R 3AW United KingdomWe are a consultancy committed to launching products that make a difference in people’s lives. We work across a product’s lifecycle, supporting biotech, pharmaceutical, and medical technology companies across the globe. Our 5 key services and two products include: Outcomes Research Our team provide unequalled accuracy and quality whilst delivering all aspects of systematic reviews, meta-analyses and patient-level data analyses. Economic Modelling We develop a range of robust health economic models that meet the commercial needs of our clients from simple Markov models to complex discrete event simulations. Health Technology Assessment We have extensive experience delivering successful HTA submissions in the UK and across the globe. Value Communication We effectively communicate the value of your products in a logical and insightful manner; from internal value dossiers to external scientific publications. Pricing & Reimbursement We partner with our clients to develop strategies for global pricing and reimbursement, harnessing our extensive KOL and payer network. FIECON challenge the conventional and think outside the box to provide game-changing, innovative products that meet your commercial needs. FIECON Model Builder can help you build best-in-class Excel-based cost-effectiveness models, whilst significantly reducing building time. Our online platform automates the design and development process of cost-effectiveness models, removing the risk of human error and guaranteeing accuracy. Ratified, endorsed, and used by key payers and HTA agencies, models can be built in a matter of minutes rather than weeks. FIECON Value Platform can help you manage and optimise your product’s pricing and market access processes. Your online portal helps Global teams quickly understand progress, priorities, and support needs in local markets, saving you time, increasing team efficiency, and ensuring unity and alignment.
England United KingdomAt the heart of FieldArm there are five agronomists holding BASIS, FACTS and NPTC qualifications, together with trained support staff, who have many years of agricultural and trials expertise between them. Since our inception in early 2009, we have conducted over 800 trials (400 in the last two years) mostly in the UK for many of the multi-national agrochemical companies, farming groups and distributors.
Suite 8525, 16-18 Circus Road St. John's Wood London, United KingdomFinetech Industry specializes in developing, manufacturing and marketing fine organic compounds and intermediates for the pharmaceutical industry.
Oakley Road OX39 4TW United KingdomFinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Our state-of-the-art facilities, highly experienced scientific team and commitment to work closely with clients every step of the way, have helped us to build an excellent reputation in the gene therapy market. We are authorised under EMA for the production of gene therapy products for clinical and commercial supply. We offer services across a wide range of viral-based product types, including Adenoviral, AAV, and Lentiviral-based vectors. From our cutting-edge fully-licensed GMP manufacturing facility in Finland, we have built an extensive pipeline of gene therapy products and technologies for our clients.
Sanderum House Oakley Road Chinnor OX39 4TW United KingdomFinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Our state-of-the-art facilities, highly experienced scientific team and commitment to work closely with clients every step of the way, have helped us to build an excellent reputation in the gene therapy market. We are authorised under EMA for the production of gene therapy products for clinical and commercial supply. We offer services across a wide range of viral-based product types, including Adenoviral, AAV, and Lentiviral-based vectors. From our cutting-edge fully-licensed GMP manufacturing facility in Finland, we have built an extensive pipeline of gene therapy products and technologies for our clients.
Woodside Bishop's Stortford Herts CM23 5RG UKFisher Bioservices offers biorepository and biobanking services, clinical trial sample management, specimen processing, DNA/RNA extraction, and PCR/QPCR services including WGA PCR, cell therapy storage and logistics, and biologic API transport, storage and handling.
Sanderum House Oakley Road Chinnor, Oxon OX39 4TW, United KingdomFlavorActiV is dedicated to providing Sensory Taster Management, Taster Validation and Sensory Training to customers worldwide with our team of multilingual Global Sensory Managers. FlavorActiV is the world’s only provider of pharmaceutical quality produced and controlled GMP Flavour Standards for use in beer, wine, cider, carbonated soft drinks, waters and many other beverages to help train professional sensory panels.
38 Oakley Road England, OX39 4TW United KingdomFlavorActiV is dedicated to providing Sensory Taster Management, Taster Validation and Sensory Training to customers worldwide with our team of multilingual Global Sensory Managers. FlavorActiV is the world’s only provider of pharmaceutical quality produced and controlled GMP Flavour Standards for use in beer, wine, cider, carbonated soft drinks, waters and many other beverages to help train professional sensory panels.
Unit 1, Pale Lane Farm Hartley Wintney, Hampshire, RG27 8DH United KingdomFleet Bioprocessing Ltd. is a specialist CRO providing expert immunoassay development, lateral flow assay (LFA) development and advanced bioconjugation services. Operating under ISO 9001 and ISO 13485 certified quality systems, we support clients from early-stage R&D through regulated product development to commercial manufacture. Immunoassay Development: We design and optimise ELISA, automated and microfluidic assays including Gyrolab®, supporting clinical diagnostics and bioanalytical applications (PK, PD, ADA). Lateral Flow Assay Development: Our LFA services cover antibody screening, proof-of-concept, feasibility, optimisation, performance verification, stability studies and technical transfer, providing robust, scalable solutions. Bioconjugation: As recognised leaders, we deliver tailored antibody, antigen and small molecule conjugates (enzyme, gold, latex, fluorescent, luminescent, biotin/streptavidin, magnetic beads), supported by protein purification, lyophilisation, formulation and dispensing.
RG27 8DH United KingdomFleet Bioprocessing Ltd. is a specialist CRO providing expert immunoassay development, lateral flow assay (LFA) development and advanced bioconjugation services. Operating under ISO 9001 and ISO 13485 certified quality systems, we support clients from early-stage R&D through regulated product development to commercial manufacture. Immunoassay Development: We design and optimise ELISA, automated and microfluidic assays including Gyrolab®, supporting clinical diagnostics and bioanalytical applications (PK, PD, ADA). Lateral Flow Assay Development: Our LFA services cover antibody screening, proof-of-concept, feasibility, optimisation, performance verification, stability studies and technical transfer, providing robust, scalable solutions. Bioconjugation: As recognised leaders, we deliver tailored antibody, antigen and small molecule conjugates (enzyme, gold, latex, fluorescent, luminescent, biotin/streptavidin, magnetic beads), supported by protein purification, lyophilisation, formulation and dispensing.
94 Rickmansworth Road Watford Herts WD18 7JJ United KingdomFleet Laboratories provides manufacturing of toiletry and pharmaceuticals.
Suite 6 The Brew Tower Marlow Bucks SL7 2UQ UKWe have been providing competitive intelligence for our clients since 1988—before Google, before e-mail, before LinkedIn. While we have grown and adapted as the world has changed and use everything we can to get the job done ethically, we also know that the new technologies can easily become crutches, and many users never scratch below the surface of search results.
Unit A The Paddocks Business Centre Cherry Hinton Road Cambridge, Cambridgeshire, CB1 8DH United KingdomFluidic Analytics – Understand the Machinery of Life Fluidic Analytics envisions a world where information about proteins and their behaviour transforms our understanding of how the biological world operates, and helps all of us make better decisions about how we diagnose diseases, develop treatments and maintain our personal well-being. By building the world’s best tools, software and services for protein characterisation and making them universally accessible in the lab, in the clinic or at home, we are making this vision a reality not just for a small group of expert users, but for everyone who can benefit. www.fluidic.com
Cherry Hinton Road Cherry Hinton Road England, CB1 8DH United KingdomFluidic Analytics – Understand the Machinery of Life Fluidic Analytics envisions a world where information about proteins and their behaviour transforms our understanding of how the biological world operates, and helps all of us make better decisions about how we diagnose diseases, develop treatments and maintain our personal well-being. By building the world’s best tools, software and services for protein characterisation and making them universally accessible in the lab, in the clinic or at home, we are making this vision a reality not just for a small group of expert users, but for everyone who can benefit. www.fluidic.com
27-29 Jarman Way ROYSTON, Hertfordshire, SG8 5HW United KingdomAt Fluidic Sciences, the home of the Fluidity One-M and Sphere Bio, we deliver an end-to-end portfolio for complex biology. Move seamlessly from multiple single-cell screening to in-solution biophysics; reducing assumptions and accelerating confident decisions.
Science Building University of Hertfordshire Hertfordshire, England, AL10 9AB United KingdomFluid Pharma are a technology licensing organisation who are experts in the development of novel oral solid and liquid dosage forms. Our primary focus is to leverage our technology to develop easy to swallow and highly acceptable formulations comprising coated micropellets. The technology can be used for taste masking, time controlled or site controlled drug release applications.
167-169 Great Portland Street, Fifth Floor London, W1W 5PF United KingdomR&D Consultancy providing bespoke machine learning solutions to big data challenges in health and biosciences
2nd Floor, 6 Arlington St London, SW1A 1REFreenome (free•nohm) is the dynamic collection of genetic material floating in your blood (cell-free) derived from the trillions of cells in your body. It is your living cell-free genome changing over time and space. Your freenome is the genomic thermometer of who you are as you grow, live, and age. Our platform allows you to track the health of your freenome so you can make the best decisions for you. Your freenome helps you design your “healthy" and then serves as a warning system for “unhealthy" conditions such as cancer so that you can get the care that you need, when you need it. It is precision wellness - for your freenome - for your health.
6th Floor Manfield House 1 Southampton Street London, London, WC2R 0LR United KingdomAt GCATbio, we are revolutionizing DNA synthesis through our innovative high-throughput DNA synthesizer, mMPS (microchip-based Massive Parallel Synthesis) and the Gene Synthesis Auto Workstation, delivering high-quality, low-cost genes for a broad range of applications in life science and biotechnology. > Revolutionary mMPS Technology: Our mMPS platform harnesses thousands to millions of individually barcoded microchips, each dedicated to synthesizing a single oligonucleotide at the pmol–nmol scale. This enables: - Unmatched quality and consistency in DNA synthesis, - Scalable and flexible production for diverse research needs, and - Significant cost and time efficiencies across workflows. > The mMPS system is optimized for applications including: - Variant library construction - Custom DNA/RNA synthesis - NGS panel generation - DNA data storage Whether your research focuses on gene or genome synthesis, gene editing, antibody discovery, protein or pathway engineering, or molecular diagnostics, GCATbio’s mMPS platform empowers your innovation with speed, precision, and scalability. > Integrated Solutions for Life Science Research: Beyond synthesis, GCATbio is committed to advancing the entire research ecosystem by developing complete solutions for essential raw materials. Our portfolio includes: - Reagents, kits, and consumables (e.g., peptides, functional proteins, molecular biology reagents, and biochemicals) - Custom R&D and synthesis services - Comprehensive support for synthetic biology, protein engineering, and biochemistry research
Analytical Chemistry Centre 6 Fen End, Astwick Road Stotfold, Hitchin, SG5 4BA, UKG C Laboratories Ltd was incorporated in 1972 and are thus in our 39th year of successful trading. Over this period we have analysed numerous samples and, as a consequence, have gained a wide and varied client base. A large number of our clients, many 'blue chip' as well as international and foreign companies, have been with us for 25 years or more. Our dedication to analytical excellence has gained us the confidence of major international organisations and governments, our Certificates of Analysis being accepted by companies and regulatory authorities around the world. G C Laboratories has steadily grown since its conception and, as a consequence, in 1998, moved to our much larger premises at Stotfold. G C Laboratories analytical performance and commitment to good science is recognised by the fact that we are accredited to the internationally accepted Good Laboratory Practice (GLP) standard. This very exacting Quality Standard, which is applied to Laboratories worldwide, is overseen in this country by the Medicines Control Agency, and is subject to Statutory Regulation under the UK Good Laboratory Practice Regulations 1999 (SI No. 3106), the Good Laboratory Practice (Codification Amendments, Etc.) Regulations 2004 (SI No.994), and the OECD Principles of Good Laboratory Practice (as revised in 1997) ENV/MC/CHEM(98)17, which are in accordance with the requirements of Directives 2004/9/EC and 2004/10/EC. GC Laboratories Ltd was one of the first laboratories in this country to be accredited to this standard in 1989 and have maintained this accreditation right up to the present day. Copies of our current GLP Certificate are available if required.
Fen End Stotfold, England, SG5 4BA United KingdomG C Laboratories Ltd was incorporated in 1972 and are thus in our 39th year of successful trading. Over this period we have analysed numerous samples and, as a consequence, have gained a wide and varied client base. A large number of our clients, many 'blue chip' as well as international and foreign companies, have been with us for 25 years or more. Our dedication to analytical excellence has gained us the confidence of major international organisations and governments, our Certificates of Analysis being accepted by companies and regulatory authorities around the world. G C Laboratories has steadily grown since its conception and, as a consequence, in 1998, moved to our much larger premises at Stotfold. G C Laboratories analytical performance and commitment to good science is recognised by the fact that we are accredited to the internationally accepted Good Laboratory Practice (GLP) standard. This very exacting Quality Standard, which is applied to Laboratories worldwide, is overseen in this country by the Medicines Control Agency, and is subject to Statutory Regulation under the UK Good Laboratory Practice Regulations 1999 (SI No. 3106), the Good Laboratory Practice (Codification Amendments, Etc.) Regulations 2004 (SI No.994), and the OECD Principles of Good Laboratory Practice (as revised in 1997) ENV/MC/CHEM(98)17, which are in accordance with the requirements of Directives 2004/9/EC and 2004/10/EC. GC Laboratories Ltd was one of the first laboratories in this country to be accredited to this standard in 1989 and have maintained this accreditation right up to the present day. Copies of our current GLP Certificate are available if required.
1379 High Road LONDON N20 9LP UKGentaur is a supplier of life science research products.
The Stables, Springfield Farm Lewes Road Haywards Heath, RH17 7NG United KingdomThe company’s research and production divisions focus in particular on the synthesis of benzothiazoles, benzimidazoles, furanes, indoles, isocyanates, isothiocyanates, thiophene derivatives, phosphorus compounds, pyridines, and rare sugars capable of providing these synthetic products from a few grams to many kilograms.
36 Gordon Square London WC1H 0PD UNITED KINGDOMGeorge Clinical provides trial management, strategy development, clinical monitoring, and regulatory expertise.
12 Deer Park Road Lombard Business Park Wimbledon London SW19 3FB United KingdomGlentham Life Sciences is a leading supplier of fine chemicals, biochemicals and life science products.
John Carpenter House John Carpenter Street London, London, EC4Y 0AN United KingdomWe have decades of experience in being the trusted, gold standard intelligence provider to leading Pharmaceutical brands, manufacturers, and suppliers, helping them to make faster, more informed decisions.
Park Street London, W1K 6SS United KingdomGlobal Pricing Innovations are drug pricing specialists, supporting pharma and biotech companies to maximise product value through data driven pricing and market access solutions. Headquartered in London, GPI provide best-in-class data analytics platform and consulting services, providing evidence-based decision support helping clients to make better investment decisions and with GPI horizon, has the only value assessment and price prediction platform on the market. As a team of leading domain specialists, GPI provide high quality, curated and rapid insights. We are ideally placed to make recommendations on global drug pricing strategy, market access optimisation, asset evaluation, value perception and payer analytics. GPI’s suite of technology and bespoke service offerings are powered by GPI pulse™, a solution that harnesses the power of technology, data, and collective expertise to produce rapid insights. Company Culture Our team are as passionate about your success as you are, and we strive to help our customers succeed. As a team of domain specialists, we bring energy, enthusiasm and expertise into everything we do. People are at the core of any business and that’s no different at GPI. We are always working with our staff to ensure a happy, healthy and prosperous relationship, recruiting and retaining the best in the industry. Visit our website www.globalpricing.com for more about who we are, our innovative solutions and career opportunities.
64 North Row Mayfair London, W1J 5RL United KingdomGlobal Pricing Innovations are drug pricing specialists, supporting pharma and biotech companies to maximise product value through data driven pricing and market access solutions. Headquartered in London, GPI provide best-in-class data analytics platform and consulting services, providing evidence-based decision support helping clients to make better investment decisions and with GPI horizon, has the only value assessment and price prediction platform on the market. As a team of leading domain specialists, GPI provide high quality, curated and rapid insights. We are ideally placed to make recommendations on global drug pricing strategy, market access optimisation, asset evaluation, value perception and payer analytics. GPI’s suite of technology and bespoke service offerings are powered by GPI pulse™, a solution that harnesses the power of technology, data, and collective expertise to produce rapid insights. Company Culture Our team are as passionate about your success as you are, and we strive to help our customers succeed. As a team of domain specialists, we bring energy, enthusiasm and expertise into everything we do. People are at the core of any business and that’s no different at GPI. We are always working with our staff to ensure a happy, healthy and prosperous relationship, recruiting and retaining the best in the industry. Visit our website www.globalpricing.com for more about who we are, our innovative solutions and career opportunities.
116 Park Street Park House London, W1K 6SS United KingdomGlobal Pricing Innovations are drug pricing specialists, supporting pharma and biotech companies to maximise product value through data driven pricing and market access solutions. Headquartered in London, GPI provide best-in-class data analytics platform and consulting services, providing evidence-based decision support helping clients to make better investment decisions and with GPI horizon, has the only value assessment and price prediction platform on the market. As a team of leading domain specialists, GPI provide high quality, curated and rapid insights. We are ideally placed to make recommendations on global drug pricing strategy, market access optimisation, asset evaluation, value perception and payer analytics. GPI’s suite of technology and bespoke service offerings are powered by GPI pulse™, a solution that harnesses the power of technology, data, and collective expertise to produce rapid insights. Company Culture Our team are as passionate about your success as you are, and we strive to help our customers succeed. As a team of domain specialists, we bring energy, enthusiasm and expertise into everything we do. People are at the core of any business and that’s no different at GPI. We are always working with our staff to ensure a happy, healthy and prosperous relationship, recruiting and retaining the best in the industry. Visit our website www.globalpricing.com for more about who we are, our innovative solutions and career opportunities.
Eastcastle House 27/28 Eastcastle Street London, Please select, W1W 8DH United KingdomGlobal Pricing Innovations are drug pricing specialists, supporting pharma and biotech companies to maximise product value through data driven pricing and market access solutions. Headquartered in London, GPI provide best-in-class data analytics platform and consulting services, providing evidence-based decision support helping clients to make better investment decisions and with GPI horizon, has the only value assessment and price prediction platform on the market. As a team of leading domain specialists, GPI provide high quality, curated and rapid insights. We are ideally placed to make recommendations on global drug pricing strategy, market access optimisation, asset evaluation, value perception and payer analytics. GPI’s suite of technology and bespoke service offerings are powered by GPI pulse™, a solution that harnesses the power of technology, data, and collective expertise to produce rapid insights. Company Culture Our team are as passionate about your success as you are, and we strive to help our customers succeed. As a team of domain specialists, we bring energy, enthusiasm and expertise into everything we do. People are at the core of any business and that’s no different at GPI. We are always working with our staff to ensure a happy, healthy and prosperous relationship, recruiting and retaining the best in the industry. Visit our website www.globalpricing.com for more about who we are, our innovative solutions and career opportunities.
The Old Barrel Store Draymans Lane Marlow, Buckinghamshire, SL7 2FF United KingdomG&L utilizes decades of experience and a wealth of Subject Matter Expertise in Regulatory Affairs, Quality Assurance and Clinical Development to design and deliver solutions to the biggest challenges faced by global healthcare today. G&L’s reputation for designing and delivering highly effective solutions to the biggest challenges in global healthcare and our commitment to ensuring that our clients’ specific requirements are always met have seen the company experience phenomenal growth since our establishment in 2016. From product development and submissions to company-wide change management, G&L Healthcare Advisors is proud to design, implement, and maintain high-quality, results-focused outcomes for everyone with whom we work. As regulatory experts across the entire product lifecycle, we assist in early development, filing strategy, pre- and post-approval CMC, MAA/NDA support, publishing, post-approval lifecycle management (LCM), and global projects. Whether you require specific technical skills, short or long-term temporary workload support, or a comprehensive project team, we would love to discuss your needs further. On the Quality Assurance side - from clinical to commercial, our expertise will help you guarantee compliance, maintain oversight and eradicate risk, allowing you and your team to focus on your core deliverables. We provide: • QMS development and gap analysis • Clinical trial audits and site inspection preparation • Vendor management support • Inspection readiness, including inspection support • API and DP audits • Remediation support • eTMF gap analysis and audits • Clinical trial material and commercial product release
Unit 5 Greaves Way Industrial Estate Stanbridge Road Leighton Buzzard, Beds, LU7 4UB United KingdomManufacturer and Distributor of Laboratory Equipment, Glassware, Chemistry, Life Science and Sustainable products.
Quantocks, Beehive Road, Binfield, BRACKNELL, Berkshire, RG12 8TT United KingdomGreen Room Space Limited develops and launches novel initiatives and software products such as ASKr (www.askrapp.net) to help pharma and biotech companies collaborate with healthcare professionals and patients with the aim of improving healthcare outcomes.
30 St Thomas Place Cambridgeshire Business Park Ely Cambridgeshire CB7 4EX UKGregory Fryer Associates provides regulatory, clinical, and quality services.
30 Guilford Street London, England, WC1N 1EH United KingdomGuilford Street Laboratories (GSL) is a global leader in biomarker assay development and advanced diagnostic solutions. With decades of scientific expertise in biochemistry, mass spectrometry, and AI-driven analytics, we deliver end-to-end solutions that accelerate clinical development, improve patient outcomes, and transform complex data into actionable insights. Services provided worldwide.
London, England United KingdomHammersmith Medicines Research provides phase I services, patient studies, quality services, and regulatory.
Cumberland Avenue London NW10 7EWHammersmith Medicines Research provides phase I services, patient studies, quality services, and regulatory.
52 Grosvenor Gardens London, SW1W 0AU United KingdomExpert-driven, Life Science Market Intelligence Solutions At Hanson Wade, we cover 100s of novel drug modalities. We talk to thousands of people to hear their opinions. We make it understandable for every client. Eradicate indecision and leverage our support in your strategic decision making. We are experts at researching emerging niches in drug development, navigating complex stakeholder networks, and conducting qualitative and quantitative analysis. Whether it’s primary or secondary research, we work hard to curate the timely insights you need to drive your company forward.
71 Shelton Street London, England, WC2H 9FD United KingdomHarken is a healthcare consultancy partner that combines deep sector expertise with expansive thinking to deliver real-world solutions that accelerate measurable value and create lasting advantage. Working alongside Medical Education, Medical Affairs, Commercial, and Marketing teams, Harken helps clients meet today's pressures - demonstrating value, moving faster, and doing more with less - through three strategic priorities: creating product equity for sustained differentiation and advocacy, enabling competitive agility to stay ahead of market shifts, and driving industry leadership that shapes perceptions and leads transformation. Harken pairs innovative, AI-enabled products with a transparent, outcome-focused model that is faster, clearer, and more effective than traditional time-based engagements - built, above all, for what's next.
45 Moorfields Moorgate London, London, EC2Y 9AE United KingdomWe are leaders in real world data and digital solutions for healthcare and life sciences, with a clear mission to transform patient outcomes through innovative data & technology solutions.
7 Whitechapel Road London, Please Select, E11LN United KingdomHealth iQ are leaders in real world data insight We prove and communicate the value of interventions in healthcare for successful market access based on an outstanding healthcare heritage. We work with partners in healthcare, pharmaceuticals and medical devices across Europe. Our award-winning team has worked with 25% of the best selling drugs in recent years and more than half of the top 100 global life science firms now rely on Health iQ's unique insight into real world data. Our market leading products are: - Vantage: The leading online analytics platform for real world data - HiQ Simulation: Animated models that simulate real life healthcare scenarios - LinQ: Real world data insights in bespoke reports and studies - Dynamic Costed Pathways: Map a treatment pathway based on real world data Contact us today if you need support to prove your value with unique insight from the leaders in real world data.
7 Whitechapel Road England, E1 United KingdomHealth iQ are leaders in real world data insight We prove and communicate the value of interventions in healthcare for successful market access based on an outstanding healthcare heritage. We work with partners in healthcare, pharmaceuticals and medical devices across Europe. Our award-winning team has worked with 25% of the best selling drugs in recent years and more than half of the top 100 global life science firms now rely on Health iQ's unique insight into real world data. Our market leading products are: - Vantage: The leading online analytics platform for real world data - HiQ Simulation: Animated models that simulate real life healthcare scenarios - LinQ: Real world data insights in bespoke reports and studies - Dynamic Costed Pathways: Map a treatment pathway based on real world data Contact us today if you need support to prove your value with unique insight from the leaders in real world data.
35 Ballards Lane London, N3 1XW United KingdomHealthLumen are specialists in precision epidemiology. Our solutions are centered around quantifying the current and future burden of rare genetic and non-communicable diseases and generating data-driven evidence to support decision-making at each stage of the drug development lifecycle, helping to accelerate patient access to therapies. We combine our powerful genetic database mining and microsimulation modelling methodologies to provide robust estimates of patient population sizes and project the future health and economic impacts of proposed interventions before real-world implementation. Case Studies: https://www.healthlumen.com/case_study/ Publications: https://www.healthlumen.com/publications/
South West Thames Institute for Renal Research, Renal Unit, St Helier Hospital, Wrythe Lane, Carshalton, Surrey SM5 1AA, United KingdomHSL is a young company that benefits from over a decade of expertise and experience in the field of measurement of urinary and serum biomarkers through its work with the staff of the South West Thames Institute for Renal Research (SWTIRR). Through our close links with SWTIRR we are able to offer clients innovative services including the novel patented finger prick GFR device for measuring true glomerular filtration rate in a more accessible and patient friendly manner. Research Scientists at SWTIRR have developed xMAP assays for measuring a range of growth factors, cytokines and chemokines extracted from tissue, urine and blood. We can now offer these services as well as the analysis of their results that can be tailored to your needs.
C/o SWTIRR, Renal Unit, St Helier Hospital Wrythe Lane Carshalton, SM5 1AA United KingdomHSL is a young company that benefits from over a decade of expertise and experience in the field of measurement of urinary and serum biomarkers through its work with the staff of the South West Thames Institute for Renal Research (SWTIRR). Through our close links with SWTIRR we are able to offer clients innovative services including the novel patented finger prick GFR device for measuring true glomerular filtration rate in a more accessible and patient friendly manner. Research Scientists at SWTIRR have developed xMAP assays for measuring a range of growth factors, cytokines and chemokines extracted from tissue, urine and blood. We can now offer these services as well as the analysis of their results that can be tailored to your needs.
Helier Scientific, St Helier Hospital, Wrythe lane, Carshalton, SM5 1AAHSL is a young company that benefits from over a decade of expertise and experience in the field of measurement of urinary and serum biomarkers through its work with the staff of the South West Thames Institute for Renal Research (SWTIRR). Through our close links with SWTIRR we are able to offer clients innovative services including the novel patented finger prick GFR device for measuring true glomerular filtration rate in a more accessible and patient friendly manner. Research Scientists at SWTIRR have developed xMAP assays for measuring a range of growth factors, cytokines and chemokines extracted from tissue, urine and blood. We can now offer these services as well as the analysis of their results that can be tailored to your needs.
22 Station Road Cambridge, Cambridgeshire, CB1 2JD United KingdomHelios Global Group is an independent, full-service healthcare communications network comprising three specialist medical communications agencies—Helios, Selene and Apollo—alongside a dedicated market access and HEOR agency, Cogentia. Founded in 2015, we are a science-first organisation driven by a desire to do medical communications differently. We deliver impactful, scientifically rigorous solutions that educate, influence behaviour and help shape the future of patient care. Our integrated expertise spans strategic consultancy, medical and scientific communications, commercialisation, and evidence, value and market access—supported by in-house studio, digital, innovation and editorial teams. Our therapeutic expertise is both broad and deep, encompassing cardiovascular and metabolic disease, cell and gene therapies, gastrointestinal disorders, haematology, infectious diseases, inflammation and immunology, neurology and pain, oncology and haematological oncology, ophthalmology, and rare diseases. With more than 300 professionals across five offices in the UK and USA, scientific excellence underpins everything we do. Over 70% of our client-facing team hold PhDs or higher degrees, and our industry-leading retention rate—consistently above 90%—reflects our commitment to being a great place to work and a trusted partner to our clients. Independent, agile and collaborative, we tailor our approach to meet each client’s unique challenges. In 2025, 90% of surveyed clients (N=87) rated Helios as better or much better than other agencies they had worked with. We are proud to have been awarded an EcoVadis Silver Medal in 2025 and remain firmly committed to the Science Based Targets initiative (SBTi).
The University of Greenwich, Central Avenue, Chatham, Maritime, Kent ME4 4TB, UKHerbal Analysis Services offers bioassays, spectroscopy, and chromatography services.
New Farm Mire Lane, West End Twyford RG10 0NJ UKHerbiseed has been producing specialist seeds for over 25 years. We specialise in growing seeds of plants derived from wild populations, including weeds, wildflowers, natural herbs and newly domesticated industrial crops. We have farms in England, Serbia and the Philippines which cover cool, warm and tropical climates. This enables us to grow nearly one thousand species of plants, many of which are not available from any other source. We source about 200 species from specialist seed producers, botanic gardens and qualified amateur collectors around the world. Finally, to enable us to provide our customers with a ‘one-stop-shop’ we also stock varieties of common agricultural and horticultural crops from around the world which we purchase from conventional seed merchants.
Newmarket Road Fordham, Cambridgeshire CB7 5WW UKHFL Sport Science, a wholly owned subsidiary of Quotient Bioresearch, offers services for bioanalysis, biomarker measurement, ADME analysis, custom radiochemistry, inmmunoscreening, in vivo PK and safety assessment.
1 The Markham Centre Station Road Theale Berkshire UK RG7 4PEHichrom provides HPLC columns.
Horizon Discovery Building 8100, Cambridge Research Park Waterbeach, Cambridge, CB25 9TL United KingdomBuilt upon decades of experience engineering cell lines, RNA synthesis, and bioinformatic design, we have created a unique portfolio of reagents and services that empower researchers to push their work forward with data generated from cell models. Horizon is leveraging its technological expertise to provide cell engineering tools and services to its customers in three key areas of the therapeutic ecosystem: basic research, drug discovery and development and therapeutic applications. Some of our central services include: • Screening & Cell line engineering services: tools and services that are designed to improve the outcome of drug discovery and development • BioProduction cell lines: engineered CHO cell lines that are designed to enable efficient biologics manufacturing Horizon’s customers include biopharmaceutical and diagnostics companies, contract research and manufacturing organizations and academic researchers across the globe. Horizon sells its tools and services to more than 2,000 unique customers in over 60 countries, including to 19 of the 20 largest biopharmaceutical companies by revenue. On the contract research front, Horizon’s service group supports researchers with cell line engineering, functional genomic screening, high-throughput immuno-oncology assays, compound profiling, drug combination screening, using CRISPR, or siRNA for a variety of cell-based assays. Horizon is now part of Revvity. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
8100 Cambridge Research Park Waterbeach, Cambridge, , CB25 9TL United KingdomBuilt upon decades of experience engineering cell lines, RNA synthesis, and bioinformatic design, we have created a unique portfolio of reagents and services that empower researchers to push their work forward with data generated from cell models. Horizon is leveraging its technological expertise to provide cell engineering tools and services to its customers in three key areas of the therapeutic ecosystem: basic research, drug discovery and development and therapeutic applications. Some of our central services include: • Screening & Cell line engineering services: tools and services that are designed to improve the outcome of drug discovery and development • BioProduction cell lines: engineered CHO cell lines that are designed to enable efficient biologics manufacturing Horizon’s customers include biopharmaceutical and diagnostics companies, contract research and manufacturing organizations and academic researchers across the globe. Horizon sells its tools and services to more than 2,000 unique customers in over 60 countries, including to 19 of the 20 largest biopharmaceutical companies by revenue. On the contract research front, Horizon’s service group supports researchers with cell line engineering, functional genomic screening, high-throughput immuno-oncology assays, compound profiling, drug combination screening, using CRISPR, or siRNA for a variety of cell-based assays. Horizon is now part of Revvity. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
Cambrigbe, UKThe Human Research Tissue Bank (HRTB) which includes the Cambridge Brain Bank (CBB), is funded by the Biomedical Research Centre (BRC). It is housed within the Department of Histopathology at Addenbrooke’s Hospital, as its procedures require it to work closely with the medical and non medical staff within the department. It offers a wide range of services for translational research and drug discovery purposes. High quality processing and storage of tissue samples underpins high quality research and the expert specialist pathologists and well-trained and experienced biomedical scientists select and prepare well-characterised material to the highest standards. The Tissue Bank is licensed by the Human Tissue Authority (HTA) and accredited by Clinical Pathology Accreditation (CPA). The facility routinely supplies a wide range of human material for cellular and molecular phenotyping to a variety of BRC themes, including Cancer, as well as to University researchers, quality assurance schemes, clinical trials and commercial companies. The Human Research Tissue Bank Management Committee oversee the management of tissue bank activities. It ensures compliance with Trust and HTA governance procedures, and regularily invites researchers to feedback on their experience of tissue bank. Committee membership and terms of reference can be downloaded below.
Woolley Road Alconbury Huntingdon Cambridgeshire PE28 4HS UKHuntingdon Life Sciences offers genetic toxicology services and assays for irritation, corrosivity, teratogenicity, permeability, in vitro metabolism, cardiac safety, dermal penetration and microbiological testing.
40 Bank Street London, England, E14 5NR United KingdomhVIVO Services Limited is a full service early phase CRO, offering *Human Challenge Trials*, *infectious disease lab services and HBS*, *Ph1 Clinical Trials* and *Consulting and BioMetrics* services. *Laboratory Services* Our GCLP accredited labs are designed to support drug and vaccine clinical trials and research. We are based and regulated in the UK. We specialise in Respiratory viruses: hMPV (human metapneumovirus), SARS-CoV-2 and variants, RSV(respiratory syncytial virus) A and B, influenza A and B, HRV (human rhinovirus), H5N1, H1N1,H3N2 but can support other virology studies including BSL-3 containment requirements including Dengue, including asthma and COPD patient cohorts and malaria. _An array of services_ *Molecular Biology* : ELISAs, qPCR, Cell based infectivity assays (e.g. microneutralisation assays(MNA), FRNA,HAI), ELISpot, multi-pathogen screening, TCID50 assays, Plaque Assays, Drug potency assays(IC50/IC90), viral resistance monitoring, NGS, viral NGS, droplet digital PCR (up to 21 target from a single drop) Some of our equipment: MiSeq i100 Series by Illumina, Biofire system by biomereux, droplet digital PCR qx700 by BioRad, MSD Meso plate reader *Biomarker Analysis* : Multiplex Cytokine and chemokine analysis (on MSD platform) *Assay Development and Validation* : can help develop and validate an array of assays against BSL-2 and BSL-3 viruses *Human Biological Samples* : healthy and infected biofluids and PBMCs *Biobank Storage* : Biological and non-biological long term storage for trial samples, libraries and agents *Collection kits* : Creation and distribution of sample collection kits, including sample transport matrix and hLAB’s proprietary RSV stabilisation matrix, which is specifically designed to address the challenge of maintaining RSV sample integrity during storage and shipment. *hVIVO's Controlled Human Infection Models (CHIM)* The world’s leading specialist in human challenge trials (HCT). We specialise in infectious diseases, with a long standing expertise in respiratory viruses (RSV, Flu, hMPV, HRV. SARS-Cov-2, PIV etc) and Vaccine Development—supported by our state-of-the-art quarantine facility in London. *hVIVO Clinical Trial Solutions* Germany Our Largest and Most Versatile Phase I/II Clinic, offering a total of 94 beds, including 58 dedicated to long-term stays. The facility also features multifunctional rooms, an 800 sqm outpatient area, and a large garden, making it highly adaptable to various trial designs. From first-in-human (FiH) trials to Proof-of-Concept (PoC) Phase IIa trials, our expertise spans cardiovascular, central nervous system, dermatology, ARDS, pain management (including narcotics), and more. *Kiel* Specialised Renal and Hepatic Impairment Trials. We are dedicated to advancing therapies for kidney and liver diseases, including complex conditions where organ impairments impact standard of care. Our team specializes in the high-precision management of complex trial designs, including studies involving dose titration, diverse drug formulations and delivery methods, as well as food- and drug-interaction assessments. *hVIVO Consulting * Drug development consultancy and services to help bring products to the market quickly and efficiently. Capabilities and expertise includes CMC, Non-Clinical, Clinical Pharmacology and Development, Statistics, Study Design and Methodology, Data Management, RTSM and Regulatory Affairs across a wide variety of therapeutic areas. We have an extensive experience in discussing these development programs with global regulators. With our independent position we can design an optimal program including risk assessment and mitigation, saving time and money whilst achieving project milestone objectives. From Pre-clinical to Market authorisation.
QMB Innovation Centre 42 New Road London, E1 2AX United KingdomhVIVO Services Limited is a full service early phase CRO, offering *Human Challenge Trials*, *infectious disease lab services and HBS*, *Ph1 Clinical Trials* and *Consulting and BioMetrics* services. *Laboratory Services* Our GCLP accredited labs are designed to support drug and vaccine clinical trials and research. We are based and regulated in the UK. We specialise in Respiratory viruses: hMPV (human metapneumovirus), SARS-CoV-2 and variants, RSV(respiratory syncytial virus) A and B, influenza A and B, HRV (human rhinovirus), H5N1, H1N1,H3N2 but can support other virology studies including BSL-3 containment requirements including Dengue, including asthma and COPD patient cohorts and malaria. _An array of services_ *Molecular Biology* : ELISAs, qPCR, Cell based infectivity assays (e.g. microneutralisation assays(MNA), FRNA,HAI), ELISpot, multi-pathogen screening, TCID50 assays, Plaque Assays, Drug potency assays(IC50/IC90), viral resistance monitoring, NGS, viral NGS, droplet digital PCR (up to 21 target from a single drop) Some of our equipment: MiSeq i100 Series by Illumina, Biofire system by biomereux, droplet digital PCR qx700 by BioRad, MSD Meso plate reader *Biomarker Analysis* : Multiplex Cytokine and chemokine analysis (on MSD platform) *Assay Development and Validation* : can help develop and validate an array of assays against BSL-2 and BSL-3 viruses *Human Biological Samples* : healthy and infected biofluids and PBMCs *Biobank Storage* : Biological and non-biological long term storage for trial samples, libraries and agents *Collection kits* : Creation and distribution of sample collection kits, including sample transport matrix and hLAB’s proprietary RSV stabilisation matrix, which is specifically designed to address the challenge of maintaining RSV sample integrity during storage and shipment. *hVIVO's Controlled Human Infection Models (CHIM)* The world’s leading specialist in human challenge trials (HCT). We specialise in infectious diseases, with a long standing expertise in respiratory viruses (RSV, Flu, hMPV, HRV. SARS-Cov-2, PIV etc) and Vaccine Development—supported by our state-of-the-art quarantine facility in London. *hVIVO Clinical Trial Solutions* Germany Our Largest and Most Versatile Phase I/II Clinic, offering a total of 94 beds, including 58 dedicated to long-term stays. The facility also features multifunctional rooms, an 800 sqm outpatient area, and a large garden, making it highly adaptable to various trial designs. From first-in-human (FiH) trials to Proof-of-Concept (PoC) Phase IIa trials, our expertise spans cardiovascular, central nervous system, dermatology, ARDS, pain management (including narcotics), and more. *Kiel* Specialised Renal and Hepatic Impairment Trials. We are dedicated to advancing therapies for kidney and liver diseases, including complex conditions where organ impairments impact standard of care. Our team specializes in the high-precision management of complex trial designs, including studies involving dose titration, diverse drug formulations and delivery methods, as well as food- and drug-interaction assessments. *hVIVO Consulting * Drug development consultancy and services to help bring products to the market quickly and efficiently. Capabilities and expertise includes CMC, Non-Clinical, Clinical Pharmacology and Development, Statistics, Study Design and Methodology, Data Management, RTSM and Regulatory Affairs across a wide variety of therapeutic areas. We have an extensive experience in discussing these development programs with global regulators. With our independent position we can design an optimal program including risk assessment and mitigation, saving time and money whilst achieving project milestone objectives. From Pre-clinical to Market authorisation.
Unit 2 Greenwich Centre Business Park 53 Norman Road London, SE10 9QF United KingdomhVIVO Services Limited is a full service early phase CRO, offering *Human Challenge Trials*, *infectious disease lab services and HBS*, *Ph1 Clinical Trials* and *Consulting and BioMetrics* services. *Laboratory Services* Our GCLP accredited labs are designed to support drug and vaccine clinical trials and research. We are based and regulated in the UK. We specialise in Respiratory viruses: hMPV (human metapneumovirus), SARS-CoV-2 and variants, RSV(respiratory syncytial virus) A and B, influenza A and B, HRV (human rhinovirus), H5N1, H1N1,H3N2 but can support other virology studies including BSL-3 containment requirements including Dengue, including asthma and COPD patient cohorts and malaria. _An array of services_ *Molecular Biology* : ELISAs, qPCR, Cell based infectivity assays (e.g. microneutralisation assays(MNA), FRNA,HAI), ELISpot, multi-pathogen screening, TCID50 assays, Plaque Assays, Drug potency assays(IC50/IC90), viral resistance monitoring, NGS, viral NGS, droplet digital PCR (up to 21 target from a single drop) Some of our equipment: MiSeq i100 Series by Illumina, Biofire system by biomereux, droplet digital PCR qx700 by BioRad, MSD Meso plate reader *Biomarker Analysis* : Multiplex Cytokine and chemokine analysis (on MSD platform) *Assay Development and Validation* : can help develop and validate an array of assays against BSL-2 and BSL-3 viruses *Human Biological Samples* : healthy and infected biofluids and PBMCs *Biobank Storage* : Biological and non-biological long term storage for trial samples, libraries and agents *Collection kits* : Creation and distribution of sample collection kits, including sample transport matrix and hLAB’s proprietary RSV stabilisation matrix, which is specifically designed to address the challenge of maintaining RSV sample integrity during storage and shipment. *hVIVO's Controlled Human Infection Models (CHIM)* The world’s leading specialist in human challenge trials (HCT). We specialise in infectious diseases, with a long standing expertise in respiratory viruses (RSV, Flu, hMPV, HRV. SARS-Cov-2, PIV etc) and Vaccine Development—supported by our state-of-the-art quarantine facility in London. *hVIVO Clinical Trial Solutions* Germany Our Largest and Most Versatile Phase I/II Clinic, offering a total of 94 beds, including 58 dedicated to long-term stays. The facility also features multifunctional rooms, an 800 sqm outpatient area, and a large garden, making it highly adaptable to various trial designs. From first-in-human (FiH) trials to Proof-of-Concept (PoC) Phase IIa trials, our expertise spans cardiovascular, central nervous system, dermatology, ARDS, pain management (including narcotics), and more. *Kiel* Specialised Renal and Hepatic Impairment Trials. We are dedicated to advancing therapies for kidney and liver diseases, including complex conditions where organ impairments impact standard of care. Our team specializes in the high-precision management of complex trial designs, including studies involving dose titration, diverse drug formulations and delivery methods, as well as food- and drug-interaction assessments. *hVIVO Consulting * Drug development consultancy and services to help bring products to the market quickly and efficiently. Capabilities and expertise includes CMC, Non-Clinical, Clinical Pharmacology and Development, Statistics, Study Design and Methodology, Data Management, RTSM and Regulatory Affairs across a wide variety of therapeutic areas. We have an extensive experience in discussing these development programs with global regulators. With our independent position we can design an optimal program including risk assessment and mitigation, saving time and money whilst achieving project milestone objectives. From Pre-clinical to Market authorisation.
Angel House 24 Station Road Ely, CB7 4BS United KingdomhVIVO Services Limited is a full service early phase CRO, offering *Human Challenge Trials*, *infectious disease lab services and HBS*, *Ph1 Clinical Trials* and *Consulting and BioMetrics* services. *Laboratory Services* Our GCLP accredited labs are designed to support drug and vaccine clinical trials and research. We are based and regulated in the UK. We specialise in Respiratory viruses: hMPV (human metapneumovirus), SARS-CoV-2 and variants, RSV(respiratory syncytial virus) A and B, influenza A and B, HRV (human rhinovirus), H5N1, H1N1,H3N2 but can support other virology studies including BSL-3 containment requirements including Dengue, including asthma and COPD patient cohorts and malaria. _An array of services_ *Molecular Biology* : ELISAs, qPCR, Cell based infectivity assays (e.g. microneutralisation assays(MNA), FRNA,HAI), ELISpot, multi-pathogen screening, TCID50 assays, Plaque Assays, Drug potency assays(IC50/IC90), viral resistance monitoring, NGS, viral NGS, droplet digital PCR (up to 21 target from a single drop) Some of our equipment: MiSeq i100 Series by Illumina, Biofire system by biomereux, droplet digital PCR qx700 by BioRad, MSD Meso plate reader *Biomarker Analysis* : Multiplex Cytokine and chemokine analysis (on MSD platform) *Assay Development and Validation* : can help develop and validate an array of assays against BSL-2 and BSL-3 viruses *Human Biological Samples* : healthy and infected biofluids and PBMCs *Biobank Storage* : Biological and non-biological long term storage for trial samples, libraries and agents *Collection kits* : Creation and distribution of sample collection kits, including sample transport matrix and hLAB’s proprietary RSV stabilisation matrix, which is specifically designed to address the challenge of maintaining RSV sample integrity during storage and shipment. *hVIVO's Controlled Human Infection Models (CHIM)* The world’s leading specialist in human challenge trials (HCT). We specialise in infectious diseases, with a long standing expertise in respiratory viruses (RSV, Flu, hMPV, HRV. SARS-Cov-2, PIV etc) and Vaccine Development—supported by our state-of-the-art quarantine facility in London. *hVIVO Clinical Trial Solutions* Germany Our Largest and Most Versatile Phase I/II Clinic, offering a total of 94 beds, including 58 dedicated to long-term stays. The facility also features multifunctional rooms, an 800 sqm outpatient area, and a large garden, making it highly adaptable to various trial designs. From first-in-human (FiH) trials to Proof-of-Concept (PoC) Phase IIa trials, our expertise spans cardiovascular, central nervous system, dermatology, ARDS, pain management (including narcotics), and more. *Kiel* Specialised Renal and Hepatic Impairment Trials. We are dedicated to advancing therapies for kidney and liver diseases, including complex conditions where organ impairments impact standard of care. Our team specializes in the high-precision management of complex trial designs, including studies involving dose titration, diverse drug formulations and delivery methods, as well as food- and drug-interaction assessments. *hVIVO Consulting * Drug development consultancy and services to help bring products to the market quickly and efficiently. Capabilities and expertise includes CMC, Non-Clinical, Clinical Pharmacology and Development, Statistics, Study Design and Methodology, Data Management, RTSM and Regulatory Affairs across a wide variety of therapeutic areas. We have an extensive experience in discussing these development programs with global regulators. With our independent position we can design an optimal program including risk assessment and mitigation, saving time and money whilst achieving project milestone objectives. From Pre-clinical to Market authorisation.
2 Occam Court Surrey Research Park Guildford, Surrey GU2 7QB United KingdomID Business Solutions (IDBS) develop software that secures data and optimizes processes to support life science and health care research.
18 Crucifix Ln London, SE1 3JW United Kingdom
12A HIGH STREET OVER CAMBRIDGE, CAMBRIDGESHIRE, CB24 5ND United KingdomWe provide innovation advice and technology scouting services to assist your R&D activities and support your product portfolio. We have a combined 100+ years’ experience in the pharmaceutical & consumer goods industry: we understand your world and we bring insights from parallel industries
Illumina Centre 19 Granta Park Great Abingtom, Cambridge, CB21 6DF United KingdomIllumina offers next generation sequencing and genotyping services.
Units 15 -17, 7 Wenlock Road London, London, N1 United KingdomWe ensure pharmaceutical and healthcare companies fully comprehend their market position and engage successfully with Key Opinion Leaders (KOLs), Digital Opinion Leaders (DOLs), Patient Organisations and other key stakeholder groups. We understand that every client has distinct requirements, and that’s why we excel in creating tailor-made solutions. From unrivalled market analytics to forging meaningful stakeholder partnerships, Scout is your trusted companion in navigating the intricacies of your market.
Burlington Danes Building, Imperial College London Hammersmith Hospital Du Cane Road, London, W12 0NNImanova has world-leading expertise in imaging sciences and their application to the understanding of disease and translational drug development. An innovative joint venture, Imanova’s shareholders are the UK's Medical Research Council and three world-class London universities: Imperial College London, King’s College London and University College London. Imanova is a company with a depth of understanding in drug development and extensive experience using imaging to facilitate the development pipeline. Our academic expertise and extensive links with clinicians and scientists in our shareholder institutions provide unrivalled capabilities to facilitate drug development.
Du Cane Road England, W12 0HS United KingdomImanova has world-leading expertise in imaging sciences and their application to the understanding of disease and translational drug development. An innovative joint venture, Imanova’s shareholders are the UK's Medical Research Council and three world-class London universities: Imperial College London, King’s College London and University College London. Imanova is a company with a depth of understanding in drug development and extensive experience using imaging to facilitate the development pipeline. Our academic expertise and extensive links with clinicians and scientists in our shareholder institutions provide unrivalled capabilities to facilitate drug development.
Building 400 The Ventures Building Kent Science Park Sittingbourne, Kent, ME9 8AG United KingdomImmundnz is an immunology CRO specialised in immune modelling, immune response and tissue damage analysis, in vivo and in vitro cell culture systems for preclinical drug research and development, nanotech, medtech, cosmetics and nutrition. We are experienced scientists who will design an experimental model and use customised immune assays as well as standard assays tailored for the right solution for your problem. We will develop novel assays in our laboratory to meet your specific and unconventional need. We offer a number of customised immune assays such as dendritic cell assay, T cell assay, immune checkpoint assays, mixed lymphocyte (MLR) assay, tissue damage assay,cytokine release assay, ADCP, phagocytosis, macrophage assays, immune functional assays, M1/M2 macrophage polarisation assay, Th1/Th2/Th17/Treg differentiation assays, etc. We can offer various immune assays based on cell lines.
Unit 8, The Quadrangle 49 Atalanta Street London, SW6 6TU United KingdomImmunometrics produces immunoassay kits and provide assay services and reagents for contraceptive steroids, urinary estrone and pregnanediol glucuronides.
London, England United KingdomImmunometrics produces immunoassay kits and provide assay services and reagents for contraceptive steroids, urinary estrone and pregnanediol glucuronides.
86-90 Paul Street London, EC2A 4NE United KingdomImmunoSig Ltd is a UK-based contract research organisation (CRO) specialising in peptide and protein microarray-based immunoprofiling. We help vaccine developers and biopharmaceutical companies decode complex immune responses through high-throughput, multiplexed antibody profiling across thousands of antigens simultaneously. Our core service — immunosignature discovery — enables clients to identify the antibody repertoire elicited by vaccines, biologics, and infectious diseases, supporting antigen selection, candidate prioritisation, and mechanistic understanding of immune protection. Founded by experts with experience in academic and industry vaccine research, including collaborative work on licensed vaccines, ImmunoSig bridges the gap between exploratory immunology and translational vaccine development. Services include: Peptide and protein microarray design and manufacture Serum/plasma antibody profiling (IgG, IgA, IgM) Immunosignature discovery and biomarker identification Custom antigen panel development Data analysis and immunoinformatics reporting ImmunoSig works with pharma, biotech, and academic partners at all stages of vaccine development — from early discovery through to clinical immunogenicity studies.
Sycamore house 16 Leyden Rd, Stevenage Stevenage, Heartfordshire, SG1 2BP United KingdomHistorically, alveolar safety has relied on epithelial cell models, which, though convenient, offer a narrow scope—primarily focusing on barrier function or cytotoxicity. Such limited endpoints may overlook potential long-term adverse effects on lung health, especially concerning inflammation from chronic product administration. The lung's first responders, alveolar macrophages, play a pivotal role in homeostasis and regulating inflammation. Inflammation is not only a marker of acute reactions but also indicative of long-term health implications in the respiratory tract. Therefore, to ensure the comprehensive safety of inhaled products, it's imperative to employ immune-competent models that capture the nuanced responses of alveolar macrophages. Only through understanding these responses can we truly gauge the safety and potential inflammatory impact of inhaled substances. Our services, products and experts enable you to understand, in detail how alveolar macrophages respond to inhaled chemicals/particulates and support classification of the response as being adaptive or adverse. Our unique in vitro models and multi-endpoint assessments deliver results spanning morphology, function and biochemistry to provide companies with clarity on the toxicological and mechanistic impact of their products. We provide a a cost-effective, multi-endpoint alternative which is more human-relevant and reduces animal testing, exploring various interpretations of a read-out. We carry out a wide variety of in vitro services in-house, with a specialisation in alveolar cell painting assays. Our morph_ONE™ assay combines detailed cell morphology with cell health and biochemical readouts to help classify the mechanism of ‘foamy’, highly vacuolated macrophages to support safety assessment. Our two novel products – ImmuPHAGE™ and ImmuLUNG™ – provide in-depth analysis of macrophage responses in the lungs and epithelial tissue of the alveoli.
Science Building University of HEartfordshire Hatfeild, Heartfordshire, AL10 9PN United KingdomHistorically, alveolar safety has relied on epithelial cell models, which, though convenient, offer a narrow scope—primarily focusing on barrier function or cytotoxicity. Such limited endpoints may overlook potential long-term adverse effects on lung health, especially concerning inflammation from chronic product administration. The lung's first responders, alveolar macrophages, play a pivotal role in homeostasis and regulating inflammation. Inflammation is not only a marker of acute reactions but also indicative of long-term health implications in the respiratory tract. Therefore, to ensure the comprehensive safety of inhaled products, it's imperative to employ immune-competent models that capture the nuanced responses of alveolar macrophages. Only through understanding these responses can we truly gauge the safety and potential inflammatory impact of inhaled substances. Our services, products and experts enable you to understand, in detail how alveolar macrophages respond to inhaled chemicals/particulates and support classification of the response as being adaptive or adverse. Our unique in vitro models and multi-endpoint assessments deliver results spanning morphology, function and biochemistry to provide companies with clarity on the toxicological and mechanistic impact of their products. We provide a a cost-effective, multi-endpoint alternative which is more human-relevant and reduces animal testing, exploring various interpretations of a read-out. We carry out a wide variety of in vitro services in-house, with a specialisation in alveolar cell painting assays. Our morph_ONE™ assay combines detailed cell morphology with cell health and biochemical readouts to help classify the mechanism of ‘foamy’, highly vacuolated macrophages to support safety assessment. Our two novel products – ImmuPHAGE™ and ImmuLUNG™ – provide in-depth analysis of macrophage responses in the lungs and epithelial tissue of the alveoli.
Imperial College London, South Kensington Campus, London SW7 2AZ UKImperial College Consultants provides consulting, project management, and testing facilities.
King's College London Rayne Institute 123 Coldharbour Lane London SE5 9NUBiospecimens (tissues, tissue products and body fluids) from adult patients with haematological dyscrasias: mainly myeloid disorders (AML, AA, CML, MDS, MPD, PNH), but some lymphoid disorders (CLL, Myeloma) are also represented and there are plans to bank lymphoma in the future.
England, SW7 2AZ United KingdomThe Centre for Bio-Inspired Technology hosts a Microelectronics Laboratory comprehensively equipped for the development, test & measurement of biomedical circuits & systems.
England, SW7 2AZ United KingdomThe Cross-faculty Nuclear Magnetic Resonance Centre is located in a purpose-built suite in the RCS1 building of Imperial College's South Kensington campus.
England, SW7 2AZ United Kingdom
MS Society Tissue Bank Wolfson Neuroscience Laboratories Imperial College London Hammersmith Hospital Campus 160 Du Cane Road London W12 0NNThe MS Society Tissue Bank allows both people with and without MS to donate their brain and spinal cord tissue after their death. Understanding MS damage will help us understand the causes of MS and find more effective treatments. The Tissue Bank is the largest MS-specific brain donor scheme operational in Europe, and donated tissue samples are sent all over the world to help scientists enhance their knowledge of the condition. This world-class resource has supplied over 10,000 individual samples to laboratories since the bank was set up in 1998.
Level 1 MediaWorks 191 Wood Lane London, United Kingdom, W12 7FP United KingdomLegal status : Private Company - Limited by Shares. Wholly owned by Imperial College of Science, Technology & Medicine
Pale Lane Hartley Wintney, Hampshire, RG27 8DH United KingdomIMSL is a testing and consultancy service specialising in the microbiology of industrial processes, materials and products. It is a private limited company that was formed in October 1996 and is located in purpose-built laboratories and offices 50 km west of London, near Fleet in Hampshire, UK. It has a regional sales office in Potsdam, Germany. IMSL has a diverse customer base from throughout the UK, mainland Europe, the Middle East, USA and the Far East.
BioPark, Broadwater Rd Welwyn Garden City, Hertfordshire AL7 3AX, United Kingdomin2phase is a group of experienced integrated pharma service providers dedicated to drug development and provides capabilities in strategic planning, project management, quality assurance, regulatory affairs, CMC development, and manufacturing services.
83-85 Baker Street London, W1U 6AG United KingdomInbeeo delivers tailor-made solutions to address the toughest market access challenges faced by pharmaceutical and MedTech companies. With our unique combination of experience, expertise, and insight, we will help you realize the full value of your health technologies for patients, payers, physicians, and healthcare systems. Inbeeo has recently joined forces with Enosium Life Science, offering our clients access to a range of services spanning the entire product value chain, from clinical studies to marketing activities. Contact us today to learn more! https://inbeeo.com/ https://www.enosium.com/en/home
14 Bedford Square London, England, WC1B 3JA United KingdomInbeeo delivers tailor-made solutions to address the toughest market access challenges faced by pharmaceutical and MedTech companies. With our unique combination of experience, expertise, and insight, we will help you realize the full value of your health technologies for patients, payers, physicians, and healthcare systems. Inbeeo has recently joined forces with Enosium Life Science, offering our clients access to a range of services spanning the entire product value chain, from clinical studies to marketing activities. Contact us today to learn more! https://inbeeo.com/ https://www.enosium.com/en/home
2nd Floor, Vega House Eastlake Park, Fox Milne Milton Keynes, Bedfordshire, MK15 0DF United KingdomIndigo Medical is a specialist Medical Communications and full-service compliance agency. Indigo Medical Communications supports commercial, medical affairs and medical diagnostic teams working in oncology-focused precision medicine. Indigo Medical Compliance focusses on the review and approval of assets utilising our dedicated in-house team of life scientist reviewers and pharmacist and physician nominated signatories. (Legal entity: R2R Holdings trading as Indigo Medical)
Challenge House, G06 Sherwood Drive, Bletchley Milton Keynes, MK3 6DP United KingdomIndigo Medical is a specialist Medical Communications and full-service compliance agency. Indigo Medical Communications supports commercial, medical affairs and medical diagnostic teams working in oncology-focused precision medicine. Indigo Medical Compliance focusses on the review and approval of assets utilising our dedicated in-house team of life scientist reviewers and pharmacist and physician nominated signatories. (Legal entity: R2R Holdings trading as Indigo Medical)
51 Chambers Grove England, AL7 4FG United KingdomThe INFOTOX is a consulting company specialized in the regulation of chemicals by providing technical support for the public and private sectors. Our services include technical support and independent advice in several areas: - Chemicals Regulation - Toxicology and Risk Assessment - Environmental health We conduct integrated, multidisciplinary and cost-effective risk assessments so our customers can meet their regulatory requirements and Product Management objectives.
High Wycombe, Buckinghamshire, UKInHealth NHS PET/CT Diagnostic Imaging Service provides imaging services.
The Glenn Berge Building Babraham, Cambridge, CB22 3FH United KingdomInivata is a leader in liquid biopsy. Its InVision® platform unlocks essential genomic information from a simple blood draw to guide and personalize cancer treatment, monitor response and detect relapse. Inivata’s technology is based on pioneering research from the Cancer Research UK Cambridge Institute, University of Cambridge. Its lead product, InVisionFirst®-Lung is commercially available internationally and through NeoGenomics in the US. It offers competitive sensitivity and turnaround, providing molecular insights that enable clinicians to make more informed treatment decisions for advanced NSCLC patients. Inivata has also launched the personalized RaDaR™ assay – allowing the highly sensitive detection of residual disease and recurrence. Inivata is partnering with pharmaceutical, biotechnology companies and commercial partners in a range of early and late stage cancer development programs. The Company has a CLIA certified, CAP accredited laboratory in Research Triangle Park, NC and R&D laboratories in Cambridge, UK. For more information, please go to www.inivata.com. Follow Inivata on Twitter @Inivata.
26 Southampton Buildings London, England, WC2A 1AN United KingdomInizio is a scaled commercialization platform that unlocks, activates and optimizes value for pharma and biopharma companies at every pivotal moment in the journey from discovery to post-launch . By harnessing our connected platform, we bridge best-in-class scientific expertise, market intelligence, data and analytics, technology, communications and creative execution to help clients make the right strategic choices and maximize the value of their healthcare innovations . Our integrated capabilities span evidence generation, medical communications & publications, market access, HEOR and RWE, data and decision optimization, marketing, PR and communications, medical and promotional engagement, patient engagement, training and events, and management consulting . We orchestrate cross-functional expertise to secure regulatory approval, deliver best-in-class launches, reach the right stakeholders through omnichannel engagement, and drive sustained brand growth throughout the commercialization lifecycle. Purpose-built to navigate complexity and minimize friction, Inizio provides an unrivalled connected offering across all therapeutic areas and geographies – transforming science into value, accelerating access, and ultimately helping more patients receive the medicines they need, faster.
Berkeley Works Berkley Grove London , NW1 8XY United KingdomInizio is a scaled commercialization platform that unlocks, activates and optimizes value for pharma and biopharma companies at every pivotal moment in the journey from discovery to post-launch . By harnessing our connected platform, we bridge best-in-class scientific expertise, market intelligence, data and analytics, technology, communications and creative execution to help clients make the right strategic choices and maximize the value of their healthcare innovations . Our integrated capabilities span evidence generation, medical communications & publications, market access, HEOR and RWE, data and decision optimization, marketing, PR and communications, medical and promotional engagement, patient engagement, training and events, and management consulting . We orchestrate cross-functional expertise to secure regulatory approval, deliver best-in-class launches, reach the right stakeholders through omnichannel engagement, and drive sustained brand growth throughout the commercialization lifecycle. Purpose-built to navigate complexity and minimize friction, Inizio provides an unrivalled connected offering across all therapeutic areas and geographies – transforming science into value, accelerating access, and ultimately helping more patients receive the medicines they need, faster.
Babraham Hall Babraham Cambridge CB22 3AT UKInnova Biosciences offers custom antibody labeling, diagnostics, and enzyme assays.
136 High Holborn Hogarth House London, WC1V 6PX United KingdomOperating from the North West of the UK, Inoviv specialises in providing LC-MS based quantitative proteomics services for the pharmaceutical and biotechnology sectors. Leveraging state-of-the-art proprietary mass spectrometry, Inoviv generates high-resolution, clinically relevant data sets that mitigate programme risk, optimise research expenditures, and speed up the delivery of novel therapeutics in targeted clinical programmes. The company’s suite of IP- protected platforms and customised multiplexed panels delivers clinical-grade sensitivity and regulatory-standard insights to demonstrate target engagement, therapeutic efficacy, and identifies patient responders to aid stratification. By integrating unmatched precision with rapid scalability, Inoviv serves as an end-to-end strategic partner, assisting organisations to make informed development decisions and streamline the path to patient care.
Evidence House Stokenchurch Business Park Stokenchurch, Buckinghamshire, HP143FE United KingdomLeveraging decades of research and experience, Inpharmation provides innovative research solutions designed and validated specifically for the pharmaceutical industry. Commonly used pricing and demand methodologies, originally designed for consumer goods, are not validated nor appropriately designed for generating insights for pharmaceutical products. Clients choose to work with Inpharmation because: 1. Our projects are led by industry experts. 2. Our expertise spans pricing, demand, and market access research, as well as forecast modeling. We connect the dots between these key commercial pillars. 3. Our approaches are time and cost efficient. 4. Our results are more accurate. For example, Inpharmation’s price modeling approach has a 93% predictive validity (of approval/rejection) in hold-out tests. 5. Our approaches are more reliable. For example, Inpharmation’s pharma-specific conjoint achieves standard errors of less than 5% with only 20 respondents. You will receive flexible deliverables to handle product profile, comparator, competitor entry, and future landscape uncertainties. We work with 75% of top 50 pharma companies and have expertise across all therapy areas, from mass-market through to ultra-orphan diseases. We have access to all key respondents (payers, HCPs, patients, etc.) and to respondents in all major and developing countries. View our project case studies at www.inpharmation.com/case-studies Clients work with us because of our expertise “...I’ve heard positive feedback on this and other Inpharmation projects. We appreciate your expertise and the team’s willingness to help us fill the gaps and run multiple scenarios when needed. The experience was great and I’m sure we’ll come back for projects in the future.” Associate Pricing Director, top 5 pharma company “Not only is the tool a must have for any pricing/market access team, but also Inpharmation's knowledge and quick response to our queries has proven invaluable in developing key commercial strategies.” Pricing Director, top 30 pharma company “…My forecasting work (using Inpharmation's model) has been called out as an example of "best practices". I've been asked to present the model to some of the highest-ranking officers at my company.” Director Strategic Planning and Decision Analysis, top 5 pharma company Contact us at info@inpharmation.com to discuss your research needs with one of our consultants.
Pirbright, England United KingdomInstitute for Animal Health provides viral disease research, integrative biology, and bioimaging.
Box 289, Addenbrooke's Site Hills Road England, CB2 0QQ United KingdomThe Genomics / Transcriptomics Core in Wellcome Trust-MRC Institute of Metabolic Science of University of Cambridge provides scientific equipments and consumables required for most genomics and transcriptomics experiments. We also have dedicated pre-PCR and post-PCR rooms for sensitive experimental procedures such as single cell studies.
Coronation Road, High Wycombe, Buckinghamshire, HP12 3SY, United Kingdom. TEL: 44 1494 456815
Linton, UKInterfocus provides fine science tools and instruments for research.
London, England United KingdomWe help our clients achieve Total Quality Assurance through customized, flexible, contract services. Our scientists, auditors and regulatory experts work with you at every stage of development, providing GMP and CMC Laboratory Services, Biopharmaceutical Development Support, Medical Device Development Support, GMP Auditing, GLP/GCP Bioanalysis, Regulatory and Toxicology Consulting, and Pharmaceutical Manufacturing Support. We have delivered flexible contract services to the global pharmaceutical industry for over 30 years and currently provide high-quality technical services to some of the world's largest and most innovative pharmaceutical companies. GMP and CMC Laboratory Services: Regulatory-driven, phase-appropriate laboratory services in support of CMC programs. Our regulatory labs include centres of excellence for method development and validation, analysis and characterisation for biologics, mRNA, oligos, cell and gene therapies or vaccine products, inhaled product development, nasal drug development, ICH stability testing and storage, extractables and leachables, formulation development, clinical trial materials manufacturing, cGMP quality control testing, and cGMP batch release testing. Bioanalysis Services: In addition to conducting regulated bioanalytical studies for small and biologics, we provide biomarkers services. Learn more: www.intertek.com/pharmaceutical https://www.intertek.com/pharmaceutical/analysis/inhalation-product-development/ https://www.intertek.com/pharmaceutical/analysis/stability/ https://www.intertek.com/pharmaceutical/analysis/extractables-leachables/ https://www.intertek.com/pharmaceutical/biopharmaceuticals/
Edison House Saxon Way Melbourn, Hertfordshire, SG8 6DN United KingdomWe help our clients achieve Total Quality Assurance through customized, flexible, contract services. Our scientists, auditors and regulatory experts work with you at every stage of development, providing GMP and CMC Laboratory Services, Biopharmaceutical Development Support, Medical Device Development Support, GMP Auditing, GLP/GCP Bioanalysis, Regulatory and Toxicology Consulting, and Pharmaceutical Manufacturing Support. We have delivered flexible contract services to the global pharmaceutical industry for over 30 years and currently provide high-quality technical services to some of the world's largest and most innovative pharmaceutical companies. GMP and CMC Laboratory Services: Regulatory-driven, phase-appropriate laboratory services in support of CMC programs. Our regulatory labs include centres of excellence for method development and validation, analysis and characterisation for biologics, mRNA, oligos, cell and gene therapies or vaccine products, inhaled product development, nasal drug development, ICH stability testing and storage, extractables and leachables, formulation development, clinical trial materials manufacturing, cGMP quality control testing, and cGMP batch release testing. Bioanalysis Services: In addition to conducting regulated bioanalytical studies for small and biologics, we provide biomarkers services. Learn more: www.intertek.com/pharmaceutical https://www.intertek.com/pharmaceutical/analysis/inhalation-product-development/ https://www.intertek.com/pharmaceutical/analysis/stability/ https://www.intertek.com/pharmaceutical/analysis/extractables-leachables/ https://www.intertek.com/pharmaceutical/biopharmaceuticals/
London Bioscience Innovation Centre 2 Royal College Street London, NW1 0NH United KingdomPharmaceutical Company
20 Wenlock Road London, England, N1 7SL United Kingdominventio Science delivers controlled-risk, high-quality outsourcing solutions to early-stage biotech companies, academic institutions and CROs conducting early-phase development including First-in-Human (FIH), healthy volunteer, and patient studies with predictable execution and senior-level expertise across Europe, North America (US/Canada), APAC, and LATAM. Our team supports: • Clinical Operations • Clinical Development • Biometrics (Data Management & Biostatistics) • Pharmacovigilance / Drug Safety • Regulatory Affairs • Outsourced DPO & Privacy Advisory
Buckinghamshire, United KingdomInVivo Technology offers in vivo monitoring services.
1 Redman Court Bell Street Princes Risborough Buckinghamshire HP27 0AA United KingdomInVivo Technology offers in vivo monitoring services.
Cambridge, England United KingdomIOTA Pharmaceuticals offers virtual screening packages, screening packages, co-crystallography of fragment-based leads, kinases, and receptors.
St Johns Innovation Centre Cowley Road Cambridge CB4 0WS UNITED KINGDOMIOTA Pharmaceuticals offers virtual screening packages, screening packages, co-crystallography of fragment-based leads, kinases, and receptors.
Robinson Building Chesterford Research Park Saffron Waldon, Essex, CB101LX United KingdomIQVIA Laboratories is a global drug discovery and development laboratory services organization supporting pharma and biotech companies across the full R&D lifecycle—from early discovery to clinical trials. Within this, Discovery Services (often branded “Discovery Sciences”) focus on the earliest stages of drug R&D, where concepts are translated into viable drug candidates. IQVIA Laboratories Discovery Services provide a comprehensive, integrated drug discovery platform combining: - Biology, chemistry, and translational science - AI-driven design and large-scale data insights - Advanced lab technologies and biomarker capabilities - Seamless pathway into clinical development They are a data-rich, end-to-end partner, focused on improving the probability that early discovery programs translate into successful clinical outcomes.
Sittingbourne, England United KingdomIR Pharma specializes in respiratory pharmacology and offers expertise in Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Disease Cough. We have in vitro and in vivo models of sensory nerve activation and cough, asthma and chronic obstructive pulmonary disease.
975 Cornforth Drive Kent Science Park Sittingbourne, Kent ME9 8PX United KingdomIR Pharma specializes in respiratory pharmacology and offers expertise in Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Disease Cough. We have in vitro and in vivo models of sensory nerve activation and cough, asthma and chronic obstructive pulmonary disease.
The Mansion Chesterford Research Park Little Chesterford Essex CB10 1XL UKThe VHH Company (TM) Smaller - Better - Faster - Stronger We work collaboratively with you, understanding your requirements and problem solving using our team's combined experience of 100s of years in antibody research. Isogenica has 3 partnered assets into clinical development. We develop proprietary LlamdA® VHH: highly versatile small format single domain antibodies, which we use to construct next generation biotherapeutics for the treatment of cancer, inflammation and other serious diseases. VHH can be assembled to create bispecific and multi-specific biotherapeutics, or used to achieve targeted drug delivery as components of ADCs and cell and gene therapies including CAR-Ts. Isogenica’s partnerships with global biopharmaceutical companies have resulted in a deep pipeline including two assets in clinical Phase 1 and one clinical Phase II asset and eleven partnered pre-clinical and discovery programs. We with partners through collaborative research and commercial licenses to further develop proprietary LlamdA® VHH or to discover novel LlamdA® VHH as direct therapeutics and targeting agents.
The Mansion Chesterford Research Park Little Chesterford , Essex, CB10 1XL United KingdomThe VHH Company (TM) Smaller - Better - Faster - Stronger We work collaboratively with you, understanding your requirements and problem solving using our team's combined experience of 100s of years in antibody research. Isogenica has 3 partnered assets into clinical development. We develop proprietary LlamdA® VHH: highly versatile small format single domain antibodies, which we use to construct next generation biotherapeutics for the treatment of cancer, inflammation and other serious diseases. VHH can be assembled to create bispecific and multi-specific biotherapeutics, or used to achieve targeted drug delivery as components of ADCs and cell and gene therapies including CAR-Ts. Isogenica’s partnerships with global biopharmaceutical companies have resulted in a deep pipeline including two assets in clinical Phase 1 and one clinical Phase II asset and eleven partnered pre-clinical and discovery programs. We with partners through collaborative research and commercial licenses to further develop proprietary LlamdA® VHH or to discover novel LlamdA® VHH as direct therapeutics and targeting agents.
Chartway Street Sutton Valence, Kent ME17 3HX United KingdomIsohelix manufactures Innovative DNA Buccal Swabs and Purification Kits for the Life Science Markets.
Newnham Building Chesterford Research Park Cambridge, Cambridgeshire, CB101XL United KingdomIsomerase is an innovation partner, based in Cambridge UK, helping companies to use microbes to make anything from therapeutics to enzymes and consumer products; sustainably, cost effectively and at scale. Isomerase leverages its decades of experience working with bacteria and fungi, combined with its knowledge, capabilities and innovations in biology, chemistry and bioprocessing, to enable partners to progress their products and processes toward commercialisation.
Solopark Station Road Pampisford, Cambridgeshire, CB223FF United KingdomIsomerase is an innovation partner, based in Cambridge UK, helping companies to use microbes to make anything from therapeutics to enzymes and consumer products; sustainably, cost effectively and at scale. Isomerase leverages its decades of experience working with bacteria and fungi, combined with its knowledge, capabilities and innovations in biology, chemistry and bioprocessing, to enable partners to progress their products and processes toward commercialisation.
Cambridge House St. Thomas' Place Ely, Cambridgeshire, CB7 4EX United KingdomJackson ImmunoResearch Laboratories specializes in the production and conjugation of affinity-purified secondary antibodies and purified immunoglobulins.
Carradine House 237 Regents Park Road London N3 3LF United KingdomJenson Pharmaceutical Services offers contract development, project management and regulatory affairs services.
Unit 11, Mole Business Park, Randalls Road, Leatherhead, Surrey, KT22 7BA, EnglandJRD Fluorochemicals offers fluoro-aromatics, benzodioxoles, benzodioxanes, trifluoromethylthio compounds, and GC services.
48-50 St. John Street London EC1M 4DGJupiter Prestige Group was launched on July 1st 2014 through the merger of the Prestige Group and the Creative Business Unit of YFYJupiter. We operate from 19 locations throughout Europe, North America, Asia and Australia. Our senior management teams are industry experts in their respective fields and take a hands-on approach in leading our team of more than 300 packaging graphics professionals. We believe this combination of expertise, passion and a commitment to excellence helps set us apart from our competitors.
122, Tyrrelway West Hendon The Hyde, Middlesex NW9 7QP London, United KingdomKGN Ingredients is located in central India and is engaged in sourcing, marketing and distribution of food, feed and pharmaceutical ingredients worldwide.
Level 39, One Canada Square Canary Wharf London, E145AB United KingdomKielo Research, part of Sanius Health, is a specialist patient-centred research organisation focused on integrating patient perspectives into the development and evaluation of medicines, medical technologies, and healthcare services. By combining Kielo’s scientific expertise in patient preference research, patient-reported outcomes, qualitative research, and health economics with Sanius Health’s secure research infrastructure, patient engagement capabilities, and advanced analytics, the organisation generates high-quality evidence that reflects real patient experiences, priorities, and unmet needs. Our services support pharmaceutical, biotechnology, medical device, and healthcare partners across the product lifecycle, from early development and clinical trial design to regulatory engagement, market access, real-world evidence generation, and commercialisation. Core capabilities include patient preference studies, patient experience research, patient-reported outcome strategy, qualitative and mixed-methods research, health economics and outcomes research, real-world data analytics, patient engagement, and evidence generation across a broad range of therapeutic areas, including rare and underserved conditions.
Tuition HouseKinapse provides consulting and outsourcing services for life science companies.
9 Orion Court, Ambuscade Road, Colmworth Business Park, St. Neots Cambridgeshire, PE19 8YX United KingdomWe are leading international suppliers and servicers of chromatography, liquid handling, sample storage and medicinal chemistry consumables and equipment.
The Infectious Diseases BioBank Department of Infectious Diseases Kings College London 2nd Floor, Borough Wing Guy's Hospital London SE1 9RT UKThe Infectious Diseases BioBank (IDB) is embedded within the Department of Infectious Diseases at the Guy’s Campus of King’s College London. Its aim is to make medical research easier, more efficient and faster to perform. The IDB collects valuable clinical samples from patients with infections who are attending our partner NHS-Trust clinics and is funded by the Guy’s and St Thomas’ Charity and by the NHS via the comprehensive Biomedical Research Centre. Our core collections include blood samples from patients infected with human immunodeficiency virus (HIV), hepatitis B (HBV) & hepatitis C (HCV) viruses or methicillin resistant Staphylococcus aureus (MRSA). Blood samples are separated so that patients’ DNA, plasmas (cell-free blood) and lymphocytes (white blood cells) can be frozen into a comprehensive library. Medical researchers can access complete sets of samples to answer important clinical questions, if their research project is approved by the IDB’s Management Committee. For this reason we are actively recruiting ‘medically interesting’ patients who are infected with HIV, for example: those who remain well – despite being infected for many years; others who are exposed to HIV but remain uninfected; others who develop AIDS very quickly; and, those who are in the process of sero-converting.
England, WC2R 2LS United KingdomKing’s offers a range of Core Research Facilities across the Health Schools, providing access to essential technology and equipment to facilitate and enhance the research conducted by King’s scientists and external researchers.
King's College London Strand London WC2R 2LS United KingdomKing’s offers a range of Core Research Facilities across the Health Schools, providing access to essential technology and equipment to facilitate and enhance the research conducted by King’s scientists and external researchers.
London, England United KingdomKing's College London focuses on research in its academic departments and provides cell culture, natural product screening, spectroscopy, and NMR services.
Strand England, WC2R United Kingdom
Ground Floor, Counting House Guy's Hospital London SE1 9RTCancer and normal tissue in FFPE and frozen format and blood from patients diagnosed with a variety of malignancies. This includes the breast biobank (established 1975) which has 9000 primary cancer samples. Samples are available in different formats including frozen or FFPE sections, tissue microarrays, DNA, RNA, plasma and serum. All samples have associated donor clinico-pathological data.
Denmark Hill, London SE5 9RSKingsPath offers Clinical Diagnostic Pathology Services including pathology disciplines in biochemistry, hematology, histopathology, immunology, microbiology/virology, and toxicology.
London, England United KingdomKingsPath offers Clinical Diagnostic Pathology Services including pathology disciplines in biochemistry, hematology, histopathology, immunology, microbiology/virology, and toxicology.
2 Vardens Road London, SW11 1RH United KingdomKite Insights works at the intersection of human and planetary issues.We believe that global challenges require urgent and thoughtful action, and that systems transformation should leave no one behind. Through cutting-edge content, learning and education programmes, event curation and coalitions, we prepare organisations and their people for the green economy
53 Woodlark Road, Cambridge, Cambridgeshire CB3 0HT United KingdomWe at Koniku are focused on improving the complex and costly drug discovery process by providing tools that allow researchers to focus on finding new therapies quickly. Combining cutting edge technologies in a variety of disciplines we are able to reveal human cell actions and interactions that have never before been observed and studied. Our focus is on the use and interaction of human neurons which contains the keys to unlocking discoveries that have the potential to cure and treat diseases, such as Alzheimer’s, Huntington’s, and other diseases that effect millions of people everyday. We use proprietary lab-on-chip technologies to replicate human drug interaction in preclinical testing. Our system delivers data that can better predict which drugs will succeed in clinical trials prior to making costly investments. Our team is dedicated to driving break through research and development focused on biotechnology and drug discovery. Using a combination of proprietary micro electrode array (MEA) technology, iPS cell biology, nano fabrication, and software we provide patch clamp quality electrophysiological data over extended monitoring periods.
London BioScience Innovation CentreL2D Services provides consulting and operational management of services ranging from preclinical development to manufacturing.
184 Cambridge Science Park Cambridge Cambridgeshire CB4 0GA UKLab21 is a specialist diagnostic company offering fully accredited clinical trial support services and a full range of product and Companion Diagnostics development, manufacture and commercialisation capabilities.
Imperial Incubator, Level 2 Bessemer Building Imperial College Road London, SW7 2AZ
Gunnels Wood Road Stevenage SG1 2FX United KingdomLabstract provides a sample storage and shipping service.
Labstract Ltd Stevenage Bioscience Catalyst Gunnels Wood Road Stevenage, SG1 2FX United KingdomLabstract provides a sample storage and shipping service.
Sycamore Park Mill Lane, Alton Hampshire GU34 2PR UKLaleham Healthcare manufactures health and beauty products.
Sage House, 319 Pinner Road,Lambda Therapeutic Research provides bioanalytical services, clinical trials, pharmacovigilance, bioequivalence studies, and quality assurance.
95 Wigmore Street London, England, W1U 1DQ United KingdomLCP’s Health Analytics department was founded in 2020 by Dr Jonny Pearson-Stuttard, Chair of the Royal Society for Public Health, who leads the department alongside continuing his NHS work as a Public Health Consultant and Chair of the Health Inequalities Programme Board at Northumbria Healthcare NHS Foundation Trust. The team is currently approximately 35 people comprising clinicians, epidemiologists, statisticians, data scientists and technology experts. The team have a wealth of experience in using CPRD through their collective academic track records. Several of the team maintain honorary academic affiliations. The team’s work covers evidence generation approaches predominantly with pharmaceutical companies, helping to identify the variation in health needs of patients with given chronic conditions. This recent publication funded and co-authored by NICE is an example of this type of work the team conduct - https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00314-5/fulltext. The Health Analytics team have and continue to use Discover-NOW (HDRUK dataset), UK Biobank and the SAIL (Wales) datasets for this research. The second area of the team’s work includes helping to design new payment models for the NHS to better align payments with patient outcomes. Some of this work, with NHS Wales and Pfizer, was recently presented at ISPOR health economics conference - https://www.ispor.org/heor-resources/presentations-database/presentation/euro2022-3566/122883 . Alongside this work, the Health Analytics team have provided pro-bono analytics support to a range of groups to further the public’s health including the Royal College of Obstetrics and Gynaecology for their ‘Left for too Long’ report on NHS Waiting Lists, providing visualisations for the Office for National Statistics (ONS) National Health Index and currently working collaboratively with OHID, ONS and NHS investigating excess mortality and the indirect impact of the covid-19 pandemic on cardiovascular disease through a programme of work for the Chief Medical Officer led by our Head of Health Analytics. LCP is a financial, actuarial and analytics consultancy. In these roles LCP undertakes risk modelling across a range of sectors including across large pension schemes, energy and health analytics. LCP is an 80-year partnership and historically has focused on advising large occupational pension schemes. That advice includes actuarial support in calculating the liabilities of pension schemes, advice on investment options according to the liability of the pension scheme and the administration of pension schemes (i.e. the processing required when a pension scheme member retires and draws down on their pension). A very small portion of LCP’s work (approximately 5%) provides actuarial advice to general insurers (such as motor or home insurance). This is not related to health insurance.
95, Wigmore street W1U 1DQ London, UK, W1U 1DQ United KingdomLCP’s Health Analytics department was founded in 2020 by Dr Jonny Pearson-Stuttard, Chair of the Royal Society for Public Health, who leads the department alongside continuing his NHS work as a Public Health Consultant and Chair of the Health Inequalities Programme Board at Northumbria Healthcare NHS Foundation Trust. The team is currently approximately 35 people comprising clinicians, epidemiologists, statisticians, data scientists and technology experts. The team have a wealth of experience in using CPRD through their collective academic track records. Several of the team maintain honorary academic affiliations. The team’s work covers evidence generation approaches predominantly with pharmaceutical companies, helping to identify the variation in health needs of patients with given chronic conditions. This recent publication funded and co-authored by NICE is an example of this type of work the team conduct - https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00314-5/fulltext. The Health Analytics team have and continue to use Discover-NOW (HDRUK dataset), UK Biobank and the SAIL (Wales) datasets for this research. The second area of the team’s work includes helping to design new payment models for the NHS to better align payments with patient outcomes. Some of this work, with NHS Wales and Pfizer, was recently presented at ISPOR health economics conference - https://www.ispor.org/heor-resources/presentations-database/presentation/euro2022-3566/122883 . Alongside this work, the Health Analytics team have provided pro-bono analytics support to a range of groups to further the public’s health including the Royal College of Obstetrics and Gynaecology for their ‘Left for too Long’ report on NHS Waiting Lists, providing visualisations for the Office for National Statistics (ONS) National Health Index and currently working collaboratively with OHID, ONS and NHS investigating excess mortality and the indirect impact of the covid-19 pandemic on cardiovascular disease through a programme of work for the Chief Medical Officer led by our Head of Health Analytics. LCP is a financial, actuarial and analytics consultancy. In these roles LCP undertakes risk modelling across a range of sectors including across large pension schemes, energy and health analytics. LCP is an 80-year partnership and historically has focused on advising large occupational pension schemes. That advice includes actuarial support in calculating the liabilities of pension schemes, advice on investment options according to the liability of the pension scheme and the administration of pension schemes (i.e. the processing required when a pension scheme member retires and draws down on their pension). A very small portion of LCP’s work (approximately 5%) provides actuarial advice to general insurers (such as motor or home insurance). This is not related to health insurance.
Daley House, Unit 7, Bridge Road Business Park Bridge Road Haywards Heath, West Sussex, RH16 1TX United KingdomMedical communications working with medical and marketing teams to provide HCP education and communications.
Leatherhead, England United KingdomLeatherhead Food Research provides scientific and regulatory support about food and drink.
Queens Rd Teddington, Middlesex, TW11 0LY United KingdomLGC is a global manufacturer and distributor of high-quality certified reference materials, research chemicals (TRC), genomics solutions, proficiency testing, and analytical testing services. We employ our 180 years of scientific heritage, cutting-edge expertise in measurement science and track record of innovation to progress research & development and improve outcomes across pharmaceuticals, diagnostics, food, environment, industry and consumer products. Our products and services stand out, producing to the highest quality, continually adapting to changing regulation, and providing expert support and documentation to help ensure the accuracy of your analytical results. LGC. Science for a safer world. We serve as the UK’s National Measurement Institute for chemical and bioanalytical measurements. Meet our brands: - TRC TRC offers 150,000+ research chemicals, with a large inventory readily available globally. Discover our wide range of bioactive small molecules, stable isotope labelled & controlled substances to advance your research. - AXIO Proficiency Testing AXIO Proficiency Testing is a global provider of proficiency testing schemes. We support over 13,000 laboratories, with over 2,700 proficiency tests, in over 165 countries worldwide, to meet their regulatory and accreditation requirements. - Dr Ehrenstorfer Dr Ehrenstorfer provides a comprehensive range of high-quality reference materials. Over 50% of the portfolio is accredited to ISO 17034, with 14,000+ reference materials available. - LGC Industrial LGC Industrial offers innovative & agile measurement tools for a safe global infrastructure. Combining VHG, ARMI, MBH & Paragon Scientific, we deliver a wide range of petrochemical, metal, mining, powder & physical reference materials. - Mikromol Mikromol offers a portfolio of 7,000+ high-quality accredited pharmaceutical API, impurity & excipient reference standards, >95% ready to ship alongside market leading COAs. We also provide RMs management services & custom manufacturing. - Clinical Diagnostics LGC Clinical Diagnostics develops and manufactures a comprehensive portfolio of catalogue and custom-developed diagnostic quality solutions, biological and reagent component materials for the extended life sciences industry. - LGC Genomics LGC Genomics offers a custom DNA sequencing service. It is comprised of Biosearch Technologies & LGC Axolabs. i) Biosearch Technologies offers GMP and RUO Oligonucleotides, Molecular biology reagents, NGS kits and enzymes, Oligo synthesis reagents and instruments, PCR reagents and instruments, and sample prep reagents and instruments. ii) LGC Axolabs offers a unique services portfolio for the development of nucleic acid therapeutics and nucleic acid-based medicines.
Newmarket Road Fordham , Cambridgeshire, CB7 5WW United KingdomLGC is a global manufacturer and distributor of high-quality certified reference materials, research chemicals (TRC), genomics solutions, proficiency testing, and analytical testing services. We employ our 180 years of scientific heritage, cutting-edge expertise in measurement science and track record of innovation to progress research & development and improve outcomes across pharmaceuticals, diagnostics, food, environment, industry and consumer products. Our products and services stand out, producing to the highest quality, continually adapting to changing regulation, and providing expert support and documentation to help ensure the accuracy of your analytical results. LGC. Science for a safer world. We serve as the UK’s National Measurement Institute for chemical and bioanalytical measurements. Meet our brands: - TRC TRC offers 150,000+ research chemicals, with a large inventory readily available globally. Discover our wide range of bioactive small molecules, stable isotope labelled & controlled substances to advance your research. - AXIO Proficiency Testing AXIO Proficiency Testing is a global provider of proficiency testing schemes. We support over 13,000 laboratories, with over 2,700 proficiency tests, in over 165 countries worldwide, to meet their regulatory and accreditation requirements. - Dr Ehrenstorfer Dr Ehrenstorfer provides a comprehensive range of high-quality reference materials. Over 50% of the portfolio is accredited to ISO 17034, with 14,000+ reference materials available. - LGC Industrial LGC Industrial offers innovative & agile measurement tools for a safe global infrastructure. Combining VHG, ARMI, MBH & Paragon Scientific, we deliver a wide range of petrochemical, metal, mining, powder & physical reference materials. - Mikromol Mikromol offers a portfolio of 7,000+ high-quality accredited pharmaceutical API, impurity & excipient reference standards, >95% ready to ship alongside market leading COAs. We also provide RMs management services & custom manufacturing. - Clinical Diagnostics LGC Clinical Diagnostics develops and manufactures a comprehensive portfolio of catalogue and custom-developed diagnostic quality solutions, biological and reagent component materials for the extended life sciences industry. - LGC Genomics LGC Genomics offers a custom DNA sequencing service. It is comprised of Biosearch Technologies & LGC Axolabs. i) Biosearch Technologies offers GMP and RUO Oligonucleotides, Molecular biology reagents, NGS kits and enzymes, Oligo synthesis reagents and instruments, PCR reagents and instruments, and sample prep reagents and instruments. ii) LGC Axolabs offers a unique services portfolio for the development of nucleic acid therapeutics and nucleic acid-based medicines.
Pindar Road Hertfordshire, Hoddesdon, EN11 0WZ United KingdomLGC is a global manufacturer and distributor of high-quality certified reference materials, research chemicals (TRC), genomics solutions, proficiency testing, and analytical testing services. We employ our 180 years of scientific heritage, cutting-edge expertise in measurement science and track record of innovation to progress research & development and improve outcomes across pharmaceuticals, diagnostics, food, environment, industry and consumer products. Our products and services stand out, producing to the highest quality, continually adapting to changing regulation, and providing expert support and documentation to help ensure the accuracy of your analytical results. LGC. Science for a safer world. We serve as the UK’s National Measurement Institute for chemical and bioanalytical measurements. Meet our brands: - TRC TRC offers 150,000+ research chemicals, with a large inventory readily available globally. Discover our wide range of bioactive small molecules, stable isotope labelled & controlled substances to advance your research. - AXIO Proficiency Testing AXIO Proficiency Testing is a global provider of proficiency testing schemes. We support over 13,000 laboratories, with over 2,700 proficiency tests, in over 165 countries worldwide, to meet their regulatory and accreditation requirements. - Dr Ehrenstorfer Dr Ehrenstorfer provides a comprehensive range of high-quality reference materials. Over 50% of the portfolio is accredited to ISO 17034, with 14,000+ reference materials available. - LGC Industrial LGC Industrial offers innovative & agile measurement tools for a safe global infrastructure. Combining VHG, ARMI, MBH & Paragon Scientific, we deliver a wide range of petrochemical, metal, mining, powder & physical reference materials. - Mikromol Mikromol offers a portfolio of 7,000+ high-quality accredited pharmaceutical API, impurity & excipient reference standards, >95% ready to ship alongside market leading COAs. We also provide RMs management services & custom manufacturing. - Clinical Diagnostics LGC Clinical Diagnostics develops and manufactures a comprehensive portfolio of catalogue and custom-developed diagnostic quality solutions, biological and reagent component materials for the extended life sciences industry. - LGC Genomics LGC Genomics offers a custom DNA sequencing service. It is comprised of Biosearch Technologies & LGC Axolabs. i) Biosearch Technologies offers GMP and RUO Oligonucleotides, Molecular biology reagents, NGS kits and enzymes, Oligo synthesis reagents and instruments, PCR reagents and instruments, and sample prep reagents and instruments. ii) LGC Axolabs offers a unique services portfolio for the development of nucleic acid therapeutics and nucleic acid-based medicines.
Queens Road Teddington, TW11 0LY United KingdomATCC biomaterials are available in Europe through LGC Standards, ATCC’s exclusive distribution partner. The portfolio spans primary cells, organoids, authenticated cell lines, microorganisms, viruses, and molecular standards that support reliable research and preclinical progress. Applications include oncology and immuno-oncology, tumour microenvironment and cell-cell interaction models, toxicology, and infectious disease research. These resources help enable reproducible, decision-ready data across translational research, functional characterisation, assay development, candidate screening, and biomarker validation.
Queens Road Teddington Middlesex, TW11 0LY United KingdomBiotechnology
1 Blaydon Road Sandy, Bedfordshire, SG19 1RZ United KingdomLife Science Group is a specialist UK-based full-service CDMO for media and liquid solutions. LSG provides both catalogue and custom solutions for Cell Culture and Molecular Biology applications with customers spanning Pharma, Biotech, CROs, Academia, and Private Research. The company manufactures custom media and liquids, a range of high-quality life science reagents, biospecimen sourcing, and a variety of lab services via an on-site cell culture lab. Antibody Production Services (APS), a division of Life Science Group, provides flexible and professional contract generation of antibodies, both monoclonal and polyclonal, together with a large range of associated services, including the optimisation and production of existing antibody hybridomas, adaptation of cells to serum-free conditions, bulk antibody production, and purification.
Bischheim House 19-20 Berners Street London, London, W1T 3NW United KingdomExperts in recruitment, specifically within Life Sciences. Providing talent advisory tailored to maximising success in the industry.
199 Bishopsgate London, London, EC2M 3TY United KingdomLightning Health is a global stakeholder engagement and market access strategy consultancy. Lightning Health help you explore your landscapes, build meaningful evidence and optimise go to market strategies. Offering both online platform and traditional stakeholder engagement methods, we house a dedicated engagement team that match you with fit for purpose respondent samples for your research needs.
8 Devonshire Square London, London, EC2M 4PL United KingdomLightning Health is a global stakeholder engagement and market access strategy consultancy. Lightning Health help you explore your landscapes, build meaningful evidence and optimise go to market strategies. Offering both online platform and traditional stakeholder engagement methods, we house a dedicated engagement team that match you with fit for purpose respondent samples for your research needs.
The Leather Market London, London, SE1 3ER United KingdomLindus Health is an anti-CRO running radically faster, more reliable clinical trials for life science pioneers like AstraZeneca, Pharmanovia, and George Medicines. We do this thanks to a unique software platform, access to 20 million Electronic Health Records and a world class clinical operation team. We handle the end to end execution of clinical studies, including design, patient recruitment, clinical data capture, monitoring and project management. We have helped over 80 sponsors run entire clinical studies up to 3x faster than typical CROs.
London, England United KingdomLogos Technologies specializes in electronic data capture to support clinical studies.
Keppel Street London , WC1E 7HT United KingdomThe London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health. School building from gardensOur mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice. Founded in 1899, the School has expanded in recent years at its two main sites on Keppel Street and Tavistock Place. Our staff, students and alumni work in more than 150 countries in government, academia, international agencies and health services. Research income has grown to more than £110 million per year from national and international funding sources including UK government and research councils, the European Union, the Wellcome Trust, Gates Foundation and other philanthropic sources. The School’s multidisciplinary expertise includes clinicians, epidemiologists, statisticians, social scientists, molecular biologists and immunologists, and we work with partners worldwide to support the development of teaching and research capacity. Our education provision has expanded to more than 1,000 London-based Master's and Research students, 3,000 studying postgraduate courses by distance learning, and 1,000 each year on short courses and continuous professional development. Our free online courses (Moocs) are studied by more than 30,000 participants globally. The School performs well in various global university league tables. In the US News Best Global Universities Ranking 2017, we are ranked sixth in the world (together with Oxford University) in the fields of social sciences and public health. In the 2016 CWTS Leiden Ranking, the School was ranked fifth in the world for research impact across all disciplines, based on the share of institutions’ outputs within the top 1% of papers by citation in all areas of science and independent of size of output. The School was named University of the Year 2016 by Times Higher Education, in recognition of our response to the Ebola epidemic. The School is a member of the M8 Alliance of Academic Health Centers, Universities and National Academies, the Association of Schools of Public Health in the European Region, and the Consortium of Universities for Global Health. Our Values: The School seeks to foster and sustain a creative and supportive working environment based upon an ethos of respect and rigorous scientific enquiry. We embrace and value the diversity of our staff and student population and seek to promote equality as an essential element in contribution to improving health worldwide.
228 Bath Road , Slough, Berkshire, SL1 4DX Great BritainLonza is one of the world’s largest contract development and manufacturing organizations (CDMOs) dedicated to serving the healthcare industry. Working across five continents, our colleagues work alongside pharma and biotech companies to turn their breakthrough innovations into viable therapies. We support our customers in bringing life-saving and life-enhancing treatments to patients worldwide with a combination of cutting-edge science, smart technology and lean manufacturing.
Granta Park Great Abington, Cambridge, CB216GS, Great BritainLonza is one of the world’s largest contract development and manufacturing organizations (CDMOs) dedicated to serving the healthcare industry. Working across five continents, our colleagues work alongside pharma and biotech companies to turn their breakthrough innovations into viable therapies. We support our customers in bringing life-saving and life-enhancing treatments to patients worldwide with a combination of cutting-edge science, smart technology and lean manufacturing.
Building 200, Chesterford Research Park Little Chesterford, Saffron Walden, CB10 1XL United KingdomWe offer a complete line of in silico and in vitro services for manufacturability, immunogenicity, humanization, and protein engineering. These technologies include our award winning and patented Epibase® T cell epitope screening platform for immunogenicity assessment along with our proprietary technology platform for structural protein engineering. Our Cambridge, UK-based Early development Services scientists will help you determine a testing strategy, analyze and interpret the data, and recommend next steps throughout the process. In addition to our protein design and optimization services, we also offer a protein production service for mg to g quantities of non-GMP material. Lonza’s Light Path™ programs are streamlined and available for both mammalian and microbial applications. Lonza’s protein design and optimization services were developed to mitigate risks, reduce attrition, and improve the quality and safety of therapeutic proteins. They also address the challenges and accelerate the design and development of efficacious vaccines. These services provide a complete portfolio for your late discovery and early development needs. Our early stage services are diverse, include but not limited to: MAPPS, post translational modification, CDC assays, Humanisation, ADCC assays, Cell proliferations, Cytokine assays, PTM prediction, Humanization, Deimmunization, Aggregation analysis, in silico T cell epitope prediction, B cell assays, T cell activation, T cell assays, Developability assessment, Immunogenicity, Immunogenicity prediction, Manufacturability assessment.
Sea Containers 6th Floor 22 Upper Ground London, London, SE19PD United KingdomMulti capability agency maximising the life-cycle curve of healthcare brands. We specialise in Strategic Consultancy, Scientific & Medical Communications and Commercial Communications
Great Suffolk Yard 2nd Floor, 131 Great Suffolk Street London, London, SE1 1PP United KingdomLumanity was purpose built to integrate the capabilities required to successfully commercialize assets into a tightly woven, solutions-oriented organization. We impact key value inflection points on the medicine development path, bringing clarity and confidence to all stakeholders involved. Lumanity ensures that every decision, milestone, and engagement is interconnected, amplifying impact and driving sustained success.
Bartholomews WalkLumora offers assay optimization, assay design, lyophilization, and quality assurance testing services.
The Gateway Building, 1 Collegiate Square Thames Valley Science Park (TVSP) Reading, England, RG2 9LH United KingdomM2M Pharma is a contract research organisation (CRO) that supports early stage product development for pharmaceutical, food, biological and biotechnology companies across the globe as a “Fee for Service”. We are an ISO 9001:2015 certified company. We are your company of choice for amorphous content determination by Solution and/or Perfusion Calorimetry, DVS (with aqueous and organic solvents) techniques. With having 15 years of hand-on experience in handling 100s API and 1000s of batches, expert data interpretation and in-house rich instrumentation clearly put us as "The Material Science Powerhouse". We ensure "Quality Service Delivered on Time."
South Avenue Thames Valley Science Park (TVSP) Shinfield, RG2 9LH United KingdomM2M Pharma is a contract research organisation (CRO) that supports early stage product development for pharmaceutical, food, biological and biotechnology companies across the globe as a “Fee for Service”. We are an ISO 9001:2015 certified company. We are your company of choice for amorphous content determination by Solution and/or Perfusion Calorimetry, DVS (with aqueous and organic solvents) techniques. With having 15 years of hand-on experience in handling 100s API and 1000s of batches, expert data interpretation and in-house rich instrumentation clearly put us as "The Material Science Powerhouse". We ensure "Quality Service Delivered on Time."
Unit 125 (Gr Fl) Wharfedale Road Winnersh Triangle Reading, England, RG41 5RB United KingdomM2M Pharma is a contract research organisation (CRO) that supports early stage product development for pharmaceutical, food, biological and biotechnology companies across the globe as a “Fee for Service”. We are an ISO 9001:2015 certified company. We are your company of choice for amorphous content determination by Solution and/or Perfusion Calorimetry, DVS (with aqueous and organic solvents) techniques. With having 15 years of hand-on experience in handling 100s API and 1000s of batches, expert data interpretation and in-house rich instrumentation clearly put us as "The Material Science Powerhouse". We ensure "Quality Service Delivered on Time."
5th FloorMakroCare is a clinical research organization and offers late phase studies, quality assurance, regulatory affairs, clinical monitoring and data management.
Unit 3, Hogarth Business Park, Burlington LaneMarken offers its expertise in biological asset logistics, clinical trial support, and medical devices. Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient services and biological sample shipments and offers a state-of-the-art GMP compliant depot network and logistic hubs in 45 locations worldwide. Marken’s 753 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 150 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.
Matrix Science Ltd 64 Baker Street London W1U 7GB UKYou are welcome to submit searches to this free Mascot Server. Searches of MS/MS data are limited to 1200 spectra and some functions, such as no enzyme searches, are unavailable. Automated searching of batches of files is not permitted. If you want to automate search submission, perform large searches, search additional sequence databases, or customise the modifications, quantitation methods, etc., you’ll need to license your own, in-house copy of Mascot Server.
The Station House 15 Station Road St. Ives, Cambrideshire, PE27 5BH United KingdomMaverex are experts in market access and HEOR, including Market access strategy, HTA support, HE modelling, meta-analyses, value communications, RWE and environmental impact/sustainability. We specialize in providing health economic, market access, epidemiological, environmental and outcomes research expertise to support pharmaceutical, medical device, and diagnostic companies demonstrate and communicate the value of their product, from early clinical development through to post-launch commercialisation. Our goal is to help maximise launch success. We are a thriving senior team offering a range of core market access deliverables, including evidence generation (systematic reviews, meta-analyses, RWE, database analyses), value demonstration (health economics models), communication and payer negotiation materials (global value dossiers, negotiation strategies, publications, HTA submissions etc.), environmental impact/sustainability of disease pathways and products, and digital tools for internal use (like electronic global value dossiers) and field use (like payer toolkits and economic model apps). Our collaborative, flexible approach, reputation for delivering high quality, insightful products, and exceptional customer service set us apart from other businesses in the field. We continually strive to achieve this through investing in our relationships and through our commitment to long-term collaborations with our customers. At Maverex we ensure that our customers always deal with the people actually doing the work, from the initial proposal right through to the final deliverable. We understand the customer’s perspective as many of us were once the customer ourselves, and we care about the successful outcome of projects as much as our customers do. Maverex is a team of highly experienced professionals with +20 years of experience and a wide skill base. Our scientists have a long track record in development of market access deliverables with experience working in pharma, consultancy and academia.
Meldreth, England, SG8 United KingdomMCA Services is UK-based contract analytical service and consultancy provider with experience and expertise in the physical characterisation of materials from a wide range of industries and sectors worldwide.
Unit 1A Long Barn, North End Meldreth, Cambridgeshire SG8 6NT United KingdomMCA Services is UK-based contract analytical service and consultancy provider with experience and expertise in the physical characterisation of materials from a wide range of industries and sectors worldwide.
Stane Street Slinfold, England, RH13 0SZ United Kingdom
England United KingdomMedical Research Network is a clinical trial support organization offering home trial support, site nurse support and bespoke solutions.
Talon House Presley Way Milton Keynes Buckinghamshire MK8 0ES UKMedical Research Network is a clinical trial support organization offering home trial support, site nurse support and bespoke solutions.
Allia Future Business Centre Kings Hedges Road Cambridge, Cambridge, CB4 2HY United KingdomMedicilon is a leading integrated CRO/CDMO providing one-stop drug discovery and preclinical development services to global pharmaceutical, biotechnology, and academic partners. From hit identification and lead optimization to IND-enabling studies, we accelerate the development of innovative therapeutics through a fully integrated platform encompassing medicinal chemistry, biology, DMPK, pharmacology, toxicology, CMC, API process development, formulation, and bioanalytical services. Our flexible collaboration models, including fee-for-service (FFS), dedicated FTE teams, and fully integrated discovery programs which allow us to support projects of any size and stage. Backed by GLP- and GMP-compliant facilities, AAALAC-accredited animal research capabilities, and extensive regulatory experience, Medicilon delivers high-quality, reliable data that supports global IND submissions. By combining scientific expertise, operational efficiency, and seamless cross-functional collaboration, we help clients shorten development timelines and bring promising therapies to patients faster.
152, Staplehurst Road Sittingbourne, Kent, ME101QZ United KingdomMedicys was founded in 2002, as an independent and privately owned fieldwork agency dedicated to serving clients in the healthcare industry, globally. Our team of experts provide clients with innovative, intelligent fieldwork solutions to meet their objectives while ensuring that the highest standards, ethical and legal, are always met. We offer market research companies, contract research organizations, public relations, digital and creative agencies, as well as leading strategic consultancy companies the full gamut of healthcare fieldwork and linguistic services, globally
Kingfisher House 21-23, Elmfield Road, Bromley BR1 1LT, London, United KingdomMedpace is a Full Service CRO and offers clinical development services including medical writings, biometrics, regulatory affairs and quality assurance. Also offered are Central Lab Services, Bio-Analytical, Biomarker Testing, BioSample Storage and Management, Long-term BioRepository, Core Lab Services, Imaging, and a Phase I Safety Clinic.
Unit 1 Chancellor Court 50 Occam Road Guildford, GU2 7AB United KingdomMedPharm is the world’s leading contract provider of topical and transdermal product design, formulation development, and semi-solid and liquid manufacturing services. MedPharm's experts specialize in mitigating risk and accelerating development times for generic and proprietary pharmaceutical customers through the use of its unique, cost-effective, and industry-leading performance testing models. Well established as the global leader in dermal and transdermal, inhalation, ungual, and buccal product development, MedPharm also offers innovative solutions for ophthalmic, vaginal, anal, and otic development. MedPharm is recognized for its scientific rigor by regulators and investors alike and has facilities in both the USA and the UK.
64 Speldhurst Road London, England, W4 1BZ United KingdomMedShr is the world’s leading professional network and clinical case discussion platform for healthcare professionals (HCPs), connecting over 2.5 million verified members across 195 countries. For commercial clients—particularly in the pharmaceutical, medical device, and digital health sectors—MedShr serves as a high-impact digital channel to engage doctors and deliver medical education at scale.
Melbourn Scientific Saxon Way Melbourn Royston SG8 6DNMelbourn Scientific provides high quality cGMP analytical and formulation services to the pharmaceutical, biotech and healthcare industries.
Room 2.52W, Hodgkin Building, King’s College London Guy’s Post room 18-20 Newcomen Street London, London, SE1 1UL United KingdomIMU is a discovery engine mapping the immune system in unprecedented detail and scale to deliver unique, systems-level immune insights. IMU is powered by an unprecedented high-resolution and high content immunophenotyping measuring over 1500 discrete cell subsets capturing a comprehensive, systems-level immune profile from 2ml of fresh or cryopreserved blood. We are building a massive immune database from biobanks and population data to account for the immune variation and provide exceptional resolution to identify immune signatures relating to disease and treatment response. The IMU platform is coupled by innovative ML analytics and data processing for real-time cell classification, contextualisation and understanding of individual immune profiles and signatures. About us IMU was founded on the belief that deep immunophenotyping at population level scale powered by machine learning could unlock the power of the immune system to help develop the next generation of immune medicines. We believe that in the future, no medical decision will be made without an understanding of a patient's immune system. We’re a team of healthcare experts, immunologists, clinicians, technologists, developers and researchers with a bold ambition: To revolutionise our understanding of the immune system and derive tangible, actionable value from that understanding.
C/O Mark Davies & Associates LTD, City Tower, 40 Basinghall Street London, London, EC2V 5DE United KingdomIMU is a discovery engine mapping the immune system in unprecedented detail and scale to deliver unique, systems-level immune insights. IMU is powered by an unprecedented high-resolution and high content immunophenotyping measuring over 1500 discrete cell subsets capturing a comprehensive, systems-level immune profile from 2ml of fresh or cryopreserved blood. We are building a massive immune database from biobanks and population data to account for the immune variation and provide exceptional resolution to identify immune signatures relating to disease and treatment response. The IMU platform is coupled by innovative ML analytics and data processing for real-time cell classification, contextualisation and understanding of individual immune profiles and signatures. About us IMU was founded on the belief that deep immunophenotyping at population level scale powered by machine learning could unlock the power of the immune system to help develop the next generation of immune medicines. We believe that in the future, no medical decision will be made without an understanding of a patient's immune system. We’re a team of healthcare experts, immunologists, clinicians, technologists, developers and researchers with a bold ambition: To revolutionise our understanding of the immune system and derive tangible, actionable value from that understanding.
9 Kingswood Avenue Hounslow, Middlesex London, UK TW3 4LLMeruvax Pharma offers medicinal chemistry and API manufacturing services in addition to supplying building blocks, peptides, intermediates, and other fine chemicals.
London, England United KingdomMetabometrix provides drug toxicity testing and metabonomics technology for analyzing metabolic information from fluids and tissues.
St Johns Innovation Centre Cambridge, CB4 OWS United KingdomMetisox is a technology company with tech and people, meaning that we have a proprietary technology platform and a group of senior industry experts. Our tech and people are helping our clients for both: de-risk pharmaceutical projects as well as help predict and discover unpresedented innovative therapeutic options. We do that by a combination of industry expert team and a technology deploying artificial intelligence and machine learning solutions, database and software for researchers and decision makers in the pharmaceutical, chemical, nutrition and agrochemical industries. We are the leaders in reports for de-riskng pharmaceutical projects by generating predictive as we ll as Weight of Evidence reports about: modality safety assessment reports, target safety assessment reports, polypharmacology reports, toxicology study curation, multi-omics data analysis,
Lakinrose, Cambridge House Camboro Business Park Girton , Cambridge, CB3 0QH United KingdomMetisox is a technology company with tech and people, meaning that we have a proprietary technology platform and a group of senior industry experts. Our tech and people are helping our clients for both: de-risk pharmaceutical projects as well as help predict and discover unpresedented innovative therapeutic options. We do that by a combination of industry expert team and a technology deploying artificial intelligence and machine learning solutions, database and software for researchers and decision makers in the pharmaceutical, chemical, nutrition and agrochemical industries. We are the leaders in reports for de-riskng pharmaceutical projects by generating predictive as we ll as Weight of Evidence reports about: modality safety assessment reports, target safety assessment reports, polypharmacology reports, toxicology study curation, multi-omics data analysis,
St Johns Innovation Centre CB4 OWS Cambridge United KingdomMetisox is a technology company with tech and people, meaning that we have a proprietary technology platform and a group of senior industry experts. Our tech and people are helping our clients for both: de-risk pharmaceutical projects as well as help predict and discover unpresedented innovative therapeutic options. We do that by a combination of industry expert team and a technology deploying artificial intelligence and machine learning solutions, database and software for researchers and decision makers in the pharmaceutical, chemical, nutrition and agrochemical industries. We are the leaders in reports for de-riskng pharmaceutical projects by generating predictive as we ll as Weight of Evidence reports about: modality safety assessment reports, target safety assessment reports, polypharmacology reports, toxicology study curation, multi-omics data analysis,
Lakin Rose Pioneer House, Vision Park, Histon Cambridge , CB24 9NL United KingdomMetisox is a technology company with tech and people, meaning that we have a proprietary technology platform and a group of senior industry experts. Our tech and people are helping our clients for both: de-risk pharmaceutical projects as well as help predict and discover unpresedented innovative therapeutic options. We do that by a combination of industry expert team and a technology deploying artificial intelligence and machine learning solutions, database and software for researchers and decision makers in the pharmaceutical, chemical, nutrition and agrochemical industries. We are the leaders in reports for de-riskng pharmaceutical projects by generating predictive as we ll as Weight of Evidence reports about: modality safety assessment reports, target safety assessment reports, polypharmacology reports, toxicology study curation, multi-omics data analysis,
Riverside 3, Suite 1 Granta Park Great Abington, Cambridgeshire, CB21 6AD United KingdomMetrion Biosciences is a specialist preclinical drug discovery contract research organization (CRO) focussed on delivering a range of high quality ion channel, cardiac safety and neuroscience services. We provide highly skilled electrophysiology screening and high-throughput screening (HTS) services to support medicinal chemistry optimisation programmes, hERG screening, including GLP compliant hERG screening, plus CiPA compliant cardiac safety profiling assays, neuroscience assays, CNS and translational assays. Working closely with collaborators, we also offer an expert integrated drug discovery service. Business models are flexible according to the scope of each programme, with both fee-for-service and collaborative options available. Metrion's highly expert and dedicated specialists support diverse ion channel, cardiac safety and neuroscience drug discovery projects and modern safety assessment research. We combine in depth target class knowledge and high quality screening assays with experienced and collaborative project managers to keep your research focused upon meeting both objectives and timelines.
TWI Stores Granta Park, Great Abington Cambridge, CB21 6AL United KingdomMetrion Biosciences is a specialist preclinical drug discovery contract research organization (CRO) focussed on delivering a range of high quality ion channel, cardiac safety and neuroscience services. We provide highly skilled electrophysiology screening and high-throughput screening (HTS) services to support medicinal chemistry optimisation programmes, hERG screening, including GLP compliant hERG screening, plus CiPA compliant cardiac safety profiling assays, neuroscience assays, CNS and translational assays. Working closely with collaborators, we also offer an expert integrated drug discovery service. Business models are flexible according to the scope of each programme, with both fee-for-service and collaborative options available. Metrion's highly expert and dedicated specialists support diverse ion channel, cardiac safety and neuroscience drug discovery projects and modern safety assessment research. We combine in depth target class knowledge and high quality screening assays with experienced and collaborative project managers to keep your research focused upon meeting both objectives and timelines.
60 Great Portland Street London, W1W 7RT United KingdomPR company
CTBI Building, Papworth Hospital NHS Foundation Trust Papworth Everard, Cambridge CB23 3REMesobanK is collecting archived FFPE mesothelioma tumour samples and associated clinical and pathology data to form a large Tissue MicroArray (we aim for 1000 patients). Prospective samples of blood, tumour and pleural fluid with clinical, pathology and outcome data from proven mesothelioma cases will be processed, frozen and stored starting end of 2013.
4 Heath Square, Boltro Road Haywards Heath, West Sussex RH16 1BL United KingdomMicrozone manufactures and supplies reagents and kits to support DNA extraction, amplification, and sequencing.
87 Church Street England, RG45 7AW United Kingdom
BioPark Broadwater Road Welwyn Garden City Hertfordshire AL7 3AX United KingdomMind the Byte is a bioinformatics company that develops and provides software for computational drug discovery using Big Data and Machine Learning (AI) approaches. We work with partners on a consultancy basis or offer an easy to use Software as a Service (SaaS) package to allow clients to apply the High-performance computing platform on a flexible pay-per-use basis without investment in hardware or software licenses. Mind the Byte has developed a versatile set of applications using cloud computing which lowers the entry barrier to the technology, e.g. i) virtual profiling methods to facilitate the identification of targets and mechanisms of action of phenotypic screening hits or natural products with reported activity ii) virtual screening methods to identify compounds acting on a specific target by mining internal or commercial compound libraries, to expand hit or lead series and to conduct repurposing of known drugs. iii) MtBDock - a fully integrated docking protocol reducing the amount of false positives by incorporation of all prosthetic groups and conformational minimization iv) SmartDock - an experimentally validated docking protocol with further improved performance based on machine learning of PDB target-ligand interactions Mind the Byte is an Amazon Web Services technology partner - a seal of quality that has only been awarded to five companies in this sector – to ensure security and reliability. The company was founded in 2011 by Alfons Nonell-Canals, a specialist in computer-aided drug design and in large-scale chemical and biological analyses, and has since expanded with an experienced staff.
53 Quarry Road Godalming, Surrey, GU7 2RW United KingdomMinerva Regulatory Consulting 1. Who We Are Minerva Regulatory Consulting supports organisations as they transition from early scientific innovation into the complex, high‑expectation world of global regulatory requirements. We specialise in biologics including ATMPs/CGTs, GMO‑regulated products, and small molecules, ensuring programmes evolve with the clarity, structure, and regulatory maturity needed for global success. 2. Our Value Proposition Minerva enables teams to demonstrate: - Regulatory alignment from the earliest stages - CMC maturity appropriate for each development phase - Operational discipline under increasing regulatory scrutiny - Credible, inspection‑ready documentation and processes We reduce risk, accelerate progress, and strengthen the regulatory standing of development programmes. 3. Leadership Dr Lara Stevanato — Founder & Principal Consultant Strategic Regulatory Affairs Leader with 20+ years of experience across biotech and CRO environments. Expert in: - Global regulatory strategies for biologics including ATMPs/CGTs, GMO applications, and small molecules - High‑complexity CMC submissions and lifecycle management - Direct engagement with MHRA, EMA, and FDA - Navigating evolving regulatory frameworks and identifying critical risks early Dr Stevanato brings a rare combination of scientific depth, regulatory insight, and operational leadership. 4. What We Deliver Minerva provides practical, implementation‑driven regulatory enablement: - Proportionate, sustainable solutions embedded within existing operations - Clear, structured regulatory pathways aligned with development and commercial objectives - Early‑phase to late‑phase readiness for global submissions and agency interactions - Strengthened internal capability through hands‑on support and strategic guidance Our approach avoids unnecessary complexity and focuses on what truly moves programmes forward. 5. Why Organisations Choose Minerva Deep expertise in high‑complexity, high‑scrutiny modalities - Proven track record from FIH to approval - Ability to translate scientific ambition into regulatory‑credible strategies - Practical, execution‑focused support that integrates seamlessly with existing teams - Confidence and readiness for global submissions, inspections, and agency meetings 6. Our Impact Minerva positions organisations to: - Advance development programmes with confidence - Meet rising regulatory expectations without disruption - Strengthen credibility with regulators and investors - Build the foundations for long‑term growth and product advancement
The Exchange Building, Colworth Park, Sharnbrook Bedford, Bedfordshire, MK44 1LQ United KingdomTozaro is a technology leader in the field of synthetic affinity ligands. The business has developed a novel, proprietary design and development process to make Smart Polymers(TM) for scalable affinity purification processes, starting in the viral vector space. - Target biomarkers where antibodies have previously failed - Create new purification solutions where affinity ligands need to be stable to extreme conditions - Achieve continuous supply security with an animal free, chemically produced product - Deliver improved performance in purification processes The company was formerly known as MIP Discovery / Diagnostics
The Exchange Building Colworth Science Park SHARNBROOK, Bedfordshire, MK44 1LQ United KingdomTozaro is a technology leader in the field of synthetic affinity ligands. The business has developed a novel, proprietary design and development process to make Smart Polymers(TM) for scalable affinity purification processes, starting in the viral vector space. - Target biomarkers where antibodies have previously failed - Create new purification solutions where affinity ligands need to be stable to extreme conditions - Achieve continuous supply security with an animal free, chemically produced product - Deliver improved performance in purification processes The company was formerly known as MIP Discovery / Diagnostics
London, England United KingdomMole Chemical Corporation specializes in small molecule design and synthesis and supplies various intermediates and fine chemicals.
Longfield, Kent, UKMolecular Connections offers software tools for drug discovery.
1180 Eskdale Road Winnersh Triangle Wokingham, Berkshire, RG41 5TU United KingdomMolecular Devices is a life-science technology innovator. Our integrated hardware and software solutions enable automated workflows—from start to finish—for any research application. Whether its 3D biology, drug screening, cell line development—or a combination of the three—our technology maximizes throughput and reproducibility to give researchers more time and greater insights. Molecular Devices offers: 1. Organoid Expansion Service 2. Kits for the screening of GPCRs, ion channels, enzymes, and transporters. 3. Instrumentation: plate-readers, high content imaging, automated cell culture, colony pickers, high throughput screening
660-665 Eskdale Road Winnersh Triangle Wokingham, Berkshire, RG41 5TS United KingdomMolecular Devices is a life-science technology innovator. Our integrated hardware and software solutions enable automated workflows—from start to finish—for any research application. Whether its 3D biology, drug screening, cell line development—or a combination of the three—our technology maximizes throughput and reproducibility to give researchers more time and greater insights. Molecular Devices offers: 1. Organoid Expansion Service 2. Kits for the screening of GPCRs, ion channels, enzymes, and transporters. 3. Instrumentation: plate-readers, high content imaging, automated cell culture, colony pickers, high throughput screening
Unit 6, Goodwin Business Park Willie Snaith Road, Newmarket, Suffolk CB8 7SQ United KingdomMolecular Dimensions provides protein crystallography research products.
MK44 2YP United KingdomWith more than 30 of the most talented scientists in the world and an array of first-class equipment at Mologic, we’d love to put them at your disposal. Our unbeaten record of successful project delivery is largely down to our diverse range of skills in these areas: * Innovative biotechnology research * Applied immunoassay technology * Medical diagnostic devices * Antibody development * Protein and peptide chemistry * Applied microbial physiology and biochemistry This is a selection of what we can do – but it’s not all we can do. If you can’t see what you need, contact us. We’d love to help – and if we can’t, we’ll definitely know someone who can.
BEDFORD TECHNOLOGY PARK THURLEIGH, BEDFORDSHIRE, MK44 2YP UNITED KINGDOMWith more than 30 of the most talented scientists in the world and an array of first-class equipment at Mologic, we’d love to put them at your disposal. Our unbeaten record of successful project delivery is largely down to our diverse range of skills in these areas: * Innovative biotechnology research * Applied immunoassay technology * Medical diagnostic devices * Antibody development * Protein and peptide chemistry * Applied microbial physiology and biochemistry This is a selection of what we can do – but it’s not all we can do. If you can’t see what you need, contact us. We’d love to help – and if we can’t, we’ll definitely know someone who can.
London, England United KingdomMoorfields Pharmaceuticals offers contract clinical manufacturing services including filling and labelling services.
Blk 211 Woodlands Avenue 9Moritex provides semiconductor manufacturing, imaging systems, electronic equipment, information technology, and laboratory automation.
1-3 Burtonhole LaneMRC Technology provides antibody humanization, small molecule drug discovery, antibody reagents, and IP licensing.
Lynton HouseMRC Technology provides antibody humanization, small molecule drug discovery, antibody reagents, and IP licensing.
Wokingham, England United KingdomSGS M-Scan offers mass spectrometry and chromatography services, including protein analysis, glycosylation analysis, antibody analysis, oligonucleotide analysis and bioanalysis.
The Bradfield Centre, 184 Cambridge Science Park, Milton Road, Milton, Cambridge London , CB4 0GA United KingdomWe’re excited to announce that Mtech Access has joined forces with Delta Hat as Petauri Evidence. Petauri Evidence is an innovative new business unit within the Petauri platform that unites Mtech Access and Delta Hat, along with Petauri’s US HEOR business. Together, we are dedicated to helping pharmaceutical, biotechnology, and medical device companies generate, apply, and communicate evidence to inform healthcare decision-making. At Petauri Evidence we work in partnerships with our clients to deliver high-quality work that is tailored to their commercial strategy, whilst meeting the needs of healthcare stakeholders. Our team are passionate about what they do and love to work with clients to find the best solutions to their challenges. We carefully construct our project teams to provide the right balance of technical expertise, strategic consultancy and senior oversight, and pride ourselves on our first-class project management. Our services are informed and validated by our panel of more than 90 NHS Associates and our global network of payers, healthcare professionals and local market experts. Our core services include: - Global market access and pricing strategy - Global value proposition development / global value dossiers - European market access and reimbursement - Systematic literature reviews and network meta-analysis - Health economic modelling and evaluation - HEOR strategy and support - Health technology assessment (HTA) support - pre-submission, submission development and post-submission support - Local customer communication tools - Interactive value proposition and budget impact model tools - Stakeholder and healthcare system insights - NHS insight and interaction We are proud of our collaborative, nurturing environment, where we encourage growth, celebrate success and care for each other. We are an ethical company and act with impartiality and integrity towards everyone we encounter in our working lives. We are known for our high standards, for expert-led work that is exemplary and credible, and for being agile, proactive and innovative.
Unit 2.28, St John's Innovation Centre Cowley Road Cambridge , CB4 0WS United KingdomWe’re excited to announce that Mtech Access has joined forces with Delta Hat as Petauri Evidence. Petauri Evidence is an innovative new business unit within the Petauri platform that unites Mtech Access and Delta Hat, along with Petauri’s US HEOR business. Together, we are dedicated to helping pharmaceutical, biotechnology, and medical device companies generate, apply, and communicate evidence to inform healthcare decision-making. At Petauri Evidence we work in partnerships with our clients to deliver high-quality work that is tailored to their commercial strategy, whilst meeting the needs of healthcare stakeholders. Our team are passionate about what they do and love to work with clients to find the best solutions to their challenges. We carefully construct our project teams to provide the right balance of technical expertise, strategic consultancy and senior oversight, and pride ourselves on our first-class project management. Our services are informed and validated by our panel of more than 90 NHS Associates and our global network of payers, healthcare professionals and local market experts. Our core services include: - Global market access and pricing strategy - Global value proposition development / global value dossiers - European market access and reimbursement - Systematic literature reviews and network meta-analysis - Health economic modelling and evaluation - HEOR strategy and support - Health technology assessment (HTA) support - pre-submission, submission development and post-submission support - Local customer communication tools - Interactive value proposition and budget impact model tools - Stakeholder and healthcare system insights - NHS insight and interaction We are proud of our collaborative, nurturing environment, where we encourage growth, celebrate success and care for each other. We are an ethical company and act with impartiality and integrity towards everyone we encounter in our working lives. We are known for our high standards, for expert-led work that is exemplary and credible, and for being agile, proactive and innovative.
The Bradfield Centre, 184 Cambridge Science Park, Milton Road, Milton Cambridge , CB4 0GA United KingdomWe’re excited to announce that Mtech Access has joined forces with Delta Hat as Petauri Evidence. Petauri Evidence is an innovative new business unit within the Petauri platform that unites Mtech Access and Delta Hat, along with Petauri’s US HEOR business. Together, we are dedicated to helping pharmaceutical, biotechnology, and medical device companies generate, apply, and communicate evidence to inform healthcare decision-making. At Petauri Evidence we work in partnerships with our clients to deliver high-quality work that is tailored to their commercial strategy, whilst meeting the needs of healthcare stakeholders. Our team are passionate about what they do and love to work with clients to find the best solutions to their challenges. We carefully construct our project teams to provide the right balance of technical expertise, strategic consultancy and senior oversight, and pride ourselves on our first-class project management. Our services are informed and validated by our panel of more than 90 NHS Associates and our global network of payers, healthcare professionals and local market experts. Our core services include: - Global market access and pricing strategy - Global value proposition development / global value dossiers - European market access and reimbursement - Systematic literature reviews and network meta-analysis - Health economic modelling and evaluation - HEOR strategy and support - Health technology assessment (HTA) support - pre-submission, submission development and post-submission support - Local customer communication tools - Interactive value proposition and budget impact model tools - Stakeholder and healthcare system insights - NHS insight and interaction We are proud of our collaborative, nurturing environment, where we encourage growth, celebrate success and care for each other. We are an ethical company and act with impartiality and integrity towards everyone we encounter in our working lives. We are known for our high standards, for expert-led work that is exemplary and credible, and for being agile, proactive and innovative.
19 Eastbourne Terrace London , W2 6LG United KingdomWe’re excited to announce that Mtech Access has joined forces with Delta Hat as Petauri Evidence. Petauri Evidence is an innovative new business unit within the Petauri platform that unites Mtech Access and Delta Hat, along with Petauri’s US HEOR business. Together, we are dedicated to helping pharmaceutical, biotechnology, and medical device companies generate, apply, and communicate evidence to inform healthcare decision-making. At Petauri Evidence we work in partnerships with our clients to deliver high-quality work that is tailored to their commercial strategy, whilst meeting the needs of healthcare stakeholders. Our team are passionate about what they do and love to work with clients to find the best solutions to their challenges. We carefully construct our project teams to provide the right balance of technical expertise, strategic consultancy and senior oversight, and pride ourselves on our first-class project management. Our services are informed and validated by our panel of more than 90 NHS Associates and our global network of payers, healthcare professionals and local market experts. Our core services include: - Global market access and pricing strategy - Global value proposition development / global value dossiers - European market access and reimbursement - Systematic literature reviews and network meta-analysis - Health economic modelling and evaluation - HEOR strategy and support - Health technology assessment (HTA) support - pre-submission, submission development and post-submission support - Local customer communication tools - Interactive value proposition and budget impact model tools - Stakeholder and healthcare system insights - NHS insight and interaction We are proud of our collaborative, nurturing environment, where we encourage growth, celebrate success and care for each other. We are an ethical company and act with impartiality and integrity towards everyone we encounter in our working lives. We are known for our high standards, for expert-led work that is exemplary and credible, and for being agile, proactive and innovative.
Solario Building, Brewer street Dairy Business Park Brewer Street Bletchingley Surrey RH1 4QP United KingdomMycoplasma Experience provides services and products for mycoplasmas and closely related organisms.
Brewer Street Dairy Business Park Solario Building, 1 Brewer St Bletchingley, Redhill , Surrey, RH1 4QP United KingdomMycoplasma Experience provides services and products for mycoplasmas and closely related organisms.
Incubator building, Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2FX United KingdomNanoFCM provide technology and services which allow for single nanoparticle characterization applicable to EVs, LNPs, and viruses. Size, concentration, empty/loaded ratios, mRNA quantification, surface protein/ligand quantification are all parameters capable of being measured simultaneously. The NanoFCM centre of excellence offers a bespoke analysis service for individual projects to simplify access to this advanced characterization of nanoparticle samples and formulations. Whether you require greater understanding of NP samples and formulations, or want to see whether nano-flow cytometry devices are right for your lab, our teams in Europe and North America are ready to help.
Block Y, Northwick Park & St Mark's Hospital Watford Road Harrow, Greater London, Ha1 3UJ United KingdomNanomerics is an award winning speciality pharmaceutical company. Nanomerics develops precision medicines that address medical need by focusing on reducing the typical development costs, resources and timelines. Nanomerics' proprietary technology addresses medical and non-medical applications with a focus on conditions at the front and back of the eye, CNS conditions and challenging oral active pharmaceutical ingredients (APIs)
Huntingdon Road, Cambridge CB3 OLE UKNIAB is a pioneering plant science organisation based at the heart of the Cambridge science, technology and university communities and a thriving UK agricultural industry. With over 90 years experience in the agricultural and food sectors, NIAB has an internationally recognised reputation for independence, innovation and integrity. Our traditional activities have always focused on science-led plant variety and seeds characterisation, evaluation, quality control and knowledge transfer.
Teddington, England, TW11 0LW United KingdomThe National Physical Laboratory (NPL) is the UK's National Measurement Institute and is a world-leading centre of excellence in developing and applying the most accurate measurement standards, science and technology. NPL solutions are delivered in world-class research facilities using the outputs from significant research programmes supported by UK Government, and have been shown to be world leading in over 80% of science areas. Customers have access to over 500 multi-disciplinary scientists along with an extensive national and international network of partners. Our collaboration network of other science organisations, industry, academia and international laboratories prove invaluable to deliver the requirements of our customers who range from government departments, start-ups to large global multi-national corporations. Independence and a reputation proven from our testimonials give absolute confidence that we will translate our science excellence in to current and future real world requirements of our customers.
National Physical Laboratory Hampton Road Teddington UK TW11 0LWThe National Physical Laboratory (NPL) is the UK's National Measurement Institute and is a world-leading centre of excellence in developing and applying the most accurate measurement standards, science and technology. NPL solutions are delivered in world-class research facilities using the outputs from significant research programmes supported by UK Government, and have been shown to be world leading in over 80% of science areas. Customers have access to over 500 multi-disciplinary scientists along with an extensive national and international network of partners. Our collaboration network of other science organisations, industry, academia and international laboratories prove invaluable to deliver the requirements of our customers who range from government departments, start-ups to large global multi-national corporations. Independence and a reputation proven from our testimonials give absolute confidence that we will translate our science excellence in to current and future real world requirements of our customers.
Unit S5-S6 The Saxon Building Eastern Counties Leather Industrial Estate London Road, Pampisford, Cambridge, 53, CB22 3FJ United KingdomSpecialist veterinary endocrine assay laboratory
Unit S5-S6 The Saxon Building Eastern Counties Leather Industrial Estate London Road, Pampisford, Cambridge, CB22 3FJ United KingdomSpecialist veterinary endocrine assay laboratory
7 High Street Carshalton Surrey SM5 3APOur complete skincare range and also available in bulk sizes, alongside bulk bottles and jars. If you want to place a large order, it can take a couple of hours before your order is ready, so it is best to place your order online and choose Naturallythinking Croydon Pickup if you do not have time to wait. We are just 2 minutes from Valley Park where you will find Ikea and a wide range of food and drink establishments whilst you wait.
14 Tower Square Huntingdon, Cambridgeshire PE29 7DT United KingdomNBS Biologicals Ltd is part of Bio Basic Inc, and we are a manufacturer and supplier of high quality reagents, kits, biochemicals, lab ware and services to the research industry. In addition to supplying the full range of Bio Basic products and services, we also represent several other major international brands in the UK.
London, England United KingdomNBScience offers clinical research and laboratory testing services to support clinical trials in phases I-IV.
86-90 Paul Street England, EC2A 4NE United KingdomNCube provides high-end software development services to companies worldwide. We offer strategic consulting, custom software development and dedicated team extension services.
Prime House Challenge Court Barnett Wood Lane Leatherhead, KT22 7DE United KingdomNDA Regulatory Science provides regulatory affairs, pharmacovigilance, quality assurance, and product development.
Glenn Berge Building Babraham Research Park Cambridge CB22 3FH, United Kingdom, 27713 2849 United KingdomAccelerate Precision Oncology with a Trusted Biopharma Partner NeoGenomics empowers biopharma innovators to advance precision therapies from discovery through commercialization. Our integrated multi-modal testing, biomarker expertise, and real-world data insights help de-risk development, accelerate critical milestones, and bring transformative therapies to patients faster. Trusted by 300+ biopharma partners, including 85% of the top 20 • End-to-end multi-modal testing services through CAP-accredited and CLIA-certified laboratories in the United States and the United Kingdom. • Comprehensive, validated off-the-shelf assays and integrated data analysis. • Advanced customization for your program’s needs. • Experience across 25+ oncology indications, including solid, hematologic, and rare cancers. • Complimentary scientific consultation and strategic biomarker guidance. • Beyond lab data - de-risk your biomarker strategy with multi-modal real-world data and accelerate your timeline with qualified, timely patient insights and alerts. Core Capabilities Histopathology • Spatial Analysis • Genomics • Flow Cytometry • FISH & Cytogenetics • Multi-Modal Real-World Evidence
Ground Floor 2 Woodberry Grove North Finchley, London N12 0DR United KingdomNeurexpert provides specialist neurophysiology expertise and bespoke electrophysiology assays for research into treatments of nervous system disorders.
Squires House 205a High Street West Wickham Kent, BR4 0PH United KingdomNeurexpert provides specialist neurophysiology expertise and bespoke electrophysiology assays for research into treatments of nervous system disorders.
Clinical Lecturer Medical Oncology Medical Genomics UCL Cancer Institute University College London Paul O'Gorman Building 72 Huntley Street London WC1E 6BT, UKThe Neuroendocrine Tumour (NET) Unit at the Royal Free Campus of UCL Hospitals has an international reputation for the management of neuroendocrine tumour patients. It currently receives around 10 new referrals per month and has an active patient cohort of over 800 patients. We receive referrals from across the UK as well as from abroad. It is the designated centre for NETs within the North London Cancer Network.
Oak House Reeds Crescent Watford Hertfordshire WD24 4QN
1 The Cam Centre Wilbury Way Hitchin Hertfordshire SG4 0TW United KingdomNiche Generics is a company dedicated to the launch of generic pharmaceutical products.
Hills Road Box 277 Hills Road England, CB2 0SS United KingdomUniquely, the facility is housed within the Genetic Laboratories of the East Anglian Medical Genetics Service, allowing us to offer researchers access to clinical grade next generation sequencing services. We offer a range of services from; nucleic acid extraction (from whole blood, buffy coat, tissue etc), full library preparation, sequencing only, and complete end to end services. We have a full suite of Illumina sequencing instruments (MiSeq (Dx), NextSeq 500, HiSeq 2500 & HiSeq 4000), which allows us to offer a large sequencing capacity. Allied to the sequencing equipment, we have a wide range of ancillary resources, including; Agilent Tapestation 4200, Qiagen QiaSymphony extraction platform, Covaris E220 Ultra-Sonicator, Beckman Biomek FXp Liquid Handling Automation Station, all of which is backed by our Clarity Gold Laboratory Information Management System (LIMS).
Department of Medical Genetics, Box 238, Level 6, Addenbrooke's Treatment Centre Cambridge, CB2 0QQ United KingdomUniquely, the facility is housed within the Genetic Laboratories of the East Anglian Medical Genetics Service, allowing us to offer researchers access to clinical grade next generation sequencing services. We offer a range of services from; nucleic acid extraction (from whole blood, buffy coat, tissue etc), full library preparation, sequencing only, and complete end to end services. We have a full suite of Illumina sequencing instruments (MiSeq (Dx), NextSeq 500, HiSeq 2500 & HiSeq 4000), which allows us to offer a large sequencing capacity. Allied to the sequencing equipment, we have a wide range of ancillary resources, including; Agilent Tapestation 4200, Qiagen QiaSymphony extraction platform, Covaris E220 Ultra-Sonicator, Beckman Biomek FXp Liquid Handling Automation Station, all of which is backed by our Clarity Gold Laboratory Information Management System (LIMS).
B260 Babraham Research Campus 1011 Meditrina Cambridge, CB22 3AT United KingdomThe Nikon BioImaging Lab provides contract research services for microscope-based imaging and analysis to biotech, pharma, and larger research communities. We provide a solution to your imaging needs by leveraging our four core competences: Speed - Our unique combination of advanced imaging hardware and scientific expertise ensures that we can set up your imaging solution in record time. Unlike other imaging facilities, the Nikon BioImaging Lab offers full-service cell culture capabilities – our experienced staff is equipped to handle cell thawing, maintenance, expansion, differentiation, and other essential operations. Speeding up your assay development. Quality - Nikon is a world leader in the development and manufacture of optical and digital imaging technology for biomedical applications. Now in its 104th year, Nikon provides complete optical systems that offer optimal versatility, performance and productivity. Reproducible - Perfect focus assisted hardware and custom software solutions to allow for near unprecedented precision. For example one of our high-content assays allows for high-resolution cell segmentation with incredibly low between-plate variability. Flexible - Custom configurations allow for a vast array of imaging applications ensuring that our scientists can find a custom solution for your imaging needs. We are expert biologists and microscopists, who are available to provide quality cell culture, sample preparation, data acquisition, and data analysis services. Leveraging our expertise to ensure that your imaging needs are met so you can focus on your research.
Europe and LondonThe cloud is rapidly transforming the way we live and work. It makes our lives more convenient, accessible, and secure, and for organisations it drives them to be more competitive, agile, and profitable. We're currently witnessing a mass migration to cloud, which at Nordcloud we call #TheCloudRevolution. It was this observation that led our team of founders to establish Nordcloud in 2011 with the mission of helping organisations gain the maximum benefits the cloud has to offer. Since then we've grown into a global leader of cloud services having helped over 200 organisations gain the benefits of the cloud from our offices in Helsinki, Stockholm, Oslo, London, Munich, and Malmö. We're making the world a more cloudy place, one migration at a time.
Welwyn Garden City, England United KingdomNovacta Biosystems provides natural product and metabolite synthesis services.
Richmond House Walkern Road Stevenage, Hertfordshire SG1 3QPNovella Clinical offers clinical research resourcing in investigator recruitment and phase I-IV clinical monitoring, data management, pharmacovigilance, and regulatory consultation services.
Cambridge Science Park 25, Milton Road Cambridgeshire, Cambridgeshire, CB4 0FW United KingdomNovogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise. With one of the largest sequencing capacities in the world, we utilise our deep scientific knowledge, first-class customer service and unsurpassed data quality to help clients realise their research goals in the rapidly evolving world of genomics. We provide a complete end-to-end solution for DNA and RNA sequencing projects from extraction to data analysis. With over 2,000 employees, multiple locations around the world, 37 NGS related patents and over 790 publications in top tier journals such as Nature and Science, we have rapidly become a world-leader in NGS services
Richmond, England United KingdomThe Biotechnology team at NPL provides expertise in an array of spectroscopic techniques, such as Ultraviolet-Visible (UV-Vis) absorption spectroscopy, Circular Dichroism (CD), Fourier Transform Infrared (FTIR) and fluorescence spectroscopy. These techniques can be utilised to study the structure of proteins as structural changes can have a major impact on their activity, stability and toxicity, and consequently can compromise the efficacy and shelf life of products.
1 Coldbath Square London, England, EC1R 5HL United KingdomWe are An agency for medical content and AI based researchntam health is a global medical transformation and communications company specializing in scientific engagement, digital innovation, and AI-enabled healthcare solutions. We support leading pharmaceutical, biotechnology, and medical device organizations across more than 30 markets through services spanning medical strategy, education, clinical trial enablement, and omnichannel engagement. Our ISO-certified operations combine scientific excellence with advanced technology and sustainability principles, ensuring every project delivers measurable impact, compliance, and efficiency. With multi-hub offices in Europe, North America, the Middle East, and Asia—and a 24/7 Metaverse Service Hub—ntam health provides continuous, data-driven support to help clients shape the future of healthcare communications responsibly and effectively.
One Vision Park Station Road, Histon Cambridge, Cambridgeshire, CB24 9NP United KingdomNuclera exists to remove uncertainty from protein science. As the pioneer of multiplex protein screening, we help researchers start with clarity, so ideas move faster to result. We believe access to your protein should be a certainty, not a gamble. eProtein Discovery™ is how we deliver on that promise, but our aim is bigger: to make protein access routine for every lab, accelerate breakthroughs in human health, and empower scientists to spend more time on discovery and less on delay. Our eProtein Discovery™ system combines unique cell free expression systems, novel digital microfluidics, and robust screening data, to create an effortlessly multiplex protein screening solution that empowers you to perform your own protein screening, characterization, and small-scale expression in-house within days — even challenging membrane proteins Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.
Mill SciTech Park Mill Lane, Hauxton, Cambridge, Chambridge , CB22 5HX United Kingdomo2h Discovery has an integrated drug discovery platform operating from our offices in Cambridge and our state-of-the-art research centre in India. We have the in-house capability to execute hit-lead optimisation programs leading into patent and IND filing incubator with expertise in discovery chemistry, biology/pharmacology and the on-going project management of pre-clinical development. We are also in the process of developing a biology capability in Cambridge, UK that will be able to support our collaborators with cell biology and protein expression/purification. Our UK office also supports our collaborators with medicinal chemistry/design. We have developed an engine for seeding a pipeline of early stage life science assets through collaborations, in-licensing, spin-out and investments. Please see https://o2h.com/discovery/chemistry/ for more details.
Cambridge, England United Kingdomo2h Discovery has an integrated drug discovery platform operating from our offices in Cambridge and our state-of-the-art research centre in India. We have the in-house capability to execute hit-lead optimisation programs leading into patent and IND filing incubator with expertise in discovery chemistry, biology/pharmacology and the on-going project management of pre-clinical development. We are also in the process of developing a biology capability in Cambridge, UK that will be able to support our collaborators with cell biology and protein expression/purification. Our UK office also supports our collaborators with medicinal chemistry/design. We have developed an engine for seeding a pipeline of early stage life science assets through collaborations, in-licensing, spin-out and investments. Please see https://o2h.com/discovery/chemistry/ for more details.
Unit 13 Suna House 65 Rivington St London, EC2A 3QQ United KingdomOccam Research Ltd is a boutique consultancy company specializing in academic quality research to support value demonstration for the pharmaceutical/device industry. They specialise in developing health economic models, value messaging, medical communications and patient engagement research Occam’s name comes from ’Occam’s Razor’, also knows as the ‘principle of parsimony’ that states that when faced with multiple explanations for a phenomenon, the simplest explanation is usually the best.
London BioScience Innovation CentreOctagon Research provides regulatory services and clinical consulting.
7th Floor, 105 Victoria Street London, UNITED KINGDOM, SW1E 6QT United KingdomFounded in 2002, OHE Consulting provides client-focused, specialised expertise on policy and strategic issues affecting the delivery of health care and the future of the pharmaceutical and life sciences industries. We are dedicated to providing objective, independent advice to help our clients achieve their objectives. OHE’s professional research activities ensure our in-house team remains at the forefront of the latest thinking, underpinning the advice we provide. This is further strengthened by OHE’s global network of outside experts, which complements the international diversity of our team, and increases our local, on-the-ground knowledge and insights to the benefit of our clients. We maintain strong relationships with leading academics, policy makers, payers, HTA bodies, health care providers, and pharmaceutical and life sciences companies worldwide.
1 Tower Place West London, EC3R 5BU United KingdomOliver Wyman is a global consultancy that co-creates strategic solutions with clients that have a positive, tangible impact on their business. Its Healthcare and Life Sciences practice recently expanded significantly with the addition of 80 life sciences consultants acquired from Huron Consulting Group. Our expertise in healthcare and life sciences are complemented by capabilities in value communications, pricing strategy and negotiation, digital and organizational effectiveness . As well as major hubs in London and New York, we are present in multiple markets across Europe, the middle east and Asia Pacific region, including China.
Chesterford Research Park Cambridge, CB10 1XL United KingdomOncologica® is a leading precision oncology services laboratory and contract research organisation based in the prestigious Chesterford Research Park, Cambridge, UK. Oncologica® provides precision oncology testing to address the growing demand for molecular profiling of cancer patients for targeted therapies and functions as a Contract Research Organisation to support biomarker and drug development programmes worldwide. Our technology addresses this new era of precision medicine by exploiting state of the art molecular profiling enabling a patient’s tumour to be matched directly with the most appropriate molecular targeted therapy.
Suite 15-16 The Science Village Chesterford Research Park Little Chesterford Cambridge CB10 1XLOncologica® is a leading precision oncology services laboratory and contract research organisation based in the prestigious Chesterford Research Park, Cambridge, UK. Oncologica® provides precision oncology testing to address the growing demand for molecular profiling of cancer patients for targeted therapies and functions as a Contract Research Organisation to support biomarker and drug development programmes worldwide. Our technology addresses this new era of precision medicine by exploiting state of the art molecular profiling enabling a patient’s tumour to be matched directly with the most appropriate molecular targeted therapy.
Suite 15-16, The Science Village, Chesterford Research Park United Kingdom Chesterford, Cambridge, CB10 1XL United KingdomOncologica® is a leading precision oncology services laboratory and contract research organisation based in the prestigious Chesterford Research Park, Cambridge, UK. Oncologica® provides precision oncology testing to address the growing demand for molecular profiling of cancer patients for targeted therapies and functions as a Contract Research Organisation to support biomarker and drug development programmes worldwide. Our technology addresses this new era of precision medicine by exploiting state of the art molecular profiling enabling a patient’s tumour to be matched directly with the most appropriate molecular targeted therapy.
Wilburton, England, CB6 United KingdomOncoLytika is leveraging its business planning and R&D experience together with its network of contacts in preclinical development to provide a range of consultancy packages to the Pharma and Biotech industry
1 The Firs Wilburton Ely Cambridgeshire CB6 3FL United KingdomOncoLytika is leveraging its business planning and R&D experience together with its network of contacts in preclinical development to provide a range of consultancy packages to the Pharma and Biotech industry
20 Old Bailey London, EC4M 7AN United KingdomAt OPEN Health, we connect visionary minds, pioneering science, and advanced technology to drive real impact. By uniting people, science, and technology, we activate new opportunities for biopharma innovation. Our expertise across medical affairs and market access unlocks faster, smarter routes to market. We are committed to improving patient outcomes worldwide. OPEN Health. The right combination to unlock possibilities. Medical Affairs Our highly skilled medical communications specialists bring data to life, engaging with the healthcare community to unlock behavior change. Patient Engagement We are experts in strategic patient innovation and engagement, building bespoke patient solutions, always through the lens of a patient. HEOR & Market Access We remain at the forefront of HEOR through the development and application of innovative solutions, to unlock better and faster access for patients. Consulting (Acsel Health) Combining deep industry expertise, scientific rigor, and actionable analysis, Acsel Health partners to guide life-changing innovations through their critical stages, from early development through market maturity. To learn more, visit www.openhealthgroup.com.
The Weightbridge Brewery Courtyard, High Street Marlow, Buckinghamshire, SL7 2FF United KingdomAt OPEN Health, we connect visionary minds, pioneering science, and advanced technology to drive real impact. By uniting people, science, and technology, we activate new opportunities for biopharma innovation. Our expertise across medical affairs and market access unlocks faster, smarter routes to market. We are committed to improving patient outcomes worldwide. OPEN Health. The right combination to unlock possibilities. Medical Affairs Our highly skilled medical communications specialists bring data to life, engaging with the healthcare community to unlock behavior change. Patient Engagement We are experts in strategic patient innovation and engagement, building bespoke patient solutions, always through the lens of a patient. HEOR & Market Access We remain at the forefront of HEOR through the development and application of innovative solutions, to unlock better and faster access for patients. Consulting (Acsel Health) Combining deep industry expertise, scientific rigor, and actionable analysis, Acsel Health partners to guide life-changing innovations through their critical stages, from early development through market maturity. To learn more, visit www.openhealthgroup.com.
UH.2.43B, University House School of Health, Sport & Bioscience University of East London Stratford Campus Water Lane London, London, E15 4LZ United KingdomWith a collaborative approach we can use our experience to support early stage anti-infective drug development projects. With access to our own isolate collection and a friendly, flexible and cost effective approach, we can cater to any organisation with any budget. We offer a range of in vitro microbiological laboratory testing services on a contract basis, in vitro test methods including: Minimum Inhibitory Concentration Testing Minimum Bactericidal Concentration Testing Time/ Kill Analysis, Post Antibiotic Effect Serial Passage/ Mutation Frequency Testing Biochemical Pathway Modelling Services: Oppilotech believe target selection is a vital step in drug development. To this end we have created an AI driven, whole cell model of the biochemical processes of E.coli, a world first, and used it to identify new biology and novel drug targets. Our pathway modelling expertise can be offered as a service. Firstly with access to our modelling platforms, we would be interested in collaborations to exploit our current and new drug targets. Secondly, we can apply the platform to modelling any eurkaryotic or prokaryotic area of interest. Allowing optimal drug target selection and delivering increased chances of a successful therapeutic development programme. If you are interested in better pre-clinical drug target selection using our AI modelling approach, please get in touch or see further info on our website.
London Bioscience Innovation Centre, London NW1 0NH UK 2 Royal College Street London, NW1 0NH United KingdomWith a collaborative approach we can use our experience to support early stage anti-infective drug development projects. With access to our own isolate collection and a friendly, flexible and cost effective approach, we can cater to any organisation with any budget. We offer a range of in vitro microbiological laboratory testing services on a contract basis, in vitro test methods including: Minimum Inhibitory Concentration Testing Minimum Bactericidal Concentration Testing Time/ Kill Analysis, Post Antibiotic Effect Serial Passage/ Mutation Frequency Testing Biochemical Pathway Modelling Services: Oppilotech believe target selection is a vital step in drug development. To this end we have created an AI driven, whole cell model of the biochemical processes of E.coli, a world first, and used it to identify new biology and novel drug targets. Our pathway modelling expertise can be offered as a service. Firstly with access to our modelling platforms, we would be interested in collaborations to exploit our current and new drug targets. Secondly, we can apply the platform to modelling any eurkaryotic or prokaryotic area of interest. Allowing optimal drug target selection and delivering increased chances of a successful therapeutic development programme. If you are interested in better pre-clinical drug target selection using our AI modelling approach, please get in touch or see further info on our website.
66 Buckingham Gate London, Westminster, SW1E 6AU United KingdomOTG-i is a full service Clinical Research Organisation (CRO) dedicated to the ophthalmic field. As a CRO, OTG-i offers an independent test facility for the ophthalmic pharmaceutical industries for ophthalmic drugs and devices including contact lenses and contact lens care products. The services offered by OTG-i encompass all stages of clinical investigations from the inception of the investigation to the production of the final report. The company is BS EN ISO 9001: 2008 certified to carry out aspects specific to the provision of contract research, consultancy, research and development, professional affairs and regulatory support services for the contact lens, ophthalmic pharmaceutical, ophthalmic device and sports industries.
1st Floor, North Westgate House, The High. Harlow, Choose State/Province, CM20 1YS United KingdomOrizzonte is a UK-based Site Management Organisation (SMO) specialising in decentralised, community-based clinical trials. We partner with General Practices (GPs) to deliver efficient, patient-centric trials through two primary functions: Patient Identification Centres (PICs) and Visit Centres (VCs). Our model integrates primary care into clinical research, enhancing recruitment, retention, and representation across all therapeutic areas.
1 Pancras Square London, England, N1C 4AG United KingdomOwkin is an agentic AI company on a mission to explore complex biology to speed up and scale research for the creation of new treatments and diagnostics for patients. Owkin K, our AI co-pilot combines unparalleled access to multimodal data, cutting-edge AI to quantify biology and pioneering agentic AI to achieve Biological Artificial Superintelligence in the future.
Unit 183, Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, E8 3FF United KingdomOwlstone Medical has developed and commercialized Breath Biopsy technology, a breathalyzer for disease capable of the reliable identification and analysis of biomarkers in exhaled breath, with the mission to become the global leader in non-invasive diagnostics for early detection and precision medicine. Breath Biopsy is now an established method that enables the reliable collection and analysis of a wide range of volatile organic compounds (VOCs) on human breath. The company has run the world’s largest breath based clinical trials and has established the first high volume breath analysis lab with ISO 9001 certification and quality checks at every stage of the workflow. In addition to capabilities around biomarker discovery and validation, Owlstone have also developed miniaturized VOC detection technologies based on Field-Asymmetric Ion Mobility Spectrometry (FAIMS) which have already been deployed for field based applications in military and industrial applications. Once suitable clinical biomarkers have been identified on breath, this same technology could be adapted as a cost effective, rapid, small footprint device for point of care or near patient testing. Finally, Owlstone is also developing methods for the collection and analysis of larger macro-molecules in exhaled breath aerosol including bacteria, viral particles and proteins. Unlike liquid and tissue biopsies, which require blood or tissue samples to be taken, Breath Biopsy provides a completely non-invasive solution that maximizes patient comfort. Owlstone offers an end-to-end non-invasive biomarker service to pharmaceutical and academic partners from in vitro headspace analysis of VOCs from cell culture samples to clinical deployment of biomarkers on breath.
Unit 183, Cambridge Science Park, Milton Road Cambridge, Cambridgeshire, CB4 0GJ United KingdomOwlstone Medical has developed and commercialized Breath Biopsy technology, a breathalyzer for disease capable of the reliable identification and analysis of biomarkers in exhaled breath, with the mission to become the global leader in non-invasive diagnostics for early detection and precision medicine. Breath Biopsy is now an established method that enables the reliable collection and analysis of a wide range of volatile organic compounds (VOCs) on human breath. The company has run the world’s largest breath based clinical trials and has established the first high volume breath analysis lab with ISO 9001 certification and quality checks at every stage of the workflow. In addition to capabilities around biomarker discovery and validation, Owlstone have also developed miniaturized VOC detection technologies based on Field-Asymmetric Ion Mobility Spectrometry (FAIMS) which have already been deployed for field based applications in military and industrial applications. Once suitable clinical biomarkers have been identified on breath, this same technology could be adapted as a cost effective, rapid, small footprint device for point of care or near patient testing. Finally, Owlstone is also developing methods for the collection and analysis of larger macro-molecules in exhaled breath aerosol including bacteria, viral particles and proteins. Unlike liquid and tissue biopsies, which require blood or tissue samples to be taken, Breath Biopsy provides a completely non-invasive solution that maximizes patient comfort. Owlstone offers an end-to-end non-invasive biomarker service to pharmaceutical and academic partners from in vitro headspace analysis of VOCs from cell culture samples to clinical deployment of biomarkers on breath.
Unit 183, Cambridge Science Park, Milton Road, Cambridge, Other, CB4 0GJ United KingdomOwlstone Medical has developed and commercialized Breath Biopsy technology, a breathalyzer for disease capable of the reliable identification and analysis of biomarkers in exhaled breath, with the mission to become the global leader in non-invasive diagnostics for early detection and precision medicine. Breath Biopsy is now an established method that enables the reliable collection and analysis of a wide range of volatile organic compounds (VOCs) on human breath. The company has run the world’s largest breath based clinical trials and has established the first high volume breath analysis lab with ISO 9001 certification and quality checks at every stage of the workflow. In addition to capabilities around biomarker discovery and validation, Owlstone have also developed miniaturized VOC detection technologies based on Field-Asymmetric Ion Mobility Spectrometry (FAIMS) which have already been deployed for field based applications in military and industrial applications. Once suitable clinical biomarkers have been identified on breath, this same technology could be adapted as a cost effective, rapid, small footprint device for point of care or near patient testing. Finally, Owlstone is also developing methods for the collection and analysis of larger macro-molecules in exhaled breath aerosol including bacteria, viral particles and proteins. Unlike liquid and tissue biopsies, which require blood or tissue samples to be taken, Breath Biopsy provides a completely non-invasive solution that maximizes patient comfort. Owlstone offers an end-to-end non-invasive biomarker service to pharmaceutical and academic partners from in vitro headspace analysis of VOCs from cell culture samples to clinical deployment of biomarkers on breath.
Wade Road Basingstoke Hampshire, RG24 8PW United Kingdom
200 Northcote Road London , E17 7DH United KingdomOXON Epidemiology is a European-based, full-service Contract Research Organization (CRO) combining advanced scientific expertise with global operational capability to deliver Real-World Evidence (RWE) and RWE-driven clinical research solutions. We support pharmaceutical and medical device companies with strategic, scientific, and executional services across the full product lifecycle—from early-phase development through post-marketing. Our offerings include observational studies (field, database, and hybrid), pragmatic trials, disease/product registries, evidence synthesis (systematic reviews, meta-analyses), and full-phase clinical trials (I–IV). We address needs in safety, clinical effectiveness, HEOR, market access, and regulatory compliance. What sets OXON apart is our highly experienced, multidisciplinary team—epidemiologists, statisticians, health economists, clinicians, and qualitative researchers—combined with strong academic partnerships (e.g., London School of Hygiene & Tropical Medicine) and global collaborators. With MSAs in place with top-20 pharmaceutical companies and a publication record including 11 articles in The Lancet, we are trusted to deliver high-quality, cost-effective RWE worldwide. Our scale and structure allow for flexibility, senior team involvement, and client-focused delivery. We operate across Europe, LATAM, Asia, and North America, and are committed to scientific excellence, transparency, and impact on patient and public health.
London, England United KingdomPA Consulting Group provides consulting for management, IT, technology and innovation for several industries.
123 Buckingham Palace Road London SW1W 9SR United KingdomPA Consulting Group provides consulting for management, IT, technology and innovation for several industries.
London, England United KingdomPanthera Solutions offers efficacy models in inflammation, cardiovascular, CNS, pain, gastrointestinal, and respiratory indications as well as cell based assay services.
Papworth Everard, England, CB23 3RG United KingdomPapworth Hospital is one of the largest specialist cardiothoracic (heart and lung) hospitals in Europe and includes the country's main heart and lung transplant centre. Over the last three years, it has performed the highest number of heart surgery procedures in the UK whilst achieving the country’s lowest cardiac surgery mortality rate. The Hospital has an extraordinary commitment to delivering the highest levels of clinical quality and providing the best possible standards of personalised care to its patients. Papworth Hospital treats more than 24,400 inpatients and day cases and sees more than 73,600 outpatients each year from across the UK. Papworth Hospital’s services are internationally recognised and include cardiology, respiratory medicine, sleep medicine, cardiac surgery, thoracic surgery and heart & lung transplantation. Located in Cambridgeshire in the East of England, the hospital sees patients for the diagnosis and treatment of cardiothoracic disease, it is also a national centre for a range of specialist services, including pulmonary endarterectomy (PEA). Papworth Hospital has the largest respiratory support and sleep centre (RSSC) in the UK.
Papworth Everard Cambridge , CB23 3RE United KingdomPapworth Hospital is one of the largest specialist cardiothoracic (heart and lung) hospitals in Europe and includes the country's main heart and lung transplant centre. Over the last three years, it has performed the highest number of heart surgery procedures in the UK whilst achieving the country’s lowest cardiac surgery mortality rate. The Hospital has an extraordinary commitment to delivering the highest levels of clinical quality and providing the best possible standards of personalised care to its patients. Papworth Hospital treats more than 24,400 inpatients and day cases and sees more than 73,600 outpatients each year from across the UK. Papworth Hospital’s services are internationally recognised and include cardiology, respiratory medicine, sleep medicine, cardiac surgery, thoracic surgery and heart & lung transplantation. Located in Cambridgeshire in the East of England, the hospital sees patients for the diagnosis and treatment of cardiothoracic disease, it is also a national centre for a range of specialist services, including pulmonary endarterectomy (PEA). Papworth Hospital has the largest respiratory support and sleep centre (RSSC) in the UK.
Papworth Everard Cambridge CB23 3RE United KingdomPapworth Hospital's laboratory pathology service is managed by the clinical lead for pathology, a consultant pathologist and the laboratory manager, a chartered biomedical scientist.
1394 High Road, London, N20 9YZ, United KingdomParatopes offers custom monoclonal antibody synthesis services.
London, England United KingdomParatopes offers custom monoclonal antibody synthesis services.
Northwick Park HospitalAt Parexel, speeding life-changing medicines to market begins by engaging patients With Heart™ With more than 24,000 life science professionals in 49 countries across six continents, Parexel’s people are the engine that drives clinical trial delivery, outcomes, and new medicines forward. We have made significant investment in our operations infrastructure to ensure consistent, predictable delivery all around the world as clinical research complexity continues to rise. Our trial execution framework integrates the latest innovations to efficiently manage increased research complexity, reach more patients while driving faster results for our customers and better outcomes for patients. And around the world, we’re investing today to develop a talent pool ready to deliver your next big breakthrough. The integration of clinical operations excellence and unparalleled regulatory consulting strength gives us an advantage when tackling the most complex trials in oncology, cell and gene therapies, rare diseases, and central nervous system disorders. We have a proven track record of strong performance in these areas, along with immunology, inflammation, and many more. We apply clinical operations and regulatory expertise to design clinical trials that help life-saving medicines reach patients sooner. From Phase I to Phase IV, global life sciences professionals work in partnership with biopharmaceutical sponsors to create trial experiences that are easier for patients to participate in and can serve as a viable care option for patients across a range of disease areas. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas while our innovation ecosystem offers solutions throughout the product lifecycle – optimising data quality, creating better clinical trial experiences, and improving operational efficiencies – with the goal of driving better results for our customers and outcomes for patients. With the people, insight, and operational excellence to support a thriving R&D community, Parexel works With HeartTM to treat patients with dignity and learn from their experiences, so every trial makes a difference. In 2021, Parexel was acquired by EQT and Goldman Sachs Asset Management. We are headquartered in Raleigh, North Carolina, and employ 20,815 professionals in 49 countries. We are united by a core value that we believe influences every aspect of our work: We Care. We care about our people, our customers, our sites, and our partners.
The Quays 101-105 Oxford Rd Uxbridge, Middlesex, UB8 1LZ United KingdomAt Parexel, speeding life-changing medicines to market begins by engaging patients With Heart™ With more than 24,000 life science professionals in 49 countries across six continents, Parexel’s people are the engine that drives clinical trial delivery, outcomes, and new medicines forward. We have made significant investment in our operations infrastructure to ensure consistent, predictable delivery all around the world as clinical research complexity continues to rise. Our trial execution framework integrates the latest innovations to efficiently manage increased research complexity, reach more patients while driving faster results for our customers and better outcomes for patients. And around the world, we’re investing today to develop a talent pool ready to deliver your next big breakthrough. The integration of clinical operations excellence and unparalleled regulatory consulting strength gives us an advantage when tackling the most complex trials in oncology, cell and gene therapies, rare diseases, and central nervous system disorders. We have a proven track record of strong performance in these areas, along with immunology, inflammation, and many more. We apply clinical operations and regulatory expertise to design clinical trials that help life-saving medicines reach patients sooner. From Phase I to Phase IV, global life sciences professionals work in partnership with biopharmaceutical sponsors to create trial experiences that are easier for patients to participate in and can serve as a viable care option for patients across a range of disease areas. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas while our innovation ecosystem offers solutions throughout the product lifecycle – optimising data quality, creating better clinical trial experiences, and improving operational efficiencies – with the goal of driving better results for our customers and outcomes for patients. With the people, insight, and operational excellence to support a thriving R&D community, Parexel works With HeartTM to treat patients with dignity and learn from their experiences, so every trial makes a difference. In 2021, Parexel was acquired by EQT and Goldman Sachs Asset Management. We are headquartered in Raleigh, North Carolina, and employ 20,815 professionals in 49 countries. We are united by a core value that we believe influences every aspect of our work: We Care. We care about our people, our customers, our sites, and our partners.
The Quays, 101-105 OXFORD RD UXBRIDGE, MIDDLESEX, UB8 1LZ United KingdomAt Parexel, speeding life-changing medicines to market begins by engaging patients With Heart™ With more than 24,000 life science professionals in 49 countries across six continents, Parexel’s people are the engine that drives clinical trial delivery, outcomes, and new medicines forward. We have made significant investment in our operations infrastructure to ensure consistent, predictable delivery all around the world as clinical research complexity continues to rise. Our trial execution framework integrates the latest innovations to efficiently manage increased research complexity, reach more patients while driving faster results for our customers and better outcomes for patients. And around the world, we’re investing today to develop a talent pool ready to deliver your next big breakthrough. The integration of clinical operations excellence and unparalleled regulatory consulting strength gives us an advantage when tackling the most complex trials in oncology, cell and gene therapies, rare diseases, and central nervous system disorders. We have a proven track record of strong performance in these areas, along with immunology, inflammation, and many more. We apply clinical operations and regulatory expertise to design clinical trials that help life-saving medicines reach patients sooner. From Phase I to Phase IV, global life sciences professionals work in partnership with biopharmaceutical sponsors to create trial experiences that are easier for patients to participate in and can serve as a viable care option for patients across a range of disease areas. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas while our innovation ecosystem offers solutions throughout the product lifecycle – optimising data quality, creating better clinical trial experiences, and improving operational efficiencies – with the goal of driving better results for our customers and outcomes for patients. With the people, insight, and operational excellence to support a thriving R&D community, Parexel works With HeartTM to treat patients with dignity and learn from their experiences, so every trial makes a difference. In 2021, Parexel was acquired by EQT and Goldman Sachs Asset Management. We are headquartered in Raleigh, North Carolina, and employ 20,815 professionals in 49 countries. We are united by a core value that we believe influences every aspect of our work: We Care. We care about our people, our customers, our sites, and our partners.
Huckletree, 8 Bishopsgate London, 6213 BV United KingdomPartners4Access are experts in orphan drug, cell and gene therapy access, partnering with the biotechnology industry to support launches worldwide. Our services focus on four key areas: Access Strategy, Price Optimisation, Launch Excellence, and Value Communications As one of the only consultancies with comprehensive experience in cell and gene therapies, P4A are excellently placed to help clients successfully achieve access. Through various media initiatives, P4A are able to inform and shape the conversation around orphan drugs. The team at P4A believe in striking an equilibrium in the rare disease world. That means helping drive access to the most appropriate treatments for patients and physicians, a fair return on investment for manufacturers at an affordable proposition for payers.
Huckletree 8 Bishopsgate London, London, EC2N 8BQ United KingdomPartners4Access are experts in orphan drug, cell and gene therapy access, partnering with the biotechnology industry to support launches worldwide. Our services focus on four key areas: Access Strategy, Price Optimisation, Launch Excellence, and Value Communications As one of the only consultancies with comprehensive experience in cell and gene therapies, P4A are excellently placed to help clients successfully achieve access. Through various media initiatives, P4A are able to inform and shape the conversation around orphan drugs. The team at P4A believe in striking an equilibrium in the rare disease world. That means helping drive access to the most appropriate treatments for patients and physicians, a fair return on investment for manufacturers at an affordable proposition for payers.
One London Square UK, GU1 1UNPatient Connect empowers patients to take control of their diseases by addressing the issues of non-compliance that are specific to them. Patient Connect works with community pharmacists – trusted and respected healthcare professionals – to educate patients about the importance of their medicine, how to take it correctly and how to deal with side-effects and other issues that affect compliance. The market-leader in optimising patient health at the point-of-dispensing Reaching 365 million patients worldwide
Plane Tree Crescent, Feltham Middlesex , TW13 7HF United KingdomPDP Couriers is a truly global specialist courier for clinical trials, transport of clinical and medical research and logistics management. It is the number one choice for Clinical Trial Project Managers, logistics consultants and healthcare professionals, offering them solutions for time critical and temperature sensitive shipments for pre-clinical trials and phase I – IV clinical trial material. Customers value PDP's experience and reliability with over 20 years of success in international courier services and transport of clinical trials and clinical research materials. PDP has built trust with its customers for its proven ability as a logistics specialist to respond to the specific and challenging requirements of clinical trial logistics on a global scale. PDP has a truly integrated worldwide operation with wholly owned offices and trained staff in all key continents. We are able to deal with local regulatory authority and customs import and export regulations.
Imperial College White City IHub 84 Wood Lane London, W12 0BZ United KingdomPear Bio is a computational biology company that has developed a functional precision medicine platform to guide therapy choice in cancer patients, based on growing patients' tumors in a lab and performing therapy dosing on parallel microtumors to assess response. The platform uses organ-on-a-chip and computer vision to measure cancer progression over time. Pear Bio cultures patient tumor samples and tests potential treatment options and combinations ex vivo. A proprietary computer vision/ML pipeline finds image-based spatial biomarkers in time-course 3D microscopy data of the patient tumor cultures. The platform has applications in drug development (including combination therapy screening) and clinical biomarkers. Pear Bio can provide lab services including: - Compound screening - 3D image analysis/computer vision services - Combination therapy synergy testing - Drug translation services using primary tumors - Clinical biomarkers and patient stratification
Unit 13 Newman Lane, Alton, Hampshire, GU34 2QR, UKPelGar International is the leading manufacturer of highly effective rodenticide and insecticide products, for controlling public health and agricultural (non-crop) pests. PelGar has invested heavily in regulatory support and has complete dossiers on the three rodenticide actives difenacoum, bromadiolone and brodifacoum, with a wide range of registered formulations. Operating from its UK headquarters in Hampshire and through local offices in mainland Europe, Australia and North America, PelGar provides products and expertise to pest controllers in over 50 countries worldwide. Not only does it support customers who are directly involved in controlling nuisance pests, but it also works more strategically in national campaigns against the vectors of disease. Experienced staff and efficient in-house manufacturing give the company the flexibility to provide innovative and novel products that customers really want, while retaining tight control on quality and service. With an active and dynamic R&D programme which draws on a wide range of market intelligence and technical feed-back PelGar ‘s product development strategy aims to provide the answers to any global pest problem.
Unit 26, Surrey Technology Centre 40 Occam Road Guildford, Surrey, GU2 7YG United KingdomPeploBio is a leading clinical contract research organization (CRO) based in the UK, providing a suite of analytical testing services to medical device manufacturers and pharmaceutical orginisation. With a cutting-edge molecular laboratory capable of processing 5,000 samples/day, our ISO 15189-accredited facility emerged as a top private lab in the UK during the COVID-19 pandemic. We have since evolved as an organization and currently offer clinical services using Sanger Sequencing, Immunoassays and Flow Cytometry solutions to the biopharmaceutical sector. Our comprehensive service package includes assay development, clinical trial testing, project management, and report drafting, thus supporting IVD/medical device manufacturers and biopharma with IVDR and FDA projects.
Burlington Danes Building Du Cane Rd London, W12 0NN United KingdomCalyx and Invicro are now Perceptive, a leading global technology-enabled service provider for preclinical and clinical trial imaging and IRT/RTSM (Interactive Response Technology/Randomized Trial Supply Management) for drug developers and the global clinical research community. Perceptive’s market-leading service, scientific knowledge, expertise, and technology offering help speed up the delivery of life-saving treatments to millions of patients around the world by accelerating andimproving clinical trial outcomes. With operations in the US, Europe, the UK and Asia, the company provides 24/7 services to most of the world’s leading pharma and biotech companies.
Cowley Road Milton, England, CB4 0WS United KingdomDo you want to pay purely for the hours for which the job is being done, without all the hassle of employing a new person? Are you a small- or middle-sized cosmetic business, distributor or manufacturer? Is the regulation going to impose too much pressure on your human resources, albeit not enough to hire a new employee? We have the right solution to sort out all the regulatory issues surrounding your finished product: Regulatory compliance support 1- Assembly of PIP, based on the new regulation 2- Labelling check for compliance with EU regulations 3- Providing a safety assessment report (Parts A & B) 4- Registration of your product on the EU portal 5- Providing a service as a Responsible Person 6- Checking your labeling complies with EU regulations
St John’s Innovation Centre Cowley Road Cambridge CB4 0WS United Kingdom
Southwark Bridge Rd, London, SE1 0AS United KingdomPharmacoevidence is an experienced team of Health Economics and Outcomes Research (HEOR) specialists offering strategic consultancy services to pharmaceutical companies and global consultancies. We support comprehensive global projects involving systematic literature reviews (SLRs), network meta-analyses (NMAs), indirect treatment comparisons (ITCs), economic modeling, global value dossiers (GVDs), and scientific writing, all designed to communicate and enhance product value across markets. Leveraging the power of Generative AI, we now offer automated solutions for SLRs, evidence synthesis, and manuscript drafting—streamlining timelines while maintaining scientific rigor. Our advanced analytics team also provides end-to-end support for clinical trial data analysis, including survival analysis, time-to-event modeling, and patient-reported outcomes (PRO) analytics, ensuring robust evidence generation for regulatory and payer engagement. In addition to full-service project delivery, Pharmacoevidence specializes in rapid, ad hoc validation of HEOR materials. We conduct independent quality checks, resolve modeling and methodological issues, and troubleshoot submission-critical deliverables for HTA, payer, and publication needs—helping teams meet deadlines with confidence and precision.
2a Orchard Road Royston, Hertfordshire, SG85HA United KingdomPharmagene specialise in using human biospecimens in-vitro to support preclinical drug discovery by helping to characterise disease and validate therapeutic targets and biomarkers. Our expert team of scientists deploy state of the art spatial biology technologies, primary human cell models and sophisticated genomic analyses to accelerate and finesse R&D for drug developers. We excel in supporting preclinical development of biotherapeutics, and consummately excel in performing GLP Tissue Cross Reactivity Studies.
Marlow Road SL8 5SP Bourne End England, SL8 5SP United KingdomPharmaLex is a leading provider of specialized services for the pharma, biotech and medical device industries. We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-enabled solutions to support you through the entire product lifecycle. We deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions worldwide.
Vandervell HousePharmalink Consulting offers expertise in CMC/Manufacturing compliance, regulatory affairs, clinical, and non-clinical consulting and staffing solutions.
Pegasus Way Crown Business Park Rushden , Northamptonshire, NN10 6ER United KingdomPharmaron (Stock Code: 300759.SZ/3759.HK) is a leading fully integrated pharmaceutical service provider platform supporting the life science industry. Established in 2004, our firm commitment to excellence is exemplified by the continuous investment in our highly skilled team and 20 state-of-the-art facilities, ensuring excellent quality throughout our operations. As an integrated service provider, Pharmaron seamlessly supports clients from Discovery to Market, offering a comprehensive suite of services for the entire drug discovery, preclinical, clinical development, and manufacturing continuum. Our commitment extends across diverse therapeutic modalities, encompassing small molecules, biologics, medical devices and cell and gene therapy products. Boasting a global presence with over 21,000 skilled professionals and operational hubs in China, the U.S., and the U.K., we have consistently delivered innovative solutions. Our partner’s success is our mission. Supporting the development and successful approval of medicines for the patients Key highlights of Pharmaron’s diverse service capabilities: • Synthetic, medicinal and analytical chemistry • in vitro and in vivo Biology • ADME/DMPK • In vivo Pharmacology • Drug safety assessment • Recombinant protein expression, purification and characterization • Custom antibody expression • Biophysical screening • Radiochemistry and isotopically labelled metabolism • Chemical & pharmaceutical development • Process Chemistry & GMP API synthesis • GMP Formulation preparation • Clinical Pharmacology • GMP API Manufacturing • Clinical Trials • GMP Drug product manufacturing • Clinical development, including applications of 14C microtracer AMS technology • Plasmid and AAV Manufacturing • Analytical Services • Cell and Gene Therapy preclinical services (IND package) • Biologics and Biosimilars Manufacturing • ADC • Ophthalmology preclinical development services (small molecule, CGT and medical device) • Clinical Trials
Hertford Road West Hill England, EN11 9BU United KingdomPharmaron’s UK Radiolabeled Science sites include the following service offerings: 1. 14C (GMP/non-GMP) & 3H Radiolabeling and radiosynthesis projects 2. In Vivo DMPK/ADME studies (e.g. QWBA/MARG, Met ID, etc.) 3. In Vitro DMPK/ADME studies 4. Environmental Fate and Pharma risk assessment 5. BioAnalysis and AMS (Accelerator Mass Spectrometry) No other radiosynthesis CRO has a more experienced team with over 60 years radiolabeling more than 70,000 different 14C and 20,000 different 3H molecules, the most sheer numbers of any commercial vendor. Our synthetic chemists, analytical chemists and drug metabolism scientists synthesize and use 14C and 3H radiolabeled compounds to study the absorption, distribution, metabolism, excretion (ADME) and fate of a wide variety of compounds, including peptides (wet & dry chemistry), oligonucleotides, polymers, ADC’s, chiral synthesis or separation, and even fermentations, in clinical, preclinical, and discovery investigations.
Pegasus Way Crown Buisness Park England, NN10 6ER United KingdomPharmaron’s UK Radiolabeled Science sites include the following service offerings: 1. 14C (GMP/non-GMP) & 3H Radiolabeling and radiosynthesis projects 2. In Vivo DMPK/ADME studies (e.g. QWBA/MARG, Met ID, etc.) 3. In Vitro DMPK/ADME studies 4. Environmental Fate and Pharma risk assessment 5. BioAnalysis and AMS (Accelerator Mass Spectrometry) No other radiosynthesis CRO has a more experienced team with over 60 years radiolabeling more than 70,000 different 14C and 20,000 different 3H molecules, the most sheer numbers of any commercial vendor. Our synthetic chemists, analytical chemists and drug metabolism scientists synthesize and use 14C and 3H radiolabeled compounds to study the absorption, distribution, metabolism, excretion (ADME) and fate of a wide variety of compounds, including peptides (wet & dry chemistry), oligonucleotides, polymers, ADC’s, chiral synthesis or separation, and even fermentations, in clinical, preclinical, and discovery investigations.
Pegasus Way, Crown Business Park Rushden, Northamptonshire, NN10 6ER United KingdomPharmaron’s UK Radiolabeled Science sites include the following service offerings: 1. 14C (GMP/non-GMP) & 3H Radiolabeling and radiosynthesis projects 2. In Vivo DMPK/ADME studies (e.g. QWBA/MARG, Met ID, etc.) 3. In Vitro DMPK/ADME studies 4. Environmental Fate and Pharma risk assessment 5. BioAnalysis and AMS (Accelerator Mass Spectrometry) No other radiosynthesis CRO has a more experienced team with over 60 years radiolabeling more than 70,000 different 14C and 20,000 different 3H molecules, the most sheer numbers of any commercial vendor. Our synthetic chemists, analytical chemists and drug metabolism scientists synthesize and use 14C and 3H radiolabeled compounds to study the absorption, distribution, metabolism, excretion (ADME) and fate of a wide variety of compounds, including peptides (wet & dry chemistry), oligonucleotides, polymers, ADC’s, chiral synthesis or separation, and even fermentations, in clinical, preclinical, and discovery investigations.
Office 3.05, Atlas House 1 King Street London, EC2V 8AU United KingdomPharmidex is an AAALAC-accredited, UK-based CRO founded in 2002. We provide high-quality, cost-effective, flexible and rapid solutions in drug metabolism and pharmacokinetics (DMPK), bioanalysis (non-GLP/GLP/GCP), toxicology (non-GLP/GLP), histology, clinical chemistry, hematology, and in vitro ADME. Pharmidex also offers in silico modelling and efficacy models supporting oncology, CNS, respiratory, stroke, autoimmune, and metabolic disease programs. We work with over 250 global clients, including medical charities, academic groups, biotech, and pharma, and have undertaken over 15,000 studies. In addition to our fee-for-service offering, Pharmidex actively seeks collaboration opportunities in grant-funded projects. To date, we have successfully participated in over 30 collaborative grant-funded projects, partnering with more than 167 global collaborators.
167-169 Great Portland Street Fifth Floor London, London, W1W 5PF United KingdomPharmidex is an AAALAC-accredited, UK-based CRO founded in 2002. We provide high-quality, cost-effective, flexible and rapid solutions in drug metabolism and pharmacokinetics (DMPK), bioanalysis (non-GLP/GLP/GCP), toxicology (non-GLP/GLP), histology, clinical chemistry, hematology, and in vitro ADME. Pharmidex also offers in silico modelling and efficacy models supporting oncology, CNS, respiratory, stroke, autoimmune, and metabolic disease programs. We work with over 250 global clients, including medical charities, academic groups, biotech, and pharma, and have undertaken over 15,000 studies. In addition to our fee-for-service offering, Pharmidex actively seeks collaboration opportunities in grant-funded projects. To date, we have successfully participated in over 30 collaborative grant-funded projects, partnering with more than 167 global collaborators.
European Knowledge Centre Mosquito Way Hatfield, Hertfordshire, AL10 9SN United KingdomPharmidex is an AAALAC-accredited, UK-based CRO founded in 2002. We provide high-quality, cost-effective, flexible and rapid solutions in drug metabolism and pharmacokinetics (DMPK), bioanalysis (non-GLP/GLP/GCP), toxicology (non-GLP/GLP), histology, clinical chemistry, hematology, and in vitro ADME. Pharmidex also offers in silico modelling and efficacy models supporting oncology, CNS, respiratory, stroke, autoimmune, and metabolic disease programs. We work with over 250 global clients, including medical charities, academic groups, biotech, and pharma, and have undertaken over 15,000 studies. In addition to our fee-for-service offering, Pharmidex actively seeks collaboration opportunities in grant-funded projects. To date, we have successfully participated in over 30 collaborative grant-funded projects, partnering with more than 167 global collaborators.
250 Cambridge Science ParkPharmorphix is one of Europe’s leading providers of solid-form research services to the international pharmaceutical and biotech industries.
Cambridge, England United KingdomPharmorphix is one of Europe’s leading providers of solid-form research services to the international pharmaceutical and biotech industries.
White Hart Meadows Ripley, Woking, GU23 6ND United KingdomPharSafer® is a specialist Global CRO focusing on Pharmacovigilance & Medical Services. Formed in 2002 and Headquartered in the UK, PharSafer® has enjoyed continued annual client growth, global expansion and increased staffing. As a privately owned company we have the freedom to invest in our staff and react quickly to investment in any necessary equipment, premises and additional resources, without reference or approval of any external investors. This allows us to prudently invest where necessary to ensure clients get the best people to help them, and the most up to date technical equipment. We can act as your complete outsourced Pharmacovigilance and Medical Services Department/Organisation, performing all of the activities expected of your own Pharmacovigilance and Medical Information teams. We ensure that your company is compliant with all of the necessary legislation and our Philosophy is simple; Quality and Excellence in all we do because patient safety is not a cost, but a commitment. Let PharSafer take care of: Full case processing and expedited reporting globally Aggregate report writing, such as, DSURs, PSURs/PBRERs and PADERs Risk Management Plan (RMP) writing and management Safety review/Signal Detection and Benefit-Risk assessments EU QP PV Services Medical services Audits With clients spanning across seven continents, we are a 24 hour business, able to respond to the needs of our global clients in all time zones. With over 25 years’ experience in the Pharmacovigilance marketplace, PharSafer® has developed a strong and trusted network of business affiliates, associates and strategic partners around the globe. PharSafer® has recognised that at certain times our clients will need services and skills beyond our area of immediate expertise, however, via our network of strategic partners you can trust PharSafer® to deliver on overall project KPI’s and act as the ‘one-stop shop’.
Marlow, England, SL7 United KingdompH Associates is an independent healthcare consultancy delivering high quality innovative solutions to drive improvement in patient care through bespoke Real World Data.
Derwent House Dedmere Road Marlow, Bucks SL7 1PG United KingdompH Associates is an independent healthcare consultancy delivering high quality innovative solutions to drive improvement in patient care through bespoke Real World Data.
Unit 2, 2a Bollo Lane Chiswick London, W45LE United KingdomPHASTAR is a specialist biometrics contract research organization offering statistical consulting, clinical trial reporting, data management and data science services by providing expert consultants and managing and delivering in-house projects, FSP-style arrangements and preferred partnerships. Our number one priority is ensuring on time, quality work: every project undertaken is supervised on methodology and utilizes internal processes designed to guarantee optimal quality, inspired by 4,000 years accumulated technical experience across the company. PHASTAR is headquartered in London (UK) and North Carolina (US) and has 14 offices across five continents.
Norton Park Norton Road Stevenage Herts, England SG1 2BB United KingdomPhosphor Technology manufactures inorganic phosphor powders and offers particle size and spectral analysis services.
Containerville, Unit 9, 35 Corbridge Crescent London, E2 9EZ United KingdomA track record in providing innovative solutions. Special interest in point-of-care diagnostics/detection and amyloid research
Station Road Forest Row England, RH18 5FS United KingdomPion Inc. is the leading provider of analytical instruments and services that support the development of lifesaving and life-enhancing drugs for drug developers, formulations scientists, and pharmaceutical production. Our cutting-edge analytical technologies and services enable in vitro measurements that provide essential data to improve candidate selection and formulations decisions, while our high-pressure homogenizers ensure material consistency from bench- to production-scale.
Forest Row Business Park Station Road Forest Row, East Sussex, RH18 5DW United KingdomPion Inc. is the leading provider of analytical instruments and services that support the development of lifesaving and life-enhancing drugs for drug developers, formulations scientists, and pharmaceutical production. Our cutting-edge analytical technologies and services enable in vitro measurements that provide essential data to improve candidate selection and formulations decisions, while our high-pressure homogenizers ensure material consistency from bench- to production-scale.
Cambridge, United KingdomPiraee Consultancy offers natural products drug discovery consulting services.
Ash Road Pirbright, Woking, GU24 United Kingdom'Preventing and controlling viral diseases' We are a world leading centre of excellence in research and surveillance of virus diseases of farm animals and viruses that spread from animals to humans. We receive strategic funding from the Biotechnology and Biological Sciences Research Council (BBSRC), and work to enhance capability to contain, control and eliminate these economically and medically important diseases through highly innovative fundamental and applied bioscience. The Institute employs around 450 staff plus research students and visiting scientists, and has recently moved to one campus in Pirbright, Surrey, where investment by BBSRC has resulted in a redevelopment of the site and the construction of a high level containment facility – the BBSRC National Virology Centre: The Plowright Building and a SAPO level two facility, The Jenner Building.
Ash Road, Pirbright, England GU24, GB'Preventing and controlling viral diseases' We are a world leading centre of excellence in research and surveillance of virus diseases of farm animals and viruses that spread from animals to humans. We receive strategic funding from the Biotechnology and Biological Sciences Research Council (BBSRC), and work to enhance capability to contain, control and eliminate these economically and medically important diseases through highly innovative fundamental and applied bioscience. The Institute employs around 450 staff plus research students and visiting scientists, and has recently moved to one campus in Pirbright, Surrey, where investment by BBSRC has resulted in a redevelopment of the site and the construction of a high level containment facility – the BBSRC National Virology Centre: The Plowright Building and a SAPO level two facility, The Jenner Building.
Babraham Research Campus Moneta Building Babraham , Cambridge , CB22 3AT United Kingdompixlbio is redefining predictive biology. Formed from the merger of DefiniGEN (UK) and Phenaros (Sweden), we combine iPSC-derived human models with high-throughput imaging and AI-powered phenomics to uncover subtle cellular insights that animal models can’t. Our platform captures millions of images and profiles hundreds of millions of cells each week, turning complex biology into predictive clarity for drug discovery and safety. What we offer: - iPSC-derived hepatocytes, stellates & intestinal organoids - Validated disease models (MASLD/MASH, A1ATD, Wilson’s) - Fully automated AI-driven phenomics (large scale Cell Painting) on iPSC derived models as well as immortalised cell lines and primary cells - Proprietary automation and SaaS access Trusted by 11 of the top 20 pharma companies, leading biotechs, and research institutions worldwide. We’re ISO 9001:2015 certified and expanding into cardiac and renal models in late 2026 — building the next generation of predictive biology. Every cell tells a story. Every pixel holds a clue.
Babraham Moneta Building Cambridge, England, CB22 3AT United Kingdompixlbio is redefining predictive biology. Formed from the merger of DefiniGEN (UK) and Phenaros (Sweden), we combine iPSC-derived human models with high-throughput imaging and AI-powered phenomics to uncover subtle cellular insights that animal models can’t. Our platform captures millions of images and profiles hundreds of millions of cells each week, turning complex biology into predictive clarity for drug discovery and safety. What we offer: - iPSC-derived hepatocytes, stellates & intestinal organoids - Validated disease models (MASLD/MASH, A1ATD, Wilson’s) - Fully automated AI-driven phenomics (large scale Cell Painting) on iPSC derived models as well as immortalised cell lines and primary cells - Proprietary automation and SaaS access Trusted by 11 of the top 20 pharma companies, leading biotechs, and research institutions worldwide. We’re ISO 9001:2015 certified and expanding into cardiac and renal models in late 2026 — building the next generation of predictive biology. Every cell tells a story. Every pixel holds a clue.
Babraham Research Campus Moneta Building Cambridge, England, CB22 3AT United Kingdompixlbio is redefining predictive biology. Formed from the merger of DefiniGEN (UK) and Phenaros (Sweden), we combine iPSC-derived human models with high-throughput imaging and AI-powered phenomics to uncover subtle cellular insights that animal models can’t. Our platform captures millions of images and profiles hundreds of millions of cells each week, turning complex biology into predictive clarity for drug discovery and safety. What we offer: - iPSC-derived hepatocytes, stellates & intestinal organoids - Validated disease models (MASLD/MASH, A1ATD, Wilson’s) - Fully automated AI-driven phenomics (large scale Cell Painting) on iPSC derived models as well as immortalised cell lines and primary cells - Proprietary automation and SaaS access Trusted by 11 of the top 20 pharma companies, leading biotechs, and research institutions worldwide. We’re ISO 9001:2015 certified and expanding into cardiac and renal models in late 2026 — building the next generation of predictive biology. Every cell tells a story. Every pixel holds a clue.
Babraham Research Campus CB22 3AT United Kingdompixlbio is redefining predictive biology. Formed from the merger of DefiniGEN (UK) and Phenaros (Sweden), we combine iPSC-derived human models with high-throughput imaging and AI-powered phenomics to uncover subtle cellular insights that animal models can’t. Our platform captures millions of images and profiles hundreds of millions of cells each week, turning complex biology into predictive clarity for drug discovery and safety. What we offer: - iPSC-derived hepatocytes, stellates & intestinal organoids - Validated disease models (MASLD/MASH, A1ATD, Wilson’s) - Fully automated AI-driven phenomics (large scale Cell Painting) on iPSC derived models as well as immortalised cell lines and primary cells - Proprietary automation and SaaS access Trusted by 11 of the top 20 pharma companies, leading biotechs, and research institutions worldwide. We’re ISO 9001:2015 certified and expanding into cardiac and renal models in late 2026 — building the next generation of predictive biology. Every cell tells a story. Every pixel holds a clue.
BioPark Broadwater Road Welwyn Garden City, Hertfordshire AL7 3AX United KingdomPlanimeter offers data management, statistical programming, and statistical expertise in drug development.
London Innovation Centre 20 Water Street London, E14 9QA United KingdomSNPsaurus offers whole plasmid sequencing with its plasmidsaurus service.
Plvs Ultra Ltd, Suite 2, Beechwood House, 5 Arlington Business Park, Whittle Way Stevenage, Herts, SG1 2FS United KingdomHere's a short description for PLVS Ultra: PLVS Ultra Ltd is an AI-powered enterprise intelligence company purpose-built for the pharmaceutical and life sciences industry. Our proprietary ontology engine connects fragmented data across manufacturing, CMC, and supply chain operations into a single, searchable intelligence layer — delivering insights in weeks, not years. Founded by industry specialist, PLVS Ultra helps life sciences organisations unlock the full value of their data, accelerate decision-making, and drive operational excellence from lab to commercial scale.
NPIMR HARROW Middx, ha13uj United KingdomPneumolabs offers in vitro and in vivo models to study asthma, lung inflammation, COPD and cough.
402B Vanguard Way 7 London, E176ZR United KingdomPolyModels Hub is a biotech software and consultancy firm specializing in developing advanced process modelling and software solutions for the pharmaceutical industry. The Company’s services are designed to accelerate and optimize the development of pharmaceutical processes and products, combining cutting-edge software technology with advance modelling solutions to enhance efficiency, compliance and innovation in drug development and manufacturing.
1 Ramsey Rd Cambridgeshire, PE27 5BZ United KingdomTough economic and regulatory environments place increasing pressure on life sciences companies to justify the value of their innovations to consumers, payers and policymakers. To interpret these evolving market dynamics and the overall needs of the healthcare ecosystem, organizations need a trusted partner to help them both set a strategic direction and put the plan into action. The combination of Huron and Pope Woodhead provides life sciences, biotech and healthcare companies with deep market and industry experience and an end-to-end market access solution. Pope Woodhead’s strength in market access strategy combined with Huron’s deep commercial expertise provides an integrated and agile partner and the right value based solutions, globally.
4 Windsor Square, Silver Street Reading, Berkshire, RG1 2TH United KingdomMarket research - Primary Research agency specialising in strategic pharmaceutical insights.
Windsor Square Reading, England, RG1 2TH United KingdomPorterhouse Medical is a healthcare communications agency serving global and US markets and specializing in medical communications and scientific publications. With offices across the UK and in the US, our teams of carefully selected medical and scientific writers, account managers, strategists, research specialists and creatives work closely together to deliver imaginative and intelligent omnichannel communications for a growing number of global pharmaceutical, biopharma and diagnostic client partners. Porterhouse is part of SCIRIS, a global family of agencies delivering exceptional healthcare communications and consultancy services across all phases of development and commercialization.
Windsor Place 139 Faraday Rd Crawley, West Sussex, RH10 9TF United KingdomOur services span quantitative and qualitative research, as well as sensory profiling and analysis. We also provide a specialist field and tab service for other market research companies. This breadth of skills enables us to take an objective view of any brief and advise you on the best approach, which may require a combination of methods.
Windsor Place faraday Road Crawley, West Sussex, RH10 9Tf United KingdomOur services span quantitative and qualitative research, as well as sensory profiling and analysis. We also provide a specialist field and tab service for other market research companies. This breadth of skills enables us to take an objective view of any brief and advise you on the best approach, which may require a combination of methods.
England United KingdomPPSI provides strategic consulting, advocacy development, medical writing, and branding.
2A Orchard Road Royston, Hertfordshire, SG8 5HD United KingdomPrecision for Medicine is a global CRO with integrated specialty and central lab services, purpose-built for the complexities of modern drug development. Our model unites clinical trial execution, advanced laboratory capabilities, and data intelligence to accelerate breakthroughs from concept to commercialization. At the heart of this continuum are our ethically sourced, clinically annotated biospecimens—the critical entry point for discovery. With thousands of IRB-approved samples, Precision offers researchers access to a diverse and deeply characterized inventory of samples. Human Biological Samples: • Tissue: Over 3 million FFPE blocks and fresh or frozen tissues from healthy and diseased subjects, all pathologist-verified and ready for downstream applications like RNAseq, IHC, and molecular profiling. • Blood and Biofluids: Whole blood, plasma, serum, CSF, saliva, urine, and other biofluids collected from healthy and diseased subjects, including both clinically consented and remnant samples. • Viable Cells and Liquid Biopsy Kits: Including PBMCs, BMMCs, and dissociated tumor cells, with full kitting, logistics, and profiling services. • Matched Tissue and Blood Sets: Fresh, frozen, and FFPE tumor tissues paired with plasma, serum, or whole blood from the same subject, enabling integrated omics research, biomarker correlation, and immuno-oncology studies. • Custom Prospective Collections: Tailored to your research protocols, including rare disease cohorts, longitudinal samples, and fresh tissue for immune profiling, supported by Precision’s global clinical network. Lab Services Include: • Flow Cytometry & Cell-Based Assays: High-parameter flow cytometry, Immune cell profiling and functional assays, Rare cell detection and sorting • Genomics & Molecular Biology: qPCR, ddPCR, and NGS-based assays, Gene expression and mutation analysis, Epigenetic profiling • Proteomics & Biomarker Analysis: ELISA, multiplex immunoassays (Luminex, MSD), Western blotting and protein quantification, Custom biomarker development and validation • Immunology & Immuno-Oncology: Cytokine and chemokine profiling, T-cell activation and proliferation assays, Immunophenotyping and checkpoint analysis • Histology & Tissue-Based Services: FFPE tissue sectioning and staining, IHC/IF assay development and scoring, Digital pathology and image analysis • Bioanalytical & PK/PD Services: LC-MS/MS and ligand-binding assays, Pharmacokinetic and pharmacodynamic studies, Method development and validation under GLP/GCLP • Custom Assay Development: Fit-for-purpose assay design, Analytical validation and optimization, Regulatory support for clinical applications
High Wycombe, England United KingdomPremier Analytical Services offers food safety, authenticity, and composition studies.
The Lord Rank Centre Lincoln Road High Wycombe, Buckinghamshire HP12 3QR United KingdomPremier Analytical Services offers food safety, authenticity, and composition studies.
Unitech House, Bond Close, Kingsland Business Park, Basingstoke, Hampshire, RG24 8PZPresearch provides HPLC techniques and GC services.
Linea House, Harvest Crescent Ancells Business Park Fleet, GU51 2UZ United KingdomPolicy, Access, Value, and Evidence: your best-in-class integrated offering from early pipeline to patient access. - Global HEOR From early-stage development through to successful launch and beyond, our HEOR capabilities provide robust analytics and evidence-based strategic insights to support the value of assets – helping inform what healthcare should be provided, how it should be delivered, and to whom. - Global market access From the US to Asia-Pacific, and across Europe, clients depend on our best-in-class capabilities to optimize access and demonstrate the full value of their innovative products to payers. Our multidisciplinary experts and digital visionaries are shaping the market. - Global value engagement Bringing value to life through compelling, insight-driven, evidence-based strategy and communication that makes the complex simple, engages stakeholders, and ensures the value of your assets stand out from the crowd. - Policy and due diligence Our team of healthcare policy, regulatory, and legislative experts will guide you through the complexities of all aspects of federal and state healthcare policies and help you prepare for how changes will impact coverage, access, payment, care delivery, and consumer choice. Thinking like investors, we deliver customized, deep, data-driven analysis to quantify relevant risks, opportunities, and trends to inform financial models and potential goal achievement. These services are provided by Avalere Health. Avalere Health partners with its clients to navigate the complex and rapidly changing healthcare ecosystem. Established in 2001, is it a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Its 1,500+ experts combine their knowledge and expertise across its core disciplines—Consulting; Medical; Policy, Access, Value, and Evidence; Marketing; and Digital Experience Technology. Together, its experts help clients connect patients with life-changing therapies, realizing the potential of strategies and solutions to accelerate innovation that improves lives and creating the connections that make better health happen.
The Featherstone Building 66 City Road London, EC1Y 2AL United KingdomPolicy, Access, Value, and Evidence: your best-in-class integrated offering from early pipeline to patient access. - Global HEOR From early-stage development through to successful launch and beyond, our HEOR capabilities provide robust analytics and evidence-based strategic insights to support the value of assets – helping inform what healthcare should be provided, how it should be delivered, and to whom. - Global market access From the US to Asia-Pacific, and across Europe, clients depend on our best-in-class capabilities to optimize access and demonstrate the full value of their innovative products to payers. Our multidisciplinary experts and digital visionaries are shaping the market. - Global value engagement Bringing value to life through compelling, insight-driven, evidence-based strategy and communication that makes the complex simple, engages stakeholders, and ensures the value of your assets stand out from the crowd. - Policy and due diligence Our team of healthcare policy, regulatory, and legislative experts will guide you through the complexities of all aspects of federal and state healthcare policies and help you prepare for how changes will impact coverage, access, payment, care delivery, and consumer choice. Thinking like investors, we deliver customized, deep, data-driven analysis to quantify relevant risks, opportunities, and trends to inform financial models and potential goal achievement. These services are provided by Avalere Health. Avalere Health partners with its clients to navigate the complex and rapidly changing healthcare ecosystem. Established in 2001, is it a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Its 1,500+ experts combine their knowledge and expertise across its core disciplines—Consulting; Medical; Policy, Access, Value, and Evidence; Marketing; and Digital Experience Technology. Together, its experts help clients connect patients with life-changing therapies, realizing the potential of strategies and solutions to accelerate innovation that improves lives and creating the connections that make better health happen.
London, England United KingdomProcess Systems Enterprise offers modelling for systems, reactions, crystallization, separation, fuel cells, and batch process optimization.
Cowley Road Milton, England, CB4 0WS United KingdomProductLife offers consulting and support services for life sciences including expertise in regulatory affairs and pharmacovigilance.
Delta HousePromega’s Tailored R&D Solutions (TRS) offer collaborative, milestone-driven services that empower drug discovery teams to overcome capacity, expertise, and technology gaps. Whether you're advancing early-stage discovery or preparing for clinical and commercial production, our team delivers bespoke solutions that align with your specific project goals, empowering you through innovation, collaboration, and operational excellence at every step of the drug discovery process. Our service offerings include: Custom Materials & Reagents: Design and synthesis of custom vectors, NanoBRET® tracers, and antibody labeling to support assay development and screening Assay Development Services: Custom development of cell-based assays for target engagement (TE), targeted protein degradation (TPD), protein-protein interaction (PPI), biologics, and immunoassays using Promega technologies such as NanoBRET®, NanoBiT®, Lumit®, and reporter cell lines Bioassay Optimization & Qualification: Optimization and qualification of bioassays for QC and lot release of biologics in clinical and commercial manufacturing Screening & Profiling Services: High-throughput screening and selectivity profiling using Promega’s validated live-cell platforms to accelerate your pipeline from hit identification through lead optimization Each project is supported by a dedicated program manager who provides regular updates and coordinates touchpoints with our scientists. Additionally, clients can monitor progress through our client portal, ensuring transparency and seamless communication. Partner with Promega TRS to accelerate your drug discovery workflow with customized solutions and expert support from start to finish—and beyond. Visit our website to learn more: https://www.promega.com/custom-solutions/tailored-solutions/
Cambridge, England United KingdomProMetic BioSciences expertise includes the design, development and manufacture of affinity separation products and technologies.
211 Cambridge Science Park Milton Road Cambridge, CB4 0WA United KingdomProMetic BioSciences expertise includes the design, development and manufacture of affinity separation products and technologies.
The Courtyard 30 Worthing Road Horsham West Sussex RH12 1SL U.K.ProPharma Partners provides a broad range of advisory and consulting services to biotechnology and pharmaceutical industries.
Profile West, 950 Great West Road, Brentford,, England, TW8 9ES United KingdomSince 2014 ProRelix Research has been supporting our clients with outstanding clinical research services. The successful growth of ProRelix Research has been achieved by putting high quality and client focus at the heart of everything we do. We leverage our experience and expertise at the early stages of discussions with our clients to freely advise them on the optimal project plan. We then reach decision with each client on the scope of service, timelines and budget. ProRelix Research then commits to deliver those services on time and within budget – according to our End-to-End Guarantee. Our commitment to guaranteed delivery is unique in the clinical research environment which is otherwise notable for the routine occurrence of delays and cost overruns. Acting through Pharmaceutical, Medical Device Research teams, and with a comprehensive portfolio of services, we offer a flexible approach to ensure ProRelix Research optimally support the unique needs of each client. This could mean providing regulatory consultancy to a small company at the early stages of development programme, through to provision of full services to a company performing an international mega trial to support registration of their product. Whatever the size and scope of the project, each receives the same level of attention to detail and commitment to delivery of a high quality service within budget and to timelines agreed.
Newton Hall Town Street Newton Cambridge CB22 7ZE United KingdomProsarix offers screening services, de novo design, fragment based design, and protein-protein interactions.
158-160 North Gower Street London, - None -, NW1 2ND United KingdomAt Protagoras, our mission is to enable our life science Clients to better serve their patients through custom-made strategy & transformation consulting. Our team has worked with all of the top 10 pharma companies, driven growth at several smaller biopharma and biotech firms, and specialises in a variety of therapeutic areas including Oncology, Metabolic diseases, Neurology, Respiratory and Dermatology. We help clients across the product life cycle including in R&D, clinical operations, Medical & Commercial strategy and organisational effectiveness.
20 Station Road Cambridge Cambridge, Cambridgeshire, CB1 2JD United KingdomProtavio is a leading multiplex proteomics company with over 20 years of experience. Harnessing the power of multi-platform proteomics, we combine the benefits of state-of-the-art technologies, including Olink & Luminex, to offer novel products and services for biomarker discovery, development and validation. Our GMP, ISO13485 and ISO9001 compliant quality management systems enable us to move beyond traditional CRO offerings and support our clients all the way from biomarker discovery to commercialization. Protavio has a proven track record in developing and commercializing assays under IVDR and ISO13485 standards, which have been successfully validated and are being used either as Laboratory Developed Tests (LDT) in CLIA labs or IVD kits. Finally, Protavio’s manufacturing facility currently produces over 1 million tests annually under cGMP conditions. SOLUTIONS Protavio offers cutting-edge proteomic analysis and assay development services, utilizing advanced platforms like Olink Explore and Luminex™ to cater to diverse research and clinical needs. Our services include: High-Plex Protein Analysis: Utilizing the Olink Explore platform, we provide comprehensive protein measurement capabilities, with options ranging from focused studies analyzing 384 proteins to large-scale investigations measuring up to 5700 targets from as little as 2ul of sample. Our tailored solutions, including Explore Individual 384x Target Kits, Explore 3k, and Explore HT, are designed to meet various research requirements and sample throughputs, offering precision, breadth, and high-throughput options. Mid-Plex Protein Analysis: Offering cost-effective and fast turnaround analysis for up to 100 proteins, our Mid-Plex solutions are powered by Luminex™ technology. Researchers can rely on validated panels or choose from over 1300 pre-made panels for robust protein landscape understanding and important biological mechanism validation. C-Plex Custom Assay Development: With our customizable C-Plex service, we develop protein assays tailored to your specific needs using Luminex™ technology. Our process is ISO13485 compliant and adheres to regulations for in-vitro diagnostic assays development, ensuring high-quality, reliable assays for your lab or as part of our mid-plex analysis service. GMP Production: We assist in translating biomarker research into clinical products, including RUO, IVD, and LDT assays. Our GMP production service encompasses design, development, production, and commercialization, adhering to IVDR, ISO13485 standards, and GMP to ensure the quality, safety, and efficacy of diagnostic products. This regulatory-centered approach enhances the commercial viability of your discoveries and contributes to healthcare improvements. FACILITIES Protavio has a global presence with offices in Cambridge, UK and sample storage facilities in MA, USA. Our headquarters & Lab/production facilities are housed in Demokritos Scientific Park Lefkippos, Athens, Greece. These state-of-the-art facilities are designed to meet the rigorous demands of proteomic analysis and production. With dedicated spaces for high-plex and mid-plex analyses, custom assay development, and IVD/GMP-compliant manufacturing, we have created environments that are as advanced as the science we conduct within them. Our labs are outfitted with the latest in Olink, Luminex and automation technology, ensuring that every sample is processed to deliver high-quality and actionable results.
The Bradfield Centre 184 Cambridge Science Park Cambridge, Cambridgeshire, CB4 0GA United KingdomProtavio is a leading multiplex proteomics company with over 20 years of experience. Harnessing the power of multi-platform proteomics, we combine the benefits of state-of-the-art technologies, including Olink & Luminex, to offer novel products and services for biomarker discovery, development and validation. Our GMP, ISO13485 and ISO9001 compliant quality management systems enable us to move beyond traditional CRO offerings and support our clients all the way from biomarker discovery to commercialization. Protavio has a proven track record in developing and commercializing assays under IVDR and ISO13485 standards, which have been successfully validated and are being used either as Laboratory Developed Tests (LDT) in CLIA labs or IVD kits. Finally, Protavio’s manufacturing facility currently produces over 1 million tests annually under cGMP conditions. SOLUTIONS Protavio offers cutting-edge proteomic analysis and assay development services, utilizing advanced platforms like Olink Explore and Luminex™ to cater to diverse research and clinical needs. Our services include: High-Plex Protein Analysis: Utilizing the Olink Explore platform, we provide comprehensive protein measurement capabilities, with options ranging from focused studies analyzing 384 proteins to large-scale investigations measuring up to 5700 targets from as little as 2ul of sample. Our tailored solutions, including Explore Individual 384x Target Kits, Explore 3k, and Explore HT, are designed to meet various research requirements and sample throughputs, offering precision, breadth, and high-throughput options. Mid-Plex Protein Analysis: Offering cost-effective and fast turnaround analysis for up to 100 proteins, our Mid-Plex solutions are powered by Luminex™ technology. Researchers can rely on validated panels or choose from over 1300 pre-made panels for robust protein landscape understanding and important biological mechanism validation. C-Plex Custom Assay Development: With our customizable C-Plex service, we develop protein assays tailored to your specific needs using Luminex™ technology. Our process is ISO13485 compliant and adheres to regulations for in-vitro diagnostic assays development, ensuring high-quality, reliable assays for your lab or as part of our mid-plex analysis service. GMP Production: We assist in translating biomarker research into clinical products, including RUO, IVD, and LDT assays. Our GMP production service encompasses design, development, production, and commercialization, adhering to IVDR, ISO13485 standards, and GMP to ensure the quality, safety, and efficacy of diagnostic products. This regulatory-centered approach enhances the commercial viability of your discoveries and contributes to healthcare improvements. FACILITIES Protavio has a global presence with offices in Cambridge, UK and sample storage facilities in MA, USA. Our headquarters & Lab/production facilities are housed in Demokritos Scientific Park Lefkippos, Athens, Greece. These state-of-the-art facilities are designed to meet the rigorous demands of proteomic analysis and production. With dedicated spaces for high-plex and mid-plex analyses, custom assay development, and IVD/GMP-compliant manufacturing, we have created environments that are as advanced as the science we conduct within them. Our labs are outfitted with the latest in Olink, Luminex and automation technology, ensuring that every sample is processed to deliver high-quality and actionable results.
Unit 10 Delta Court Manor Way Borehamwood Hertfordshire WD6 1FJ United KingdomProTec Ingredia
Coveham House Downside Bridge Road Cobham, Surrey, KT11 3EP United KingdomAbout Proteome Sciences plc. (www.proteomics.com) Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. SysQuant® and TMT®MS2 are unbiased methods for identifying and contextualising new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator™ provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. Targeted assay development using mass spectrometry delivers high sensitivity, interference-free biomarker analyses in situations where standard ELISA assays are not available. The Company has its headquarters in London, UK, with laboratory facilities in Frankfurt, Germany.
Mabledon Place Mabledon Place England, WC1H 9BS United KingdomAbout Proteome Sciences plc. (www.proteomics.com) Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. SysQuant® and TMT®MS2 are unbiased methods for identifying and contextualising new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator™ provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. Targeted assay development using mass spectrometry delivers high sensitivity, interference-free biomarker analyses in situations where standard ELISA assays are not available. The Company has its headquarters in London, UK, with laboratory facilities in Frankfurt, Germany.
Hamilton House Mabledon Place London, WC1H 9BB United KingdomAbout Proteome Sciences plc. (www.proteomics.com) Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. SysQuant® and TMT®MS2 are unbiased methods for identifying and contextualising new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator™ provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. Targeted assay development using mass spectrometry delivers high sensitivity, interference-free biomarker analyses in situations where standard ELISA assays are not available. The Company has its headquarters in London, UK, with laboratory facilities in Frankfurt, Germany.
3rd Floor 91-93 Farringdon Rd London EC1M 3LN UKProximagen offers development and commercialization of novel therapeutics for CNS diseases.
4th Floor, 16 Dufour's Place London, England, W1F 7SP United KingdomInstar provides pharmaceutical brand teams with an innovative online platform for faster and more cost-effective research, supported by a team of experienced researchers. This is important as budgets are shrinking and answers are still needed to help deal with everyday business issues quicker than ever before. Instar can accomplish this by: o Recruiting respondents from the world’s largest validated community of online physicians, over 2.5 million worldwide across most geographies o By offering an innovative menu-based service, allowing you to pick and choose only what you need, and nothing more o By being more efficient in the research process and production o By creating an Instar Soundboards to accelerate project initiation and provide free bonus research. Instar conducts business in: US, Canada, UK and France. We conduct mainly quantitative research but also have qualitative expertise using online qualitative methodologies
61 Colindale Avenue London NW9 5EQGastrointestinal bacteria reference unit (GBRU) is the national reference laboratory for a range of gastrointestinal pathogens and provide specialist testing of clinical, food, water and environmental samples.
Snowdon Drive Milton Keynes, England, MK6 1GJ United KingdomQED Clinical Services offers clinical research services such as project management, clinical monitoring, regulatory affairs, safety/pharmacovigilance, and data management.
Unit 1 Murdoch House Garlic Row Cambridge, CB6 3LL United KingdomWe manufacture high quality growth factors and cytokines for stem cell, organoid and regenerative medicine applications Spun-out from the University of Cambridge in 2016, we use proprietary protein purification and engineering technology to make recombinant proteins in E.coli. Our proteins are properly folded, free from contaminating related TGF beta family proteins (unfortunately often present in mammalian protein expression systems) and we include full QC data for every batch – mass spec, analytical reverse phase, recovery, SDS-PAGE, bioassay data and endotoxin testing.
152 Cambridge Science Park Milton Road Cambridge, CB4 0GN United KingdomWe manufacture high quality growth factors and cytokines for stem cell, organoid and regenerative medicine applications Spun-out from the University of Cambridge in 2016, we use proprietary protein purification and engineering technology to make recombinant proteins in E.coli. Our proteins are properly folded, free from contaminating related TGF beta family proteins (unfortunately often present in mammalian protein expression systems) and we include full QC data for every batch – mass spec, analytical reverse phase, recovery, SDS-PAGE, bioassay data and endotoxin testing.
Office 25, 105 London Street Reading, England, RG1 4QD United KingdomBoutique market access solution-provider with global expertise focusing on key markets worldwide. Specialist areas: payer insights underpinned by analytics. reimbursement for med-tech / digital health solutions, market access databases, analogue research, market access due diligence and custom market access insights solutions implemented within SharePoint environment.
Level 4, 84 Wood Ln White City, London, W12 0BZ United KingdomThe Quaisr Platform gives your teams the power to (1) connect and share their analysis steps, (2) apply inbuilt AI / machine learning, and (3) build no-code internal applications backed by enterprise scalability, data security and real-time streaming.
Hitchin, England United KingdomQuanticate offers clinical research services including data management, statistical consultancy/programming/analysis, medical writing, and pharmacovigilance.
33 Oyster Lane, Byfleet, West Byfleet, Surrey, KT14 7HS U.KQuA vodis offers quality management and consulting services to achieve regulatory compliance.
The Bradfield Centre, 184 Cambridge Science Park Milton Cambridge, CB4 0GA United KingdomTransforming imaging data into actionable predictions We design pioneering tools that unlock imaging data to improve patient outcomes. From clinical research to personalized care. Healthcare providers, biopharma companies, research and academic institutions and RWE specialists partner with Quibim to power up the imaging portion of their business, accelerating the arrival of precision medicine. Our unique multi-scale ways of seeing problems can guide decision-making at every stage in the drug development program. Quibim can reveal a full suite of novel imaging biomarkers from existing and new patient datasets to enhance the power of multi-omics: deeply analyze disease mechanisms, find the right candidates for clinical studies, stratify patients with different risks, predict patient outcomes and drug response and monitor treatment progress using a tissue-agnostic approach. As a global leader in medical imaging analysis and processing, our best-in-class software medical devices and solutions extract objective and highly accurate information versus traditional methods, using the latest AI technology. We have advanced image harmonization techniques generating a standardized image quality that minimizes variability across equipment manufacturers and acquisition protocols. Quibim has access to large scale databases and can analyze any image modality and any tissue from thousands of consecutive patients. *Please note that we do not analyze pathological images.
Shire Hill Saffron Walden, Essex CB11 3AZ United KingdomRadleys specialise in supplying innovative chemistry tools including instruments and consumables.
3 Fernbank Place Ascot Ascot, England, SL5 8HT United KingdomOffice-based consultancy to the pharmaceutical, food & chemical industries offering scientific, engineering and project management services.
Flat 2 1 Blaker Road London, E15 2PY United KingdomPricing, Reimbursement, and Market Access expert with over 15 years’ experience in biopharmaceutical commercialization with global experience across healthcare systems and payer archetypes. Interim director level experience at multiple biopharma companies including: UCB (Immuno-dermatology global pricing director), Sanofi (Oncology, CVD, and MS EU Market Access Lead), Novartis (Ophthalmology Global Patient Access Director), and Takeda Oncology (Global Pricing and Market Access Lead). MSc in Finance from the London School of Economics and BSc in Pharmacology from University College London.
Burymead Road, Hitchin, Hertfordshire SG5 1RT UKRansom develops and supplies exclusive natural botanical extracts to the pharmaceutical, food and drink industries of the world.
England United KingdomRansom develops and supplies exclusive natural botanical extracts to the pharmaceutical, food and drink industries of the world.
2-3 Millars Business Centre Wokingham, RG41 2TZ United KingdomReading Scientific Services Ltd is the complete partner for your analytical, consultancy and training requirements as we work towards our mission of 'Science Enhancing Lives'. Supported by extensive Quality systems and working to GMP standards, our multidisciplinary teams and technical experts don't just provide test results, but go much further to provide practical solutions, rapid outcomes, expert interpretation and sound advice. Our wide-ranging chemical, physical, biopharmaceutical, impurity and microbiological services are all about supporting you through the drug development and manufacturing process, ensuring your products integrity from raw material to market. Amongst other accolades, in 2019 we were named Best Contract Research Organisation (OBN Awards), in 2019 and 2021 Business of the Year (Thames Valley Business Magazine Awards) and also Employer of the Year in 2021 (Thames Valley Business Magazine Awards).
10 Chiswell Street, London, EC1Y 4UQ United KingdomReal Chemistry was established in 2001, currently partners with 30 of the top 30 pharma companies, and employs 2,000+ professionals with deep expertise in pharmaceuticals, biotech, digital health, device and Dx, payers and providers and patient advocacy. We're a full-service agency, helping our clients with marketing, advertising, PR/communications, patient advocacy, social media, analytics and market research, medical affairs/scientific communications, market access/payer strategy, clinical trial recruitment and targeting services, and more. From Publications to Promotional Medical Education, what we offer is truly end-to-end. We are insights driven and outcome focussed, partnering with our clients to deliver an innovative and impactful science story that resonates and brings meaning to the intended audience. We have over 500 experts in Medical across Medical Communications, Medical Education, Medical Affairs and Scientific Visualisation. Core offerings in Medical Affairs include: Medical Strategy & Planning, Medical Thought Leadership, Scientific Narratives, Publication Planning and Development, MSL Education, Advisory Boards, Patient Experience Communications, Anayltics (KOL Mapping, Congress Insights), Data Releases, Congress Support, External Expert Engagement/Education (e.g. case-based learning, AR/VR, Mobile and gaming, Med ed events, podcasts, webinars). Core offerings in Scientific Visualisation include: MOA/VR/AR/MR, Medical Illusatration, Scientific Animation, Digital, Booth Design and Production, Educational Materials. Core offerings in Promotional Medical Education include: Speaker Bureaus, Patient Engagement Communications, Meetings (Sales and HCP), Disease State Education, Omnichannel Programming and Measurement, Sales Training and Enablement, Thought Leader Summits. Advertising: Powered by 21GRAMS, we combine data and the human spirit to understand what makes our audiences tick, and drive action. By applying insight, creativity, design, and partnership, we motivate behaviour change, accelerating adoption of therapies and reshaping treatment approaches in healthcare, and effectively reach and connect with core audiences. Core capabilities include HCP + Patient Advertising, Strategy, and Execution and Promotional Medical Education Analytics & Insights: By combining the expertise of our data scientists, developers, researchers and analysts with cutting-edge, AI-enabled technology and an expansive data universe, we help healthcare and life sciences companies better understand their markets, be more effectively engage with their customers and drive better commercial outcomes. Integrated Communications: Bringing science, health and wellness to life through storytelling. Our Integrated Communications teams are driven by their desire to make an impact for patients, one story at a time. We work in a truly integrated fashion, leveraging our experience and expertise while also collaborating with a best-in-class team and dedicated digital and omnichannel partners. Core capabilities include: Product Communications, Corporate Reputation & Financial Communications, Corporate Pricing & Public Affairs, Global Inclusion & Health Equity, and 360 Degree Execution.
310 Centennial Park Elstree Avenue Hertfordshire, WD6 3TJ United KingdomRegenerative Medical System (RMS) offers cell therapy, CMC, cell collection, cell culture, cell banking and ADME services.
43 Crescent West Barnet, Hertfordshire, EN4 0EQ United KingdomRemedium addresses the affordability and risk related access challenges of innovative medicines with an approach which meets Health System / Payer needs and enables Manufacturers to further optimise launch pricing, cashflows and product value using insurance-like arrangements.
Building 8100 Cambridge Research Park Waterbeach, Cambridge, CB25 9TL United KingdomScientist.com is the world’s largest marketplace for medical research. We help pharmaceutical scientists discover life-saving medicines in less time and at lower cost. Our mission is to make it possible to cure all human disease by 2050. By connecting scientists and enabling them to exchange ideas and transact seamlessly online, Scientist.com is speeding up and reducing the cost of medical research. We were founded in 2007, launched our first research outsourcing marketplace in 2008 and built our first enterprise marketplace for Pfizer in 2009. Today, we operate enterprise marketplaces for 24 of the world’s top 30 pharmaceutical companies, 100+ biotechnology companies and the US National Institutes of Health (NIH).
Unit 3, Felthambrook Ind Est Felthambrook Way Feltham, Greater London, TW13 7DU United KingdomScientist.com is the world’s largest marketplace for medical research. We help pharmaceutical scientists discover life-saving medicines in less time and at lower cost. Our mission is to make it possible to cure all human disease by 2050. By connecting scientists and enabling them to exchange ideas and transact seamlessly online, Scientist.com is speeding up and reducing the cost of medical research. We were founded in 2007, launched our first research outsourcing marketplace in 2008 and built our first enterprise marketplace for Pfizer in 2009. Today, we operate enterprise marketplaces for 24 of the world’s top 30 pharmaceutical companies, 100+ biotechnology companies and the US National Institutes of Health (NIH).
Unit 24 Norman Way Industrial Estate, Over Cambridge Cambridge, CB24 5WE United KingdomScientist.com is the world’s largest marketplace for medical research. We help pharmaceutical scientists discover life-saving medicines in less time and at lower cost. Our mission is to make it possible to cure all human disease by 2050. By connecting scientists and enabling them to exchange ideas and transact seamlessly online, Scientist.com is speeding up and reducing the cost of medical research. We were founded in 2007, launched our first research outsourcing marketplace in 2008 and built our first enterprise marketplace for Pfizer in 2009. Today, we operate enterprise marketplaces for 24 of the world’s top 30 pharmaceutical companies, 100+ biotechnology companies and the US National Institutes of Health (NIH).
2-3 Munro House, Trafalgar Way Bar Hill Cambridge, CB23 8SQ United KingdomScientist.com is the world’s largest marketplace for medical research. We help pharmaceutical scientists discover life-saving medicines in less time and at lower cost. Our mission is to make it possible to cure all human disease by 2050. By connecting scientists and enabling them to exchange ideas and transact seamlessly online, Scientist.com is speeding up and reducing the cost of medical research. We were founded in 2007, launched our first research outsourcing marketplace in 2008 and built our first enterprise marketplace for Pfizer in 2009. Today, we operate enterprise marketplaces for 24 of the world’s top 30 pharmaceutical companies, 100+ biotechnology companies and the US National Institutes of Health (NIH).
Thames Valley Science Park The Gateway, 1 Collegiate Square Reading, RG2 9LH United KingdomScientist.com is the world’s largest marketplace for medical research. We help pharmaceutical scientists discover life-saving medicines in less time and at lower cost. Our mission is to make it possible to cure all human disease by 2050. By connecting scientists and enabling them to exchange ideas and transact seamlessly online, Scientist.com is speeding up and reducing the cost of medical research. We were founded in 2007, launched our first research outsourcing marketplace in 2008 and built our first enterprise marketplace for Pfizer in 2009. Today, we operate enterprise marketplaces for 24 of the world’s top 30 pharmaceutical companies, 100+ biotechnology companies and the US National Institutes of Health (NIH).
Whiteleaf Business Centre 11 Little Balmer Buckingham, MK18 1TF United KingdomScientist.com is the world’s largest marketplace for medical research. We help pharmaceutical scientists discover life-saving medicines in less time and at lower cost. Our mission is to make it possible to cure all human disease by 2050. By connecting scientists and enabling them to exchange ideas and transact seamlessly online, Scientist.com is speeding up and reducing the cost of medical research. We were founded in 2007, launched our first research outsourcing marketplace in 2008 and built our first enterprise marketplace for Pfizer in 2009. Today, we operate enterprise marketplaces for 24 of the world’s top 30 pharmaceutical companies, 100+ biotechnology companies and the US National Institutes of Health (NIH).
145 Frimley Road Camberley, Surrey, GU15 2PS United KingdomEnabling effective engagement in health. Resonant Group is an award-winning independent group of agencies driven by the same core values and a common belief that lives can be transformed through better health communication. Resonant comprises of three agencies; Bedrock (Medical Communications), Anthem (PR and Healthcare Communications), and Origins (Patient Focus).
London, England United KingdomRetroscreen Virology offer in vitro antiviral assays.
2 Royal College Street London NW1 0NH UKRetroscreen Virology offer in vitro antiviral assays.
London, England United KingdomRexam provides consumer packaging and is a leading global beverage can maker.
4 Millbank London SW1P 3XR UKRexam provides consumer packaging and is a leading global beverage can maker.
St George's University LondonRichmond Pharmacology offers early phase clinical research services including project management, data management, and patient recruitment.
1 Springfield Drive Leatherhead, Surrey, KT22 7AJ United KingdomRINA Tech UK Limited delivers engineering and consulting services for the energy sector, covering oil & gas, power generation, renewables, and grid infrastructure. Our expertise spans design, certification, risk assessment, and sustainability solutions, ensuring regulatory compliance, safety, and performance throughout global project lifecycles. We also provide advanced engineering, renewable integration, and digital innovation, offering comprehensive support from feasibility and design through operation and decommissioning—driving the transition to a sustainable future with reliable, efficient solutions
73 Englefield Road England, N1 4HD United KingdomROSE CHEMICALS is a family owned business, established in 1977 WE SUPPLY: quantities from laboratory to semi-bulk and bulk requirements WE STOCK: many rare and difficult to obtain materials
71-75 Shelton Street, Covent Garden London, WC2H 9JQ United KingdomRosettaPath is a pathology consultancy offering the following services: digital, translational, toxicologic and experimental pathology support for projects from a board certified pathologist (DECVP). Founded with over 25 years of Pharma experience, RosettaPath provides primary microscopic evaluation and reporting of pathology data and peer review of efficacy and safety studies, enabled globally through a digital image workflow. Advice on investigative studies, human relevance of findings, strategic input to nonclinical assessments of safety and responses to regulatory questions.
West Common, Harpenden AL5 2JQ, United KingdomRothamsted is the longest running agricultural research station in the world, providing cutting-edge science and innovation for nearly 170 years. Our mission is to deliver the knowledge and new practices to increase crop productivity and quality and to develop environmentally sustainable solutions for food and energy production. No single approach can deliver sustainable agriculture with high productivity and value. A broad perspective that encompasses the whole plant system is needed and a careful balance of approaches is required. Rothamsted integrates biotechnology with other areas of science such as agronomy and agro-ecology so both existing and new knowledge can be implemented through agricultural practice. Our strength therefore lies in our integrated, multidisciplinary approach to research in plant and soil science.
Royal College StreetRoyal Veterinary College at University of London focuses on research but also offers clinical services for animal subjects.
Brickendonbury Hertford SG13 8NL United KingdomRubber Consultants, which in 2014 celebrates 30 years of assisting companies all over the world to improve their businesses by offering world class testing of rubber and other elastomeric materials and products, can supply your rubber testing and polymer testing services.
Suite 36 88-90 Hatton Garden Holborn, London, EC1N 8PG United Kingdom
Chiltern Hill Chalfont, St Peter , SL9 9FG United KingdomRWS is the world leader in translation and localization, intellectual property support solutions and life sciences language services.
Babraham Research Campus, Babraham, Cambridge CB22 3AT United KingdomRxCelerate is the perfect partner for virtual, asset-centric companies. If you locate an asset (perhaps in academia or out-licensed from a pharma company) the quickest and cheapest route to the clinic is with RxCelerate. We can deliver the entire programme of GLP toxicology, ADME and efficacy studies in state of the art preclinical models of disease to secure an investigational new drug (IND) approval to begin clinical trials. Typically, for small molecule candidates such a programme can be executed with RxCelerate in under 12 months. RxCelerate is the perfect partner for larger drug development companies. If you are developing a drug candidate in-house, but need to out-source specific elements of the programme, RxCelerate offers world-leading capabilities in preclinical efficacy studies, toxicology and ADME to supplement your internal skillset. Our philosophy is to eliminate compromises: to deliver more high quality data, quicker and at lower cost. The economics of drug development only make sense if you can rapidly de-risk preclinical candidates at low cost. Uniquely, RxCelerate offers combination study designs, investigating efficacy, toxicology and ADME in a single experiment – providing more insight per dollar than conventional approaches. We take industry-standard preclinical disease models, and improve them by adding additional end-points. A smarter approach means more data, quicker and at lower cost.
Babraham Research Campus Babraham, Cambridge, CB22 3AT United KingdomRxCelerate is the perfect partner for virtual, asset-centric companies. If you locate an asset (perhaps in academia or out-licensed from a pharma company) the quickest and cheapest route to the clinic is with RxCelerate. We can deliver the entire programme of GLP toxicology, ADME and efficacy studies in state of the art preclinical models of disease to secure an investigational new drug (IND) approval to begin clinical trials. Typically, for small molecule candidates such a programme can be executed with RxCelerate in under 12 months. RxCelerate is the perfect partner for larger drug development companies. If you are developing a drug candidate in-house, but need to out-source specific elements of the programme, RxCelerate offers world-leading capabilities in preclinical efficacy studies, toxicology and ADME to supplement your internal skillset. Our philosophy is to eliminate compromises: to deliver more high quality data, quicker and at lower cost. The economics of drug development only make sense if you can rapidly de-risk preclinical candidates at low cost. Uniquely, RxCelerate offers combination study designs, investigating efficacy, toxicology and ADME in a single experiment – providing more insight per dollar than conventional approaches. We take industry-standard preclinical disease models, and improve them by adding additional end-points. A smarter approach means more data, quicker and at lower cost.
Babraham, England, CB22 3AT United KingdomRxCelerate, recently acquired Total Scientific in May 2018, is an outsourced drug discovery and development platform. Our experienced team design and deliver on integrated programs to drive your asset or project through drug discovery, preclinical research to clinical proof-of-concept. We specialise in bespoke experimental design with data-rich endpoints; maximising your chances of reaching the clinic. We optimise translation from preclinical research to clinical studies by the early integration of mechanism-validation and biomarker-development into preclinical pharmacology strategies. One of our main experience is in all aspects of biomarker research, from biomarker identification using ‘omics technology through assay design, development and validation to multi-site clinical studies designed to validate or test biomarkers. In addition to the above biomarker related activities, we also provide a wide range of in vitro laboratory services including: Biacore (SPR) to study the real time binding of two molecules. Multiplex assays, using Luminex technology. Enzyme and binding assays. Mass Spectrometry - LC-MS/MS Data management and biostatistics. GLP / GxP We also like to think that our honest, flexible and bespoke approach means that we are often one of the first CROs our clients turn to for something a bit different, whether that is plugging a gap in a project plan or a complete development project. Our clients include biotech, virtual or early stage start-ups, diagnostics and universities.
69 Southend Road Hockley, England, SS5 4PZ United KingdomSabal Health & Pharma has established itself, through its market insight, sourcing expertise and worldwide contacts, as major worldwide distributor of APIs to leading pharmaceutical manufacturers. Supported by technical and regulatory expertise we are able to ensure a consistent high level of customer satisfaction.
Runway East Aldgate 2 Whitechapel Road London, London, E1 1EW United KingdomSable Bio builds a target intelligence platform helping pharmaceutical industry scientists assess target safety risks
Cambridge, England United KingdomSAGE Labs - A Horizon Discovery Group Company offers custom mouse and rat knockout models.
8100 Cambridge Research Park Waterbeach Cambridge, Cambridgeshire, CB259TL United KingdomSAGE Labs - A Horizon Discovery Group Company offers custom mouse and rat knockout models.
Britannia House 68 Hanbury Street Other Address Info City London E1 5JLThe only fully independent laboratory based in London, providing consulting and analytical testing services to clients in the United Kingdom and across the World. Extensive range of analytical services relating to the animal feeds, cereals and grains, oils and fats, sugar, fertilisers and food sectors. Widely recognised in the global commodity trade with a reputation built on principles of independence, impartiality, reliability, and integrity. Accredited by the United Kingdom Accreditation Service (UKAS) to the international standard EN ISO/IEC 17025:2005 Approved GAFTA analysts and FOSFA Full Member Analysts.
Berkshire RG6 6BZ United KingdomSaretius offers their expertise in preclinical pharmacokinetic and pharmcodynamic models as well as preclinical efficacy studies of inflammation, pain, metabolic and CNS disorders and safety. Saretius has considerable experience with the research models offered and all Saretius efficacy models have been validated with clinically effective treatments. Saretius offer bespoke research services and are happy to provide advice based on our wide industrial experience as to the best approach to achieve client objectives.
Whiteknights House University of Reading Reading, Berkshire, RG6 6UR United KingdomSaretius offers their expertise in preclinical pharmacokinetic and pharmcodynamic models as well as preclinical efficacy studies of inflammation, pain, metabolic and CNS disorders and safety. Saretius has considerable experience with the research models offered and all Saretius efficacy models have been validated with clinically effective treatments. Saretius offer bespoke research services and are happy to provide advice based on our wide industrial experience as to the best approach to achieve client objectives.
Pampisford, England, CB22 United KingdomSareum is a cancer drug discovery company.
Twickenham, England United KingdomSavanta offers consultancy services in support of pharmacutical analysis including method development/validation, drug substance synthesis/characterization, and formulation development.
Brambleside Bellbrook Industrial Estate England, TN22 United KingdomScientifica’s friendly, helpful and knowledgeable staff empower researchers to achieve breakthroughs in neuroscience by overcoming experimental hurdles with world-class laboratory equipment. We do this by designing and developing our systems with leading scientists to ensure they are cutting-edge, ideally suited to their task and future-proof. From the UK, we manufacture and distribute high-quality instruments to universities, pharmaceutical companies and research laboratories to more than 40 countries worldwide. Specialising in equipment for electrophysiology, multiphoton imaging and optogenetics studies, we help researchers gain a better understanding of the nervous system, including neurological diseases such as Alzheimer’s, Parkinson’s and epilepsy. At the beginning of 2016, Scientifica opened an office in the United States, its first office outside of the UK. The new office, based in New Jersey, will improve our ability to support our growing number of customers in North America. We also have a number of selected local distributors in countries around the world.
Goleigh Farm, Selborne Hampshire, England, GU34 3SESelborne Biological Services supplies animal blood products, protein fractions, and custom polyclonal antibody services.
Unit 326, 121 Ability House Brooker Road Waltham Abbey London, ---, EN9 1JH United KingdomSelleck Chemicals is one of the world's leading suppliers of biochemical products and services. We offer a diverse, well-curated and data-rich catalog of over 6000 small molecule inhibitors and modulators for multiple cell signaling pathways including MAPK, PI3K/Akt/mTOR, Apoptosis, Angiogenesis, and JAK/STAT, among others. In addition, we also provide a variety of screening libraries for High Throughput Screening and High Content Screening to advance drug discovery and systems biology research. All the inhibitors are well classified, so you can directly choose inhibitors according to signaling pathways or research areas listed in our company website. We boast a global operations network and overnight delivery on all in-stock items. Selleck Chemicals has established long-term and stable relationships with more than 10,000 customers from pharmaceutical and biotech companies to universities and research institutions. We have headquarters in the United States, Asia, Europe, and 38 distributors worldwide. We help the scientists of today deliver on the technologies of tomorrow. Put your research on the fast track with Selleck Chemicals. We look forward to supporting you!
Selvita Ltd. CB1 Business Centre 20 Station Rd Cambridge CB1 2JD UKSelvita offers integrated drug discovery and development services spanning from medicinal chemistry, process chemistry, assay development and screening, recombinant protein production, structural studies, ADME/DMPK, in vitro and in vivo pharmacology, translational research and toxicology. Our major expertise is in oncology, inflammation, fibrosis, respiratory diseases, infectives and neuroscience. In the field of drug development we offer analytical support for small molecules and biologics, including methods development and validation, QC, stability studies, GMP batch release, formulation development, IMP manufacturing for solid dosage, impurities identification and testing, cell-based assays and biophysical methods. The services are performed according to GMP or GLP certification.
Nine Hills Road Cambridge, CB2 1GE United KingdomSelvita offers integrated drug discovery and development services spanning from medicinal chemistry, process chemistry, assay development and screening, recombinant protein production, structural studies, ADME/DMPK, in vitro and in vivo pharmacology, translational research and toxicology. Our major expertise is in oncology, inflammation, fibrosis, respiratory diseases, infectives and neuroscience. In the field of drug development we offer analytical support for small molecules and biologics, including methods development and validation, QC, stability studies, GMP batch release, formulation development, IMP manufacturing for solid dosage, impurities identification and testing, cell-based assays and biophysical methods. The services are performed according to GMP or GLP certification.
Maxwell Centre JJ Thomson Avenue Cambridge , Cambridgshire, CB3 0HE United KingdomSemarion's SemaCyte® microcarrier platform leverages novel materials physics to barcode, move, and freeze adherent cells within assaying workflows. This innovative solution introduces flexibility, speed, and miniaturisation into in vitro drug discovery. SemaCytes enable you to produce better data faster from a wide variety of adherent cell assays using the tools and equipment at your disposal.
Cavendish Laboratories JJ Thomson Avenue Cambridge, Cambridgshire, CB3 0HE United KingdomSemarion's SemaCyte® microcarrier platform leverages novel materials physics to barcode, move, and freeze adherent cells within assaying workflows. This innovative solution introduces flexibility, speed, and miniaturisation into in vitro drug discovery. SemaCytes enable you to produce better data faster from a wide variety of adherent cell assays using the tools and equipment at your disposal.
10, St James Close Pangbourne, RG8 7AP United KingdomSequoia Research Products supplies natural products and biochemicals.
16 Brune Street, Coppergate House, Office 409, London E1 7NJSince 2009, we have built systems to alleviate the burdens of bioinformatics IT. We simplify infrastructure, make software more robust, and enable analysis at scale. Because when time is spent installing and troubleshooting software and moving large files around, it can't be used to get analysis done. Our team of more than 100 bioinformaticians, engineers, and other experts can work with your institution's unique infrastructure, workflows, and needs to scale analyses and find answers. We offer researchers more than 30 tested, peer-reviewed pipelines, and about 400 open source applications for analyzing DNA-seq and RNA-seq data, from QC tools to data visualizations.
Mary Sheridan House, 11-19 St Thomas St London, Greater London, SE19RY United KingdomWe are a boutique management consultancy, based in London, serving global clients - including a specialism in major Pharma. We specialise in transformation consulting - including op model, programme management, cost reduction, launch excellence, change management and tech adoption.
48 Park Road Hampton Hill, TW12 1HP United KingdomShape Health is a specialist consultancy focused on helping healthcare companies get innovative medicines and medical technologies into healthcare systems, accessible to patients and with their full value recognised. Our specific expertise is in the strategy of shaping favourable public policy environments and building and mobilising advocacy from within the healthcare policy community.
71 Lambeth Walk London, SE11 6DX United KingdomSitilop has developed world-leading expertise in clinical research and development. We work with public and private clients, providing services for clinical research and offering specialised consultancies. Our consultancies include specialised solutions across disorders of the Central Nervous System, with expertise in clinical research and neuroimaging. We provide state-of-the-art services in all aspects of clinical research, ranging from clinical activities, to establishment of research protocols, regulatory and ethics submission, data analysis using innovative methodologies and preparing materials for publication. Our services for clinical research include solutions spanning from single site observational studies to complex multi-site interventional studies. Our vision is to drive healthcare forward, and accelerate this progress with our unique insights, and with our ability to reimagine and reinvent. Our Clinical Services include: 1. Study Design 2. Protocol Development 3. Regulatory & Ethics Submission 4. Site assessment & selection 5. SOPs, CRFs & Reports 6. Recruitment & Retention 7. Clinical assessments 8. Data analyses, including Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT) and Magnetic Resonance Imaging (MRI) 9. Publication oversight & writing Our Consultancies include: 1. Neurology 2. Neurodegeneration 3. Mental Health 4. PET & SPECT imaging, which include quantitative analysis of Amyloid PET scans and visual and semi-quantitative analysis of DaTSCAN 5. MR imaging 6. Education
46-48 Grosvenor GardensSkyePharma is a specialist drug delivery company developing oral and inhalation products.
London, England United KingdomSkyePharma is a specialist drug delivery company developing oral and inhalation products.
Hertfordshire, London, United KingdomSmartAnalyst provides strategic consulting and analytics services to bio-pharma companies. In support of our clients’ efforts to identify and commercialize novel innovative therapies to improve patient outcomes and garner market success, we support their strategic decisions at the Disease Area, Asset and Portfolio levels. Additionally, we partner with Value teams, by providing Health Economics and Outcomes Research Services, including analysis and delivery of Real-World Evidence studies. Lastly, we provide Insights, with a series of products and services that help companies make clinical development decisions, inform commercial and BD&L strategy, and benchmark their programs against the competition.
10 Lyon Road London, SW19 2RL United KingdomSmartway Clinical Trial Supplies (SCTS) is a dedicated business unit of Smartway Pharmaceuticals Limited, an established UK based company, which holds a Wholesale Distribution Authorisation (Human & Veterinary) issued by the MHRA, Controlled Drug Licence (Schedules 2-5) issued by the Home Office and an MS licence which allows importation of products from outside the EU. At Smartway CTS we can provide a customised service to fulfill all your Clinical trial supply requirements and reduce your logistical burden. In addition, we are able offer a range of specialist transport options and storage facilities for cold chain products, which form an integral part of a secure and successful clinical trial supply chain.
Cleeve Road Leatherhead Surrey KT22 7RU United Kingdom
Cleeve Road England, KT22 United Kingdom
Scale Space 58 Wood Lane LONDON, W12 7RZ United KingdomSOLVE Chemistry is a London-based start-up focusing on making chemical process development more efficient through autonomous high-throughput reaction data collection and machine learning methods to provide meaningful data and insights through its software platform.
William James House Cowley Road Cambridge CB4 0WUSource BioScience is an international business providing high quality services and products to the pharma biotech, life science research and healthcare diagnostic communities.
Units 24/25 William James House Cowley road Cambridge, Cambridgeshire, CB4 0WU United KingdomSource BioScience is an international business providing high quality services and products to the pharma biotech, life science research and healthcare diagnostic communities.
12-12a Margaret Street 12-12a Margaret's Street England, W1W 8RH United KingdomWe are a consultancy specialising in health economics, data analysis, systematic literature review, medical writing, and health technology assessment.
Portland House, Stag Place London SW1E 5RS, UKSparta Systems, with its global enterprise quality management solutions (EQMS), enable high-value organizations to safely and efficiently deliver products and services to market.
Royal Holloway University of London Egham, Surrey TW20 0EX United KingdomSporeGen offers analysis of Bacillus strains and contract services including antibody production, genetic analysis, immune response analysis, enterotoxin analysis, in vivo efficacy, and phylogenetic studies.
The Campus 4 Crinan Street London, N1 9XW United KingdomWe are a global leader in healthcare education and communications Drawing on the vast experience and expertise of our worldwide network, Springer Healthcare delivers strategic medical communications solutions, high-level clinical and scientific content, specialized training programs, and targeted medical education initiatives across the full range of therapeutic areas.
Unit 4 Tanners Drive Blakelands Milton Keynes MK14 5NA UKStarlab provides liquid handling technology, injection moulding services, and pipette servicing.
Minerva Building 250 Babraham Research Campus Cambridge CB22 3AT United KingdomStem Cell Sciences uses stem cell biology to discover, develop and commercialize breakthrough therapeutics for stem-cell based research and drug discovery.
7100 Cambridge Research Park, Beach Drive Waterbeach, Cambridge, CB25 9TL United KingdomSTEMCELL Technologies provides products and services to support life sciences research, including human primary cells, specialized culture media, cell separation technologies, instruments, accessories, and scientific services. Discover our latest promotions to advance your research Limited Time Offer: Free EasySep™ Sample and a Chance to Win Prizes Experience an easier way to isolate cells with EasySep™—the easy choice for simplified cell isolation. Proven in published research for over 20 years, EasySep™ combines the specificity of monoclonal antibodies with the simplicity of a column-free magnetic system. Delivering exceptional purity in as little as 8 minutes, EasySep™ ensures efficient and reliable cell isolation from a wide range of species and sample sources. Try EasySep™ now, and share your experience for a chance to win prizes to fuel your research, including a grand prize worth up to $3,000!* To take advantage of this offer, please visit this form page. A member of our team will contact you to follow up. *This offer is available only to new customers who have not previously purchased EasySep™ products since October 20, 2023. Limit of one offer per kit/product, for any user or laboratory. Offer is valid in select countries only. Certain products are only available in select territories. See form page for full terms and conditions. Developing workflows for large-scale biomedical research, including drug discovery and the development of cell-based vaccines and therapeutics, requires significantly larger starting biological materials than conventional research methods. To meet the demands of scalable workflows, scientists need to find ways of sourcing, isolating, and culturing large numbers of cells as efficiently as possible. Scale up your research with ethically sourced large-scale human primary cell sources such as peripheral blood-sourced leukopaks, whole blood, or mononuclear cells (PBMCs). Additionally, save time on your manual cell isolations from large-volume samples with the Easy 250 EasySep™ Magnet , which allows you to process up to 225 mL and 12 billion cells in a single isolation step. To ensure optimal activation, expansion, and differentiation of cells for specific downstream applications, STEMCELL also offers ImmunoCult™ cell culture reagents as well as cytokines and recombinant proteins. The ImmunoCult™ cell culture media, activators, and supplements allow you to culture various cell types, including T cells, B cells, NK cells, dendritic cells, and macrophages, under defined stimulatory conditions for consistent and reliable results. About STEMCELL Technologies Inc. Get the Cells You Need from STEMCELL Technologies Driven by science and a passion for quality, STEMCELL Technologies supports life sciences research with more than 2500 specialized cell culture media, cell separation technologies, instruments, accessory products, and scientific services. Scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research are among those who rely on our products and services. At STEMCELL, we are dedicated to improving lives through advanced knowledge and scientific discovery, our commitment to fostering diversity and inclusion in STEM, and our investments in sustainability, community, and social responsibility. We are a company of Scientists Helping Scientists, and we care deeply about making the world a better place. About Our Offerings on Scientist.com Partner with the Right Primary Cell Supplier The success of your primary cell-based research depends on partnering with the right cell supplier. Having a dependable source of quality human primary cells that consistently meet your requirements can reduce experimental uncertainty and increase confidence in your results. STEMCELL’s human primary cell products are ethically sourced using Informed Consent Forms (ICFs) and protocols approved by either an Institutional Review Board (IRB), the Food and Drug Administration (FDA), the U.S. Department of Health and Human Services, and/or an equivalent regulatory authority. You can choose human primary cells based on donor specifications that include sex, age range, BMI range, ethnicity, blood type, smoker status, and more. Ensure you get the cells you need by placing multiple lots on hold for testing, and save time by using our characterization services, including high-resolution HLA typing (Class I and II), CMV status, EBV status, vaccination status, genotyping, phenotyping, and FACS analysis. Visit STEMCELL.com/PrimaryCells to learn more about human primary cells. Our portfolio* of ready-to-use, fresh or cryopreserved human primary cells from blood, cord blood, and bone marrow includes: Induced pluripotent stem cells Leukopaks LRS cones Mobilized peripheral blood Mononuclear cells (MNCs) Purified immune cells (e.g. NK, T cells, monocytes, B cells, macrophages, pan-T cells, dendritic cells) Serum-free cultured immune cell subsets (e.g. dendritic cells, macrophages) Hematopoietic stem and progenitor cells (e.g. CD34+ cells) Stromal cells (MSCs) STEMCELL also offers a wide range of disease-state samples and customizations for your needs. Schedule the collection and delivery of fresh cells* at your convenience, or reserve multiple lots of cryopreserved cells while you test them in your assays. If you have a question about ready-to-use fresh or frozen human primary cells from STEMCELL, please contact us. Your Contract Research Organization Partner Contract Assay Services (CAS) is a contract research organization (CRO) established within STEMCELL that performs assay services based on in vitro and in vivo primary cell assays. The use of primary cells in our in vitro assays can provide more physiologically relevant results than cell line-based assays. We specialize in the various applications of the in vitro hematopoietic colony-forming unit (CFU) assay, also known as the colony-forming cell (CFC) assay. In addition, we perform standardized and customized immunological and mesenchymal cell-based assays for use at a variety of points in the drug discovery and development pathway. We combine STEMCELL Technologies' specialized media and reagents with the practical knowledge of our scientists, to provide both standardized and customized assay services that help researchers obtain the high-quality data they require. To explore our full product listing or educational and scientific resources, visit www.stemcell.com. *Certain products are only available in select territories. Please contact your sales representative or the Product & Scientific Support team at techsupport@stemcell.com for further information. STEMCELL employs over 1,700 people worldwide and operates in nine countries. Three locations are in North America: our headquarters in Vancouver, Canada, a sales support office in Cambridge, MA, and a distribution center in Seattle, WA. As well as three European offices, we have five Asia Pacific offices to serve our customers. We provide direct sales and support in more than 30 countries throughout North America, Europe, Asia, and Australia, as well as through a network of distributors. For full contact information worldwide, visit our locations page for specific details.
46 Harvist Road London, NW6 6SH United Kingdom
Unit 27, The io Centre Salbrook Road, Salfords Redhill, Surrey, RH1 5GJ United KingdomFor over 30 years, SteriTech has supplied, managed, and maintained critical process equipment for the pharmaceutical industry in the Irish and UK markets. We proudly represent industry leaders Fedegari, Stilmas, Dara, and Olsa, Bonfiglioli and offer cutting-edge equipment solutions, process optimisation, validation, and lifecycle support services.
Cranmer Terrace,St George's University of London focuses on research with facilities for genomics, trasncriptomics, proteomics, and metabolomics.
Newmarket, England, CB8 United KingdomStratech provides primary and secondary antibodies, along with reagents for immunology, neurology, and apoptosis.
Oaks Drive, Newmarket, Suffolk, CB8 7SYStratech provides primary and secondary antibodies, along with reagents for immunology, neurology, and apoptosis.
Newton Hall, Town St Newton Cambridge CB227ZEStrem Chemicals, Inc. established in 1964, is a privately–held company that manufactures and markets specialty chemicals of high purity. Its clients include academic, industrial and government research and development laboratories as well as commercial scale businesses in the pharmaceutical, microelectronic and chemical / petrochemical industries. Strem also provides custom synthesis (including high pressure synthesis) and cGMP manufacturing services.
Strem Chemicals UK 24-25 Newton Hall, Town Street, Cambridge, Cambridgeshire, CB22 7ZE We distribute a wide range of high purity chemicals and specialty materials. These include: 1. A range of metals, inorganics, organometallics and nanomaterials 2. We offer patent-free and proprietary catalysts and ligands for organic synthesis, often at kilo-scale, including many for asymmetric transformations 3. For the materials science/electronic community we include a wide range of MOCVD, CVD and ALD precursors & bubblers, metal-based nanomaterials (including PURE nanoparticles that are reactant and surfactant-free) quantum dots (CdSe, PbS) and carbon nanomaterials (nanotubes, fibers, cones, CNT arrays, graphene), rare-earth and electronic grade chemicals for ultra-high purity needs and ionic liquids Our licensed technologies come royalty-free for R&D purposes. Our clients include academic, industrial and governmental research laboratories as well as commercial scale businesses in the pharmaceutical, microelectronic and chemical industries. We have a QA system in alignment with ISO 9001 and 14001 which is independently audited
Strem Chemicals UK Town Street, Newton Cambridge, Cambridgeshire, CB22 7ZE United Kingdom We distribute a wide range of high purity chemicals and specialty materials. These include: 1. A range of metals, inorganics, organometallics and nanomaterials 2. We offer patent-free and proprietary catalysts and ligands for organic synthesis, often at kilo-scale, including many for asymmetric transformations 3. For the materials science/electronic community we include a wide range of MOCVD, CVD and ALD precursors & bubblers, metal-based nanomaterials (including PURE nanoparticles that are reactant and surfactant-free) quantum dots (CdSe, PbS) and carbon nanomaterials (nanotubes, fibers, cones, CNT arrays, graphene), rare-earth and electronic grade chemicals for ultra-high purity needs and ionic liquids Our licensed technologies come royalty-free for R&D purposes. Our clients include academic, industrial and governmental research laboratories as well as commercial scale businesses in the pharmaceutical, microelectronic and chemical industries. We have a QA system in alignment with ISO 9001 and 14001 which is independently audited
Stetchworth Ley, England, CB8 9TX United KingdomThe trials business relocated in 2009 from Great Wilbraham, Cambs to Stetchworth Estate Farms, Newmarket due to lease expiry. The estate is run by Ron Gabain for the Duke of Sutherland and extends to 1215Ha (3000 acres) situated some 2 miles south west of Newmarket. The soil overlies chalk and varies from a sandy loam to chalky boulder clay. Current cropping includes Wheat, Barley, Sugar Beet, Winter Beans and Linseed.
Sittingbourne, England United KingdomSunnyLab supplies proteins, patient samples, serum, plasma, antibodies and tissues.
Charing Cross HospitalSupra-Regional Assay Service offers various assay services.
unit 5 Whatfside Rosemont Rd Middlesex Alperton London, England, HA0 4PE United KingdomAt Surface Measurement Systems LLC (SMS), we aim to expand the frontiers of particle, materials, and surface science. SMS companies are well-known for their expertise in developing unique characterization solutions for solid-state materials, from manufacturing state-of-the-art instrumentation to offering tailored characterization solutions. Starting with a first-of-its-kind single instrument sold in 1992, SMS Holdings now operates worldwide, with 5 subsidiaries between its instrumentation branches and contract laboratories. Whether it’s our unrivalled series of sorption analyzer instruments or the in-depth contract analysis services on offer, SMS is a globally-renowned organization that remains synonymous with innovative engineering and scientific excellence, unmatched in the field of sorption science. Particle Characterisation Laboratories (PCL), is part of the SMS group and offer a unique service in the scientific landscape. Unlike other CROs, PCL offers a fully comprehensive suite of particle characterisation analysis, enabling us to provide detailed insight into the properties of solid materials. Working with laboratories around the world, the aim of PCL is to provide access to advanced characterisation services to researchers and equip their teams with the knowledge to understand the results and their broader implications. Standard sample analysis services available are particle size analysis, Dynamic Vapor Sorption, Inverse Gas Chromatography, DSC, TGA, SSA BET, light scattering and more!
Bourne House Prince Edward Street Prince Edward Street, Hert, HP4 3EZ United KingdomSWM Partners are a Global Medical Events & Communications Agency. We deliver precision-crafted scientific communications and bespoke medical events that create clarity, confidence, and meaningful connections. By translating complex science into trusted, scalable experiences — from trial engagement through to medical education — we empower healthcare professionals with a confident understanding and support improved patient outcomes.
8 Devonshire square London, EC2M 4PL United KingdomWe are a small group of highly experienced researchers with international backgrounds in academia, government and industry. Our deep knowledge and nimble approach allows us to meet your needs with flexibility, technical excellence, timeliness and good humour. We take pride in our work and we get results. We are experts in achieving reimbursement for pharmaceuticals and devices in countries around the world, and communicating value in healthcare to diverse audiences.
Room 3.042 Y Block (c/o NPIMR) St Mark's Hospital Watford Road, Harrow London, Middlesex , HA1 3UJ United KingdomSynexa Life Sciences is a leading provider of biomarker and bioanalytical services, specialising in the development, validation, and delivery of a wide range of complex and custom-designed assays. With a team of over 200 staff across four global laboratory locations; Cape Town, London, Manchester, and Turku (Finland), we provide innovative solutions to support our customers to achieve their clinical milestones. Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry and ELISpot) and genomic services to support clinical trials and translational studies. We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis. Synexa, improving the quality of human health through innovative biomarker and bioanalytical solutions.
London, United KingdomSynexa Life Sciences is a leading provider of biomarker and bioanalytical services, specialising in the development, validation, and delivery of a wide range of complex and custom-designed assays. With a team of over 200 staff across four global laboratory locations; Cape Town, London, Manchester, and Turku (Finland), we provide innovative solutions to support our customers to achieve their clinical milestones. Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry and ELISpot) and genomic services to support clinical trials and translational studies. We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis. Synexa, improving the quality of human health through innovative biomarker and bioanalytical solutions.
Beacon House Nuffield Road Cambridge, CB4 1TF T United KingdomManufacturer/developer of scientific instruments based on digital imaging technology. Synoptics Ltd has four divisions:- Syngene - is one of the world leading providers of gel documentation and analysis systems used by molecular biologists in genomic and proteomic studies. Synbiosis - provides systems for colony counting and zone measuring applications. Market focus is on the food, water and pharmaceutical markets. Syncroscopy - provides digital imaging software to microscope users for use in image reconstruction. Synoptics Health - in conjunction with Queen Mary College, London, Synoptics Health has developed a patented system for the detection of residual proteins left on surgical instrumens after the washer disinfector process
Suite 3 Cori Building, 11 Granta Park Cambridge Cambridgeshire, CB21 6GP United KingdomTagomics offers multiomic solutions for drug discovery and development, as well as diagnostic development.
Babraham Research Campus CB22 3AT United KingdomTalisman Therapeutics is a human stem cell, drug discovery company, based in Cambridge UK. We are committed to revolutionising the discovery of disease-modifying treatments for neurodegenerative diseases. We use cutting-edge stem cell technologies to answer the most difficult biological questions in target discovery and validation. Our novel human patient-derived stem cell models of neurodegenerative disease provide a transformative platform for rapid and relevant compound identification, significantly accelerating drug discovery and development. Talisman’s primary goal is the exploitation of these systems to identify novel pharmacological treatments for neurodegenerative diseases through our external collaborative work and through our in-house drug discovery programme.
Jonas Webb Bldg Babraham Research Campus Cambridge, Cambridgeshire, CB22 3AT United KingdomTalisman Therapeutics is a human stem cell, drug discovery company, based in Cambridge UK. We are committed to revolutionising the discovery of disease-modifying treatments for neurodegenerative diseases. We use cutting-edge stem cell technologies to answer the most difficult biological questions in target discovery and validation. Our novel human patient-derived stem cell models of neurodegenerative disease provide a transformative platform for rapid and relevant compound identification, significantly accelerating drug discovery and development. Talisman’s primary goal is the exploitation of these systems to identify novel pharmacological treatments for neurodegenerative diseases through our external collaborative work and through our in-house drug discovery programme.
York Way Royston, Hertfordshire SG8 5WY United KingdomTAP Biosystems (formerly The Automation Partnership) provides innovative automation systems and consumables to improve productivity in life science research, development and production.
1st Floor, 2 Woodberry Grove Finchley, London, N12 0DR United KingdomTargeted Transgenesis Limited is a UK headquartered biotherapeutics company with a strong background and experience in transgenic technologies. Invented and developed by PhD Scientists and industry experts with extensive International preclinical experience, Targeted Transgenesis has developed an important pipeline of novel proprietary technologies around gene targeting and gene therapeutics. With strong links to industry and CRO partners worldwide, we are able to offer comprehensive transgenic services, including generation of animal models (small and large animals), and full phenotyping, imaging and analytical services, at a fraction of the time and cost of our competitors and with specificity and speed that has not been possible until today.
1 Kingsway London WC2B 6AT United KingdomTate & Lyle is a global provider of distinctive, high quality ingredients and solutions to the food, beverage and other industries
TCS Biosciences Ltd Buckingham, mk18 2LR United KingdomTCS is a manufacturer and distributor of laboratory reagents, test kits and quality control reagents for the Clinical, Pharmaceutical, Food and Water sectors. Our commitment to supplying quality and innovative products helps our customers to excel in the provision of clinical care, medicines, food and drinking water. In our 60 year history we have established ourselves as Europe's foremost supplier of animal blood and sera for microbiological use. We are also a prominent player in the UK water industry and in the European pharmaceutical market. At TCS, we are focused on developing our presence and product portfolio in each market sector, without compromising our core business value . . . . Quality.
Berner Str. 119Telstar Life Science Solutions designs, manufactures, sell and support of high technology equipment solutions for the pharmaceutical, biotech and related industries
BioPark Broadwater Road Welwyn Garden City, Hertfordshire AL7 3AX United KingdomTemag Pharma specializes in manufacturing and supply of controlled drugs and various drug forms.
254. Ground Floor,The Centre for Genomic Applications (TCGA) offers microarray, oligonucleotide synthesis, high throughput fragment analysis, genotyping, high throughput sequencing, bioinformatics, and proteomics services.
Cambourne Business ParkThe Clinical Trial Company offers clinical research services including project management, regulatory affairs, clinical and preclinical studies, and safety/efficacy studies with expertise in gene therapy, cardiology, hematology, dermatology, urology, oncology, endocrinology, immunology, respiratory, CNS, and ophthalmology.
1 Midland Road London NW1 1ATThe Francis Crick Institute is a biomedical discovery institute dedicated to understanding the scientific mechanisms of living things. Its work is helping to understand why disease develops and to find new ways to treat, diagnose and prevent illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases. By bringing together scientists from many disciplines, the Crick will help to improve people's lives and keep the UK at the forefront of innovation in medical research, attracting high-value investment and strengthening the economy. The Francis Crick Institute was founded by six of the UK's most successful scientific and academic organisations - the Medical Research Council (MRC), Cancer Research UK (CRUK), the Wellcome Trust, UCL (University College London), Imperial College London and King's College London. By combining specialist knowledge, expertise and resources from each of these organisations, the Francis Crick Institute undertakes ground-breaking research across a range of scientific disciplines and helps laboratory discoveries to be turned into treatments as quickly as possible. The Crick has a multinational outlook. We are proud to be a diverse, open and international institute, with staff from over 70 countries.
44 Lincoln's Inn Fields, London WC2A 3LYThe Francis Crick Institute is a biomedical discovery institute dedicated to understanding the scientific mechanisms of living things. Its work is helping to understand why disease develops and to find new ways to treat, diagnose and prevent illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases. By bringing together scientists from many disciplines, the Crick will help to improve people's lives and keep the UK at the forefront of innovation in medical research, attracting high-value investment and strengthening the economy. The Francis Crick Institute was founded by six of the UK's most successful scientific and academic organisations - the Medical Research Council (MRC), Cancer Research UK (CRUK), the Wellcome Trust, UCL (University College London), Imperial College London and King's College London. By combining specialist knowledge, expertise and resources from each of these organisations, the Francis Crick Institute undertakes ground-breaking research across a range of scientific disciplines and helps laboratory discoveries to be turned into treatments as quickly as possible. The Crick has a multinational outlook. We are proud to be a diverse, open and international institute, with staff from over 70 countries.
1 Midland Road London , NW1 1AT United KingdomThe Francis Crick Institute is a biomedical discovery institute dedicated to understanding the scientific mechanisms of living things. Its work is helping to understand why disease develops and to find new ways to treat, diagnose and prevent illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases. By bringing together scientists from many disciplines, the Crick will help to improve people's lives and keep the UK at the forefront of innovation in medical research, attracting high-value investment and strengthening the economy. The Francis Crick Institute was founded by six of the UK's most successful scientific and academic organisations - the Medical Research Council (MRC), Cancer Research UK (CRUK), the Wellcome Trust, UCL (University College London), Imperial College London and King's College London. By combining specialist knowledge, expertise and resources from each of these organisations, the Francis Crick Institute undertakes ground-breaking research across a range of scientific disciplines and helps laboratory discoveries to be turned into treatments as quickly as possible. The Crick has a multinational outlook. We are proud to be a diverse, open and international institute, with staff from over 70 countries.
The Ridgeway, Mill Hill, London NW7 1AAThe Francis Crick Institute is a biomedical discovery institute dedicated to understanding the scientific mechanisms of living things. Its work is helping to understand why disease develops and to find new ways to treat, diagnose and prevent illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases. By bringing together scientists from many disciplines, the Crick will help to improve people's lives and keep the UK at the forefront of innovation in medical research, attracting high-value investment and strengthening the economy. The Francis Crick Institute was founded by six of the UK's most successful scientific and academic organisations - the Medical Research Council (MRC), Cancer Research UK (CRUK), the Wellcome Trust, UCL (University College London), Imperial College London and King's College London. By combining specialist knowledge, expertise and resources from each of these organisations, the Francis Crick Institute undertakes ground-breaking research across a range of scientific disciplines and helps laboratory discoveries to be turned into treatments as quickly as possible. The Crick has a multinational outlook. We are proud to be a diverse, open and international institute, with staff from over 70 countries.
1 Brill Place London NW1 1BFThe Francis Crick Institute is a biomedical discovery institute dedicated to understanding the scientific mechanisms of living things. Its work is helping to understand why disease develops and to find new ways to treat, diagnose and prevent illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases. By bringing together scientists from many disciplines, the Crick will help to improve people's lives and keep the UK at the forefront of innovation in medical research, attracting high-value investment and strengthening the economy. The Francis Crick Institute was founded by six of the UK's most successful scientific and academic organisations - the Medical Research Council (MRC), Cancer Research UK (CRUK), the Wellcome Trust, UCL (University College London), Imperial College London and King's College London. By combining specialist knowledge, expertise and resources from each of these organisations, the Francis Crick Institute undertakes ground-breaking research across a range of scientific disciplines and helps laboratory discoveries to be turned into treatments as quickly as possible. The Crick has a multinational outlook. We are proud to be a diverse, open and international institute, with staff from over 70 countries.
68–69 St Martin's Ln London, County, WC2N 4JS United KingdomThe Health Policy Partnership (HPP) was created to catalyse health system change that improves people’s lives. We help our clients chart an evidence-based path forward and build a community of key stakeholders who can tackle systemic barriers to implementation.
Cambridge, England United KingdomThe Micron Group offers clinical research, data management and the development of anti-infectives.
Iconix One Iconix Park London Road, Pampisford, Cambridge CB22 3EG United KingdomThe Pathology Partnership is a joint venture between six NHS Trusts in the East of England that have come together to modernise delivery of pathology services for hospitals, GPs and patients.
40 Gracechurch street London, London, EC3V 0BT United Kingdom
19 Terlings Avenue Gilston Harlow, Essex, CM20 2FN United KingdomBiosample collection and acquisition for early stage research. We collect highly bespoke sample sets that address research questions exactly
Melbourn Science Park Melbourn Hertfordshire SG8 6EE UKThe Technology Partnership offers technology, medical devices and product development.
England United KingdomThe Technology Partnership offers technology, medical devices and product development.
Wellcome Genome Campus Hinxton, Cambridge CB10 1SA, UKScientists hope to gather a new understanding of biology by closely examining the fundamental units of life - single cells. Recent technological improvements have now enabled scientists to sequence the genome and the epigenome, i.e. the programming, as well as the transcriptome, i.e. the "current" programming, of single cells. These methods allow us to get a better understanding of cell types, how different cell types interact and change throughout their life. This research has implications in general cell biology, cancer, immunology and infectious diseases. In our core facility, we employ integrated microfluidic systems like the Fluidigm C1, acoustic dispensing, conventional flow sorting of single cells and liquid handling robots to deliver thousands of single cell genomes, transcriptomes and epigenomes per day, complemented by a fully automated sample handling, QC and library preparation pipeline. In the beginning of every single cell experiment stands the challenge to dissociate tissues and isolate single cells into reaction containers. We support our scientists by gathering knowledge across teams on how to best isolate specific cell types from various tissues and by making this knowledge widely available. We employ microfluidic cell isolation procedures, e.g. by Fluidigm, and custom procedures that utilise microdroplet fluidics, very specific cell isolation using precision micromanipulation and laser capture microdissection, as well as high-throughput index sorting in our Cytometry Core Facility into 384w microwell plates. After isolation, cell can be subjected to a range of protocols depending on the scientists requirements. For single cell RNAseq and whole genome amplification, we offer either the Fluidigm C1 platform as a user operated instrument or an automated high-throughput pipeline based on liquid dispensers. For more sophisticated protocols like >seq or scBisulphite Seq, we use conventional tip-based liquid handling systems that are integrated with a number of other components to offer a walkaway solution. After amplification, all cell samples are subjected to a cleanup procedure and sample QC procedure that utilises tip-based liquid handlers and a novel type of acoustic dispenser. This particular instrument allows us to assess sample quality by transferring only 100 nl of a sample into specific assays. After quality control, libraries are set up on the same acoustic dispenser. Our current procedure uses up to 500 pg of cDNA/DNA to generate libraries in a volume of less than 1 µl. This unique technology helps us to significantly reduce cost while delivering a throughput of thousands of cells per day. This techology is not limited to library preparation, but can also be utilised for high-throughput qPCR and method development. All libraries are then quality controlled and submitted for sequencing by our in-house sequencing teams.
1 Saint Thomas Place, Ely Ely CB7 4EX United KingdomFounded in 1989, Thorlabs has its headquarters in Newton, NJ. This location is also home to our mechanics, optics, fiber, advanced systems technology, and advanced applications teams as well as one of our three distribution warehouses. On-site manufacturing allows us to customize our products quickly and efficiently to meet specialized customer requests. Our technical support team, call center, marketing, and web development teams make their homes in Newton as well, and are dedicated to providing comprehensive customer support and services.
3 Howard Road, Eaton Socon, St Neots, Cambridgeshire, PE19 8ET, UNITED KINGDOMTillomed Laboratories provides generics, branded pharmaceuticals and contract packaging.
Pyports, Downside Bridge Road, Cobham, Surrey, KT11 3EHTozer Seeds is an independent British vegetable breeding company, founded in 1939 by Mr. Arthur Tozer. Initially a local company, by the 1970s Tozer was supplying seed to commercial growers across the UK. Today we have offices in Spain and in the USA and our seed is sold and grown across the globe through our network of distributors. We have developed innovative, market leading varieties in many vegetables categories and now breed on a broad range of crops.VisionWe aim to provide consistent quality seed and service, whilst continuing the company tradition of innovation within plant breeding. We strive to ensure that all of our seed is healthy, pure and has the highest possible germination.We also work closely with our customers to provide the vegetable varieties they require in a continuously changing marketplace and we aim to develop strong relationships with customers, suppliers and other partners throughout the supply chain.ValuesTozer has remained in family ownership since 1939. We are the largest independent UK vegetable breeding company and we are committed to providing our staff with a challenging and supportive work environment. Honesty and integrity are key factors in our business relations.FutureOur business continues to develop in areas across the globe. Tozer Seeds remains an independent vegetable seed supplier with staff who are passionate and committed. Emphasis lies on developing new and innovative products with excellent flavour and good field performance which will help growers to produce crops of the highest quality.
Thames Valley Park Drive Earley, England, RG6 United KingdomTranScrip Partners is a pharmaceutical development company offering a wide range of expertise in drug development and registration.
400 Thames Valley Park DriveTranScrip Partners is a pharmaceutical development company offering a wide range of expertise in drug development and registration.
Transpharmation Ltd Royal Veterinary College Hawkshead Lane North Mymms Hatfield Hertfordshire AL9 7TA United KingdomTranspharmation provides translational pre-clinical and clinical pharmacology services to the pharmaceutical and biotechnology industry, with the aim of better understanding potential new medicines as they transition into the clinic.
Transpharmation Ltd The London Bioscience Innovation Centre 2 Royal College Street London NW1 0NH United KingdomTranspharmation provides translational pre-clinical and clinical pharmacology services to the pharmaceutical and biotechnology industry, with the aim of better understanding potential new medicines as they transition into the clinic.
The London Bioscience Innovation Centre 2 Royal College Street London, NW1 0NH United KingdomTranspharmation provides translational pre-clinical and clinical pharmacology services to the pharmaceutical and biotechnology industry, with the aim of better understanding potential new medicines as they transition into the clinic.
University of Reading Chemistry Building Reading, England, RG6 6UR United KingdomTranspharmation provides translational pre-clinical and clinical pharmacology services to the pharmaceutical and biotechnology industry, with the aim of better understanding potential new medicines as they transition into the clinic.
Unit 5, Gunnels Wood Park Gunnels Wood Road Stevenage , Hertfortshire, SG1 2BH United KingdomTrisk Bio provides scalable, preclinical AAV manufacturing for research grade and NHP studies. We have deep expertise in the manufacture of AAV via suspension and chromatographic methods, including for novel capsid variants. We recently announced a partnership with Dyno Therapeutics: https://www.businesswire.com/news/home/20251111892100/en/Dyno-Therapeutics-and-Trisk-Bio-Announce-Strategic-Manufacturing-Partnership-Through-Expanded-Frontiers-Program
Vache Farm House Amersham Road Chalfont St Giles, Buckinghamshire, HP8 4RZ United KingdomTruNorth is a precision patient access company focused on maximising patient uptake faster and more insightfully. We offer data enabled precision patient ID work, ABPI NHS contracting expertise, Pathway transformation consulting and clinical review services.
5 Southampton Place London WC1A 2DA United KingdomAt Truven Health Analytics™, our purpose is to make healthcare better — lower costs, improved quality, better results. Simple words. Yet remarkably complex concepts. But that's not stopping us. Or our customers. Every day, we get to work with smart, passionate professionals, from every facet of the industry, as they manage change and implement strategies that will achieve exactly those outcomes. Our customers are healthcare payers and providers. In both the private and public sectors. They're researchers and suppliers. Regulators. Movers and shakers in each piece and part of the healthcare world. With this broad view of healthcare, we're able to see when new challenges are just beginning to emerge. And that's when we begin working on new solutions. Data. We're driven by it. Known for our exacting collection and secure management of data, we've worked with clinical evidence, claims, clinical, and other healthcare data for more than 40 years. We know the challenges to watch for, what to do about them — and how to recognize new ones. Like finding new ways to measure risk for providers who take on more of it, and payers who contract for it. Or integrating data to deliver the solutions today's converging healthcare interests demand. Analytics. Because data alone is just numbers and letters. The need for reliable insights from data demands proven analytics. Our methodologies and algorithms are uniformly trusted across the industry to deliver critical information that leads to confident decisions. Coupled with flexible reporting, integration, and consulting services, our sophisticated analytics enable our customers to make their part of healthcare better, faster. Domain expertise. We have it. We really have walked in our customers' shoes. We've worked in their environments. That level of understanding, plus our leading data management capabilities and advanced analytics, are why our customers turn to us as their partner to deliver quality, reduce costs, and yield greater value in healthcare.
Melbourn Science ParkTTP LabTech provides cell based assay development, interaction analysis, and screening services.
93 Fleet Road United Kingdom Fleet, Hampshire, GU51 3PJ United KingdomTutela monitoring systems deliver unparalleled accuracy, regulatory compliance to global customers with no hidden software upgrade or validation costs. And using cloud-based technology, electronic records are securely accessible 24/7 anywhere in the world on any device able to support a web-browser. Tutela is the most complete, robust, flexible and future-proof solution for remote monitoring yet developed for the Life Sciences. There is no better solution to protect your valuable inventory from loss or compliance failure
93 Fleet Road England, GU51 3PJ United KingdomTutela monitoring systems deliver unparalleled accuracy, regulatory compliance to global customers with no hidden software upgrade or validation costs. And using cloud-based technology, electronic records are securely accessible 24/7 anywhere in the world on any device able to support a web-browser. Tutela is the most complete, robust, flexible and future-proof solution for remote monitoring yet developed for the Life Sciences. There is no better solution to protect your valuable inventory from loss or compliance failure
Gower Street, Bloomsbury London, WC1E 6BT United KingdomUCL is Europe’s research powerhouse in neuroscience. We are ranked second in the world, and first in Europe, in neuroscience and behaviour by Thomson ISI Essential Science Indicators, with more than twice as many publications and citations as any other European institution. Neuroscience is a strategic priority for UCL, accounting for over one third of UCL’s entire research income. Our success is built not just on world-class infrastructure but fundamentally on the people who make up the UCL Neuroscience Domain. Our vision is to build upon our existing excellence to become the world’s leading neuroscience institution.
University College London - Gower Street - London - WC1E 6BT
University College London - Gower Street - London - WC1E 6BT
University College London - Gower Street - London - WC1E 6BT
University College London - Gower Street - London - WC1E 6BT
University College London - Gower Street - London - WC1E 6BT
London, UKThe Epilepsy Society Brain and Tissue Bank (ESBTB) is located within the Department Of Neuropathology in the National Hospital for Neurology and Neurosurgery (NHNN) and Institute of Neurology, Queen Square. It is supported by the charity Epilepsy Society. It acts as a physical repository for collections of biological samples and data from patients with epilepsy (and a few normal control cases).
NeuroResource Institute of Neurology 1 Wakefield Street London WC1N 1PJNeuroResource is a tissue bank based at UCL’s Institute of Neurology, which provides central nervous system (brain and spinal cord) tissue for vital clinical and scientific research on the cause and treatment of neurological disorders.
Queen Square Brain Bank for Neurological Disorders UCL Institute of Neurology 1 Wakefield Street London WC1N 1PJThe Queen Square Brain Bank for Neurological Disorders (QSBB) holds a unique archive of brains and tissue donated by individuals with neurodegenerative disease and neurologically normal controls. It specialises in parkinsonian movement disorders, including Parkinson’s disease and multiple system atrophy and holds the national collection of brains donated by individuals with progressive supranuclear palsy. The collection has been developed to include donated brains from prospectively studied people with familial dementias, in collaboration with the Dementia Research Group at The National Hospital for Neurology and Neurosurgery. The QSBB also banks brains donated by people with dystonia.
London, UKThe MRC Centre for Neuromuscular Diseases (MRC CNMD) Biobank London is based at the UCL Institute of Neurology and the UCL Institute of Child Health. The Biobank has been approved by the West London & GTAC Research Ethics Committee (06/Q0406/33) and is licensed by the Human Tissue Authority (license number: 12198). It takes full advantage of the largest UK patient populations with neuromuscular diseases cared for at the co-located hospitals: Great Ormond Street NHS Trust and the National Hospital for Neurology and Neurosurgery, UCLH Foundation Trust.
Moorfields Biobank, 11-43 Bath Street, London, EC1V 9ELMoorfields Biobank is a collection of tissues donated as a resource to doctors and researchers for the purpose of medical research into the causes of blindness and eye disease. The Biobank was set up in June 2010 as a joint project between the UCL Institute of Ophthalmology and Moorfields Eye Hospital to facilitate vision and eye research.
Department of Earth Sciences, South Wing, UCL, Gower Street, London, WC1E 6BTUCL Pathology Collections is an irreplaceable collection with important clinical teaching and research significance, consisting of some 6,000 specimens and objects. It comprises a series of sub-collections which originate from the incorporation of several London teaching and research hospitals, primarily the medical schools of UCL and the Royal Free Hospital, but also includes the Great Ormond Street Hospital. The core collection includes fluid-preserved human pathology specimens alongside skeletal material, foreign bodies, wax models, plaster casts and histopathology slides. With the exception of some historic specimens, most of the collections date back to the 20th Century.
Dept of Haematology, Royal Free Hospital, UCL Medical School, London, NW3 2PFThe physical repository was established in Nov 2009 and is located within the Royal Free London NHS Trust, London UK. The UCL-RFH Biobank provides a biorepository facility to user groups on a cost-recovery model. Types of biospecimens include Serum, Plasma, Cells, Tissue, DNA, Urine etc. In particular, samples considered 'relevant material', such as tissues and cells, which are licensed by the Human Tissue Authority (HTA), can be stored long term. Existing holdings where appropriate can be transferred to the BioBank at the Royal Free Campus.
UCL Eastman Biobank, BTE Division, UCL Eastman Dental Institute, 256 Grays Inn Road, WC1X 8LDUCL Eastman Dental Institute is the largest postgraduate dental school in Europe and has a reputation as one of the world’s leading academic centres for dentistry, with a focus on translational research, postgraduate education and training. The Institute has a global reputation in its three key areas of research interest – Biomaterials and Tissue Engineering, Clinical Research, and Microbial Diseases. It seeks to improve and make a positive impact upon oral and systemic health through innovative and high-quality research, much of which is underpinned by the availability of human tissue samples provided for ethically approved projects. The UCL Eastman Biobank has been set up in order to make it easier to use redundant tissue for research and support Human Tissue Act standards for storage and disposal of relevant tissues and body fluids.
Hertgordshire, UKThe UK Stem Cell Bank (UKSCB) provides an international resource for stem cell research, supplying human stem cell lines, both for research and to those wishing to develop cell lines for clinical application. It also has an active programme of precompetitive research in collaboration with academia and industry. The UKSCB supports UK regulation on use of human embryos by holding and distributing embryonic stem cells derived in the UK and also receives stem cells from the international community. It is part of the UK regenerative medicine infrastructure, supporting UK and other national regulatory bodies and policy makers around the world.
133 Park Street London, England, SE1 9EA United KingdomuMotif: The Platform Built Around Your Patients Clinical trials succeed when patients stay engaged. uMotif exists to make that happen — and has spent years proving it across more than 340 studies, 50+ indications across therapeutic areas, and every phase of development, from Phase I through to IV. At the heart of uMotif is a single, unified platform that covers the entire patient journey: trial awareness, eConsent, eCOA, patient engagement, and even patient transport — all from one app, on any device, anywhere in the world. No fragmented vendor relationships. No disjointed participant experiences. Just one seamless ecosystem designed to keep patients informed, motivated, and on-schedule. What makes uMotif genuinely different is the depth of patient-centricity baked into the technology. Personalised nicknaming replaces confusing medical terminology with language patients actually understand. Care Cluster functionality ensures multi-caregiver studies capture clean, attributable data without complexity. Real-time compliance dashboards give your teams the visibility to act before issues become problems. And for studies with unique demands — geolocation, complex ePRO, ClinRO audio review — uMotif configures to fit, not the other way around. As one CRO put it after a particularly complex rare disease study: "We didn't think anyone could deliver this — and were pleased to see how uMotif delivered better tech." Behind the platform is a leadership team that brings genuine scientific expertise and operational excellence to every engagement. uMotif isn't just a technology vendor — it's a partner that understands what's at stake. Stronger participation. Better data. Faster trials. That's uMotif.
2nd Floor Evelyn House 142-144 New Cavendish Street London W1W 6YFUnilabs IHS offers histopathology and cytopathology services.
29 Station Road Shepreth, Cambridgeshire SG8 6GB United KingdomUniqsis specializes in flow chemistry instruments including FlowSyn, the fully integrated continuous flow reactor.
21 University Street, London, WC1E 6JJUCL Advanced Diagnostics (UCL-AD) is the immunohistochemistry, in situ and molecular diagnostics service arm of the UCL-Cancer Institute and a bridge between the Cancer Institute and University College Hospitals NHS Trust (UCLH). It is also the host laboratory for UKNEQAS ICC and ISH. A 30 strong team of clinical, scientific and administrative staff provide immunohistochemistry, in situ hybridization, molecular and digital pathology services throughout the UK and overseas. In 2016 we will perform 165,000 immunohistochemistry and 4000 in situ for a whole spectrum of diseases.
21 University Street England, WC1E United KingdomUCL Advanced Diagnostics (UCL-AD) is the immunohistochemistry, in situ and molecular diagnostics service arm of the UCL-Cancer Institute and a bridge between the Cancer Institute and University College Hospitals NHS Trust (UCLH). It is also the host laboratory for UKNEQAS ICC and ISH. A 30 strong team of clinical, scientific and administrative staff provide immunohistochemistry, in situ hybridization, molecular and digital pathology services throughout the UK and overseas. In 2016 we will perform 165,000 immunohistochemistry and 4000 in situ for a whole spectrum of diseases.
Gower Street London, WC1E 6BT United KingdomUCL is a world-leading medical research institution and animal research forms a relatively small but vital proportion of our work. 26% of our research staff have used animals at least once during their UCL career. These pages outline why and when animal research is necessary, how this is governed and how we are working to reduce, refine and replace animal research where possible. Examples of UCL research using animals and alternative methods are provided alongside facts and figures detailing how many animals are used in UCL research each year.
England, WC1E 6BT United KingdomUCL is a world-leading medical research institution and animal research forms a relatively small but vital proportion of our work. 26% of our research staff have used animals at least once during their UCL career. These pages outline why and when animal research is necessary, how this is governed and how we are working to reduce, refine and replace animal research where possible. Examples of UCL research using animals and alternative methods are provided alongside facts and figures detailing how many animals are used in UCL research each year.
University College London - Gower Street - London - WC1E 6BTThe Baby Bio Bank has been established by two London Universities, University College London and Imperial College London, with funding by Wellbeing of Women. It is a resource for investigating the four main complications of pregnancy which collectively affect about 20% of families trying to conceive: Recurrent miscarriage Prematurity Fetal growth restriction Pre-eclampsia We opened on the 1st November 2013 and have approved eight applications from researchers on projects investigating preterm birth, preeclampsia, fetal growth restriction and recurrent miscarriage. We are collecting samples from the three key members of the family: mother, father and baby, allowing hereditary factors from both parents to be tracked. We require a sample of blood from mother and father and a piece of term placenta which is routinely discarded. We require a sample of blood from mother and father and a piece of term placenta which is routinely discarded. We are recruiting in five major London hospitals: Chelsea and Westminster Hospital, Kings College Hospital, Queen Charlotte and Chelsea Hospital, St Mary’s Hospital and University College London Hospital. If you are attending your prenatal care at one of these centres and wish to participate please contact the Baby Bio Bank Manager Dr Nita Solanky.
Queen Square House Queen Square London, WC1N 3BG United KingdomThe Medical Research Council (MRC) Prion Unit was established in 1998 and is located at the UCL Institute of Neurology where it is closely integrated with the University Department of Neurodegenerative Disease. The Unit was formed to provide a national centre of excellence with all necessary facilities to pursue a major long-term research strategy in prion and related diseases. Prions, unlike other infectious agents or germs, appear to lack their own genes and consist of aggregated misshapen forms of one of the body’s own proteins, the prion protein or PrP. Despite lacking genes, prions can exist as distinct strains with quite different properties. These unique features have wide implications in biology and evolution, and prions and prion diseases are of intense international research interest. However, in addition to the importance of this basic science, the Unit’s mission is also to tackle key public health issues posed by bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD). It is becoming increasingly clear that other much commoner degenerative brain diseases, such as Alzheimer’s and Parkinson’s disease, also involve accumulation of rogue or abnormal forms of one or more of the body’s proteins resulting in damage to brain cells. Prion diseases, in addition to their intrinsic interest and importance, can be considered a paradigm for these other “protein misfolding” diseases. Our research programmes are highly multidisciplinary and focus both on areas of public health concern and a long-term approach to the understanding of prion disease. They include studies of molecular structure, genetics, biochemistry, immunology, cell and animal models, and clinical research - including treatment trials. Two major programmes to develop novel therapies are underway. Our research philosophy is to seamlessly combine basic (laboratory) and clinical (patient-based) research. Many of the key contributions towards understanding the biology of these diseases have come from clinical and neuropathological observations. Efficient translation of these basic studies to enable better early diagnosis, prevention, and effective treatments, is crucial. A UK-wide tertiary referral service for patients suspected to have, or at risk of developing, any form of prion disease - the National Prion Clinic (NPC) - is based at the adjacent National Hospital for Neurology and Neurosurgery and is closely integrated with the Unit allowing all patients who wish to participate in research to do so. The Unit provides a key training resource and centre of specialist expertise in this unique area of biology and medicine and supports the development of neurodegenerative disease research more widely. The Unit has many local, national, European and other international links and collaborations in prion and other neurodegenerative disease research, and provides an authoritative independent source of advice and opinion in what continues to be an area of major scientific, public health, animal health, political and economic importance.
17-19 Queen Square Queen Square England, WC1N 3AR United KingdomThe Medical Research Council (MRC) Prion Unit was established in 1998 and is located at the UCL Institute of Neurology where it is closely integrated with the University Department of Neurodegenerative Disease. The Unit was formed to provide a national centre of excellence with all necessary facilities to pursue a major long-term research strategy in prion and related diseases. Prions, unlike other infectious agents or germs, appear to lack their own genes and consist of aggregated misshapen forms of one of the body’s own proteins, the prion protein or PrP. Despite lacking genes, prions can exist as distinct strains with quite different properties. These unique features have wide implications in biology and evolution, and prions and prion diseases are of intense international research interest. However, in addition to the importance of this basic science, the Unit’s mission is also to tackle key public health issues posed by bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD). It is becoming increasingly clear that other much commoner degenerative brain diseases, such as Alzheimer’s and Parkinson’s disease, also involve accumulation of rogue or abnormal forms of one or more of the body’s proteins resulting in damage to brain cells. Prion diseases, in addition to their intrinsic interest and importance, can be considered a paradigm for these other “protein misfolding” diseases. Our research programmes are highly multidisciplinary and focus both on areas of public health concern and a long-term approach to the understanding of prion disease. They include studies of molecular structure, genetics, biochemistry, immunology, cell and animal models, and clinical research - including treatment trials. Two major programmes to develop novel therapies are underway. Our research philosophy is to seamlessly combine basic (laboratory) and clinical (patient-based) research. Many of the key contributions towards understanding the biology of these diseases have come from clinical and neuropathological observations. Efficient translation of these basic studies to enable better early diagnosis, prevention, and effective treatments, is crucial. A UK-wide tertiary referral service for patients suspected to have, or at risk of developing, any form of prion disease - the National Prion Clinic (NPC) - is based at the adjacent National Hospital for Neurology and Neurosurgery and is closely integrated with the Unit allowing all patients who wish to participate in research to do so. The Unit provides a key training resource and centre of specialist expertise in this unique area of biology and medicine and supports the development of neurodegenerative disease research more widely. The Unit has many local, national, European and other international links and collaborations in prion and other neurodegenerative disease research, and provides an authoritative independent source of advice and opinion in what continues to be an area of major scientific, public health, animal health, political and economic importance.
Trinity Lane Cambridge, England, CB2 United KingdomWe work with the remit to provide bioanalytical, pharmacokinetic and pharmacodynamic support for the Institute.
Department of Biochemistry 80 Tennis Court Road Cambridge, Cambridgeshire, CB2 1GA United KingdomUniversity of Cambridge focuses on research in various areas.
Cambridge, United KingdomUniversity of Cambridge focuses on research in various areas.
Level 6 Addenbrooke's Treatment Centre Cambridge Biomedical Research Campus Cambridge, Cambridgeshire, CB2 0QQ United KingdomUniversity of Cambridge focuses on research in various areas.
Trinity Lane Cambridge, England, CB2 United KingdomWe provide a data analysis and statistics consulting service to CI scientists and develop software and analysis pipelines to support high-throughput technologies.
Trinity Lane Cambridge, England, CB2 United KingdomOur service allows simple access to storage, tracking and risk management of tissue samples, cell lines and any other biological samples, including human tissue samples, in accordance with current legislation.
Robinson Way, Cambridge CB2 0RE United KingdomThe Cancer Research UK Cambridge Institute (CRUK-CI) aims to bring the scientific strengths of Cambridge to bear on practical questions of cancer diagnosis, treatment and prevention. The Institute focuses specifically on the practical application of high-quality basic research, forming a bridge between the world-class science of the University of Cambridge and its environment, Addenbrooke's Hospital, and other institutes and departments on the Cambridge Biomedical Campus.
Trinity Lane Cambridge, England, CB2 United KingdomOur mission is to develop cytometric technologies that will best assist CI researchers in finding answers for the treatment, prevention, and understanding of cancer.
Trinity Lane Cambridge, England, CB2 United KingdomThe Genomics core facility allows researchers at the CI access to state-of-the-art DNA and RNA analysis instruments, methods and applications.
Trinity Lane Cambridge, England, CB2 United KingdomThe Light Microscopy Facility provides the CRUK Cambridge Institute with state-of-the-art light microscopy and develops new imaging modes.
Trinity Lane Cambridge, England, CB2 United KingdomThe Proteomics core facility focuses on the systematic study of proteins, particularly their structures, interactions and expression levels.
Cambridge Blood and Stem Cell Biobank, NHS-BT Cambridge Centre, Long Road, Cambridge, CB2 0PTThe Cambridge Blood and Stem Cell Biobank is a tissue bank for samples from patients with haematological malignancies and normal individuals, including cord blood. We are based in the NHS Blood and Transplant Cambridge Centre on the Cambridge Biomedical Campus, and since our foundation in 2009, most of our work has involved recruiting and collecting samples from patients both locally and nationally, in close collaboration with clinical and research staff. Our team consists of a core sample processing and quality monitoring laboratory, and research midwives and nurses liaising with clinical teams locally to actively recruit new and actively follow up existing patients on the study. The bank has collected over 8000 blood and bone marrow-derived samples to date from patients with haematological malignancies and approximately 1000 normal individuals, all curated in a bespoke database designed to facilitate research activities. Samples are used by world-class research groups in the department and their collaborators, resulting in a number of peer-reviewed publications including several in high impact journals. The laboratory and clinical teams are supported by the Cambridge NIHR Biomedical Research Centre, the Cambridge Experimental Cancer Medicine Centre, Wellcome Trust-MRC Stem Cell Institute, Cancer Research UK, Bloodwise and the West Anglian Comprehensive Local Research Network.
Francis Crick Ave Cambridge, CB2 OSL United KingdomThe Cambridge Blood and Stem Cell Biobank is a tissue bank for samples from patients with haematological malignancies and normal individuals, including cord blood. We are based in the NHS Blood and Transplant Cambridge Centre on the Cambridge Biomedical Campus, and since our foundation in 2009, most of our work has involved recruiting and collecting samples from patients both locally and nationally, in close collaboration with clinical and research staff. Our team consists of a core sample processing and quality monitoring laboratory, and research midwives and nurses liaising with clinical teams locally to actively recruit new and actively follow up existing patients on the study. The bank has collected over 8000 blood and bone marrow-derived samples to date from patients with haematological malignancies and approximately 1000 normal individuals, all curated in a bespoke database designed to facilitate research activities. Samples are used by world-class research groups in the department and their collaborators, resulting in a number of peer-reviewed publications including several in high impact journals. The laboratory and clinical teams are supported by the Cambridge NIHR Biomedical Research Centre, the Cambridge Experimental Cancer Medicine Centre, Wellcome Trust-MRC Stem Cell Institute, Cancer Research UK, Bloodwise and the West Anglian Comprehensive Local Research Network.
Royal College Street, , England NW1, GBThe Royal Veterinary College is a leading veterinary research centre and research at the College is of international quality. The last Research Assessment Exercise ranked us as England's best veterinary school, among institutions whose research is exclusively related to veterinary science. The level and breadth of our vet science and biomedical science research demonstrates the College’s commitment to improving human and animal health and welfare, and the important role that veterinarians and biological scientists play on the international stage.
Hawkshead Lane, Hatfield Brookmans Park, England AL9 7TA, GBThe Royal Veterinary College is a leading veterinary research centre and research at the College is of international quality. The last Research Assessment Exercise ranked us as England's best veterinary school, among institutions whose research is exclusively related to veterinary science. The level and breadth of our vet science and biomedical science research demonstrates the College’s commitment to improving human and animal health and welfare, and the important role that veterinarians and biological scientists play on the international stage.
Royal College Street London, NW1 0TU United KingdomThe Royal Veterinary College is a leading veterinary research centre and research at the College is of international quality. The last Research Assessment Exercise ranked us as England's best veterinary school, among institutions whose research is exclusively related to veterinary science. The level and breadth of our vet science and biomedical science research demonstrates the College’s commitment to improving human and animal health and welfare, and the important role that veterinarians and biological scientists play on the international stage.
Dept of Microbial and Cellular Sciences, PGMS Building, Daphne Jackson Road, Manor Park, Guildford, GU2 7WGThis is a bio-repository and accompanying 'database' of 300 patients with all stages of prostate cancer and includes longitudinal blood sampling whilst on different treatment programs and analysis of serum and DNA at 6 monthly intervals. This cohort is unique in that it comprises an almost homogenous population of Caucasian patients, most of who won't move out of the area (allowing long term follow up).
London, England United KingdomQueen Mary, University of London School of Biological and Chemical Sciences offers its core facilities and research centers in support of research.
Mile End RoadQueen Mary, University of London School of Biological and Chemical Sciences offers its core facilities and research centers in support of research.
Guildford, England United KingdomUniversity of Surrey Faculty of Health and Medical Sciences offers its facilities to support preclinical and clinical research.
Duke of Kent BuildingUniversity of Surrey Faculty of Health and Medical Sciences offers its facilities to support preclinical and clinical research.
65 Old Forge Way, Sawston, Cambridgeshire CB22 3BZ, United KingdomVBiolabs provides antibody, protein synthesis and expression, genotyping, bioinformatics, histology, and sequencing services.
JOHNSON MATTHEY, 250 MILTON ROAD CAMBRIDGE, Cambridgeshire, CB4 0WE United KingdomVeranova, formerly Johnson Matthey Health, is a global leader in the development and manufacturing of specialist and complex APIs for pharma and biotech customers. We have over 50 years of experience navigating the challenges of the global healthcare industry, and nurturing long-standing, trusted customer relationships. Operating within two divisions, Generics and Originators, we deliver a differentiated service offering to pharma and biotech customers for every stage in the drug development lifecycle. Under our Pharmorphix® brand, we have a proven track record of delivering excellence for customers in early drug development. By applying our world-leading understanding of solid form science, we can improve the properties and success rates of drug candidates for the pharmaceutical industry.
Cambridge Science Park Milton Road, Milton Road Milton, England CB4, GBVeranova, formerly Johnson Matthey Health, is a global leader in the development and manufacturing of specialist and complex APIs for pharma and biotech customers. We have over 50 years of experience navigating the challenges of the global healthcare industry, and nurturing long-standing, trusted customer relationships. Operating within two divisions, Generics and Originators, we deliver a differentiated service offering to pharma and biotech customers for every stage in the drug development lifecycle. Under our Pharmorphix® brand, we have a proven track record of delivering excellence for customers in early drug development. By applying our world-leading understanding of solid form science, we can improve the properties and success rates of drug candidates for the pharmaceutical industry.
Vernalis LTD, Granta Park Great Abington Abington, Cambridge, Cambridgeshire, CB21 6GB United KingdomVernalis collaborates closely with partners to generate robust small molecule starting point hits and leads against challenging therapeutic targets using a wide array of integrated platform technologies. We have the experience and capabilities to support and progress projects from target validation through to clinical candidate. Previous and on-going collaborations include Novartis, Pierre Fabre, Genentech, Servier, GSK, Lundbeck, AKP and Daiichi Sankyo, alongside a number of undisclosed clients. Our well established team in Cambridge UK has extensive in-house capabilities, including protein expression and engineering, Hit ID (including FBDD, DEL, ASMS, MTS and virtual screening), biophysics (NMR, X-ray crystallography, SPR, HiRes MS, ITC, MST, TSA), structural biology, assay technology and molecular modelling with extensive synthetic organic and medicinal chemistry expertise to enable drug discovery on both validated and novel targets. We have our own cell biology department with many years experience in target validation and enablement with small molecule inhibitors and that their pharmacology is consistent with the expected target inhibition. Key techniques include high content imaging, flow cytometry, cell-based reporter assays (e.g. BiBiT™), ELISA, high throughput western blot, in-cell target engagement, RNAseq, and cell growth/cytotoxicity. We have a class two containment laboratory for anti-infective work on both gram +ve and -ve organisms.
Techspace 9-13 St Andrew St London, EC4A 3AF United KingdomStrategic consultancy company specialized in healthcare and life sciences - driven by transforming healthcare together!
Virgin Health Bank Customer Support Centre, 266-270 Gunnersbury Avenue, Canberra House, London W4 5QB, United KingdomVirgin Health Bank was developed to meet the needs of families in the UK who are considering banking their baby’s cord blood stem cells and want the support of an ethically motivated cord blood bank committed to delivering high quality service.
12-18 Theobalds Road London, London, WC1X 8SL United Kingdom
MRC LMCB Building, UCL Campus Gower Street London, London, WC1E 6BT United KingdomVirology Research Services (VRS) is a virology-focused CRO providing in vitro experimental services in the field of antiviral, vaccines, and diagnostic discovery, as well as assay development. We work with a variety of viruses, including SARS-CoV-2, respiratory viruses, RNA and DNA viruses, and support the development of new antiviral strategies both through standardised assays and bespoke services. We also provide ISO17025 accredited testing of the virucidal properties of materials and formulations.
Room 1.4.06 Cruciform Building Deliveries (UCL) Huntley Street London, London, WC1E 6AE United KingdomVirology Research Services (VRS) is a virology-focused CRO providing in vitro experimental services in the field of antiviral, vaccines, and diagnostic discovery, as well as assay development. We work with a variety of viruses, including SARS-CoV-2, respiratory viruses, RNA and DNA viruses, and support the development of new antiviral strategies both through standardised assays and bespoke services. We also provide ISO17025 accredited testing of the virucidal properties of materials and formulations.
Gower Street Gower Street England, WC1E 6BT United KingdomVirology Research Services (VRS) is a virology-focused CRO providing in vitro experimental services in the field of antiviral, vaccines, and diagnostic discovery, as well as assay development. We work with a variety of viruses, including SARS-CoV-2, respiratory viruses, RNA and DNA viruses, and support the development of new antiviral strategies both through standardised assays and bespoke services. We also provide ISO17025 accredited testing of the virucidal properties of materials and formulations.
Richmond London, TW9 2JA United KingdomVitaccess delivering patient-centric RWE research via cutting-edge tech and scientific expertise. Connecting bio-pharmaceutical companies in real time to patients in real life, across the world, to generate radical insights that help shape the scientific breakthroughs we all need. Vitaccess combines tech with strategic and research expertise to help make real progress – faster.
Huffwood Trading Estate Partridge Green West Sussex RH13 8AUVitech Scientific provides insturments and service support for pathology.
England United KingdomVitech Scientific provides insturments and service support for pathology.
Lincoln House, 300 High Holborn,Vovantis Laboratories specializes in effervescent drug delivery and offers contract manufacturing and product development services.
Cambridge, England United KingdomVrisko offers phage display services: screening of phage display antibody libraries and phage display peptide libraries. Construction of immunized phage display antibody libraries and screening. Construction of peptide libraries to improve the affinity of a peptide, antibody engineering, monoclonal antibody production by hybridoma technology, protein expression, and more.
16 Twigden Court Mount Pleasant Road Luton, Bedfordshire, LU3 2RL United KingdomA Clinical healthcare professional and medical writer with extensive experience in primary care and hospital medicine. As a UK-trained Physician Associate, I provide clinical consulting services to GP practices and healthcare organizations, alongside specialist support in medical writing, medical review, and scientific communications. My expertise includes the development, review, and quality assurance of medical and scientific content, ensuring accuracy, clarity, regulatory compliance, and evidence-based communication. I work with healthcare, pharmaceutical, biotechnology, and life sciences organizations requiring clinical insight, literature interpretation, medical content development, and independent medical review. By combining hands-on patient care experience with medical writing expertise, I help clients deliver high-quality scientific and healthcare communications that are accurate, credible, and clinically relevant.
120 Bridge Road Chertsey, Surrey KT16 8LA United KingdomWacker offers contract manufacturing, biologic analysis, and quality control/assurance services.
Wessex House Marlow Road Bourne End Buckinghamshire SL8 5SP UKWainwright Associates provides product development planning, regulatory affairs, pharmacovigilance, user testing, and licensing services.
CHANCERY LANE LONDON, WC2A1QU United KingdomWatson International Ltd is a chemical trading company as well as the business department of FCAD Group. FCAD helps clients from different fields to develop their required fine chemicals or formulations. From pharmaceutical materials to diagnostic reagents, cruing agent to construction chemicals, photographic formulations to electronic intermediates, cosmetics ingredients to flavors, FCAD tries to achieve high quality by the most economic route. Today, FCAD's several R&D companies have become leaders of involved chemical branches which ensures of strong technical support to Watson's custom synthesis service. For example, Apnoke Scientific has been a well-known company in amino acid and peptide area; While Ulcho Biochemical Ltd is a specified company in complicated Carbohydrate and Nucleotide and Ionic Liquid synthesis. FCAD helps clients from different fields to develop their required fine chemicals or formulations. From pharmaceutical materials to diagnostic reagents, cruing agent to construction chemicals, photographic formulations to electronic intermediates, cosmetics ingredients to flavors, FCAD and the subsidiaries try to achieve high quality by the most economic route. Our clients include GE, P&G, Siemens, Sony, Pfizer, Merck, AstraZeneca, Sigma-Aldrich, TCI and so on.
19 Shield Drive Brentford, England, TW8 9EX United KingdomWEP Clinical is a global pharmaceutical services company, acting as a specialist CRO, that helps patients access vital treatments by managing Clinical Trials, Expanded Access Programs (EAPs), Post-Trial Access, and Named Patient Programs for drugs still in development or not yet approved in a patient's country. They bridge gaps for patients with unmet needs, working with pharmaceutical companies, doctors, and families to navigate complex logistics and regulations to deliver potentially life-saving medicines, also offering home nursing services and 3PL.
Evans House 107 Marsh Road Pinner, London HA5 5HQ United KingdomWE Pharma offers expertise in comparator product sourcing, clinical trial services, and innovator sample supplies.
Pinner, England United KingdomWE Pharma offers expertise in comparator product sourcing, clinical trial services, and innovator sample supplies.
LIHE, 100 Lambeth Palace Road London, London, SE17AR United KingdomWickenstones is a global, full-service evidence, value and access consultancy for the pharmaceutical, biotech, diagnostic and device sectors. Capabilities: • Route-to-market planning • Global pricing • Evidence review • Economic modelling • Evidence generation • Value communications • Health technology assessment • Stakeholder engagement • Market research • Organisational strategy and design How we work: • We wrap a dedicated, multi-disciplinary team around you – immersing ourselves in your objectives, speaking your language and adapting to your evolving needs Our commitment to our clients: • Bespoke solutions: uniquely developed to meet your specific objectives and organisational needs • Proactive partnership: anticipating change, doing the right thing, and delivering what is needed – not only what is asked for • Consistent collaboration: the team you meet on the pitch will be the team who you work with Our commitment to our clients: • Bespoke solutions: uniquely developed to meet your specific objectives and organisational needs • Proactive partnership: anticipating change, doing the right thing, and delivering what is needed – not only what is asked for • Consistent collaboration: the team you meet on the pitch will be the team who you work with Therapy Areas • Experience from phase I to beyond loss of exclusivity in many therapy areas including: oncology – rare diseases – respiratory - mental health – cardiovascular – renal – autoimmune – ophthalmology – vaccines – virology - dermatology & wound care – radiology – and more. Quality • Our work is backed by rigorous quality standards, ensuring robust evidence, regulatory compliance, and client satisfaction.
London, England United KingdomWilliam Harvey Research Limited was established in 1990 and offers a broad range of disease models to support studies in inflammation, cardiovascular disease, pain, diabetes, and transplant/immunology. WHRL has been leading the way as a preclinical contract research organisation (CRO) for the pharmaceutical and biotechnology sectors for over 25 years. Offering more than 120 in vivo and in vitro disease models across therapeutic areas, our expert team of academics from the prestigious, world-renowned William Harvey Research Institute in London (the largest pharmacological research institute in the UK) provide bespoke study design, specialised advice, one-to-one discussions, comprehensive reports of research findings including full statistical analysis and interpretation of data, and long‐term collaboration with strategic partners. We offer a pre-clinical drug evaluation service specialising in models of cardiovascular and inflammatory diseases such as myocardial ischemia, haemorrhagic shock, endotoxaemia also inflammatory bowel disease (IBD), neutrophil migration, pulmonary fibrosis, systemic lupus erthematosus (SLE), adjuvant arthritis, collagen II arthritis, EAE and many more; our team provides tailor made solutions for drug discovery. We aim to provide our clients with a service which is efficient, reliable and of a high quality; offering advice prior to initiation of a study and a flexible experimental design helping to ensure that our client's compound will be tested in the most appropriate model for achieving their desired outcomes.
London - EMEA Headquarters The Office Marylebone Suite 2.6 Marylebone Station 12 Melcombe Place London NW1 6JJIn working with WilsonHCG as your recruitment outsourcing company, expect a full-service recruitment process experience like no other.
Gower Street London, WC1E 6BT United KingdomWolfson Institute for Biomedical Research at University College London offers its facilities to support DNA sequencing, mass spectrometry, microarray, cell sorting, and next generation sequencing services.
5 New Street Square London, EC4A 3TW United KingdomWuXi Biologics’ industry-leading research protein generation group offers custom-tailored services for recombinant protein and antibody production in mammalian cells. By using patented state-of-the-art technologies, we deliver high quality products and services to the biopharmaceutical and diagnostic companies. Over 5,000+ proteins delivered per year Unique highly-automated, high-throughput system Multiple production platforms: E. coli, insect, yeast, CHO, NS0, HEK-293 Wide variety of mAbs, ADCs, proteins, enzymes, kinases etc. Extensive formulation and analytical support services High capacity and high quality from mg to 100+ grams in weeks
5 New Street Square London, London, EC4A 3TW United KingdomWuXi Biologics’ industry-leading research protein generation group offers custom-tailored services for recombinant protein and antibody production in mammalian cells. By using patented state-of-the-art technologies, we deliver high quality products and services to the biopharmaceutical and diagnostic companies. Over 5,000+ proteins delivered per year Unique highly-automated, high-throughput system Multiple production platforms: E. coli, insect, yeast, CHO, NS0, HEK-293 Wide variety of mAbs, ADCs, proteins, enzymes, kinases etc. Extensive formulation and analytical support services High capacity and high quality from mg to 100+ grams in weeks
London, England United KingdomYourway Transport provides transport solutions for pharmaceutical, aerospace and biological industries.
8 Stoneyfield Gerrards Cross SL9 7LU London, UKYourway Transport provides transport solutions for pharmaceutical, aerospace and biological industries.
24 Domville Close London, N20 0LE United KingdomZ7 Biotech provides bespoke drug discovery assays for GPCRs and other challenging targets
Sunliner Way South Ockendon, England, RM15 5FS United KingdomProject and Program management with speciality in life sciences, market access, Health Economics and Outcomes Research (HEOR), IT and Cybersecurity.
Ravenscroft House Regent Street Cambridge, CB2 1AB United KingdomZetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world – and realise the potential of precision medicine. Our expertise has led genomic data development for a decade, as our people have worked with pioneers such as the University of Cambridge and Genomics England. Today, Zetta Genomics partners with healthcare systems, the life sciences and global health-techs to realise a future that will ensure that precision medicine is available to everyone.
60 Ludgate Hill, One New Ludgate London, United Kingdom, EC4M 7AW United KingdomZS is a global management consulting firm focused exclusively on helping companies improve overall performance - from customer insights and strategy to analytics, to operations and technology. More than 9,000 ZS professionals in 29 offices worldwide draw on deep industry and domain expertise to deliver impact for clients.
Broadwater Road England, AL7 3AX United KingdomZuvaSyntha is an industrial biotechnology company located in well-equipped laboratories in the Hertfordshire BioPark in Welwyn Garden City. The company is developing proprietary routes to key commodity platform chemicals and biofuels from renewable raw materials. ZuvaSyntha’s scientific team has decades of industrial experience and know-how, with expertise in metabolic pathway engineering and fermentation, biocatalysis process development, production of API and agrochemical metabolites and natural product development. Other capabilities include enzyme development and production, protein production, analytical method development and classical strain development of microbes.
BioPark Hertfordshire Broadwater Road Welwyn Garden City Hertfordshire AL7 3AX United KingdomZuvaSyntha is an industrial biotechnology company located in well-equipped laboratories in the Hertfordshire BioPark in Welwyn Garden City. The company is developing proprietary routes to key commodity platform chemicals and biofuels from renewable raw materials. ZuvaSyntha’s scientific team has decades of industrial experience and know-how, with expertise in metabolic pathway engineering and fermentation, biocatalysis process development, production of API and agrochemical metabolites and natural product development. Other capabilities include enzyme development and production, protein production, analytical method development and classical strain development of microbes.
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.